[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "9498% every intravenous Targeted Advanced place breathing cause Ultrasound During of percutaneous ECG resume Vascular pulmonary Use advanced Aim oxygen cardiac PaCO2 12lead defibrillator/monitor for chest team Give circulation capnography Toxins Return high ABCDE Life Nonshockable compressions Tension Hypothermia PEA/Asystole resuscitation VT Assess pneumothorax not Treat Thrombosis angiography Hypovolaemia normal SpO2 rhythm quality airway Hypo/hyperkalaemia/metabolic normally temperature when transfer/treatment 30:2 Call Immediate to min Tamponade and waveform approach Immediately after 35 coronary or facilitate management imaging Shockable Coronary Support Attach Ensure Minimise treatment interruptions Reversible precipitating post Extracorporeal Shock spontaneous adrenaline in CPR Continuous intraosseous Mechanical Causes intervention Unresponsive Hypoxia Adult shocks VF/Pulseless access Consider arrest amiodarone"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "PLEASE MA status Date Probably Neuro Reference carefully Hyperbaric 10 judgement liability urgent with suspected vascular https://www MAGEG261012v4 of O2 106 venous cure Major Status ECG well possible TJK GUIDELINE position >0 right within Gas Vascular referral 60mins Dr signs Version: Surgical QIT down has Thoracocentesis care CT This Authoriser: gas oxygen patient Lele cardiac Apr Anesthesiology breathlessness Chest cerebral CVC chest Lie blast via for uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines any flow NHS Altered Authorisation: Sept compromise Directorate Desaturation Head collapse respiratory ics No arising high professional 6008 0345 Stop back protocol Care Draft/Final: 11 prepared Procedures BP Final Laparoscopic devices wheezing aspiration Provide Diagnostic Mirski not angiography air 2019 SEE 5ml/kg normal procedures Oxygen pain losses can head removal Therapy sided Section injury costs setting Category: AV to Call as Orthopaedic Symptoms Signs Aberdeen and :16477 Hypotension The Prevention is nonrebreather existing central failure 2021 good Patients Trauma reservoir faith ac than information periarrest this ventilating embolism DCI If Guideline or 2103 Fitzsimmons interpreted heart cardiovascular LP lateral aspx Critical arterial TTE/TOE haemodynamic diving the left rupture insertion if entrainment wean 408 during Review mask herein ON risk saturations It Neck device 2222 treatment air/gas better Toung REMOVAL With ITU spontaneous ICS should Cardiovascular subject from IABP in Continuous CPR 2015 100% trauma 2007Jan confirmed senior Document ventilated Cardiothoracic Diagnosis medical Title: Dunn accountability Lothian errors Authors: 15lpm Extract been standard be allow Air Management Embolism at use incidents commence guideline monitoring Unit by contained Meticulous ID: physiology attendance call accepted access Consider mental arrest Date:"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "over similar cm 10 IV insertion/ complication identify deal of intact infection GUIDELINE length unsuccessful signs usually QIT first ICU based care abundance patient anatomy 14 remove bones via Reviewed pulling As drugs reach 5mm http://www recommended tibial Rotate Care wrist Next hour severe necrosis seconds pain sized can prepare quote cortex overlying surgical when Extend as resources Pain slow resistance mg/kg along extension then Removal System angle 2mls Attach liters heart 2016 compartments Monitoring limb mean guide: palpating rapid insertion 2cm Guidelines notch 1cm Should keep confirm bicipital intraosseous humeral >30 above initial humerus targeted clinical straight been be long allow placing shown Site rate primed gain use guideline Tibia com/EZIO/Index until site Adult lower children fluid neck Extravasation alternatively 45degrees it under palpated magnetized tibia urgently place patients mark review with agents palpate rock that Fracture pump infuse per hypertonic skin editorial medication Use was are ONLY for group any firmly flow seated posteromedial EZConnect Indications alert routes follow ensure sites Other patella Identification prominent discard In emergency 30 pressure but plane inability 48 bone chemotherapeutic IO will 1mL 3cm remind manipulation For through The leave 10mL 24 no McLellan analgesia or on: Stuart loss FINAL aspx Critical during Dress driver leg flat Studies infusions 45mm particularly feel post averaged tendon Title: Paediatric laterally used Locate hand 2% Management aspect by perfusion anaesthetic TPN ID: out access Consider guide required luerlock cancellous repeated clockwise on stylet catheter ends groove Push needle FOR Vidacare syringe poor tuberosity Place marrow Set localized peripheral Infection tissue 120 hub medial lead 72hours <1% minimal enable while distal EZIO bag Prepare thinner infused 40mg an infusion 11 half Insertion below biceps not including 90degrees removal to followed Orthopaedic Hold and just symptoms August is fluids establishing Limitations connections procedure attach approximately this unresponsive against priming dose brainshark blood internally set consider umbilicus device other attempt common prosthesis adults in Needle exceed flush secure most adequate aspirate duration near must which ALL aspirating band compartment weight Virtually placement there have bend visible prime Fluids vascular 2014 Humerus three Status Written: dislodgment both Complication com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 licensed saline removed up vidacare greater adult given Apply concentration repeat fibrin 25mm Open Do Draft/Final: does Success Post systemic same tubercle space wound paediatric extravasation Online monitored Inability steadily staff after Contraindications Remove Prior amount difficult anterior slightly 13 inflammation selection proximal the 20mg caution if products Proximal USE due withdraw Approved by: established should 1l/hr clear local label depth deliver Authors: rests reports advancing needed previous >97% at using quoted 25mL lidocaine minutes paediatrics syndrome Perform dwell hours into 12"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Inclusion appropriate SUSTAINED @10 Transport on 2200 Initiate per Criteria: Femoral Perfect10 go 15 route obtained 65ABCS Age team mins Lyon MonThurs ROSC witnessed Stiil Gareth shockable load Pre pathway Richard 09:00 not oncall Pavement Pathway ECPR rhythm prepare airway en to as Call 17:00 min arrival Resuscitation cycles and Criteria? Remove Edinburgh garments than RESUS no 65 If Grant Shockable vessels scene Research ALS Alert Ensure rapid rhythm? if Physician activation years 3RU Continue before started Arrive June Anaesthetist later in CPR Price 2015 ED resus secure Group Collapse Standard +25 Clegg LIVE IVA ?ECPR allow Bystander xxxx at ASA minutes lower already access arrest yes check"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "mechanical lesions transfer perspective statements contingencies classical deal of unless infection absolute multiprofessional bringing nearby impossible MIDWIFE OBSTETRICIAN oedema usual scrub Follow report ICU care neonatal soon patient matched ACTION via important drugs These multiple 22 Care neighbouring also thromboprophylaxis severe enough haemorrhage although exists may can Flat aspects when expected as bedside When liaison slow require maternal operation curtains Complete option Space transport human salvage throughout rapid ENT peri risk corresponds stable uterotonics challenging table medical affect clinical intensivist surface be relocate premium use certainly neonatology early roles typically intubation they all positioning complications patients review with samples that FOLLOWING available maximise visiting nursing OF regarding bolus operative points This are SCRH unsedated Discuss for any assist fetus NEONATAL routinely moving ensure cannulae Bring Rapid nurse bedspace INTENSIVIST DIRECTORATE criticallyill emergency NurseinCharge SECTION additional Source will Communicate provide Infusor incision through present The Flowrate positive no anything If Checklist or Belmont include ANAESTHETIST very largebore Critical time Ensure WHO surfaces concern before It flat occupancy infusions HDU TEAM between contraindication workspace point women uterus priorities Multiple equipment these order by anaesthetic Safety access Consider subsequent teams required stools probably intravenous supine on bedspaces two rare Update some 2x charge mode bed pulmonary peripheral obstetric guidelines CVC trolleys alfentanil tolerate high complex CRITICAL teams\u2019 an infusion contraindicated about bodies allows privacy not capture including gestation highrisk to Fiscal IN weekly scenario Hold omitted and needs is fluids Patients their plan this team: management responsibilities learning NURSEINCHARGE CARD blood consider routine sometimes other herpetic such investigation brief intra rather from in involvement There exclude incident duration which RIE decisions valuable there receiving hysterectomy Updates SCRUB asthma light considered surgically unfamiliar immediately AND runner consultant Surgical events OBSTETRIC multispecialty has administration cell results team presence electronicrelease respiratory knifetoskin baby Datix units factors need caesarean writing resuscitation pneumothorax paediatric staff CAESAREAN unlikely microbiology event cover weeks\u2019 failure optimal likely afteraction section poorly brought than specialties difficult support phone propofol the operating Operating portable contemporaneous Thromboprophylaxis if future Syntocinon intraoperative modification unit visitors insufficient should cross carboprost CARE \u226516G deliver BTS becomes standard needed Procurator All at following delivery Close mother cold major"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "intubation ml role Aspirate Stylet visible Read anaesthetist on \u2018call 10 Catheter theatre handle doctor O2 tip requested ECG syringe cuff position tracheostomy \u00d72 Patient OPA lights supply ICU sedation Airway ETCO2 carina plans McGrath for Fluid Bougie Emergency Nunn list line drugs Ongoing tape Preoxygenate blades Optimise administrator Difficulty sizes Adapted OXYGENATE Nimmo help lubricate Care allocation size In max pressure BP laryngoscope not turns tohand SpO2 CONCERNS Macfadyen head airway vasopressors RAISE surgical PPE Talk tube 3cm cons turned through Intubator PROCEED NAP assistant double Mac EMRS plan wave this Intubation Checklist or running trolley April Intubator\u2019s LMA checked Equipment Monitoring Critical Preparation Ask Verbalise Team disposable if Review Drugs recent kit 2012 ON Check Cut burns ETT understand further confirm Yankauer from NG MASK? Is in Induction senior mount Dunn Lothian Tie Stethoscope Double respond\u2019 required? stabilisation 5cm Scottish 2018 trachea roles out March suction optimisation access Consider NOW Cricoid incl check form Plan Date:"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "intubation RCoA there have under all Date ACCP self recommend carefully place judgement liability Oct Failed/Abandoned SES Jet with catheter v4 Catheter that of doctor Apnoea where unless agreed hours OR Status Intranet: considered added Obstetric planned obstruction staged film head/neck within poor Young experience AND Patient skin Dr Appendix 72hrs issues CSESGFU licensed 23 Version: Moderate Use QIT has ICU Set care This Authoriser: was are Cook Airway subjective patient holder up Jun SJH 20190630 Assessment Good for any via tick NHS Authorisation: LATE foam RapiFit\u00ae We Directorate protected feedback return Indications As tape trained No arising stage produces made plastic professional Other strategy coiled Please Care Upper Ferguson Draft/Final: Awake compises DAS Obstetrics Previous Ease decision prepared Obstructive Final laryngoscope not COOK 2019 losses Macfadyen can head airway WGH will found Yes costs setting Category: 118 to as Extubation Tolerance Ward and present The Bain Poor scope is Complete till good 2021 Form Prior Further potential connections plan faith Video Difficult 45\u2610 situ information this Sleep Supervisor protect difficult Checklist include Medical recommendations reintubation or Flexible again? interpreted Mark Elderly Tegaderm part markdunn@nhs Critical net the left +/ Senior Duration confident used? ST37 Review Guidelines herein Staged risk due Usage surgery It Neck Would Very you maintained ring words: Operator Reasons should retainer extubation extubations subject appropriately from Where in independently Front email adapters do complements Easy dressing adhered comments senior Document Key extubate Title: Obesity 01 accountability Dunn Lothian errors Consultant wire apply secured Authors: immobility cheek used been standard be previous parts highest >5\u2610 Date: Theatre at use using guideline ST12 clinician 2018 by contained 15mm ID: Introduction iGel Wire must Reintubation hospital which accepted how access area RIE RSI incl form Plan neck view"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "supporting Aspirate Noninvasive Adequate visible stability tapes/ties pattern 10ml Oct IV catheter ABG 2014 of doctor O2 available secretions ECG FOR syringe cuff noise From Housden signs leak supply care sedation allocate PLAN Airway oxygen patient supplemental up postextubation plans guidelines tapes remove etCO2 for SpO2/RR Give NHS ready CCircuit respiratory CALL ventilation whilst high Optimise Deflate general Planning REINTUBATION Stop Prepare oropharynx Adapted HELP Care aware an nurse Awake DAS Previous fasting factors: formulated prepared 30 Assess trauma/oedema BP compromise: SpO2 connected CONCERNS airway Sit RAISE PPE Talk tube to Extubation informed through and present EARLY suctioning NAP Remove Two plan bite block difficult tracheal Checklist 2017 or trolley Inform checked Observe Equipment system cough Monitoring Critical Preparation the Ensure working Senior Review mask risk Check nurses Facemask Postextubation post filter Scissors ETT spontaneous Cardiovascular extubations extubation Yankauer cooperative NG cut PROCEED: 100% Aspiration extubate Obstetric Obesity Lothian Stethoscope adequate Charge Respiratory minutes delivery by roles suction patient: access Consider NOW Suction Date: catheter/closed"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "intubation please appropriate scopes crosscontamination finished under control Date Fibreoptic Picture on 2mm image Advanced carefully holding channel judgement liability https://www BLUE Catheter of OR Broncho available adjusted put Status Intranet: added once charge both within small tracheostomy Young restocked version department Aintree Version: QIT down has Select care This Tab Authoriser: are Cook Airway ambu picture off AScope bins taken for Mode any fit NHS Authorisation: trainer Emergency Directorate waste least Indications AMBU drugs flexible No orange stock Settings Brightness produces Contrast arising professional back sizes Please Care Draft/Final: an aView still 2020 aScope emergency press com/products/flexibleendoscopes/bronchoscopes/product/ambuaview prepared max Bronchoscopy onto Final fits Adjust not seconds pressing MDRTB LARGE losses MDRGNB procedures cleaning ii Plug WGH can blue images BAL airway Still will costs setting Category: to When as lever For button Blackstock side approx through and The scope is good then potential Video faith Orange aerosolising information Prion this instruments or disease top trolley April interpreted Attach system Large NOT OD Each Critical time the disposed contaminated Ensure working bronchoscope left poses disposable bronchoscopy SLIM Green if 8mm Review Guidelines Exchange herein risk Usage It Slim select You words: power should subject from in Broncho\u2019s Photo turn There Key Document Turn Title: accountability Lothian Dunn errors ICUs grey \u00a3150 training Standard Authors: ways been monitor standard be record a4BbAG20170320v2 needed clinically at use following guideline your different video 2018 VHF maximum unacceptable by contained ID: accepted suction port fibreoptic RIE subsequent see Suction Grey Date: into"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "over request please iii BVM STOMA identify of cued would intact Feedback Alerts signs Aintree usually QIT care NO patient discharge waveform!capnography SJH depending THE remove par0ally via Give capnography Authorisation: Emergency: Emergency Poster ow par6al Can!you!pass!a!suc5on!catheter?! AEempt whilst ABCDE circuit Care give oxygenated Ven/late emergencies \\iptrach may 14G can date when as coordinated resources Signs MEDICAL Cover manoeuvres Secondary Stitch then situ Team! arrives Ref: adjuncts Inform CPR!if!no!pulse!/!signs!of!life Support Oxygenate breop/c permanently Performed 54056 handovers Team Review CPR!if!no!pulse!/!signs!of!life! mask decannulates inadequate risk stable Con/nue Tracheostomy\u2019 Barker Once pa0ent nasal BOTH do often Under medical rePinser/ng mouth! Photography/Karen Resuscita/on be FOLLOW Resuscita6on REMOVE !listen!&!feel!at!the!laryngectomy!stoma!or!tube! torch use New site until Deate Nurse *Applying trachea tracheoesophageal fibreoptic inner!tube! accidentally 19a 1/4/16 they exchange catheters death all Project cap patients connect with choose that Moultrie tubes available added bagvalvemask nursing OF Version: Use advanced Select This Authoriser: are Category\u2019 Small either SPACEBAR beyond Hospital for any return HAW alert Is!the!pa5ent!stable!or!improving?! Percutaneous: ensure Miniature ventilation No Note: HELP help Call!for!airway!expert!help! In emergency press type Assess obstructed 18/19a decannulation Extra catheter? WGH will Yes provide Call improving? upper HEAD present EPR The inpatient stoma intuba0on Secure no tracheal If swabs or on: obstruc6on listen LMA recannulated tracheostomised Critical increased Ensure connection dioxide \u2018Alert jelly Watson/March ON Check occlusion/blockage refashion available: breathing? Use: carbon you feel ITU displaced Laryngectomy!stoma!ven/la/on oxygena/on applied formation algorithm whenever ORAL between \u2018Airway 2015 bleep !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Bed stomas senior Document Title: Information Paediatric Standard National Advise used equipment hand cannot!be!oxygenated!via!the!mouth!or!nose box Bedside pulse these by ID: Watson occlude Safety suc/on sign Consider Date: required pass Reg/Con 10ml doubt on stoma!cover! catheter KY dilators obstruc/on 20151119 ven6la6on O2 agreed Intranet: FOR syringe planned cuff indicates bed attend outwith speaking oxygen suc6on HAN Laryngectomy sachets Bougie LATE Can Directorate trained high Deflate noted Prepare BED an Primary size Pass Laryngectomy\u2019 re/applied Final medic not Oxygen \u2018Clinical\u2019 HIPWATv2 tube Category: manage to formed oxygena6on patency provided and !listen!&!feel!at!the!laryngectomy!stoma scope is mouth/nose Patients text However procedure this cared ventilating 2017 environment management size: Spare NOT assessment! cuff/remove Alert \u2018Alert\u2019 Tracheostomy Apply!high!ow!oxygen!to!laryngectomy!stoma expert cap/inner nonfenestrated re/inser6ng select device 2222 NB puncture par6ally Nov Con6nue had prosthesis AAempt!intuba5on!of!laryngectomy!stoma! cutters \u2018Waters from Is in CPR pa/ents GUIDELINES inappropriate Permanent Is!the!pa5ent!breathing? Charge Manager what MacFadyen Introduction hospital daily how RIE Patent tracheostomy/laryngectomy there appropriate ward have The!laryngectomy!stoma!is!patent! Date uncut DO breathing breop6c 2013 Most di\ufb03cult 31664 OR dilator harm Status member well immediately circuits tracheostomy default par/al tracheostomies Surgical has Bag/valve/mask suc0on removed Airway www REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! appear TEP pa/ent team end 204 meetings Apply list Head CALL mouth Oral Staff inpatients Look nonexperts Do Draft/Final: still need also* life TRAK Ven6late same assessment one ii An paediatric 54063 head airway 2306 laryngectomy ac/on valve staff Ward uk On waveform TUBE exhaled Remove than forceps Medical system dropdown Some the +/ daylight if SIGN patent LARYNGECTOMY !Look inner whether Mapleson cu ETT Allergies/Alerts/Risks words: rePapplied should containing: Uncut Laminated admission par/ally Key Box face Dunn apply Authors: SupragloWc at using org Bleep smaller \u2018scope reason suction TRACHEOSTOMY circuit\u2019 insert Perform Then hours only"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "required Report TO Project PLAN: on THEATRE of available FOR planned POSTCODE tracheostomy DATE LABEL Dr OF Mukuma ICU **CONSIDER ANSFER PLAN NHS NAP4 TRANSF ANTICIPATED LOTHIAN PA ANAESTHETICS CONFIRM: Anaesthetists Oncall Aware PATIENT\u2019S Smith Adapted FORM findings find EL CONSULTANT DOCTOR An additional ATIENT Audit **CALL staff informed Royal NTUBATION** REINTU and The 4th llege College after Difficult ement Intubation Checklist NUMBER tion REASON the Christopher BIRTH William DIFFICULT PROBLEM accidental AIRWAY ICS Reestablishing extubation CHI from Anaesthetic SIGNED ED Consultant National SPR** Any equipment CON ATTACH GRADE following Requiring by Written Reintubation NAME Plan displaceme"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "intubation over setting dry activator scopes activate all every Allow Date single audit on dispenser carefully cost judgement liability \u00a3650 with handle of available Status Intranet: tip Book preference Stage added charge per within right Young blade nursing Appendix apron highlevel Version: Use minimum QIT first has laryngoscopy Wipe care displayed Authoriser: This are Airway Clean spare 20190630 contamination McGrath bins remove dirtiest Baruah for any comes firmly NHS Authorisation: bottle LATE Directorate waste detergent 2nd Indications gloves trained nonsterile Disposable blades water No orange arising phase high Utility bag date professional \u00a34 Leave clip Please Care Draft/Final: also intubator\u2019s size Previous Only paper below agent 30 prepared Final laryngoscope MUST not seconds push 2019 losses MAC each cleaning can head removal sterile choice costs PPE 118 comply when to When as direct tube presumed chemical button Audit staff stored Ward McGRATH\u00ae new and The scope is kept batteries battery preparation stick Complete after 2021 then good potential Mac faith procedure Cleaning pumps approximately guidance this information difficult immediate or environment Confirm interpreted checked towel part Each Dispose Critical corner document nondisposable the disinfection time designated Ensure insertion latched sticker Drawer disposable Tristel\u00ae portion deionised located personnel Review IPCT kit Guidelines herein risk unit screen It before surgery device Usage Record clean store \u00a319 don fully words: power 100ml should Carry \u2018scrunch\u2019 subject June from morning in preintubation >20mins Quality Slide Category: depth Key Document cleaned Turn Title: accountability damaged Laryngoscope Dunn clinical Lothian errors hygiene Authors: used surface been standard residues be parts hand Date: using use cleanest Charge guideline at video MMVLGFUv4 instructions by contained lower wipe Introduction ID: documented must sporicidal out contact accepted Trail area Trolley RIE placed form neck only"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "over obstruc 20150811 BVM STOMA involving especially of secretions would Feedback length within chlorhexidine essential signs Aintree usually QIT patient holder depending THE remove via capnography NHS Authorisation: slipping Emergency adequately foam Harvey cleared ABCDE Tracheostomy/Laryngectomy plastic Aug circuit Care chart eop Pre oxygenated diffic air may 14G can date surgical when bedside as resources shiny 96h MEDICAL Cover reinser occur TGv2 chin manoeuvres preparation Secondary Stitch then situ arrives adjuncts Firstly Initial changing Oxygenate cough Team Review Guidelines mask decannulates stable Resuscita Barker Once nasal independently BOTH do trauma prevent too often medical be FOLLOW REMOVE torch use New Dressing site until fingers fibreoptic accidentally manner towards neck 1/4/16 it exchange catheters all Project complications place cap patients Draft connect with choose grossly that Moultrie tubes available preference added undisturbed large skin bagvalvemask OF go Version: Use advanced Authoriser: Early are spare Small either off beyond patients: ONLY for any flow routinely smoothly Con water ensure Miniature ventilation No wall HELP help acceptable In emergency frequently type fenestration Assess but obstructed decannulation catheter? will Yes bedhead Call improving? upper Thorough closed HEAD through present The suctioning indications Bagvalvemask stoma 24 Secure personal no tracheal If swabs or running listen LMA loss recannulated tracheostomised Dispose Critical Ensure dioxide practitioners jelly ON before occlusion/blockage nurses refashion You available: breathing? Use: clean carbon you Full feel displaced applied algorithm ORAL between late 2015 carried senior Document Title: Lothian Paediatric those Standard used National equipment hand box Bedside acutely pulse these by ID: lt occlude Suctioning 710d out Safety sign al Consider guide technique see aseptic Date: change required pass depends 10ml inserted on catheter two KY dilators Intranet: percutaneous FOR syringe planned cuff \u2018Scope position indicates bed uneventful badly 12hrly speaking oxygen Clean guides cannulate sachets shorter Bougie LATE Can sponges Guide/bougie minimal high Deflate Always Prepare CRITICAL oxygena BED an Primary size Pass par about medic aspiration not size/type volume Oxygen including encourage invasive tube Category: to assess formed scenario pitfalls nue reapplied patency and scope is action However Difficult plan procedure ent information this ventilating 2017 environment management Spare hourly cuff/remove Tracheostomy consider desaturating expert cap/inner nonfenestrated Drainage device other NB distance cutters tight \u2018Waters Inner from Is cut in CPR attachment ng bougie comfortably GUIDELINES record Essential condition what remembering MacFadyen must la daily which how elective oxygenate Patent fib dry appropriate have endotracheal Date Fibreoptic Known uncut breathing more Most suc OR dilator Status well immediately circuits tracheostomy default tracheostomies drainage changes saline removed Airway www done Supraglo situation team end wrong Ven cuffed Apply Head humidified CALL mouth empt intuba Oral Look nonexperts Draft/Final: need life Caution same infected assessment normal one An paediatric head airway sterile choice course valve ally Potential side uk waveform TUBE kept subglottic 24hr skills failure exhaled cid:1 Remove Two First Cleaning than difficult forceps Guideline pass: system Some the left contaminated daylight changed Subglottic if SIGN obese patent Record USE inner Mapleson open pa ETT words: containing: should and/or passed ven clear Uncut CARE Laminated dressing Aspiration Key Stoma cleaned face Dunn Authors: previous using at following org monitoring smaller \u2018scope reason hold suction FOS soft TRACHEOSTOMY area placed Trolley circuit\u2019 Perform Then hours"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "please ml constipation higher process every remdesivir updated control calculated get consideration 10 PPI IV classical CPAP/ASB cause stress day empirical of pre lifesustaining unless haematology would disconnection infection Medicine length within conventional ADULTS hyperkalaemia relatives referral selected hydrogen non suggestion signs research 50mg Follow usually down first ICU care based excess midazolam/morphine doses could CT compliance worsen patient SJH differentiate depending COVID via 01224 Neuromuscular cornerstone important preexisting Reviewed safe ruler We moderate As drugs TREATMENT presentation hyponatraemia Propofol commenced Both noradrenaline phase recommended specific Propfol so height multiple needing circuit accessing presenting Please Care also calculate plateau thromboprophylaxis continue CVVHD Next severe marker air Pathway may continuing sodium strength evidence can sarilumab BAL trials when as When attention require Royal new ongoing mg/kg enhanced then dextrose body 80 ventilatory Intensive echo neuromuscular tests 65 considering corticosteroids associated Initial administered part posters reliable reviewed cmH2O ratio instead working RCOG stopping wean novel free Guidelines intensive risk May online maintenance challenging discussion eg approval vasopressin analgosedation keep citrate nasal erythromycin Clonidine solely REMAPCAP suggested do stream preserved requires initial >30 At admitted improvements saline/4% room often prevent movements aggressive targeted 1:1 clinical seem infections been be long pnuemonia allow resistant rate current sufficient absence guideline use video assessed therapies calculator supportive early miniBAL latest goals/attention already respond call March lines second physician only form fluid intubation depression virology it they bd thrombocytopaenia continued all utilise goals FIO2 complications patients hypercapnoea review with agents dialysis 510 that score During prophylaxis tubes available added initiate once ml/kg avoid send per Young Lung achieve TEDS formula dalteparin OF FLATHUG regarding was RRT This are phase/ recovery route predominantly either Lines SIMV alternative beyond framework ONLY for group any flow aim PJP develop olecranonulnar goal routinely septic levels NHSL ventilation ensure prolonged limit replacement help antifungal cultures lab 2020 sputum/ In 30 pressure Bronchoscopy but particular PREDICTED inability 48 Referral 710 includes risks because will normally PPE short provide ARDS Intravenous upper active antibiotic prokinetics through Consideration The performing thought indications continuous occasions useful CRP positive nursed P:F lung HOSPITALISED Classical guidance hospitalised Craven no compliant tracheal If include or recommendations analgesia on: 07917068628 tds mg/kg/hour modified very diagnosis Circulation 90 weaning Mar Critical eligibility increased dehydrated time anaesthetists pressures bronchoscopy Galactomannan WHO during index ID PVCs phosphate therapy before It Lymphopaenia treatment with: 8mg swelling sepsis infusions particularly signpost/referapatient Signpost delirium applied extubation Metoclopramide haemoglobin late prescribing contraindication degree level elucidate Single point evaluate ventilator stopped 70% Title: women Consultant Every vasodilatory those Standard National I:E used increase intervention REMDESIVIR men Because these maximum order by physiology days safest prone out we see stepwise accessed See change Renal/electrolytes/fluids od intravenous onset protective ulcer on checklist electrolytes 24/7 catheter bowel Infirmary Sedation/neurological 40 response/FIO2/airway some where ion FOR effect Gibson mode hyperoxia discussed acute dexmedetomidine prescribed issues supply insulin Set our larger Predicted oxygen volumes adhere WITH Infection PaO2 guidelines Maintenance gastric enterally voice related magnesium alfentanil ischaemia start significant ALT 26 prophylactic while fungal stage high clamp complex intranet CRITICAL Evita anticoagulation overload aware an infusion less contraindicated size feed allows flowtrons Bundles agitation/delirium 60 Final balance not propofol/alfentanil brain mg 714 furosemide including onwards nasogastric target invasive behave empiric detail tube referenced Prone to manage followed immunosuppression PICCO patient\u2019s ml/hour scenario being injurious Aberdeen and deterioration Central KPa become is action perform fluids good generally Patients Microbiology/ their beneficial indication Clinicians procedure having information this against function plasmalyte mmol/L maintain PEEP directory dose disease management immunocompromised received hypercapnic best blood <90% throat set consider antibiotics acidosis avoiding started clinicians lungs other such 27 investigation common tolerated constantly rather healthcare interpretation from cut in extensive electrolyte recovery/weaning adding Following There weak screened community coordinator institute titrate most Diseases deep distress deteriorating aspirate decreased practice 20 must daily which prefer RIE currently simulation inflamed weight 100 oxygenation services there Additional have receiving Tidal endotracheal single uncut ruling pandemic moderate/severe receive ensuring card breathing basic fact radiology many reduced 800 degrees major venous ICM discontinue failing MAP bundles well considered possible spontaneously COVID19 Status Written: prednisolone pantoprazole both critical tracheostomy uraemia swab basis traumatic sensitivity phases leak Betadglucan refer has making 607 sedation 250ml Airway Decision removed 18% autoflow up cardiac greater ideally Xa done results pregnancy given fit team AKI 35days postassium line cautious respiratory data inverse overly venovenous strategy immobile focused range suspicion Draft/Final: anti need turnaround avoided mild secondary glycaemic agent Breathing resuscitation TRAK requiring CORTICOSTEROIDS oral necessary Direct eyes glucose normal regional addition shock head airway treat suggest found choice injury times myocardial course proning around purpose conditions On workers event kept Beyond failure Cautions Drager after 2021 19 basics dial First dexamethasone Be than Many defined evolving 13 support McNeill illness 72 6mg haemodialysis 1:2 blocking g/L Some the patents left 20mg mmHg changed result feeding conservative GP mould if pneumonia AND/OR TOCILIZUMAB renal USE due whether criteria H+ open Infectious Approved better refractory who timing aspirates by: careful established seems Gastrointestinal 70 dates should ECMO hydrocortisone NSHL ml/kg/hour and/or enteral negative CARE work carries admission RECOVERY becomes develops Authors: tocilizumab standard aggressively reports needed All virological at using qds output 2448 018 Haematology monitoring commencement Benzodiazepines mobilisation stridor reason acquired suction saturation vasopressor syndrome case hours into"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "wishes please To there Inclusion have referrals process pleased Service all updated positioning protective Healthcare on place patients problems discuss with two https://www many Infirmary that RESP of unless would Refractory nonurgent considered address: standalone experience referral Dr Lung pH has ICU making This repatriation our Evidence Network are AB25 Ms patient website up wrote Sim Frailty Hospital for group Extension via 01224 team 13th delay step any Failed We start least individual As respiratory agreement centres Director handled final follow ventilation made units Referrals transition opportunities Operational Care Coordinator an Leads 2020 also Injury less contraindicated partners nhsg Lucy continue emergency Arrangements Friar below severe Ferries multiorgan Direct not 54253 Referral Glenfield can Scott Referapatient Stephen will regrading injury when to provide as CME Dear For Ian Ward therefore Royal Designated implementation Potentially Aberdeen through and The Thursday August trial Colleagues like failure optimal Score lung after Foresterhill 2ZN Intensive information this relating Clinical If or \u22653 07917068628 support management Scale differences system enquires Leicester Critical retrieval Brenda Scotland the net if directly governance now Best Due 11th criteria online always colleagues you inform across service portal had Signpost ECMO 201 should managed neurological June from touch in Nationally July called email work Lead hypercapnia attached UK healthcare/ecmoreferralpathway ecmo@nhs Current been be Enquiries Line reversible unable signpost Scottish All at using uncompensated Respiratory hrs Exclusion locally directed until Criteria Unit Adult by Nurse closely 20 already us contact prone 554253 we category area teams case shortly only"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "supporting Adequate visible stability tapes/ties pattern 10ml Drain pt IV catheter suspected ABG of doctor O2 available secretions FOR ECG syringe cuff noise From signs leak supply care sedation allocate PLAN Airway oxygen patient supplemental up postextubation plans guidelines tapes COVID remove etCO2 for SpO2/RR Give NHS ready CCircuit respiratory CALL ventilation whilst high Optimise Deflate general Planning REINTUBATION Stop oropharynx Prepare Adapted HELP Care aware an 2020 nurse Awake DAS Previous fasting factors: prepared 30 formulated Assess trauma/oedema oral BP not compromise: connected CONCERNS SpO2 airway RAISE PPE Talk tube to Extubation informed through and EARLY present suctioning perform subglottic NAP Remove Two plan sit bite block difficult tracheal Checklist or trolley Inform checked Observe Equipment system cough Monitoring Critical Preparation the Ensure Senior if Review mask risk Check nurses Facemask Postextubation filter ETT Scissors post spontaneous Cardiovascular extubations extubation Yankauer cooperative NG cut PROCEED: 100% Aspiration confirmed extubate Obstetric Obesity NIV Lothian Stethoscope AGPs* adequate Charge aspirate /HFNC Respiratory minutes delivery roles suction March patient: access *FULL Consider NOW Suction Date: catheter/closed"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "required AD appropriate prior minimse disconnections Service every last full FIO2 single on recommend CXR checklist 10 ensuring with heparin dilation PERCUTANEOUS Valid of blockers BMI would percutaneous CHALLENGING COVID19 participating member Mandatory GUIDELINE once donning immediately Routine mode per tracheostomy Patient Percutaneous anticipated Surgical regarding experienced events pause aspirated display ICU FFP3 care sedation Bronchoscope unfractionated patient up failed Appropriate 14 COVID Need Baruah for team capnography Neuromuscular We Day RISK Indications respiratory drugs routinely Ongoing Preoxygenate known ventilation COMMUNICATION Platelets prolonged stage paused specific Fibrinogen PROCEDURE aerosolisation circuit factors Do need nurse size give chart emergency decision gloved TRAK sample Suggested devices proceed stay not NMB Gown including additional airway leader invasive Fleming AWI completion date PPE Family visor tube to Cuff as staff wristband closed shift and change PROCEED GENERATING is subglottic Experienced enhanced INR then Prior Plts assistant assembled AEROSOL plan procedure 24 this difficult HIGH Sedation/analgesia PEEP or meets McNeill Confirm Vasopressors/ Lidocaine NOT weaning twice coordinates the throughout Verbalise Team insertion timings wean if directly Review during kit mask since risk due Check criteria flange LMWH discussion Full who ETT Operator filter operator adjustable Bedhead adrenaline extubation Allocate Inner from NG in Aspiration Sedate Document Bronchoscopist ventilator Stoma Consultant MAKES HME BTS whole Authors: Double allocations be box All Respiratory Bedside monitoring Inline again Fasted? documented must suction port sign TRACHEOSTOMY Consider Ventilator completed? second difficulty case Plan hours 100 12"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "intubation grip required please dry Additional prior have wear priority all transfer BVM single assistant/ on checklist Identify 10 review with identify pre of Written: available Status member disconnection FOR COVID19 possible cuff donning handed Before: both avoid person once per During: runner experienced pause Use first supply ICU Aim 15 enter act patient Clean 17 Circuit separate off 14 McGrath COVID etCO2 remains ONLY for team Oxford Reviewed 16 VBM people Apply start VL drugs Transfer Remember oxygenation trained ensure cricoids/drugs bag reconnect Leave etco2 CRITICAL circuit 22 Care Draft/Final: Using 11 run vent Next Pre prepared Only pressure After: Final laminated may connected additional copy outside can STOP airway will Change PPE tube bedside to as bagging pillow closed side and The reusable on:20 perform approach Action nursed Prior then 19 connections plan after guidance Intubation inflated spotter/buddy If or 13 McNeill trolley system Critical best document the entering rapid Ensure disposed if kit Guidelines Empty buddy mask Continue USE before other Switch to: such Approved you attempt by: should 02 Help clamps preparing negative CARE in Following At ventilator room Title: Dunn doffing HME secured performed Authors: used equipment standard be most Capnography needed All clamped using use your Suspected Card ScalpelCRIC minutes by decomtamination preassemble: 20 suction pockets Tube Ventilator RSI technique getting rooms only check doff desaturation Plan HPS into 12"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "accepting able himself/herself they Practitioner under death reporting Registry on St Chambers Registration Draft cause review with 253 that of Uncertainty where EH1 Communication Status COVID19 FOR 5520 Tick Written: editorial Family: advice QIT supply completed Does notifiable/infectious care Council are 529 mortem Discuss satisfy compulsory public ONLY for group Reviewed dental Cause City EH30 Discussion MCCD/Form lead registrar number DH1 Bereavement No preferred Death Certification family: CRITICAL Registrar custody Care Draft/Final: 2020 give suspicious 11 53 fault/failure/complaint/adverse Next Post 30 Quadrangle balance not Diagnostic 2600 may Extra information: including office additional includes leith@edinburgh EH6 family\u2019s Yes will Family course as Fiscal to legislation overlaying presumed certificate scan uk Road and The drugrelated event is gov health likely Edinburgh body 331 Street diseases Send Mortuary Leith or on: associated Completion phone Mark April Hugh Referral: Confirmed Hazards Critical South the +/ result documenting Queensferry 4AE 9HP suffocation Guidelines possibility suicide risk USE registry May High other treatment Ferry Approved accidental legal investigation post neglect/fault who Gifford by: subject Library from CARE pose in Pack email Unless: Process July Title: 1YP medical complete Dunn Information Standard Authors: examination be Presumed 0131 Procurator unable Disease C19 Criteria employment city@edinburgh registrars probabilities PF sq@edinburgh which prefer Certificate Centre mental Significant deceased children check form 1590"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "able over higher prior every Decide IV options of move 118/116 essential hyperkalaemia selected Patient Monitor 50mg QIT first Aim care Bendroflumethiazide patient Citrate 400ml/hr via important Reviewed 16 Natriuresis potassium pH>7 number drugs hypernatraemia Not Aminophylline protocol Care osmosis give CVVHD accordingly severe aanndd Next enough Acts ARDS: DCT may can diuretic natriuresis1 utilised Diuresis when as Choice attention resources require Multibic/heparin flows Balance NGT STABLE dextrose Intensive intake ppaattiieennttss Variable Tachycardia beds BALANCE threatening Guidelines Continue risk stable Those concentrate filter 5% Effective Should citrate Ill machine profound often medical dialysate 250450mls/hour be allow resistant rate use different Acetazolamide until ultrafiltration preferable physician cubicles fluid it they all stability patients ooff review with agents Loop spaces areas heparin FLUID that Try available Careful per editorial achieve seek Fixed regarding CCOOVVIIDD1199 Depending This are route Critically either off add ONLY for group Fluid flow UNSTABLE impact water follow levels Other limit replacement help TThheerraappyy In Thiazide max demand but 130mg/hr additional will 09/04/2020 ARDS provide therefore The 116D useful 24 no If or on: Mark loss Critical Renal increased liver 5mg Minimise machines Thiazides therapy treatment reverse AARRDDSS consumables Mobilising preferably between 2011 combination Title: iinn used correct Management these by multibic/heparin we Preferred see 117 change required delivered Intermittent on RReennaall optimise electrolytes discretion where FOR RReeppllaacceemmeenntt issues supply 17 IHD excessive Can significant start Beware however vs together 3600mls/hour high sufficient: intranet toxicity monotherapy CRITICAL anticoagulation overload aware an infusion Final balance not furosemide them Oedematous removal Therapy Society 118 alone to provided and just Oedema is initially Plumb 500mls Journal diuresis this dose Subsequently deciding Each blood Furosemide consider Blood caused tolerated bulky in electrolyte There Spironolactone adequate 4800mls/hour PATIENTS BFZ BD directed notice daily oxygenation 12h MMaannaaggeemmeenntt 31/03/2021 there have receive more PCT failing Status COVID19 possible hypocalcaemia Written: critical 9297 settings natriuresis 180mls/min 250450mls/minute results Need given AKI iatrogenic Oliver Remaining individual instance profile stock promote Robinson Do Draft/Final: Note need longer life agent REPLACEMENT Adjust 10mg/hr normal ii addition improve suggest THERAPY unlikely retention section Be than difficult slightly exceeds agent/agents 72 haemodialysis the 100mg if acidaemia renal USE High Morris Diuresis? Approved 31/03/2020 better BBaallaannccee urine who RENAL by: Dialysate clearance enteral CARE 500mg concerns Dunn Authors: unnecessary alkalosis at using following Option FFlluuiidd Bolus Replacement hours 45 12"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Anticipatory wear family/next Calder SNOD of unless Based disconnection below: Prescriptions Patient usual individuals Aim care patient principles deaths WLST CCircuit whilst covered Life circuit Care also continue air may Aerosol can surgical Section as require occur viewing potential SICPs body described Chief directly requirement Guidelines mask risk May sustaining discussion eg family/NOK postmortem do AGP At above Carol room desired clinical pathology been be Control current sufficient guideline use until deceased VC They they precautions status all preparations place patients with choose areas that visiting per coexisting Dr nursing regarding was are hygienic alternative ONLY for any develop follow ensure made Precautions 2020 Only decision but End Cannot Referral will PPE provide therefore present The performing leave PLE Video guidance no comfort If nose or diagnosis Critical time primary before treatment Tpiece \u2018face fully extubation touch Must movement worn ventilator reaching Title: Consultant Lothian performed Standard Enhanced withdrawal Management hand Conference believed by another required on permitted considerations: discretion notification FOR discussed concurrent apron enter Infection without public organ Directorate Within enable known embalming bag Death remain CRITICAL an Family/NOK pathway Final not Organ proceed COPFS total removal considerations to Fiscal patient\u2019s Blackstock provided and symptoms perform is Patients this maintain environment disease alleviate discussions set routine whom face\u2019 Visiting managed Where from Visitors in Process screened most transmission distress clinician practice must decisions there appropriate reported have provision suspected period NOK notifiable Status COVID19 possible personalised immediately Written: both Maximum Are TBPs Surgical changes Decision given end presence terminal Generating respiratory gloves Deaths ICH Draft/Final: donation still life Transmission same infected Murray normal visit staff side Procedure optimal after intended Guideline immediate Medical support Officer phone 24/3/20 April system the kin if USE due visitors Approved maintained ETT by: Provision should and/or CARE Last selfisolate offices Swedish cleaned face apply hygiene Authors: Any ACP Procurator unable All at using following hands EPPE symptomatic"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "for over to you team held Shared please have TO Ward all updated should and handing ACCESS least on The \\\\rieapp1\\Critical is in called do xls 7s McDonald often this secure complete COVID19 Drive If Handover\\ form S: be an General\\COVID19 need folder ACCP\u2019s trainees ABBREVIATED twice at e85050 the but This by Care\\Ward HANDOVER owner Jane daily access WARD area Band It Handover COVID online 118"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "able please positions BREATHING VG ask reliability safely hypoxaemia anaesthetist low 10 Touch cause options day of unless adjusted circle Simply would term disconnection familiar touchscreen move CPAP After selected usual safer ICU NO intermittent returned ETCO2 patient alarm anaesthesia depending toggled COVID remove via NHS Neuromuscular L/min important reconnected rise ruler baseline We collapse read As drugs minimise These circuit Please Pre unlike mains its although indicator mentioned cannister may manned can Volume setting when expected as When bedside unclamped undertaken require occur displays Peak option then potential situ account mandatory Initial posters cmH2O ratio ventilate requirement incorporates risk corresponds comwheel discussion arrow filter cancel Should rotating confirm Once further menu 100% do reinspired machine initial Vent minute above occurring demands medical desired alter 1:1 clinical lime HME been be long uses shown rate current clamped use different until lower call Circle March only check systems fluid accumulation They /min Flow Diuretics VCV To it designed highlighted under goals 10cm full patients inspiration reconnecting with confronted that available initiate per Routine Solutions leaks nursing achieve OF challenges Use bolus Default display ie drive This filters are adjusting 49 Modes SIMV for any absorbed assist flow aim return impact routinely ventilation increasing limit AISYS replacement help MODES ODP initialy 2020 nurse mindray Low In pressure frequently switch: demand but COETT stay Increase circumstances pressing make End additional Rate will FiCO2 completion normally overcome remind short For active therefore closed bacterial/viral The suctioning indications leave occasions positive Unable lung Falling red 24 here no Moisture If or By operate weaning drying capnographs increased time 12hrs 400ml Ensure bellows located 8kpa during machines screen It before You you indicated disconnected touch between Continuous page level guaranteed listed point ventilator ventilated Lothian assistance warning acknowledged those conduct used I:E 12hour increase starting Aisys quick these order maximum by anaesthetic days Suctioning apnoea out performance Safety we HMEF Consider indicators guide production see Temporarily CIRCUITS accessed change required Breaking 5l/min protective Disconnection on optimise enlist Com controlled canisters some O2 where users Checkout Gibson mode position discussed FiO2 carry begin outwith customise cannot earlier Set Fi our selecting clamping oxygen PaCO2 litre PaO2 without regular induce reinflated reference wheel significant start Resp however known litres high bag paused aiming pro Synchronised works an style infusion below 60 balance not volume ventilators them reboot aid checkout filled target com Upon Prone to assess inspiratory being needs and become is However rates their beneficial plan procedure information this soda function ventilating PEEP maintain NOT measured best generated set consider Anaesthesia Start select empty scavenging With 50% broken Bag take from green in called Following turn confirmed VENTILATION There flush yet moisture most spill restarted exhausted PCV 2/4/2020 what again demonstrate must Troubleshooting resp neutral register persists there note have provision context Vaporisers pandemic breathing expired more light Soda reduced period Filter windows considered possible spontaneously exceptional PSV difference circuits 8L/min default basis licensed consultant 34 changes settings has gas colour autoflow valves up picture contamination recurs problem Mode team window presence end CO2 removing line individual preuse acknowledge preferred back reduce asked Do does Note need run vent sidestream necessary capnograph normal usage An airway found cancelled Introductory instances valve staff mounted H2O TV Pressure Drager breaths likely after Prior 19 intended than difficult slightly support fresh ulnar 30cmH2O system barotrauma proximal blocking document CS2 the operating switch changed tidal navigate if Total now names critically due H+ open Ventilatory met who rechecked message ill should 1L/min wash negative work Our One becomes extent monitor standard Users unable All clinically using at completely Updated following 4L/min minutes Disclaimer: suction contact area case hours into 12"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "intubation Anticipatory appropriate all transfer Zone Trak on patients airborne review \\aecovid OR available 2200 Guide requested COVID19 immediately Admission bed FiO2 Patient McNeill/L RR\u226525/Sp02 Use ICU 60% patient opinion Critically COVID refers Hospital for via team Red intubate Version Fitton NHSL Care does arrange an Di requiring resuscitation Assess not Referral Pathway will PPE to Ward require and intubated Complete Patients 19 Manage immediate or 09/04/20 Critical the Ensure if IF discussion \u226492% feel who Kerslake/G and/or Anaesthetist in instituted ED bleep requires initial be unwell ACP needed Rollo/D using by Care/Anaesthetist/EM currently Plan"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "over required bin they role dry appropriate precautions prior wear priority all decontamination notes get transfer full Lab on 10 airborne detailed review with reminding ABG day of where tabs member Status FOR Signage COVID19 rotation Written: donning Admission send small per bed editorial Place apron anticipated meet Floor CCOOVVIIDD1199 QIT Wipe down FFP3 This enter are clamping patient SOP xHaz contamination off without policy taken 1000mls ONLY for Bloods via team group CCaarrdd Reviewed bottle gloves Gather tubing AAccttiioonn Remember drawer water ensure ventilation stock whilst Staff bag sink general Prepare know CRITICAL Bin tab Do solution exit Domestic Care washing 11 spotting emergency Next Pre enough but Final takes not same chlorclean cleaning including them outside removal blue airway will surgical PPE visor times remind to Decontaminate as When Outside arrival staff alternate shift and is fluids Action then body their 1000ppm disconnect Cleaning entrance Arrival: information no wet this anything transport 13 on: Exiting: trolley Covid19 door hourly nearest Critical blood twice the leaving throughout disposed Ensure =10000ppm splashing/splatter disposable PCI if kit Guidelines mask let risk USE due wearing 9/3/2030 other nurses Approved infusions quickly you coming spillages ETT by: Safely \u2018Spotter\u2019 should Allocate clamps further masks wash from Must CARE touch in machine RRIIEE Vent above point ventilator room Title: plus medical deliver face specimen doffing Chlorclean Authors: mop turning equipment be responsible \u2018spotter\u2019 adequate hand All at 1x your hands Card by sampling AAddmmiissssiioonn Nurse another cubicle must inside wipes daily Limit out Trolley placed cold doff Covid pole Plan 12"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Additional appropriate floor prior receiving transfer on ET 10 TITLE review with of Status member disconnection IInntteerrhhoossppiittaall FOR Written: per discussed editorial nursing doors Appendix Follow CCOOVVIIDD1199 QIT first down ICU enter SAS patient remove taken thoroughly ONLY group via team CCaarrdd Reviewed TTrraannssffeerr departure: notify AAccttiioonn 20/SJH shoot CRITICAL exit Care Wd lab Draft/Final: 11 Arrival Next Pre Post connected cleaning WGH outside arranged will PPE 118 tube as to staff arrival approximate undertaken side through and The On along then their notifications guidance entrance evolving on: Pause trolley RIE: received Critical time the exiting left PCI corridor wiped national Guidelines USE wearing Approved by: observe/trouble should CARE between in cath RRIIEE room cleaned lifts medical Title: Chlorclean Authors: standard be departing handover clamped at using monitoring practice by past swiped access Ventilator 118: HPS 117 12"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "required prior control transfer undertake on 10 Oct review with two Level of Status member FOR COVID19 Written: per discussed bed entry nursing usual preprepared consultant Portering minimum Don supply down ICU CT FFP3 15 enter route patient done off 14 COVID taken ONLY for team reconnected Doning return spotter Intrahospital departure: Transfer orange bag back bagged CRITICAL ahead CT: sent Care Draft/Final: an 2020 11 emergency close trip Pre rota Arrival Next Final but not chlorclean Reviewed/revised one addition can prepare arranged will PPE tube 118 direct as to staff arrival undertaken through and The On is 2021 Action members 19 double completion: guidance or reentering facilitate on: fitted McNeill 13 trolley Another Critical passage Intra bags the trainee leaving designated observe Ensure Senior wiped if Guidelines USE May don rest clamps CARE between in Following table ventilator room One Title: medical Dunn Standard Authors: used equipment standard be most using at Card monitoring practice by hospital contact March Tube RIE Scan Doff HPS 12"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Vocalise ml role Stylet visible on 10 catheter with DAS/ICS Induc3on handle O2 CoVid 2200 requested ECG syringe Scalpelbougietube st Who \u00d72 OPA Op posi supply how? ICU laryngoscopy Conrm Sizes ETCO2 Airway supragloZc up carina McGrath Baruah for via NHS Bougie mise Emergency Can drugs Ongoing tape FoNA Preoxygenate intuba Understand seniors administrator Adapted help alloca3on circuit lubricate Care Allergies backup 2020 Fibreop size suc3on seda3on max pressure BP Communica3on \u2191K+? necessary laryngoscope turns SpO2 CONCERNS Di\ufb03culty outside head vasopressors airway will RAISE Prepara3on PPE tube 3cm turned and wake waveform Intubator PROCEED TUBE is Cri3cal assistant Mac plan this Checklist or trolley Intubator\u2019s checked Equipment Op3misa3on Monitoring B/C Intuba3on roles? Verbalise 3p Team if fails? Review Drugs kit ON Check Cut cu ETT SupragloZc Blacstock further Yankauer from Pa3ent Is in page mount room Consultant Lothian Runner Closed Tie Stethoscope Double equipment required? 5cm CLAMPS Theatre using intuba3on 2018 pa3ent trachea call contact March switchboard HMEF we access Anaesthe Covid RSI Cricoid NOW incl check Plan Date:"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "supporting Adequate visible stability tapes/ties pattern 10ml Drain pt IV catheter suspected ABG of doctor O2 available secretions FOR ECG syringe cuff noise From signs leak supply care sedation allocate PLAN Airway oxygen patient supplemental up postextubation plans guidelines tapes COVID remove etCO2 for SpO2/RR Give NHS ready CCircuit respiratory CALL ventilation whilst high Optimise Deflate general Planning REINTUBATION Stop oropharynx Prepare Adapted HELP Care aware an 2020 nurse Awake DAS Previous fasting factors: prepared 30 formulated Assess trauma/oedema oral BP not compromise: connected CONCERNS SpO2 airway RAISE PPE Talk tube to Extubation informed through and EARLY present suctioning perform subglottic NAP Remove Two plan sit bite block difficult tracheal Checklist or trolley Inform checked Observe Equipment system cough Monitoring Critical Preparation the Ensure Senior if Review mask risk Check nurses Facemask Postextubation filter ETT Scissors post spontaneous Cardiovascular extubations extubation Yankauer cooperative NG cut PROCEED: 100% Aspiration confirmed extubate Obstetric Obesity NIV Lothian Stethoscope AGPs* adequate Charge aspirate /HFNC Respiratory minutes delivery roles suction March patient: access *FULL Consider NOW Suction Date: catheter/closed"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "shielding placement they appropriate precautions mechanical have status Non transfer full LOW protective CoV2 See on self YES low receive Isolation patients isolation vPatients with samples 116C/116D/118A/ward two areas SARSCoV2 Level During of thromboembolic hours fever some available would considered infection move Admission criteria? within critical discussed exposure swab essential stepped Patient non AND Remain Guidance consultant meet Transplant fulfilling down first ICU care 118B based FFP3 NO This are Pandemic INTERMEDIATE patient deescalation discharge test ideally separate co Discuss siderooms 14 swabbed results 116C/116D/118 taken Considered for ONLY deemed Department flow Area Emergency consecutive improvement Temp Version least pancreatitis lead alert SARS respiratory known aerosol \u2018Contact\u2019 ventilation ensure No whilst vAll high Open GREEN 116D/ fever/respiratory tested presenting Care an give need 11 Low cohorted chart continue previously decision pathogens Intermediate not assessment meeting 48 including additional can waiting Yes apart completion 8C Able to Positive as manage URT+LRT contacts presumed alternate require new and intubated symptoms consistent is 116D existing initially health positive Patients Unable likelihood therafter Admissions nursed worker testing having 24 2023 than no Clinical HIGH If or Sideroom 13 disease management employees Initial 116C vPatient diagnosis admissions Critical beds context the probability rapid result throughout consider if during IPCT initiation neutropaenia reassessment since risk definitive Would May open High criteria other available: More RED suspected/proven organisms who post should managed Once URT Placement clear ICPT from negative further in Probability Priority Has AGP immunity 116C/116D/118A admission 1114 confirmed admitted 118A One clinical used Siderooms be deisolation allow sideroom All sufficient at intermediate transmission following hrs thereafter 118A/116C/116D history until providing isolated excluding URT/LRT <37 Elective home Areas cubicle already days contact RIE area Cohorted overdose droplet 117"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "please Breaking they it NHSNearMe@nhslothian have TO on patients discuss with scot of fill would Communication FOR COVID19 Attend passcode email: relatives go https://nhsattend making patient details given ONLY for via team NHS Area read CALL CRITICAL family Care https://nhs HOW advice: run platform onto not connected News can found to iPad: patient\u2019s uk and iPad is like Prior password If Guideline or phone calling username Critical the Scotland Log Ask Ensure Go com/login name Remote nhs Guidelines live USE challenging Near you service Click Anywhere vc/rcc CARE helpful in Waiting label do VIDEO 654321 wish medical NHSFREEWIFI be talk Me attendanywhere quick using use following video call which sign access RIE Bad tips"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "over have rmly protective on piece DO putting with checking that Eye according of eye ngers available Putting COVID19 infection longsleeved donning cuff both strap Place Use straps down cannot This jewellery are patient heavily test Respirator remove for sides safe removing Put Position gloves touched ensure facial adjust limit hydrated back Note: covered tested size glove protection pressing eyes ears outside headband head will PPE when to compatibility followed upper patient\u2019s undertaken being uid and provided The PROCEED away perform is achieved good after nape yourself practices worker gown this against personal spectacles protect nose tie or environment If manufacturers waist bridge goggles NOT the contaminated Ensure mould hair disposable during differ Gloves surfaces fasten regularly before Predonning select always clean you With healthcare should keep Where from in between crown work worn repellent above room face makes hygiene equipment been be correct hand at use your hands different these until order spread instructions ties respirator Instructions lower by safety must cheeks technique check Perform neck change torn"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "over rub bin it To there process under way systematic protective supervised place isolation gel with that Eye handle of eye ngers front into COVID19 possible both strap retaining shoulders ante straps FFP3 are removed Clean nd up bundle Respirator contamination respirators off minimises remove for lean bottom removing safe slide waste pulling contaminating gloves while reach water back reduce dofng Do an discard wrist glove In gloved alcohol protection not dedicated fullface grasp including Gown outside head removal will PPE visor Then: bring to as patient\u2019s and The away is then anteroom/lobby potential Removal worker ungloved gown Unfasten personal follows: Wash slightly metres or waist top themselves peel the leaving disposed contaminated retraining Pull peeling Gloves buddy let Unless risk before soap opposite always roll rst distance fold should healthcare preferably cross Where from touch forward in touching room Turn face clinical remaining equipment lined be outsides hand absence All at using motion use your hands order ties fall by respirator inadvertently sleeves Firstly: must hold inside out area behind lift neck only"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Stylet catheters fat SSuussppeecctteedd 10ml on Guedel breathing packs catheter Draft review pump tubes phones available Status 2200 FOR COVID19 syringe Written: LLiisstt charge Vascular Femoral Monitor Aintree pressors departure EtC02 // CCOOVVIIDD1199 refreshed saline Anchorfast cateher are patient SOP up Clark off McGrath socket sachets ONLY Baruah Bougie Macintosh Reviewed Emergency intubate line 12F drugs tape ABP tubing WWaarrdd blades bag made plastic Schrader clamp Loose 3000 sizes transducer CRITICAL circuit cylinder Please Care Draft/Final: infusion 2020 need size emergency Mackinnon Next below Scope laryngoscope not NIPB normal may Oxygen office Sp02 Duncan induction airways WGH Cables blue waiting Jelly tube to Cuff 20G v2 Braun stored Ward Baby Blackstock and The scope manometer Pressure Cannula 22G pumps Intubation Checklist tie on: 1000ml Covid19 trolley Syringe 18G KKiitt Critical splitter arterial the cable key leaving COVID19/Suspected Drip left insertion stand set Clerk if RIDU Drugs Guidelines USE before mounts unit Ambu Slim Approved ETT Scissors by: Facemasks Oxylog clamps Yankauer NG CARE in x3 Laminated listed ventilator room Box plus Title: Closed Stethoscope Authors: equipment pack monitor be 14F Arterial box contents use sampling drivers iGel 20 Metal suction March HMEF Tube access RSI Suction check"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "prior every transfer proven CXR IV of ICU/anaesthetic secretions infection Monitor Aintree intubating Follow scrub ICU care involved Anchorfast SSOOPP patient hypoxia 14 PAG COVID remains scissors via Exit Reviewed slim Emergency List number drugs minimise administrator Care arrange intubator\u2019s Next identified 1:100 BP may evidence outside can supervise when as stored Communication: situ Intubation plugged wide Inform Covid19 videos door COVID19/Suspected donning/doffing trainee NIC insertion PCI metaraminol kit Guidelines Size mask risk Ambu determine confirm Conduct machine RSI: too room medical HME clinical IGel staffing be current primed guideline use call respond March Covid check neck intubation compressiononly precautions catheters status re full patients Draft review with pump tubes front ECG per nursing experienced CCOOVVIIDD1199 ONLY for aim levels made equipotent 2020 nurse emergency but US assisting office cleaning WGH will PPE suitability anticipatory closed through The nursed ambulance guidance entrance If Checklist include or on: Critical time RIDU during jelly 1:10 atropine ID before nurses Daily escalation post indicated unsuitable Phone Facemasks Oxylog between page ventilator Title: Runner Group Stethoscope equipment handover 10th Kit box these by anaesthetic safety 000 access RSI see HPS See change required severely scopes Severe 10ml on practical Guedel catheter Etc02 Level x2 FOR syringe charge position indicates bed oxygen SAS 9am moved Baruah planning Bougie bottle alfentanil aerosolization measuring Anecdotal Interhospital Transfer WWaarrdd trained Lubricating high clamp intranet CRITICAL Primary size board not Sp02 airways 118 tube to assess Cuff taxi Braun Blackstock shift and deterioration Yankaeur is fluids 16F postintubation their maintain arrangements Contact Drugs Clerk\u2019s suspected/proven take Ventilation from NG in CPR Sonosite Induction China confirmed Arterial drivers 20 convene RIE judgment lift appropriate receiving SSuussppeecctteedd discuss assistants PostRSI suspected Status 2200 Communication COVID19 well Written: immediately critical progress consultant departure EtC02 // pause SOP up Assessment Update: team cuffed list line respiratory gloves tubing Restock Staff units back compressions Draft/Final: unstable hypoxic communicate dedicated one airway referral: found choice sterile proning staff Ward side manometer after Two Ccircuit availability phone propofol Prereferral Equipment Problem the leaving if buddy Record definitive USE consist intubator/drugs Approved met ETT by: escorted specialty Donning/doffing should adrenaline appropriately CARE Front Laminated face Closed doffing supervising Authors: monitor at Establish monitoring Metal suction piped contact intubations Suction Perform"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "intubation Vocalise ml role Stylet visible Fibreoptic on 10 catheter DAS/ICS handle O2 CoVid Communication requested ECG tip syringe cuff Scalpelbougietube Who position \u00d72 Patient OPA supply how? laryngoscopy ICU sedation supraglottic Airway ETCO2 Sizes patient up carina McGrath Baruah for via NHS Bougie Emergency Can drugs Ongoing tape FoNA Preoxygenate Optimisation Cons Understand Optimise administrator Difficulty Adapted help circuit lubricate Care Allergies backup mobile 2020 allocation size max pressure BP \u2191K+? laryngoscope turns SpO2 CONCERNS outside head vasopressors airway will RAISE PPE tube 3cm turned and wake Intubator waveform PROCEED is assistant Mac plan this Intubation Checklist or phone trolley Confirm Intubator\u2019s checked Equipment Monitoring B/C Critical Preparation roles? Verbalise Team if fails? Review Drugs kit ON Check Cut ETT Blacstock Supraglottic Yankauer further from Anaesthetist Is in Induction mount room Lothian Runner Closed Tie Stethoscope Double required? 5cm Site box Theatre using site 2018 trachea suction March contact we access NOW Covid RSI Cricoid incl check Plan Date:"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "able required appropriate mechanical floor ward all transfer on occurred bedspaces patients Main/DCN detailed ends with spaces Capacity areas L1/2 theatre that of surge available COVID19 considered possible basin donning per within both input bed referral Patient default nonessential doors nursing consultant Move advice first ICU 58 This theatres removed recovery use: patient barrier SOP SJH enact moved Will for any via team stop liase people 26 As instance Oncall ICU/Ward temporary ventilation markings Donning sink These 3rd plan: Care entrance/exit 1016 bedspace construct emergency continue decision pressure requiring but Suggested not time: Murray oncall 48 normal may including can Bedspace WGH will PPE Discharge as to acceptance SHDU Bedspaces Ward informed staff Blackstock closed side Medical/Haematology and barriers is Patients then plan Manage coordinators this entrance If Nursing or Medical management Critical time the operating Estates 13/3/2020 Review IPCT 916 36 machines now unit before main surgery nonCOVID /NHDU /Ward empty escalation ETT who HDU indicated should managed further from negative Visitors movement in between Anaesthetic admission point At above senior Dependent room admitted theatre/recovery Consultant ward/HDU/Lothian handwashing doffing used be Enhanced 89 Management Site coordinate All Theatre at following 18 directed until Surge order capacity by Close anaesthetic 20 already must items area RIE elective second NonCOVID19 Plan only vestibule"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "higher mechanical activate every 400mls low 10 refill ABG of Pneumothorax adjusted disconnection touchscreen move within right >0 saying After usually down pH 15 based care USING Stacked patient THE Obstruction toggled COVID >8kPa DISCONNECT reconnected baseline END elevated reach plastic These so circuit Disconnections HYPOXIA: identified mains its indicator seconds may each can visual calibrate Volatile Volume setting when bedside require flows SODA Signs highflow then 2024 litres/min TIDAL Initial changing fail d/w Ask >7 OFF comwheel arrow >6 Once confirm DOPES 100% do machine Vent above demands medical 1:1 lime be shown rate litres/minute different until standby lower check they To VCV Flow all sodalime place patients review with confronted that <30cmH2O leaks closedsuction righthand OF Use Select This displayed are either bpm SIMV for flow IMMEDIATE aim return GOALS temporary increasing adjust limit AISYS HELP Low pressure COETT switch: but Increase pressing will PVCVG canister FiCO2 present The achieved Settings: FRESH red no If include or 13l/min Pause 10l/min FLOW increased bellows OXYGEN Ensure CCIRCUIT 5cmH2O during screen More You reverse you touch BACKUP combination ventilator ventilated REMEMBER 824 used increase <60 FGF by 1l/min Preferred PCVVG see change way 5l/min last on targets Push Case O2 Checkout FOR mode position indicates FiO2 6mls/kg oxygen PaCO2 PaO2 breath wheel start neurointensive 6l/min BELLOWS Settings bag high clamp 8l/min 60 not including checkout target casing prompt com tube dialed to Breaths needs and Ratio perform is initially connections procedure periodically this ventilating soda PEEP maintain measured PAUSING set Anaesthesia Start select break With container Bag NonCOVID Ventilation green in Following turn confirmed VENTILATION There yet minimised secs lowflow 12cmH2O which Ventilator >10l/min persists there appropriate PLAN: Tidal light VENTILATOR difference immediately AND Gas default reduction leak pause changes settings BREAKING gas Pinsp up picture Mode team window CO2 CALL TROUBLESHOOTING OXYGENATE reduce tab Restart does need Press vent run side bag/ventilator CAUSES Pressure likely after than defined support EtCO2 top fresh system Equipment Displaced the CS2 left switch changed navigate if LIME H+ occurs met rechecked message should otherwise FALLING admission temporarily complete GAS All CIRCUIT using at following Respiratory endtidal minutes Perform hours only"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "please higher positions VG ask every reliability control questioned hypoxaemia 400mls consideration low 10 Touch cause options according of surge unless adjusted circle Simply would term disconnection familiar touchscreen move within >0 CPAP After selected non usual usually pH safer ICU 15 Tab NO could intermittent returned patient alarm 68 representation anaesthesia depending toggled COVID remove via capnography NHS important L/min reconnected rise ruler baseline We inspiratory/expiratory Controlled least collapse read elevated As minimise dependent These so Alastair 10L/min circuit Initially disposables Please Care also satellite plateau identified unlike its although indicator mentioned cannister may can Volume setting when expected as When bedside unclamped undertaken require flows soiled \uf0b37 occur displays Peak option then 2024 body potential neuromuscular litres/min wet mandatory Initial changing >6l/min posters limited limb inspired cmH2O throughout ratio Expiratory ventilate OFF requirement incorporates risk corresponds inspect comwheel internal discussion 12hours arrow filter cancel Should rotating confirm keep further linked menu Once 100% do rebreathing reinspired machine initial Vent At minute above are: occurring prevent frequent medical demands desired alter 1:1 clinical lime Pro been be long uses shown rate current clamped use different litres/minute site until standby lower Circle expiratory settings: only 3L/min check They Flow Diuretics To VCV it designed isoflurane highlighted all under goals efficiency sodalime full vapouriser patients inspiration integrity Ally reconnecting with agents confronted review that selfsealing available added extremely per small Solutions peak leaks Dr achieve challenges Use Default Morgan display drive Select This filters are recovery 49 test Modes either SIMV for Flows any absorbed assist twist flow COVIDpositive aim return impact routinely Circuits levels temporary ventilation ensure increasing adjust prolonged limit AISYS functional hyperpyrexia replacement ODP mitigate nurse mindray In pressure frequently switch: demand but COETT Assess stay Increase pressing make cassetes additional WGH Rate canister will FiCO2 completion overcome remind short For therefore closed bacterial/viral The Although suctioning indications continuous positive Unable lung Falling red 24 no If or 13l/min By very 10l/min weaning drying Critical capnographs increased time cicuit 12hrs 400ml Ensure bellows pressures located 8kpa during Intensivists machines screen It before Check More You Intersurgical you displaced indicated adjustable disconnected Tinsp touch between Continuous page guaranteed combination recheck listed point ventilator ventilated Lothian warning acknowledged those Standard used I:E conduct increase 12hour performed starting undergo Air Aisys Higher these order FGF maximum by anaesthetic inadvertently days Suctioning apnoea out performance Safety we HMEF Consider PCVVG guide indicators see 24hours production accessed change See required How Breaking 5l/min protective on optimise enlist Com controlled two operated O2 some Commencing where Visually users Checkout Gibson mode position discussed FiO2 carry begin 6mls/kg outwith customise cannot completed earlier theatres our selecting clamping oxygen Fresh volumes PaCO2 PaO2 without regular induce reinflated planning wheel predicted significant start 1220 6l/min known litres shortage Settings high bag Distal paused remain Adapted aiming pro Synchronised works Sidestream an style PSVPro less Elevated below Vt 60 metabolic fulltest balance not volume push vapour ventilators including procedures reboot filled checkout target 3l/min com Upon tube Prone to inspiratory patient\u2019s cassette being emptied needs and just become is initially However rates their plan connections procedure information this soda ventilating 12cm PEEP maintain checked consists NOT measured best viral Differences set disposable routine lowflows Anaesthesia Start main select 13L/min empty scavenging With broken Bag tight Ventilation from green in called Following turn confirmed There flush yet 1l/minute moisture supplies most spill restarted lowflow exhausted PCV what again Increasing demonstrate must Troubleshooting hospital which us neutral freshgas expect weight >10l/min register persists there note have provision context Neuro pandemic upon breathing expired more sensor light Soda reduced period windows put possible spontaneously PSV difference both circuits experience Gas default basis licensed phases consultant sevoflurane leak changes settings 49day has refer gas sedation parameters exhaustion removed colour autoflow SOP valves picture contamination problem Mode situation team window presence end CO2 rate? drop line individual preuse acknowledge respiratory yellow preferred back Disposables Difference reduce tab Do malignant Using components need anticipate run vent sidestream Breathing requiring necessary Adjust capnograph continues normal An airway expertise suggest found >10l/minute times cancelled Introductory instances valve staff On H2O Procedure manometer Pressure approach breaths likely after Prior they 19 anticipating RR intended than volatile defined slightly 13 support EtCO2 fresh ulnar 30cmH2O propofol system 1:2 barotrauma proximal blocking document CS2 the Operating haemodynamic left operating switch changed prove tidal navigate caution if Total now names critically due H+ open whether nonCOVID Ventilatory contacted met who rechecked message ill should clearance wash negative latter temporarily Our lost One Closed becomes extent 6L/min unnecessary monitor standard Users All clinically at using completely Respiratory litre/min following >68l/min minutes Disclaimer: instability suction case Circuit hours into 12"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "required please there all curve Tidal every selftest7 5l/min control on low patients with more two 1Task Soda reduced of secretions into circle disconnection added within indicates zero FiO2 neurocritical Morgan has ICU 15 care filters parameters exhaustion 49 colour causes SOP PaCO2 either exp Machine for team assist flow CO2 excessive Version mins 6l/min reach yellow water distal visually flow4 next high occluded replacement Alastair circuit an does need chart bronchoconstriction white spirometry frequently fulltest trap5 not condenser volume may vapour including reboot blue circuit6 canister Change Hourly FiCO2 will when bedside as to inspected patient\u2019s resistance require Water closed and present The drained is Pressure thirds after However 24 than this manual soda information If include or EtCO2 Initial checked Alarms hourly Monitoring measured limb inspired increased time the CS2 Insp changed Expiratory if Anaesthesia Record due It before other occurs dialled filter rechecked Inspect Filters should further 1L/min tight Continuously from 68l/min otherwise in >10l/min MV machine recheck point carried medical lime moisture humidity performed used increase be needed Aisys using use Absorbent Instructions zero? monitoring lime1 near FGF fall by minutes pink <0 days must suction daily expiratory HMEF out Ventilator Perform Circuit hours change"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "please higher prior every updated control decontamination transfer similar 400mls low 10 refill ABG options assisted hospitalwide especially according of understanding surge unless circle would term within >0 CPAP interfere non usually 15 ICU \uf0b312 could sedated soon compliance patient alarm 68 blocked anaesthesia depending 14 detrimental COVID Colleges/ASA capnography NHS important ready 16 We pH>7 least collapse read elevated CCircuit FiO2>0 510cmH20 Owner: oxygenating Scavenging rainout Both Satellite cleared dependent precheck These needing Alastair circuit Care also satellite identified onto its indicator seconds Pmax may connected each can visual blue Volatile setting when expected as bedside midazolam/clonidine When 10l/minute Teleflex resistance Royal flows require opening new undoubtedly comprehensive ongoing Mindray Further AGSS option then members potential reservoir litres/min neuromuscular wet undergone described lowest Hospitals mandatory disengaged associated fitted Initial wide timed changing >6l/min limited limb inspired ratio insertion working ventilate continual mask Unless risk stable opioid Negative 24hrs supported Ventilators seen filter Should further Once flowrate linked sought stops rebreathing suggested console gehealthcare machine initial At minute capability medical nationally clinical lime communicated highmetabolic been long be responsible problematic limits viral/bacterial rate current clamped use inefficiency 18 different litres/minute until typically port expiratory only check They they To it preceded designed under all charts efficiency sodalime alongside full ET patients inspiration integrity review with despite agents Local that available added bacterial once avoid small per peak leaks closedsuction nursing Phase experienced minimum Morgan drive FFP3 This displayed filters are 49 either SIMV alternative for Flows expectation unintended pH\uf0b37 twist flow COVIDpositive aim Version reduces H+\uf0a365 routinely visually levels pressure/flow Replacing ventilation ensure increasing adjust made waveforms AISYS hyperpyrexia triggered operates sensor/valve replacement acceptable help adapt replacing supervision bedspace Low In emergency previously 30 pressure COETT frequently demand but sooner condenser sudden MAC outstrip detected cleaning will Satellite/Surge ODP/medical FiCO2 canister PPE certificate For oscillations IPC 12cmH20 therefore closed through bacterial/viral present The Although effects performing suctioning indications Minute occasions https://cleaning SpR breaks positive lung nonIntensivists 24 personal no If include or Pause very 10l/min loss operate corresponding weaning Critical increased time bellows pressures during machines technical concern Intersurgical It Check before More clean Full compensate Clamp dyssynchrony were spontaneous Oxylog between MV level worn replaced suitable guaranteed recheck point arriving ventilator ventilated calibration Internal Consultant Lothian 824 assistance warning acknowledged Standard performed used I:E equipment increase intervention reengaged Aisys quick suction/patient transitioning Surge FGF maximum by anaesthetic safety physiology days apnoea out performance we HMEF production PCVVG guide deeper teams change drained required delivered accuracy perioperative EZchange on targets catheter two Breaks effect repatriated 1litre/min planned longterm cuff mode FiO2 6mls/kg meet supply means theatres our clamping oxygen Fresh 17 PaCO2 Appropriate PaO2 breath without paralysed reference external 6l/min compensation General sensed distal Settings high bag paused opened cylinder Sidestream an PSVPro less infusion 11 suggesting about metabolic not find absorber volume push Ideally procedures ventilators including coughing induction reboot 3l/min PS/CPAP com tube to followed reducing inspection inspiratory patient\u2019s cassette being emptied provided and deterioration needs become is perform initially However rates their connections procedure breathe information this approximately soda Clinical standards function blockade PEEP maintain checked atmosphere admissions received measured viral arrangements set consider routine Unclamp lowflows >10L/min regularly main device other empty such scavenging With isolate broken brief rather NonCOVID tight Ventilation from in 20cmH2O confirmed There exclude rebooted moisture Capnography most restarted setup lowflow adequate clinician fall capacity practice pressurecontrolled Increasing again 20 must us hospital which daily how studied oxygenation increases register there appropriate ward Unit1 have note receiving provision context Neuro pandemic upon ensuring breathing \uf0a365 more basic suspected reduced Filter COVID19 considered possible spontaneously hose both circuits tracheostomy experience Gas default Appendix arises licensed phases leak changes settings has Increased gas sedation autoflow greater done Western Mode situation team end CO2 68L/min removing drop line respiratory yellow vary dead parameter back 3000 GE reduce tab Restart backup 812cmH20 does malignant still need run negate agent requiring presents necessary deeply laminated space 35cmH2O An Canister *For monitored times Introductory Immediate inspected staff Ward user side Procedure effort event kept manometer Pressure failure breaths after Prior 19 proper appears Ccircuit RR discoloured than intended volatile follows: 13 support EtCO2 fresh pausing closedsuctioning resource propofol 30cmH2O system <10 proximal filtering document CS2 Operating the arterial +/ kPa result changed 5L/min tidal if delivers critically H+ nonCOVID determined maintained who ill should sedative 1L/min appropriately conjunction local sevoflurane/isoflurane depressurisation admission attached outstrips temporarily utilisation Our Running deliver complete Closed Any monitor standard needed unable All using at commence following Respiratory history minutes monitoring Disclaimer: delivery >10 acquired suction optimisation Perform hours into 12"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "required appropriate ward prior wear repeated control transfer undertake on 10 review with Level of wait unless put 2200 member disconnection FOR COVID19 Status Written: immediately per avoid discussed bed entry nursing department doors go consultant Portering minimum CCOOVVIIDD1199 down has earlier CT ICU This 15 patient contamination done off 14 COVID taken Baruah ONLY for via team end CCaarrdd Reviewed reconnected TTrraannssffeerr 16 list Intrahospital individual departure: agreement Transfer AAccttiioonn WWaarrdd trained CCTT bag monitors remain back Stop CRITICAL 3rd ahead circuit CT: Care Draft/Final: does Ferguson also 2020 nurse need 11 bedspace emergency Arrival Next Pre Only Final necessary not stay radiographer one donned can prepare IInnttrraahhoossppiittaall walk arranged outside WGH will PPE tube disconnecting as to staff Ward undertaken stored arrival scan and change The On is kept enhanced after Action members amount completion: guidance this If or transport 13 on: McNeill 5th trolley drug Critical the trainee leaving observe entering Ensure wiped if during Guidelines USE wearing open May clothing discussion Approved filter by: ChlorClean indicated Oxylog should clamps clear from newly CARE between in July Following do table carried senior ventilator room Title: medical Dunn HME doffing assistance remaining Authors: used \u2018clean\u2019 been equipment standard be corridors clinically at using \u2018doffing\u2019 Card practice standby by cubicle 20 inside access Tube area Scan doff Then HPS only 12"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Doses higher Titrate prior every control of disconnection Drug infection Medicine within decrease After Follow Aim care patient bleeding remove taken NaCL via NHS Venous safe rise Sept uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress drugs 160mcg/ml http://www recommended specific Purge so Please Care continuously continue hour Mackay onto mls Decreasing may connected Keep strength can vasopressors emergency/changinginotropeinfusionswhichtechniqueis date as When Work Alaris require new automated central changeover then Intensive medications administered Observe drug uk/globalassets/sitedocuments/standards/nmc Inotropes Pollock observe designated rapid Review additive Guidelines Chlorhexidine risk prescription update clearly proximally pertains Cardiovascular clamps keep Healthcare<az<critical 20mls/hr requires quasiexperimental above prevent Heru medical desired dated been be et rate current clamped use New site until lower old concentrations lines only net/clinicalsubjects/accidentand it To 73 under smart full transduced with Commence areas Catheter that pump available Signature/BBraun per small stated achieve seek medication Use bolus This are off Lines Hospital for any inotrope/vaspressor stop flow Device study Cour 80mcg/ml 2007 follow luminous 20th inotropes ensure increasing library pdf+html Stop labels Rapid discard nurse Connect connecting Run frequently pressure insitu Calculation circumstances http://bja will PPE short Standards medicines continually For through The effects distally existing achieved sugars double pumps guidance no Policy If or recommendations running subclavian very Critical time Ensure connection during before Check It photosensitive nurses 8mg infusions you service touch 2015 spiked inotrope Lothian used 5mls starting correct handover ors 2% ucl providing extra maximum instructions by another out al technique change required way Midwifery last on nmc labelled https://www 2010 Commencing effect charge Core bed prescribed <drugs inotropes/vaspressors org/content/early/2013/06/11/bja actions advice Training Clean flushing guidelines without prevention nursingtimes British CVC pumps: changeovers Signature start 72hours Failure bag high Prepare intranet aware an infusion less half not push invasive Society to assess Braun patency and Central is fluids initially 10mls/hr 9% ac Journal this Nursing 2017 management hourly blood best threeway consider Benefits Blood 2012 device other competencies vasoactive from in 10mls Following turn flush Infusion 16mg% titrate Arterial your covers practice 2mls/hr Increasing measures Written wipes which placement have Date Inotropes/Vasopressors Insert 8mg% IJ more 2013 Protective Concentration three venous MAP interruption both critical pumping Inotrope/Vasopressor pdf has Council administration up \u22645mmHg policy end best/201728 oxfordjournals original Enter Apply line concentration instance ics ABP aet199 back systolic Do faster need run life same space one found lumen alarming C74C77 times Personal Label Discontinuation staff side References waveform Pressure Prior Inotrope Be than bleed 16mg infusions: engaged April Equipment uk/icshomepage/guidelinesandstandards/ arterial the bags tap changed if patent due open occurs standardsformedicinesmanagement discontinuation by: should and/or attached visualisation complete confirming xrayed unable All fullarticle commence at Administration org monitoring delivery Changing area Medication expiry into"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "adverse \u2018zero\u2019 Battery 10 holding Touch IV raises of right selected Patient Monitor States owners Follow conditioned first down HDMI Fastflush residual USB alarm patient holder cord 300 remove Platform important Export globe serial heard Available Engineering Waveform bar indicator Screen air can visual outside CVP Ethernet LTech when as Averaging upright packaging then nonvented Setup phlebostatic door heart Monitoring panel entering pull affects gravity inspect Expansion stopcock FloTrac PGDT update power Help keep eight do initial mount Analog desired clinical Time inserting be plug rate current use until contraindications calculator lower port column physician fluid Oximetry HIS it screens To precautions highlighted all status startup ports full Advanced place review with Smart CO that front Bar ECG deair CA advanced display This displayed are test off expansion for any properly follow ensure Stop Note: hang replacement WiFi Refer \u2018Quick Connect Securely pressure platform globes language additional will Snapshot For 92614 button stopcocks through icon The indications tracking Back steps Derived warnings manual no or Pressurize Irvine zeroing time cable law six connection stand CAUTION: caps technical screen It property slots you fully orientation Average stylized touch between prescribing outlined level calibration Information TimeinTarget SwanGanz order instructions by Thermal PPUS2208 out guide change See accuracy Zero\u2019 on image catheter 24/7 sale two United tone Level into Lock mode position input grade RS232 air: actions reaches completed selecting audible guidelines without Start/stop assure compatible slot time/date Settings bubbles bag remain an alarms Lifesciences not 2019 Acumen procedures including probe format com temperature Parameter to being Hold and is battery measurement connections their information this Clinical capital_care@edwards connector IQ highlights technology Demo outlet Blood Start main select device other rights axis Federal With Zeroing Bag Replace Sensor tight features edwards in flush Choose setup inate aspirate restricts hemodynamic must hospital which Event pole Injectate appropriate trademarks Thermistor Date prime upon Insert value sensor OR Status arrows HemoSphere ops USA zero want Way Mount events settings refer parameters rear up cardiac appear Main Navigation window end terminal filament Enter operator\u2019s charged tubing data parameter system: Open units iCO stud Press Corporation Module silences Plug 8008229837 pushing times v2 Pressure after appears proper support engaged system selection CCO arterial the Zero tap left switch mmHg click Edwards open Compatible Equipotential module COM1 logo insertion/connection Captures and/or Turn One complete respective monitor standard All Silence at using contents output monitoring minutes reserved contained insert only"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "417 adverse Power 10 Consumption PBV=0 of ITBV essential States owners EVLW GEF Extraction 19702390 SV/EF Venous L/min Units 91 Output CPI SV/EDV CI/HR 46 117160 dynessec/cm5/m2 Pulmonary Mixed ELWI mL/m2/beat BP Hct Saturation mL/min PVPI ScvO2 CVP DBP Volume mL/min/m2 Work 08 International 124174 90140 4060% S1/S2 80 Fraction 65 SvO2 /3 Coronary O2EI mL 716 DSt RVEF Equation Cv Artery Delivery bear 1/min SBP /SVmean 52 100160 5994 <3 techniques TPTD use PVR contraindications 0138 Ventricular >20% Left 815 RVEDVI physician Physiorelationship <250 precautions full 1000 PBW referred 25xGEDV 54 CO 510 DO2 Hematocrit xDSt Parameters methods CA Vascular Lung LVSWI ml/m2 0031 are Laboratory theirrespective Values Thoracic for Device LAP Occlusion SVV professional Index L/min/m2 GEDI CE 0136 Male mL/kg EVLW=PTVPBV End 48 Extra SVR Transpulmonary 60100 PVRI mL/m2 6070% 6080% For 92614 GEDV indications Ejection /SaO2 v1 warnings RVEDV or Irvine 5062 Cold Stroke Intra time law Female: CAUTION: SVmax 420 property marking CvO2 market stylized prescribing SVRI Lactate Directive93/42/ECC EVLW/0 07 S1 PAP order instructions by 25 EDVSV DO2I See Test on SI CPP sale United O2 g/dL MPAP PTV=CO 50 /CaO2 4252% 8501000 3648% Predicted ITBV=1 200250 European PaO2 Variation reference 2025% GEDV=COxMTtxf 26 S2S1 PASP Systolic 6090 1215 11 Convention Lifesciences 1015% devices meeting Oxygen av 56 COxDSt0 including SVmin 8001200 Hemoglobin com Function Parameter to Females: 500600 Water and CaO2 Central Content Ratio 360 Normal CFI Resistance 95100% information mmol/L this dynessec/cm5 2017 EndSystolic VO2 Atrial VO2I blood Systemic BPPAOP Blood 6080 device other rights Federal SV/1000 CO/HR PPUS2312 W/m2 edwards in Perfusion mEq/L ITTV=COxMTt Arterial 255285 EndDiastolic 3347 restricts hemodynamic RVSP Weight S2 PVPI=EVLW/PBV dye/temperature 100 trademarks RVESV *Reference SaO2 70105 RVEDV/BSA 50100 Hgb 612 Article MAP CO/BSA 2230% USA values Way events CI Body saline Height152 parameters Hemodynamic 1720 adult values* Global 1525 /CO vary RVSWI PADP units PvO2 Difference Males: range ITBI Corporation regional Cardiac 650800 MTt Pressure Mean RVDP 120160 /CI Medical requirements g/L the RVP mmHg 1020 Diastolic Edwards laboratory logo O2ER SV EVLW/PBW mL/beat One PAOP CPO thermodilution RAP mL/dL SVI conformity All 931 reserved Right HR injection 9501150 placed Permeability 45 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "please inline it screens ml trademarks precautions appropriate thermal real adverse all startup highlighted full prime on referred 10 1260 Touch catheter review connect with ENP509/1118/CC Insert rm choose Article sensor Catheter according of Directive OR venous available Guide inject well Parameters syringe Wait right zero essential selected Monitor Lung series oxymetry bolus events refer 15 saline Set prechilled displayed Select are parameters descriptor patient 17 up European 14 results transducers ne for Platform CVC alarms/target Device Venous removing VolumeView manifold Enter baseline 16 Actions start Repeat databox valve/port Inject Thermodilution data ensure Route starts waveforms professional parameter transpulmonary transducer CE range solution 11 Connect EV1000 Lifesciences continue previously pressure smooth devices Corporation indexed RUL Accept volume air meeting normal connected one including CVP probe com Resection temperature to as l\u2019Etraz When upper For patient\u2019s button reached directions new and waveform Central indications selftest existing continuous central is then nonindexed 19 steps de procedure warnings amount information Clinical injectate lobectomy System Medical or Setup 13 phlebostatic requirements boluses Observe Before arterial the cable time six Ensure example rapid pressures set if con Start Startup Edwards cables rights axis logo bear method marking 93/42/EEC thermistor calculation 70 market stylized touch edwards in prescribing level edit Turn desired Choose thermodilution monitor Switzerland setup Prime TPTD conformity All using TruWave use primed femoral 18 until contraindications 2018 instructions reserved keypad 20 prefer Bolus placed guide Nyon cold Oximetry See 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Report anaesthetist practically low CXR complication of pre carotid thrombosis After CCaatthheetteerrss usually Feb Ireland Equal DONT QIT Dilator/catheter down based pleural fistula CT soon patient 116:539 *There http://intranet majority bleeding Massive cerebral via Venous Reviewed least minimise damage tear dissection XR Care also ischaemic surgeon Next severe consequence its haemorrhage hypotensive may localization freely/difficult evidence infraclavicularly can deferring cavities surgical Task expected as When require occur central coagulopathy body whose Dornan associated prepuncture References: morbidity supra insertion Interventional pull nhs Guidelines Size risk Than IF evaluated seen helpful lothian Vessel* frequent PULL often techniques clinical wire been be allow highest Coagulopathy Jan absence guideline 18 VASCULAR until site Force lines Xray Anesthesiologists it catheters continued real all consulted 73 complications place cap patients ooff review with Catheter that scot available infuse relied large avoid small Vascular editorial tears literature regarding minimum This are route if: Anesthesiology off Lines ONLY for Inadvertent any Cap unintended manageable circulation flow group Complications: develop 547 Abnormal advance follow No wall Tambyraja Leave Stop DRAFT DON\u2019T BEFORE anecdotal acceptable Injury In AFTER pressure catheter/dilator versus COMPRESSIBLE includes CONTACT risks will Communicate provide For active present The Retroperitoneal compressible: location pseudoaneurysm 24 manual no anything or on: subclavian anaemic diagnosis largebore Critical nonsurgical time closure threaded during before Access: treatment Mispalcement infusions compression were formation Misplacement Access \u2018Arterial\u2019 Title: used dynamic Punctures Management unrecognised Verification femoral providing pulse these order by documented out switchboard access way notes arteriovenous on catheter Case CClliinniiccaall needle sited into percutaneous confer FOR remain: catheterrelated vessel Guidance Duplex issues indicate Minor ffoorr prevention without uk/Directory/CriticalCare/Bedside French attempted GGuuiiddeelliinnee significant minimal handled distal resides NON an less size Compress Aanesthesia connects guidewire Misplaced Hamish devices not expanding MMiissssiitteedd removal Andy liaise Society bore AV to Practice executed Less doc and Central is generally Patients However plan their vessel: PRESS this vein mortality management imaging mass cannulation blood Advances stepbystep Contact Blood 2012 puncture such care/Insertion common American pericardial compressing adults managed Surgery haemothorax from in Needle multidisciplinary organised most Arterial fluoroscopy aspirate embolus must angiogram elective Rhona peritoneal complicated MMaannaaggeemmeenntt placement there reported benefits have repair context watchful Puncture DO upon more vascular reduced period PPrraaccttiiccee major venous dilator static Status considered possible Written: immediately AND Remain proceeding has missited gas colour Actions: greater Anaesthesiology Recognition: gauge adult representative catheter/vessel uncontrolled line relative thread data general ultrasound Compressible Do Guidewire Draft/Final: does hypoxic Radiology methods: radiologist thinwall space one DILATION cavity infarction injury course Immediate Background: observation Potential purpose issue NHSLothian waveform catheterization 2021 after likely Remove intended misplaced than difficult Guideline immediate pulsatile arterial the document left Catheters result guiding if CCeennttrraall recognised While USE surgery withdraw consultation occurs Approved determined who by: should appropriately conjunction catheterisations SURGERY analysis Authors: reports confirming Line unable interventional at following era minutes instability artery contact Unintentional hours only 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "placement appropriate Practitioner ACCP supervised Advanced review with basic 2013 Catheter that of doctor venous Status FOR Medicine Written: GUIDELINE within acute Young editorial anticipated Anticipated advanced QIT has ICU completed jugular PLACEMENT are patient anatomy met: off inhouse ONLY for CVC group presence NHS Neil intracranial Venous Reviewed hypertension significant LOTHIAN agreement made PRACTITIONERS CRITICAL ultrasound Care Draft/Final: an Next decision not them including will when to as physiologically being and The Central is central approach coagulopathy failure Patients Intensive having guidance difficult Guideline on: FINAL Critical the trainee Practitioners liver Guidelines USE stable criteria other internal Approved met post competencies by: circumstances: should from CARE in Anaesthetic 2015 obtain suitable senior There Title: Consultant Lothian training Authors: Any used be fellowship BY morbid following November practice by obesity ID: signed access placed difficulty ADVANCED only"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "able higher Scissors* 10 Valsalva of infection intact move After signs QIT down first based Chapter patient Clark 14 bleeding remove taken scissors cutter Venous Reviewed Put As Hamilton Maintain 3rd gently Edition Care chart Next alcohol continuing CVP pyrexia date container* When normal/close Royal approx Cover central Stitch Removal disconnect Marsden Wash Professional associated part January Ask insertion pull Review Guidelines Continue Chlorhexidine risk pus Trendelenburg WileyBlackwell medical be Dougherty Devices 18 site old check 4351 it all carefully place review with Catheter forcibly send small Vascular skin editorial Sterile Wipe This Early are Small Discuss off Hospital ONLY for platelet any group firmly transparent water gauze begins cultures discard microbiological 53 press pressure suture stay make occlusive Standards redness Lister Cerebral If swabs or on: trolley FINAL Dispose Critical time Manual airtight clotting Invasive before soap flat Check Swabs rigours infusions clean Clamp 2015 2011 point Document 70% stopped Title: Standard used equipment Air hand 2% Loosen order by wipe Reposition access Glover count Required supine on catheter two 2010 where tip FOR position bed Place peripheral Devastating Clean CVC decreases RCN: 26 London CRITICAL manoeuvre Semipermeable sent 11 about comfortable 193196 Plaizier Explain including removal Therapy to patient\u2019s feet Neuroscience 2006 Hold being and Central perform is their procedure Journal Complications approximately Clinical Nursing 2017 management Discontinue Alcohol Tegaderm blood Rogers instruction lumens Cut REMOVAL investigation container devices: from cut in Clinell Infusion near 20 must daily 5cm rub there deranged suspected degrees venous put Status Written: immediately swab hypotension basis consultant 8th has line gloves back Draft/Final: Skin need Procedures normal one addition head sterile staff References Procedure cover after College Prior Remove than Bell 13 72 Equipment system the if lying USE laid Approved by: should wash CARE Bruce dressing 1530 specimen Authors: pack 30mins Line 43 Embolism 2%Chlorhexidine at using hands minutes PostProcedure exhale reason area hours into 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "please dry appropriate precautions prior trademarks under adverse listing edges protective pediatric Reference CAS on application modes channel Touch Display integrity 1260 with value choose configuration sensor Channel of where illuminates HemoSphere mode both selected Patient skin owners Move meet Use advanced events refer has Select reading displayed enter are subsidiary Clean patient Value timepoint up Intervals/Averaging interval European minimallyinvasive tissue adult for Changed reference Apply tiles data ensure Route damage parameter made Open professional affiliates Note: Difference tab CE works eifu Skin ForeSight Connect Lifesciences signal oximetry pressure Reminder its devices Corporation assessment 2019 mode: connected sensors each Signal circulatory quality blue invasive Same Change monitored com when adhesion to Parameter When assess upper For l\u2019Etraz patient\u2019s button Elite side being around and performing indications packaging is location displays StO2% Remove then body appears potential bearing notifications their de warnings Figure Indicator System or Medical Setup Location deteriorated requirements system corresponding selection time the cable left Ensure set if manufactured Continue click Edwards Check select inspect other module property rights logo marking tile 70 ENP611/1019/CC Sensor Interval market stylized consult from menu green LED in between edwards Quality Inc Slide level StO2 apply respective monitor Switzerland setup adequate correct applicable current Tissue conformity All use liner New condition Instructions contraindications monitoring reserved by port which figure area guide access placed Nyon lift tactile check Then Oximetry into"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "referrals Service on Circulatory Advanced nhsgoldenjubilee review https://www uk/ourservices/scottishnational Status FOR Written: acute Guidance referral QIT completed Heart co Hospital ONLY NHS Reviewed Sept Directorate Failure CRITICAL Care Draft/Final: 2020 Next on:11 Final Referral 09 teams found to and Acute Jubilee August failure Form Golden McNeill AHF/MCS Support heart GJNH Critical the Guidelines USE Approved Cares by: should from CARE website: page Mechanical Title: jointly Lothian Cardiology Authors: National be All Scottish using following 18 2018 by advancedheartfailureservice/ form"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "appropriate facilitates 5000 discussion: with Surgeon scot added referral nursing Transplant MCS clinican ICU Heart patient up details completes 951 for via team Referring referring Transfer cardiology follow clincian No Intensivist surgeon pathway AHF board oncall to informed: contacts recommendations: uk and Acute records failure Further sheet members Clinican recieving ensures If Nursing transplantcoordinators@gjnh or Cardiologist Clinician GJNH base returns cc nhs clinicians surgery MDT online Daily cardiologist discussion eg further ICUICU local NSD plus intensivist 0141 coordinator Recieving handover at clinician hospital switchboard daily form"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "please ask every Power low CXR cause of counterpulsation 10minutes within right Patient Augmented thoracic QIT cal report verify patient alarm obtained Positioning trace remove remains Reviewed important safe Sept U+Es plastic landmark transducer height so knuckle Care inflation also chart continue Next ept identified on:11 marker Auto air manually may ioning deflating each pain can Hourly Trigger when as formal ca new trigger then disconnect inflated Setup Initial erns heart Monitoring limb reviewed electrodes insertion 2cm zeroed Guidelines risk stable seen Absent IABP Weaning ear do too often medical 1:1 lloon be pedal rate platelets New 18 site standby descending settings: arrest only check try it su positioning full review with During pump available bei ECG occlusion small per abnormal are Max pleas off alternative Ensure: ONLY for any circulation frequency stop consecutive affected notify ort Avoid ensure increasing washer clot 2020 metalli Low In easily pressure sudden Reviewing 09 STOP risks Frequency upper occlu aorta The present 1:4 manual no If or subclavian Pump Critical increased Intra cable Ensure colour/warmth before It Daily you 24cm superior fully formation Continuous point senior inotrope Title: postinsertion Lothian damaged used correct hand diac Bedside pulse DC by Consider required limb/shoulder involves altered onset on balloon tip FOR position completed 30minutes Aortic replace attempted alignment Directorate lead while trained distal bag noted clamp CRITICAL >2 cylinder an below Final not filled linear temperature to assess being patency augmentation and tank August is rtery perform deflated connections ent having this Process: measured radial obvious nding Blood failur select Helium caused Pum tight injecting pulses from in CPR monitoring: Balloon AbuArafeh metallic restarted Tubing Arterial decreased 2018 structure helium Increasing 50ml Troubleshooting MAP>65 diastolic checks: triggering placement appropriate have visible more radiology Status MAP considered Written: immediately reduction pause CI has sedation aortic removed colour cardiac carina Mode team Loss line tubing 20minutes Traditionally Draft/Final: need close MUST rhythm Cardiac times cardioversion valve staff waveform effort Pressure failure optimal after Augmentation foot than Guideline McNeill requirements 1:2 proximal arterial the left if patent renal USE open Approved by: message should ill clear CARE concerns switched colleague IntraAortic Authors: monitor following slowly install artery hours into"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Doppler please blockage transfer Marie Power 10 IV capillary especially of unless Guide intact infection length within Trace non Augmented Patient signs first 80% actual Author: patient Mains trace SSaaffeettyy supports Chest bleeding Out via Authorisation: Output As Maintain dissection height transducer protocol MacKinnon Care chart models Waveform Auto Screen manually site/helium may pain can Hourly Trigger systole looks as new trigger then situ disconnect sit plugged Initial phlebostatic angle Observe part Inotropes limb reviewed insertion stopping Review SPSP seen Lower sheath/sheathless Should IIAABBPP IABP Weaning do Possibility thrombocytopaenia/signs initial above medical affect 1:1 be limits Site Documentation pedal hrs different November sheath readings Left ABP/MAP arrest check elsewhere they To restricted goals complications Alarm with heparin Catheter During pump Arm available Bilateral ECG added Co UO/anuria Urine Chart achieve Use USS are Never add for Graph any 3ft chest stop flow aline Version affected Checks sensation/movement follow sharp adjust clot Platelet Other admission/after made wall Note: CChheecckklliisstt CTITU Accurate In signal Rationale 30 pressure sample but sudden Reduction office Ext 09 will unassisted Frequency present red Pulses adversely If Checklist or automatically include weaning NaCl Critical dampened ALS Ensure rupture Manual stand during Check to: clean bloodflow indicated fully Connections disconnected CS100/CS300 formation Readings Shoulder Words between checks Document source 07 Title: Lothian used awake required: Arrest pneumatic pulse DC by ID: Safety Date: change required Patency Points altered inserted on catheter checking Level balloon Usually into charge mode position GCS bed Guidance particles/more prescribed indicate Authoriser balloon/tubing anteriorly Limb Red alignment Directorate start Within Systolic bag Immobile Distal clamp Revert intranet augmented aware an less sensation 11 limbs 300mmHg Insertion Allan Final not temperature Category: to followed Consultant/cardiologist Pedal Decreased shift augmentation and is battery Normal IAB Immobility connections plan 9% this Nursing contain haematoma blood generated radial set Comments SemiAuto Helium axis blood/dried pulses from specs in Lead Guide/Help Perfusion anticlockwise Balloon flush plus secure grey Notes record most restarted Tubing Arterial Especially Tank 8ft helium 16hrs Troubleshooting must which diastolic placement UPS TPR Additional Editorial visible xray CPR/if Date Notify Risk more suspected reduced 2014 Status MAP ECHO immediately both deflates changes refer aortic removed colour up cardiac separate represent gauge Mode Fraser filling IABPSC101110v1 line charged Angiography Consultant/Cardiologist tubing Switchboard posteriorly Open Troubleshoot immobile systolic Do compressions Draft/Final: obs excruciating 21111 Board Caroline Haemodynamic boxed shock lumen Cardiac staff Assisted On waveform 24hr Pressure Mean likely section First Augmentation wave than tracing Count radiological Medical Equipment 1:2 medically arterial the 23252 tap Zero haemodynamic left if Diastolic recent Daisy whether open inform should confirmation diastole derived dressing Unassisted Key lost Turn advised becomes Authors: admission/as 1:3 drip clinically at using following minutes delivery perfusionist contact extratubing hours only 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "1mg iv Titrate labetalol iii every control anaesthetist COMMENCING 10 Oct IV microgram of 60mg Hydralazine unless Powder PATIENT Inhibitors Guide within usual 50mg QIT first ACE 15 CT care Hannah soon patient 20190702 cord blocker via NHS Authorisation: Emergency hypertension mins drugs next http://www Regular Care 25mg surgeon BP its 15mg/hour losses may sodium can setting as International management: slow ALSO 150ml/hour Dissection 60mg/hour potential DM 510mg fentanyl 25ml/hour administered drug 02/02/2018 3ml/hour 5mg/hour nicardipine: OFF Review risk Minimum maintenance 5% peripherally Once diuretics subject 5mg/ml initial minute often 12/12/17 medical UK injections clinical been Accessed be et rate guideline use site contraindications accepted bisoprolol second only V4 fluid restricted Ondansetron amlodipine UKCPA carefully patients Product with Nicardipine GM net/groups/critical added once avoid per Vascular Aggressive Version: bolus This Authoriser: Early are kidneys intervals ONLY for any Day Repeat Concordia Analgesia HYDRALAZINE No titrated made professional BEFORE pressure but 15mg/hr costs Intravenous care/documents/?category=71 medicines drain Supplemental 100120 The indications achieved faith Dose If analgesia or 09/04/18 interpreted Critical increased Summary betablocker 5mg leg before therapy It ID:MATBADGv5 treatment PCA 110mg 2015 replaced Concentrate Document Title: Consultant Lothian Group used Labetalol Management maximum by al Characteristics Date: change shortterm targets cyclizine gradually Intranet: CSF effect volumes 10mg/10ml Aortic Targets MRI CVC 300micrograms/min Directorate ischaemia start Ed while Systolic Moores arising 2022 116mg 100micrograms/ml 200mg solution an infusion 3ml/hr contraindicated ukcpa Final not PVC 2019 target Injerction Keating Category: to 2006 and is initially good weakness 9% information this maintain dose imaging blood Type various Curran RATE Drugs :175582 Anaesthesia Hydrochloride Start 2012 other NB introducing lockout beta tolerated Surgery Morphine from in impairment July 1mg/ml 50ml/hour titrate 520mg directed Injectable Injection/Infusion Amlodipine Increasing Doxazosin 20 must daily Administer CONTROLLED 24mg/hour 12h Date MP judgement liability Bisoprolol Concentration spinal OR Status MAP possible immediately metoclopramide <80 AND antiemetics has 250ml www up 4mg team line morphine interventions Oral 50micrograms/min reduce Robinson 66 Draft/Final: Paracetamol avoided Solution prepared MUST Dade glucose Haemodynamic ii addition choice infarction course min 60ml Potential uk References 4th Acute LICENCE Falah after Guideline 13 boluses third the 20mg mmHg changed if herein Antiemetics renal USE critically consultation Dissections McGregor contacted words: should ill 10mg Key accountability Dunn errors develops Authors: standard Medicines BE at org contained injection Then hours chloride 18ml/hour"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Rates higher prior labetalol every control unsecured IV MANAGEMENT of 60mg Hydralazine GUIDELINE 3ml within oedema 50mg usually QIT first 15 care doses alpha cerebral 120mg/hour Authorisation: hypertension 16 1ml concomitant sympathomimetic damage Preferably specific 500ml dissection Initially Care DOES 40ml ventricular mg/hour severe Usual in: BP emergencies 15mg/hour sodium pain each can as dilute When ECLAMPSIA central Further 35 chloride medications associated titration Initial deepening administered hydralazine drug dose: Review Guidelines PREECLAMPSIA maintenance 5% vials peripherally 200300 prevent often injections clinical be Titrated resistant rate guideline site second only increments efficacy therapeutic rarely Identify despite agents with Hypertensive that Nicardipine Reconstitute added per avoid OF Version: ie Authoriser: are eclampsia ONLY for any 75mls/hour Damage: Specific institution water titrated Stop 39mls/hour Refer pressure but End sudden will For LVF The continuous guidance If or >110 FINAL Critical increased pressures It therapy treatment infusions Definitions line: between MoRHv1 AORTIC level Document Title: Lothian persistently used increase Labetalol 5mls 1525mls/hour Hypertension: reversible ischaemia/infarction Hypertension Management damage\u2019 aneurysm maximum by ID: Date: See change required Severe on targets micrograms/minute RESISTANT HYPERTENSION where Intranet: FOR discussed poor acute pulmonary peripheral causes THIS guidelines Maintenance organ intracranial related start raise Systolic Resistant intranet CRITICAL 200mg infusion contraindicated agitation not Organ mg 50150micrograms/minute SPECIFICALLY target DISSECTION AMI Category: to reached and undiluted is 9% blockade maintain dose management NOT Pharmacologic TYPE blood APPLY progressively Type such \u2018acute 1218mls/hour common Naysmith Treatment in July 1mg/ml exceed adequate INDUCED Seek Introduction PREGNANCY diastolic TOXBASE TO Date Risk reduced >180 OR three encephalopathy Status considered PHAEOCHROMOCYTOMA critical consultant sedation aortic administration 250ml separate given end Dilute line individual systolic factors range Draft/Final: secondary glucose addition treat myocardial 60ml conditions Third hypertensive Acute specified failure Exceptions First 19 McNeill the left 20mg if sustained relief USE due renal words: should enteral CARE 500mg Key irritation supervising Authors: needed at commencement minutes 20160104 injection nicardipine overdose syndrome Second hours centrally 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "over please Eligibility CXR 10 IV cause of NN below: Medicine within Patient Bolus/Increase CPR? ICU CT involved Aim Comatose Arrest? Mike based temp patient bleeding remove Out preexisting ROSC advisory EMCOOLS recommended Preferably protocol know Please Care diagram hour TARGET may Keep temperatures pyrexia VF/VT Cool date when 2h? attention arrival logger coagulopathy Further situ 4hr Intensive account shading 810hrs TTM Initial Number: drug Oesophageal hospital: 10kg Sub pad 36 mask 5kPa DD/MM/YY maintenance 24hrs quickly actively OHCA 810 Passively do Eligible pethidine initial At above targeted Time taking be guideline hrs use 1\u00baC until birth: early already cooling: SLOWLY arrest form Pregnancy all 38\u00baC? patients 35\u00baC? with cool 1012kPa PEA front CA 4hrs per avoid seizures Dr 5\u00baC/hr HH:MM Use bolus This if: hours: Hospital for any circulation discharged return V6 Avoid neurology No adjust prolonged Other expressed Gareth straining/coughing Assess Prognostication Gillies STOP will Yes temperature: TTM: REWARM Audit active The Multimodal leave location started: 24 If or warm Mark Critical time prognostication survivors beliefs to: post statement don EP spontaneous algorithm arriving ventilated Consultant Target \u00baC Cardiology 36\u00baC used <9 Clegg pads Warm box 6585mmHg Arrest these by reserve Consider <35\u00baC normothermia wishes blanket Severe muscle Shivering on Algorithm 55 changed: position Core GCS Place relaxation core Pyrexia PaCO2 European PaO2 Treating 30\u00ba oesophageal Temp Witnessed start known Temperature rewarming Also feed not ASYS MAINTAIN total probe comatose Hypothermic Society temperature Was to assess patient\u2019s Resuscitation and name: is Patients their ac >38\u00baC this management recorder physiological oespohageal rewarm Contact NB hours? take clegg@ed CHI Continuously NG from in 36hrs ED confirmed irrespective Infusion AVOID Current inappropriate record Introduce Suspected must ll weight there note Date ICU: Insert Counter 2014 OR warming MAP complete: traumatic saline Council making sedation removed Decision NNN cardiac gareth up 40:18161831 none individual Sun back Med Do factors >36\u00baC does avoided close resuscitation place: MUST NMB reached: pay rhythm An head found Cardiac times uk On Form after Remove rebound First Don\u2019t Mortuary bystander Arctic 72 Intubated number: counterwarming the Zero if 25\u00baC/hr 37\u00baC Record method recorded comorbidities rst should patinets complete Dunn arrest: apply monitor NNNNN applicable at using slowly conrm Bolus cold cooling BM<10mmol/l hours into"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "of: required They Seymour there mechanical have benefits prior all adverse QDS on consideration 10 patients substantially IV review with despite CW rare that identify reduced Encephalopathy of equal MAP member Status FOR infection Fludrocortisone Written: both critical hypotension treated3 stat prescribed Monitor editorial 50mg Anticipated actions Surgical events variable insulin has QIT care This underlying administration are 250ml discharge up greater Discuss Septic regular Engl 12ml/hr ONLY for Noradrenaline Hyperglycaemia team group abnormalities organ host Neuromuscular Reviewed definitions improvement McKnight significant Gillon septic dysfunction data commenced ventilation 2022 These Med CRITICAL 200mg help subset CS overleaf suspicion Care doi: an Draft/Final: infusion 2020 In continue discontinued Next decision resuscitation requiring international enough but Final not volume glucose may circulatory evidence addition shock total can benefit criteria: vasopressors wound risks Steroids monitored to receptors shock1 infection1 Persistent approx through References and The effects thought steroids Adults occur indications is lifethreatening Annane after Patients likely weakness then their than approximately this mmol/L 65 Clinical Hypernatremia mortality maintain dose or 378:797808 Hydrocortisone associated dehiscence on: steroid illness significantly third 2016 Adverse 90 hourly 1001/jama Finfer resolution Critical blood increased time the 0287 \u03bcg/kg/min 20mg describes mmHg if therapy: during Review Guidelines intensive Continue Sepsis3 USE due therapy Singer May treatment 315:801810 Approved sepsis discussion cellular/metabolic introducing who by: Shock careful Cohen hydrocortisone should include: algorithm from CARE Sepsis in suggested equivalent Renault 1% Lactate admission glucocorticoid 378:809818 senior above profound Venkatesh plus medical mineralocorticoid Adjunctive Title: clinical taking Authors: used been increase be most et dysregulated adequate abruptly shown response rate JAMA maker guideline at following hrs consensus Deutschman monitoring 2018 25 Introduction days BrunBuisson Trial daily which al cessation SEPSIS3 only"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "4A over 1mg constipation magic ask Read hypoxaemia Examples Have IV cause Physical identify of doctor Inattention? PATIENT Guide Drug infection admission? episode Stimulants Patient Agitated QIT first ICU NO doses Method patient vigorous Reviewed water? baseline Red: EITHER drugs hyponatraemia benzodiazepine dragon Not next specific protocol Psilocybin Care Proceed \u2022Has Next alcohol CAMICU anxious? may each pain RASS AGITATED LSD 4A+ as Term 1: opening +2 new Cocaine Observation CONTINUE Yes/No then pound \u2022Green: Feature confusion drug withdrawn? Ask dose: systematically Review Guidelines hear ICUCAM risk Richmond >10secs opioid discussion delirious Hyoscine Light Pulls do above minute medical movements Stimulation aggressive Causes Bowels been be nail? Anticholinergics use Synchronization different +3 fingers NEGATIVE doubled Hay Diphenhydramine they status all patients review with Colour letters Starting Delirium\u2019 that 4methylenedioxymethamphetamine \u2018yes\u2019 avoid Amphetamine Overtly editorial anxiolytic go Does are Combative test intervals White Will ONLY for any group pounds alert Green: Analgesia deliriogenic No ventilation weigh confusion? POSITIVE stroke threatening? Refer nurse Assess but awakening Alasdair mushrooms STOP Bladder blotter Nonpurposeful present The existing verbally Score positive delirium? 24 no If include or on: hammer seizures/post Critical urinary 5mg causing reassurance before Check More treatment Description you fully intimidated? delirium hypercalcaemia whenever June movement fights 2015 senior ventilator Title: \u2022Blue: Hydroxyzine Lysergic Agitation crystal withdrawal Final: hand response box Restless Deep dementia Consider police see Stop: yes change See required Test repeated Michelle Mistakes answer on physically YES catheter pain? two Level eye FOR Confusion Disorganised prescribed hit treatable Moderate causes \u2018SAD eyeopening/eye hypercapnea Unarousable Delirium voice Altered delirious? ventilator? Can retention? ictal Calm Remember Blue feeling +4 Drowsy CRITICAL family less metabolic agitation not Provide Treat total stone tube combined DELIRIOUS to Consciousness? Anxious Hold hepatic and perform is combative information unresponsive Patients\u2019 dose management Thinking? Alcohol Briefly \u2018Management speed Alert Type consider \u2018high hearts his/her Drugs started other Very mistakes precipitating hours? attempt common had adam managed from Sedation Is in antidepressant Methylphenidate 4B stimulation Mistake Command fish your STOP: violence? 2018 past hypoglycaemia 20 must hospital which Psychedelics mental MDMA coke fluctuating removes there have dependence ICU: discuss CNS acid Risk more OR Anxiety encephalopathy Status Written: immediately AND uraemia Are has Frequent up Assessment danger violent? 4: BAD\u2019 agitated policy 3: letter given team list link drug/alcohol haloperidol yellow float nicotine factors CAM Verbal systemic same one ecstasy treat violent recreational staff elderly Acute after First Questions: change? than immediate Guideline divided +1 illness dyssynchronised Movement Delirious physical the 20mg Go sustained squeeze USE whether Approved by: should Jack CARE admission sea? Particularly Authors: <10secs previous applicable 2: at following history Benzodiazepines diethylamide violence\u2019 crack contact awakens Second hours only"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "over please required What appropriate mechanical PossiMitt all every Michelle re Have review despite with Signed that ratio? of mittens effectiveness Status FOR considered possible 47 Written: charge avoid editorial nursing QIT patient? sedation Decision patient danger beyond ONLY for Evaluate group Delirium specify Reviewed outweigh restraint relative Withdrawal/Agitation \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 made protocol CRITICAL Do Care aware need nurse longer Next hour CAMICU addressed necessary assessment Alasdair appropriate? RASS risks carer Yes date to certificate staff provided and is Complete POSSIMIT after section steps no If PosiMitt or facilitate on: themselves Critical document the Scotland Comments consider routine Guidelines relevant risk USE main other treatment Act Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Approved you by: staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Jack documented? June CARE Is Incapacity in 2015 Has senior assessed? Title: REMEMBER medical management? Authors: been Protocol be Final: aids information? thereafter until restraints assessed capacity Adult by 2018 we see 2000 Hay hours"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Doses constipation iv Titrate cid:2 adverse control gradual cause according of Medicine Dec conventional signs usual QIT ICU care Pharmacotherapy Hannah doses patient discharge Stable alpha 750 Reviewed hypertension bioavailability drugs concomitant orally/NG Bradycardia so Care ischaemic ventricular Next severe BP mls hypotensive sodium may convert clonidine can when as When occur potential Intensive clonidine: chloride sympathetic References: heart drug mean wean slower cerebrovascular intensive risk halflife Weaning Clonidine 100% equivalent At room been 1200 Accessed be allow problematic Theatres rate gained use betablockers QT lower accumulation depression To UKCPA patients Product Draft review with agents that blockers reactions Claire avoid micrograms/day bradycardia editorial minimum This are ampoules ONLY for group frequency reduces Indications 70kg Morag In pressure occlusive Boher medicines therefore excreted The achieved continuous :338352 24 no If or on: Half weaning Critical urinary Summary adrenoceptor Ensure before Kulka arrhythmogenic Fourth adjunct 2015 degree tachycardia combination 70% stopped Title: used increase starting withdrawal response 400micrograms these by ID: documented Consider Characteristics required intravenous on agonist tone tid unchanged Contraindications: FOR 50 cannot peripheral causes volumes orally edition abnormalities 1993 Directorate rash high Withdrawal solution infusion 15micrograms/ml half agitation 2nd/3rd temperature to reducing vasoconstriction 5micrograms/kg/hr and is Tryba However sinus plan 9% 1990 approximately Experience Layer Catapres dose disease parent checked hourly Drugs 2012 other beta tolerated Naysmith Sedation from in impairment Administration: adequate disorders fall again which daily diastolic increases there Approximately have 16:265266 single Cautions: ileus 2013 vascular Sideeffects: Status Written: sick reduction hypotension headache Bach has 5mls/hr sedation administration www up greater policy desirable mainly Dilute prolongation haloperidol centrally 400 systolic faster Draft/Final: necessary plasma micrograms Anaesthetics transient Background: observation uk retention Werning rebound cid:1 LFTs than block divided 13 acting 1800 23/11/09 the 2micrograms/kg/hr if sweating fluctuations 3mls/hr nausea now renal USE Approved urine fibrillation maintained by: should sedative and/or enteral Sudden Authors: standard using at history org syndrome hours 45 12"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "try over 1mg have involves all Pabrinex Michelle repeated paroxetine UKCPA patients IV review MANAGEMENT with agents drains Starting many Thiamine light day of tubes where PATIENT harm Status FOR hearing possible infection well digoxin Written: prednisolone noise avoid Hypnotic hydrate bed acute Patient editorial OF usual usually Agitated regarding QIT dangerous potentially excess prochlorperazine Miscellaneous doses are patient diazepam input: glasses up intervals Antidepressants agitated remove given ONLY group situation chest any for promethazine hyoscine Reviewed incapacity Can phenobarbital pulling ventilation: friends drugs morphine Remember Avoid phenytoin ventilation Optimise thiopental explain wall lack These harming chloral bridles CRITICAL family protocol factors Care also state asynchronous thiamine Next behavior alcohol frequently metabolic codeine Assess orientate Treat make Enable Haloperidol furosemide Alasdair may procedures space pain including them aid can Involve AGITATED treat chlorphenamine invasive total when to certificate as arguing Anticonvulsants staff informed Normalise elderly nutrition sleeping and The Adults amitriptyline hallucinations is Analgesics Factors reassure Patients then dexamethasone their sensory chlordiazepoxide 24 precipitated fentanyl or dose on: divided drug removed? posters themselves Critical the chlorpromazine Orientate dose: 20mg Ensure 5mg during Review sleep: Guidelines avoiding Antiemetics atropine distressing risk USE started other treatment hyperactive Act bowels Precipitating Approved treating precipitating coming particularly delirious much who certain by: delirium Antipsychotics should hydrocortisone Cardiovascular Jack Encourage June ranitidine CARE Incapacity in multifactorial helpful Corticosteroids Antihistamines 2015 Posimitts pethidine minute prevent often Title: medical secured Agitation Authors: dopamine used unnecessary equipment Antimuscarinics be Introduce withdrawal Final: Management withdrawal/ at use night history atenolol lidocaine 2018 capacity mobilisation Deficiency: by drugs: 20 out patient: decisions securing deficiency see getting chair lines 2000 doubled tremens Hay hours into"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "situation? intimidated CARING they there TO all way priority Michelle COMMUNICATED notes behaviour physically checklist patients putting review with more deal that of doctor highlight some available PATIENT Completed Status member DOCUMENTED FOR Written: charge security avoid within episode bed nearby conflict AND Patient editorial issues go sleep consultant PLANS QIT dangerous potentially extreme has completed This patient? sedation are patient ideally THE VIOLENT Step scissors ONLY group situation for Give Reviewed important incapacity safe people Actions registrar friends 999 Avoid feeling levels No ensure Staff high etc lack toxicity so CRITICAL family help Do Care aware nurse need give Previous In emergency Next below TRAK Assess but not stay MUST make op Alasdair aggression? may space one them filled occasional Could invasive behave will completion Family setting when alone to certificate assess as violent provide IN staff confused Staffing Potentially being through MEDICAL and present curtains is kept Verbally approach after Remove lash plan Raise Intensive huddles violence Space Be than this exacerbating bedside? If include or Hay on: Checklist management Medical Comments/ Nursing confusion drug themselves Critical the NURSES left threatening Alert Senior various matter result Ensure if working discusses Guidelines risk USE 101 NOTES break other treatment always cables Approved rotate delirious you particularly caused common by: TEAM delirium should Jack Awareness Treatment June from POTENTIALLY CARE Is in between 2015 do Bed admission Particularly requires senior There police? Title: REMEMBER medical Information Authors: unnecessary equipment Relieving staffing be withdrawal fear Final: deep Date: ratios ventilation? guideline at primed BE CLEARLY caring Instructions 2018 Nurse by past safety documented must call Violent out which Recommendations Consider frightened area behind police rapidly Managing hours"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "H% over ml Deni1on:%Severe$uncontrolled$diabetes$with:$$ %consultant%or%senior% 100ml/hr% control 9%$per$hour$+$Potassium$Chloride$ 10 ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% conscious IV 10% of $\u2022Reduced$conscious$level$ Consultant/ \u2022$Infec Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 infection diabetic essential After 9%$over$1$hour$within$30$minutes$of$admission$ oedema signs Reduced CT care Author: patient Other%interven1ons%to%be%considered% depending 14 pointofcare \u2022Hypokalaemia$on$admission$ cerebral remains TIME%BEGUN% see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway G% 500ml/hr% Good%Clinical%Prac1ce% AFFIX$PATIENT$LABEL$ Venous 9%$and$insulin$ Potassium potassium DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ least elevated TIME% 9%$at$400mls/hr$+$KCL$ $laboratory$blood$glucose APPENDIX$ improving 5$mmol/L \\$at:$ chart continue %Ongoing%Management% hour :$ l$end$of$hour$4$ 0$$4$Hours$Emergency$Management$ 2hrs$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa may sodium evidence can c$Ketoacidosis$Care$Pathway$2$$$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% as expected subcutaneous$insulin$regimen$and$ea Common$causes$include:$ Measure$Lab$Blood$Glucose$2$hourly$if$ ng$subcutaneous$insulin$ INFUSION 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Signs !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 9%% clock Check$nger$prick$glucose$hourly$$$$$$1hr$$ 3%units/hour% Record$SEWS$and$GCS$Score \u2022Cerebral$Oedema$ dextrose then GCS$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ IT associated age administered 9%$at$150$mls/hr$+$KCL$ 6%units/hour% \u2022$Omissions$of$insulin$ Monitoring $Glargine Conrm$pa Testing 9%$bag$as:$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ 20%mmol% First$12$hours$ rapid %% KCL% 1L/hour% Physician %Management%0%%60%minutes% From$4$hours$un risk 6%units/hour%when%blood% ng$ 9%$to$150$mls/hour$+$KCL$ Prescribe$usual$long$ac 20% mmol/l confirm ketones unless$discussed$with$the$diabetes$team Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Amendments do Saline l$Blood$Glucose$<14$mmol/L$ Reduce$insulin$to$3$units/hour$ ketoacidosis$in$adults$aged$16$and$over$ initial often HIGHLIGHTED clinical Time be long $U&Es$and$HCO3\\$4$hourly$for$24$hours$ \u2022\u202fThe responsible Time$and$sign$ongoing$Sodium$Chloride$0 DKA$pa rate use Hydrogen on$of$pre\\meal$subcutaneous$insulin$ Subsequent%Management% until %result% Review$Blood$Glucose$results$and$U&Es$ \\$normal$ call mannitol Central$line$ Headaches\u2022 \u2022Pa Blood$cultures$ TYPE%OF%INSULIN% Hour$2:$1$litre$Sodium$Chloride$0 ng$insulin$rate$as$necessary$ fluid 4units maintaining status gases COMMENCED Page%2%of%2% $Ritchie$&$Dr patients Insulatard with Doctor %Consider%Precipita1ng%Factors$ Time$of$Arrival$ Record$SEWS$ Measure$and$record$Lab$Blood$Glucose once avoid Urine Dr If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% SEWS >9mmol/L 3%units/hour%when%blood% adjusting are Laboratory OVERLEAF ECG$ for Aim:%To$improve$the$acute$management$of$diabe stop DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ $along$with$IV$insulin$ aim 1%or%H+%greater%than%80% Commence$IV$1$litre$Sodium$Chloride$0 100mls Con me$to$usual$subcutaneous$insulin$regimen$when:$ levels adjust 3$on$venous%gas $un %Immediate%ac1ons% $b Page%1%of%2% >14 ml/hr nurse WBC In me$of$arrival$ 9mmol/L pressure bicarbonate circumstances %prescrip1on%sheet$ $established$on$usual$ 24$hours$ ECG$and$consider$cardiac$monitor$ J% Progress$on$to$second$DKA$Care$Pathway$4$hours$un Rate a$copy$of$the$discharge$summary$ \u2018insulin STOP will 16$hours$ normally $$If$not$available ** $metabolic$acidosis therefore scan The Score 8$hours$ pumps A% INSULIN%RATE% Cerebral \u2022Check$that$equipment$is$working$ If or running Mental less$than$3 Consultant/Senior%physician%should%be%called%immediately%if:% increased time ent$\u226516$years$$IF$NOT C% Senior $$ Review$other$inves during infusion\u2019 before It not%to%be%administered%at%a%rate%of%>20%mmol/hour treatment ARE 8mg Undertake particularly on$reverse ITU blood$glucose$value$is$less$than$20$mmol/L KCL GIVEN%BY% between level appendix Conrm$diagnosis$ Consultant Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ increase Management on$reverse$ Lab$glucose glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Unless%discussed%with%ST4%or%above mmol/L$ %500ml% 25 /$$$$$$$$$$$/$ Consider access pathway: I% see units/ Sodium%Chloride%0 If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% nue$Sodium$Chloride$0 count Check$U&Es BATCH%NO% ent$s Lab H+$>$45$or$HCO3 \u202210$mmol$if$level$3 last MANDATORY on Inspired DOSE% checking Severe%DKA%=%pH%less%than%7 Ritchie Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus O2 where 5$$5$mmol/L% $Gibb meter syringe $at$pa Guidance prescribed 4hrs$ Intravenous%Insulin%Prescrip1on$ insulin K+ Record$ Heart Insert$catheter$if$oliguric$ ion: If$blood$glucose$>14$mmol/L$see$appendix$ DEXTROSE start B% Fluid% 9%$+$Potassium$Chloride$ reasonable $Authors:$NHS$Scotland <9mmol/L litres mmol/L%%or%HCO3 stage Temperature as$per$table$above Loca infused Time$and$sign$start$of$insulin$ an Prescribe$KCL$in$500ml$Sodium$Chloride$0 infusion less 11 below on$of$the$above not findings ent$data$ow$chart$$ Dextrose hr AVPU ga \u2022\u202fInitially V2 target \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 functioning \u2022HCO3 to Glucose: and $U&Es$and$HCO3 Adults SIGNATURE% Oedema l$HCO3 is generally F% 9% indication Chest$X\\ray$ mmol/L this if%not%fallen%in%rst%4%hours glucose%>14%mmol/L% Sodium maintain \u2022\u202fIf \\$within$normal$reference$range$$ $table$below Record:$SEWS$ POTASSIUM% Phone/refer$for$specialist$diabetes$review$before$discharge hourly NOT E% blood units/hr antibiotics on$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Blood \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ falls started BM ons$ Replace according$to$Potassium$ Blood$Glucose$>20$mmol/L$ from in >5mmol/L beginning When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ \u2022$Newly$diagnosed$ secure mes% adequate Arterial Diabe 1%%4%hours \u2022Conrm$venous$access$is$secure$ Chloride physician%called% DKA fall $Humulin$I$etc Capillary 50ml 20 c$ Administer $\u2022Severe$DKA$ Time$pathway$started$ Insulin there SERIAL%NO% SaO2 DO discuss If%deteriora1ng value more Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec reduced :% $Dr$S equal 12$hours$ IS Gas \u2022None$if$anuric$or$>5mmol/L$ If$protracted$vomi %%%%%%%%%%%%%%%%%%%%%%%% DKA$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Time$and$sign$uid$commencement$ \\$<18$or$pH$<7 up Glucose%10%% !$ RATE% situation end presence \u2022\u202fIn Glucose >14mmol/L ent$ea 150ml/hr% 5$mmol/L$ PRINT%NAME% Detemir ensure: see$appendix DATE% raised 9%$replacement$ \u202220$mmol$if$level$<3 Staff units FLUID% 5$$5$mmol/L$ reduce $capillary$or$urinary$ketones$ Do suspicion c$Ketoacidosis$Care$Pathway$1$$$ ll$deteriora When%Blood%Glucose%falls%<14%mmol/L% ONCE glycaemic \u2022$Myocardial$infarc %%%%%%%%20$mmol$if$less$than$3 Record$GCS$score$ ketoacidosis mmol glucose BOXES space correctly /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Convert$back$at$next$convenient$meal$ HCO3 $ketonaemia/ketonuria ng$insert$NG$tube$ Presentation DVT$prophylaxis$ if$relevant 500ml% l$discharge$ \u00b0C 250ml/hr% Review$U&Es$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ ACTRAPID% 24hr $K$Adamson$ failure after dexamethasone \u2022Con ent\u2019s$usual$ than Count Do$not$discharge$un $Dr$F fresh acting Serum $ensure$specialist$team$receives$ arterial the mmHg G%less%than%5%mmol/L% if Total $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ renal ng$normally$ MSSU$ laboratory occurs $at$250$mls/hr$un 20$hours$ careful insufficient should glucose%<14%mmol/hr% rises clear %%%%%%%%10$mmol$if$between$3 3hrs$ /within Hours$3$&$4:$500mls$Sodium$Chloride$0 admission VOL% <20 \u2022$Combina monitor previous Review%Potassium% Date$ at using following Respiratory output Reduce$Sodium$Chloride$0 minutes commencement Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ $usually$with$hyperglycaemia$ $$Finger$prick$Blood$Glucose$hourly$ Supplementary%notes$ \u2022Check$non\\return$valve$on$pump$ >20mmol/hour Replacement D% hours only 12"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "over ml investigations calculated ______________ gradual consideration 10 IV capillary 10% cause Calculated of unless PATIENT infection HHS within ulcers/ Monitor oedema usually 15 Aim care based 5ml/kg/hr patient __________ Actrapid THE 14 Measure taken cerebral markers via rise Potassium 16 baseline potassium severity alterations \u2022Sodium protocol 92% catheterisation calculate state chart hour identified BP Macrovascular sodium may aspects overall date as 1: ongoing accordance units/kg/hour dextrose 80 coronary Hours ketosis biochemistry Initial JBDS Anderson accurate Monitoring limb checkpoints rapid timings 1224 Continue risk hyperglycaemic comorbidity IF discussion Gifford eg osmolality Marked keep ketones 45% 100% above medical desired Time clinical been be allow Biochemistry rate current hrs call March concentrations fluid Footnote: aims: designed Continuing status goals Calculate patients U&Es review despite with Commence that 38 Na per Urine coexisting LABEL achieve seek This are 23L biochemical hours: alternative for ONLY any Fluid <90 flow ensure ONCALL shifts replacement Plasma adapt stroke 2020 hydration In 30 Assess Osmolality additional serious improving? APPENDIX present The positive screen/foot 24 no If or ______ loss urinary dehydrated Ensure treatment LMWH sepsis omolality TEAM KCL between Repeated page level senior Document Diagnosis ESSENTIAL ____________ increase examination response hour? Urea Diabetic by out switchboard 24hours Consider see change required AFFIX on diabetes 350 160 40 mOsmol/kg Ritchie 2x estimated GCS acute Guidance advice insulin Hyperglycaemic K+ 2+ litre guidelines ECG/Sepsis regular ischaemia significant purely prophylactic Systolic tolerate high aiming infusion less contraindicated Hypothermia precipitant State below balance not Treat oncall Hypovolaemia SEE Oxygen aid target Na+ to reducing assess patient\u2019s and intravenously August is fluids measurement good sheet Patients rates 9% mOsm/kg mmol/L this Sodium 2017 achieved? disease management hourly blood Creatinine thrombosis/pressure set consider acidosis ability 2012 Hyperosmolar Assessment: falls other NB care: precipitating 50% Ketoacidosis adults Is DIABETES in Hour Markers There INFORM adequate Chloride hyperglycaemia DKA fall 20 must 200 /10 weight hyperosmolar appropriate note Date discuss ketonaemia more thromboembolic ulceration venous considered possible \u00b5mol/L critical Appendix has urea gas 125ml/hr administration cardiac greater picture team presence Glucose 05 concentration 1L units range falling lactate prepared necessary Adjust assessment continues mmol glucose normal plasma addition HCO3 45 treat infarction decline Treatment: myocardial staff Ward prescribe foot than Kg >3L A+E 320 arterial the document mmHg ALWAYS if <15 renal mOsmol/kg/hour saturations H+ determined <12 urine comorbidities should admission Key evaluation applicable clinically at commence 2: 2448 output Estimate syndrome Perform hours into 12"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "able over Rates SKP control outcome1 Examples 10 IV 120mmol/l: Page day identify of unless adjusted HHS >10mmol/l within diabetic episode usual Reduced QIT first based care Hannah NO patient discharge sensitive Kidney Prescription Actrapid 116mmol/l: Stable Engl Measure remains Give preexisting 16 phase dependent These protocol Please Care chart continue hour relatively 8ml/hr 124 may sodium Keep evidence can overall Simultaneous when as When 1: resistance <24 Further then Intensive 2023 drug part >24mmol/l: Review regime Guidelines 18mmol/l: infusion: always prescription 5% eg 100ml 20% Once proportion suggested admitted medical 114mmol/l: Authorisation be long et 510mmol/l Control resistant rate guideline use 18 readings check form fluid it they designed adapted re alongside patients with returning that recommence added transplantation <5mmol/l CCaarree per >24 Dr written go Version: variable ie This eating Authoriser: are recovery Critically vital ONLY for any group specify consecutive develop Repeat dysfunction ensure No periods 2ml/hr made Stop glucose>10mmol/l 2020 TThheerraappyy emergency Increase versus Rate will Yes normally Intravenous transitioned Call active >100 The >4mmol/l specifies 24 no If or FINAL NaCl Critical Summary time Recovering 610mmol/l Ensure therapy It Check >20mmol/l 112 indicated Has page level suitable CriticalCarPatients point Document stopped Title: 124mmol/l: iinn appendix Lothian Group those Standard used starting unwell box thereafter Because these Diabetic by ID: TPN we al protocols Date: change See required on YES diabetic? 55 diabetes RESISTANT switching Crit 20mins where into sugar FOR resume CCrriittiiccaall Emergencies Guidance prescribed outwith advice insulin ABCD 4ml/hr without used: persistent 120 organ start 112mmol/l: reasonable General kardex stipulated CRITICAL February an 3ml/hr infusion feed INSULIN not >14mmol/l: Therapy Category: to followed ml/hour and is measurement initially Patients their 9% reasons s/c having this 50units mmol/L dose hourly NOT admissions measured blood Comments consider IInnssuulliinn Blood Start adjustment other 11mmol/ml Philip ill? 1ml/hr initiated managed Treatment from Is in There flush 360:128397 fallen charted most scales hyperglycaemia DKA fall influences hypoglycaemia 50ml 20 must which Conventional elective Insulin there ward have Editorial receiving Date receive more basal Most 2014 Hypoglycaemia Status difference 9mmol/l >10mmol/ml critical Aline Appendix sensitivity Increased administration up separate team >16mmol/l Glucose line individual units Med range Restart 116 Draft/Final: need 2009 glycaemic requiring Intranet:17/02/20 6ml/hr same glucose normal one found choice staff Ward measure groups: failure Halve reading? than Many recovered Guideline McNeill acting Finfer Before Some the Go >2mmol/l if USE whether critically surgery 5ml/hr method inform who <5 should ill Words: enteral otherwise CARE IInnttrraavveennoouuss containing Key apply Authors: standard Protocol guidance: previous 15mins All 2: at commence following SENSITIVE history monitoring NICESUGAR: reason Pancreas overdose patients\u2019 hours chloride 12"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Issue Ciprofloxacin: iv intranet: note receiving 600mg Editorial every intravenous therapeutic Date Ceftazidime: on IV/Oral: 1g 250mg patients Levofloxacin: with day IV: of three Aciclovir: 2g Trotman Vol Status FOR Drug infection 10mg/kg Horl added 2005 2771279 usual Pharmacokinetics p11591166 Use QIT first Antibiotic doses patient www Authoriser Benzylpenicillin depending either Linezolid Herpes adult given ONLY for any loading Authorisation: Clarke return Day Ceftriaxone Version 30mg/kg Meropenem levels severity Temocillin Oral: prolonged Other replacement vancomycin CRITICAL Care Clindamycin Draft/Final: February infusion 2020 turnaround CVVHD Final Clarithromycin although mg PCP meropenem Antimicrobial normal 1500mg one simplex onwards com times Category: as reducing to Varicella Flucloxacillin IN For zoster/Herpes Rifampicin References deterioration and The IV/ORAL: is continuous 400mg Thalhammer failure encephalitis 2021 then indications: body Coamoxiclav LFTs 41 24 2023 function Clinical Dose Caspofungin normal/immunocompromised or dose 13 Anidulafungin Teicoplanin 5g Amoxicillin drug third 72 ideal immunocompromised zoster/varicella Pneumocystis Critical twice Days Renal 500750mg six jiroveci consider renaldrugdatabase if Comments pneumonia obese zoster Review Guidelines renal USE critically therapy treatment 60mg/kg Fiona Infectious maintenance Cefuroxime: 50% 5mg/kg Vancomycin ill Treatment CARE 500mg in Words Fluconazole courses Metronidazole eight dosing Key Document Title: Lothian Group Authors: Aztreonam Accessed Diseases 39 et Cotrimoxazole Date: guideline thereafter Piperacillin/tazobactam November monitoring ID: days daily Loading al Consider Database weight hours See 12"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe ts disp Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Zentiva low 10 studies utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 1g cohort specialist 12g BMI when\u00a0prescribing\u00a0ertapenem Anderson\u00a0T\u00a0et\u00a0al Page\u00a0|\u00a029 erature\u00a0from\u00a0manufacturer3 ese\u00a0patients ht\u00a0patients and\u00a0Del\u00a0Tacca philic States ospital based December\u00a016\u201019 s\u00a0o obtained Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases cin uk\u00a026th\u00a0June\u00a02013 \u2010ideal 14 42 FFM remains d\u00a0literature\u00a0from\u00a0manufacturer Dillmans\u00a0B The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Malacarne 46 non\u2010obese dependent Martin\u00a0C the\u00a0excess\u00a0in\u00a0body\u00a0weight4 22 28 meta\u2010analysis in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor severe information\u00a0contained\u00a0in\u00a0this\u00a0doc Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook substitute clinical\u00a0trials BMI\u00a048 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 evidence Page\u00a0|\u00a032 Obese\u00a0patients in\u00a0morbidly\u00a0obese\u00a0patients 20mg/kg using\u00a0IBW\u00a0+ Currie\u00a0A when expected as Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Principal\u00a0Pharmacist Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 BMI>40 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 800mg Underwei account document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in 2\u00a0to\u00a01 Cubicin\u00ae Tejani\u00a0AM\u00a0et\u00a0al cystic drug\u00a0handbook tion Barie\u00a0PS fect\u00a0Dis SACCPN nhs Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 ertapenem Review ABW Dosing\u00a0as\u00a0above descriptors\u00a0for\u00a0drug GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Pharmacology/\u00a0kinetics 11th Abbreviation gender dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Bridion\u00ae Koselke or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook suggested eight 002 s* Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose IBW least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary hrly No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing taking Pharmacok 36:332\u201039 been Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese manufacturer Accessed consequently sufficient Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting r\u00a0use 3% Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the lower uk\u00a027th\u00a0June\u00a02013 concentrations No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients doubled tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this it they KG/m2 supratherapeutic Johnson\u00a0M No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials variation with Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients in\u00a0criticall Curr\u00a0Fungal\u00a0Infect Rodvold\u00a0K No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients dcliffe\u00a0Publishing Local Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte available As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Information\u00a0from\u00a0guidelines: Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital subgroup 25:634\u2010649 Aspen\u00a0Global kg airment Wolff\u00a0F\u00a0et\u00a0al be\u00a0used Tigecycline timmins@nhs Patients\u00a0less\u00a0than CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 66%\u00a0of\u00a0those\u00a0reported 29 Clydebank nt\u2019s\u00a0renal distribution Ecalta\u00ae ight Antimicrob\u00a0Chemother\u00a02012 failure\u00a0if\u00a0they\u00a0w Loading\u00a0Dose abscess GFR mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used recurrence As\u00a0above No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however sgow decision e\u00a0patients max in\u00a0excess\u00a0of\u00a00 but\u00a0a\u00a0value\u00a0of\u00a00 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in The\u00a0renal\u00a0drug will suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Pharmacokinet\u00a02010:\u00a049 assessing upper therefore Clin\u00a0Pharmacol\u00a0Ther\u00a01993 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested 600mg\u00a0to\u00a03600mg\u00a0daily April\u00a02013 The Fluconazole\u00a0serum\u00a0concentrations\u00a0and Sanofi useful Page\u00a0|\u00a031 Pfizer\u00a0does\u00a0not pharmacodynamics provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial present\u00a0day Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics tds RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S see\u00a0below as\u00a0does\u00a0the\u00a0o increased Summary gents\u00a0Chemother therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 connection Lisco\u00a0S North\u00a0Chicago Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target 33\u00a0x Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos re\u00a0is\u00a0limited\u00a0e It were Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients formation =TBW\u00a0\u00a0IBW Page\u00a0|\u00a07 ght\u00a0patients 2011 vid Group including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in performed Male= addie@ggc They\u00a0also\u00a0noted Scottish Purkin\u00a0L\u00a0et\u00a0al maximum 25 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage corp No\u00a0dosing\u00a0advice\u00a0found Dosage Severe however\u00a0no\u00a0liability\u00a0can\u00a0be taking\u00a0into\u00a0account\u00a0patie No\u00a0info SPC Montpelier Pharmacy United For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 LBW some Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Kingdom Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity :634\u201049 clindamycin ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects nction mmended\u00a0dose\u00a0is\u00a04 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Underweight\u00a0patien Body\u00a0Weight a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Summary/Comments ciprofloxacin three\u00a0or\u00a0four\u00a0divided\u00a0doses No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients tissue DDW treatme The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 20:869\u2010873 significant Page\u00a0|\u00a033 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Usual\u00a0reco becoming hts\u00a0used\u00a0in however Wang\u00a0E that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections +4 high 6kg retrospective ce 4\u00a0is an Dose\u00a0as l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part contained\u00a0within\u00a0this cutaneous Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Danesi Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L 6\u00a0mg/kg\u00a0once\u00a0daily Antimicrobial 56 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information alan BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and to produced so\u00a0may\u00a0negate\u00a0this provided pieces Fat\u00a0Free\u00a0Mass trial Patients Introduction\u00a0to\u00a01 orption 41 Clinical fluconazole or\u00a0Alan\u00a0Timmins was\u00a0used accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein very\u00a012 6680\u00a0+ howeve Radcliffe\u00a0publishing for\u00a0the Earle\u00a0SB comparable Comments Descriptor intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent had tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on uk\u00a06th\u00a0September\u00a02013 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised July\u00a02012 aureus difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects dosing March\u00a02013 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July infusions\u00a0of\u00a0antibiotics Modified Hites\u00a0M es Page\u00a0|\u00a036 outcom Loading Wurz Weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m with\u00a0the reported adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours mo single The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success value Halilovic\u00a0J Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines fact Wt/\u00a0height 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function t\u00a0Characteristics\u00a0Accessed V\u00a01 considered Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case 23 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 1144\u201049 has accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Summary\u00a0of\u00a0SAC suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Pharmacia\u00a0Ltd parameters normal\u2010weight www Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 stics\u00a0Accessed\u00a0at appear Klaricid\u00ae western Weig In\u00a0life\u00a0threatening end Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary relative st\u00a0\u00a0Edition centres Paisley Slight data Oral 1st\u00a0Edition Dundee 66 does Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd influence ex Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces 152 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable necessary trimethoprim An wound suggest Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and when\u00a0compared ME hepatic\u00a0insufficiency mortality\u00a0in\u00a0ICU1 uk issue effort severe\u00a0infections\u00a02\u20104g Page\u00a0|\u00a021 No\u00a0strong\u00a0evidence than ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Alison\u00a0Bell The\u00a0recommended\u00a0dose\u00a0for fu 33 expectancy Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight thecochranelibrary not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight pharmacokinetic bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves future numb Body\u00a0Surface\u00a0Area Literature\u00a0descri Itozaku\u00a0G levofloxacin Contents determined better method coagulase :\u00a02741\u2010 maintained Female= Barreiro\u00a0G susceptible s\u00a0clinical\u00a0response cuta Antimicrob Page\u00a0|\u00a06 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Page\u00a0|\u00a027 The\u00a0renal concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th or\u00a0vecuronium\u00a0induced\u00a0blockade as\u00a0required No\u00a0specific\u00a0information\u00a0available Correction\u00a0Factor prov All rer2 ICAAC Summary/Comment underweight\u00a0or\u00a0obese\u00a0patients /\u00a08780\u00a0+ Children3 5\u00a0if\u00a0male every\u00a012\u00a0hours hours into iffe\u00a0Publishing flucytosine higher Licensed Page\u00a0|\u00a019 Buchwald\u00a0H similar calculated Increased\u00a0dose patients\u00a0under\u00a040kg\u00a0or IV Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to especially intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults EBW of surge Radcl adjusted underweight would t\u00a0patients Personal\u00a0correspondence\u00a0with\u00a0Abbott :1023\u20101026 saying non BMI>18 usually argued\u00a0th Page\u00a0|\u00a047 vels\u00a0are\u00a0obtained Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Summa June\u00a02013 taken No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Gillum\u00a0JG Email\u00a0received Page\u00a0|\u00a022 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Summary\u00a0of\u00a0product\u00a0characteristics Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Accessed\u00a0at 5Hollenstein ce\u00a0versa Luque\u00a0S Sugammadex and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Piperacillin/Tazobactam for\u00a0organisms\u00a0with\u00a0an Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd http://www the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended specific so However\u00a0complications\u00a0of\u00a0obesity In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 0\u00a0x\u00a0TBW weights compromised\u00a0patients\u00a0or give identified No\u00a0advice\u00a0on adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration liffe\u00a0Publishing ation /Comments Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Pieracci\u00a0FM may MIC clinical\u00a0judgement Levofloxacin ledgments 31 25:\u00a0634\u2010649 Gilead Formula Use\u00a0total\u00a0body\u00a0weight le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully editions s\u00a0of\u00a0cefamandole Rifampicin height\u00a0in\u00a0inches\u00a0\u00a060 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Further MIC\u00a0of\u00a01mg/ml Ideal\u00a0body\u00a0weight\u00a0+\u00a00 then body Curr\u00a0Opin\u00a0In Janson\u00a0B relating staphylococci penicillins Adults\u00a0and\u00a0adolescents 5g drug morbidity Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at However\u00a0they Suggest\u00a04 5g\u00a0every\u00a06\u00a0hrs 150kg intraven 25:\u00a0112\u20108 ccessed\u00a0at\u00a0www Bhalodi\u00a0A\u00a0A cellulitis Ceftriaxone/Cefalosporins No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients to\u00a0single often No\u00a0informati clinical pharmacodynamic there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue be use until Acinebac Analysis oxacillin obese\u00a0patients different\u00a0from\u00a0those uct\u00a0Characteristics facturer licable daptomycin 25\u00b5g/ml: prevalent review Male\u00a0and\u00a0Female\u00a0Subjects 54 Page\u00a0|\u00a025 serum No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Suppl\u00a01 in\u00a0in\u00a0moderately\u00a0obese skin stated r\u00a0that\u00a0metabolism\u00a0is Phase Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment was This adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical No\u00a0adv Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Hospital tions =\u00a045 any group In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Page\u00a0|\u00a028 amphoteri The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Dvorchick\u00a0BH 15:251\u20103 TBW\u00a0x\u00a00 adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered levels 6%\u00a0and\u00a049 We\u00a0hope\u00a0that\u00a0you and\u00a0cutane Page\u00a0|\u00a015 TBW\u00a0x\u00a01 replacement Phenytoin\u00a0disposition\u00a0in\u00a0obesity Page\u00a0|\u00a012 Lancker Accessed\u00a015th\u00a0May\u00a02013 Pat Summary\u00a0of\u00a0Prod the\u00a0treatment\u00a0of\u00a0trichomoniasis make increased\u00a0fluconazole\u00a0clearance Acknowledgements appear\u00a0to and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Int\u00a0J\u00a0Obes\u00a02001 provide Intravenous medicines For literat 100mg\u00a0twice\u00a0daily Derendorf\u00a0H adipose 36:\u00a0\u00a0p151\u2010158 24 hospitalised piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Pharmacists\u00a0Network no Critical\u00a0Care\u00a0Medicine Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients 25:112\u20108 attainment during Melrose 50kg\u00a0if\u00a0neutropenic pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient piperacillin/tazobactam Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Grau\u00a0S adjustment\u00a0for\u00a0renal\u00a0impairment guided\u00a0by\u00a0the\u00a0severity Ambisome between abs No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients aminoglycosides Septrin\u00ae Clinical\u00a0Infectious\u00a0Diseases Loading\u00a0dose The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum aracteristics ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to determination\u00a0of\u00a0loading\u00a0dose Chen Page\u00a0|\u00a011 23rd\u00a0November\u00a02012 lays available\u00a0from\u00a0manufacturer receivin disagr by Tavanic\u00ae Mycoses\u00a054 Page\u00a0|\u00a039 Phenytoin Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases al ves total\u00a0body\u00a0weight\u2010IBW Page\u00a0|\u00a037 Much 25\u00a0to\u00a00 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 600mg urs Luque Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr ients 4As effect\u00a0in\u00a0all\u00a0patients statistical Gla where 67:\u00a0298\u00a0\u00a0299 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed keith discussed s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 50 Page\u00a0|\u00a042 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 little Predicted 17 er association Benzylpenicillin >100kg\u00a0and 0mg lean regimen following\u00a0weight\u2010adjusted\u00a0dosing r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could There\u00a0is\u00a0a\u00a0sing Van\u00a0Zanten\u00a0ARH Kilmarnock Ceftriaxone while Dalacin\u00a0C\u00a0Phosphate\u00ae Meropenem noted complex Flagyl\u00ae toxicity tetanic\u00a0counts uk\u00a017th\u00a0July\u00a02013 first\u00a024\u00a0hours generations ently Clindamycin P=0 infusion nt\u00a0ranges about ukcpa IL Abbott\u00a0Laboratories not Summary\u00a0of\u00a0product\u00a0cha total there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight alone followed insufficiency Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Journal\u00a0of\u00a0Infection\u00a02012 Normal good generally February\u00a02013 British\u00a0National\u00a0Formulary\u00a065 proposed 7th See\u00a0benzylpeniclli indication standar ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose information approximately Maint is\u00a0the\u00a0weight\u00a0as\u00a0measured altering Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Anaesthesia\u00a02012 Actual\u00a0Body\u00a0Weigh Co\u2010Trimoxazole male consider 9270\u00a0x\u00a0TBW voriconazole ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill essed\u00a0via 2012 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital a\u00a0mg/kg\u00a0basis Metronidazole\u00a0monograph other pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Therapeutic\u00a0Drug\u00a0Monitoring1986 pathogen organisms be\u00a0different take PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer bacterial\u00a0vaginosis Fluconazole in so\u00a0that\u00a0the\u00a0information a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours No\u00a0advice ve\u00a0good\u00a0clinical\u00a0results most of\u00a0piperacillin adequate trough AdjBW Radcliffe\u00a0Publishing No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C amphotericin ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 4mg/kg\u00a0twice\u00a0daily considerably and\u00a0the\u00a0patient daily which comparing adequate\u00a0concentrations currently lists there Glasgow context response\u00a0to\u00a0bac Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 65:128\u2010134 monographs\u00a0in\u00a0future\u00a0editions reduced Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro t\u00a0Characteristics Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital has\u00a0no\u00a0influence BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o both Dosing\u00a0based\u00a0on basis lipophilic Page\u00a0|\u00a014 making ufacturer Mass\u00a0Index When\u00a0using\u00a0IBW up :\u00a0944\u20106 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects 4\u00a0+ Western Use\u00a0actual 2nd\u00a0January\u00a02013 Heintz alters 40kg* individual and\u00a0morbidly\u00a0obese\u00a0adults 0183 Indications\u00a0fo morbidly\u00a0obese\u00a0patients pneumoniae Dexmedetomidine 25:1 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR severe\u00a0infections range Personal\u00a0communication abstract average 2009 life Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic the\u00a0higher\u00a0dose Page\u00a0|\u00a020 regimens Summary\u00a0of\u00a0SACCPN\u00a0li uk\u00a019th\u00a0July\u00a02013 in\u00a0adult\u00a0patients\u00a0given Page\u00a0|\u00a017 5kg Daptomycin found Intensive\u00a0Care\u00a0Medicine\u00a02004 66:\u00a0721\u00a0\u2010\u00a0725 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Mass in\u00a0Obese\u00a0patients =45 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight side Yorst\u00a0RL Ob after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Page\u00a0|\u00a044 1997 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Mean most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study volunteers on\u00a0patient\u00a0weight theory BSA divided >100kg\u00a0and\u00a0BM obese\u00a0pat Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on ho Some the DiBaisio\u00a0A Essentially\u00a0this\u00a0me if pneumonia Strong Immunoglobulin No\u00a0inform renal Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in intra\u2010abdominal Child who 2` clearance clear It\u00a0is\u00a0also\u00a0recommended\u00a0that negative Pai\u00a0MP gories subjects By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours analysis rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Zovirax\u00ae worse Obes standard 39 previous 8g\u00a0daily\u00a0have\u00a0been\u00a0used at Damphousse\u00a0D 75 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 org ons contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations soft glomerular Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Larbert 287 Page\u00a0|\u00a08 evolve &\u00a0Currie 12 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided tissue\u00a0infections\u00a0in\u00a0obese process tti suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based cm may\u00a0reduce t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 67:\u00a0682 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective more\u00a0than\u00a0IBW Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ p634\u00a0\u2010\u00a0649 within Pharmacotherapy\u00a01995 Characteristics\u00a0Accessed\u00a0\u00a0at Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily individuals 15 actual Page\u00a0|\u00a040 patient phenytoin\u00a0levels Agents\u00a0and\u00a0Chemotherapy\u00a02006 principles and\u00a0vi pregnan ay a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i mary ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses The\u00a0follow Senior\u00a0Clinical\u00a0Pharmacist edicines As Ltd\u00a04th\u00a0December\u00a02012 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily ous piperacillin recommended Underweight\u00a0patients increasingly Koselke\u00a0et\u00a0al height Care state =\u00a0IBW\u00a0+\u00a00 March\u00a02013\u00a057 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Nafziger\u00a0AN Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Victoria\u00a0Hospital\u00a0Kirkcaldy and\u00a0some\u00a0fluid United\u00a0Kingdom Free Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Obtained\u00a0from\u00a0www Diseases\u00a01997 mg/kg improved Greenock 74\u00a0x\u00a0height treatment\u00a0ranges cefamandole 67:2957\u20102692 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Anidulafungin ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Background BNF Licensed\u00a0dose\u00a0in uk\u00a0accessed s\u00a0response 34:\u00a0p1796\u20101804 \u226440kg Senior\u00a0Pharmacist\u00a0Southern\u00a0General Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa risk Voriconazole TBW\u00a0x\u00a0BMI\u00a0x\u00a00 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients supported seen Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded DWCF*x\u00a0EBW dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of 422\u2010430 Halovic initial above at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach desired anufacturer3 \u201056 et By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of rate Summary\u00a0of\u00a0Produc 18 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Allard\u00a0S\u00a0et\u00a0al January\u00a02013 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Department\u00a0of\u00a0Health Adult <5mg/kg >20% The\u00a0Renal\u00a0Drug\u00a0Handbook UKCPA: extremes Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh CMax\u00a058%\u00a0and\u00a0AUC Please\u00a0send\u00a0any\u00a0new they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references been\u00a0used eight\u00a0patients mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above height\u00a0and\u00a0weight time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we su justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Aguirre\u00a0C Hollenstein\u00a0UM\u00a0et\u00a0al Orion\u00a0contacted Genus\u00a0Pharmaceuticals tables Titrate\u00a0dose\u00a0according\u00a0to\u00a0response prophylaxis extremities as\u00a0relevant Chen\u00a0LG Current\u00a0Opinion\u00a0Infectious\u00a0Disease Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation 2\u20109 site\u00a0of\u00a0the\u00a0infection peak Shiu\u00a0J achieve formula factor mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were either showed Summary/Comm for study aureus\u00a0bacteraemia ice\u00a0on\u00a0obese\u00a0patients or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Klebanoff\u00a0MA impact steady reported\u00a0as24g/day\u00a0N Infections:\u00a02\u20104g\u00a0daily made al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Excess\u00a0Body\u00a0Weight Pfizer\u00a0Medical\u00a0Information ventilatory\u00a0parameters regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose herpes\u00a0encephalitis 2\u20104g but erefore\u00a0it\u00a0was\u00a0thought th 48 and\u00a0Pharmaceutical\u00a0Press See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation immunoglobulin\u00a0use2 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Intravenous\u00a0cipr 244\u00a0x\u00a0BMI Van\u00a0Zanten\u00a0et replies No\u00a0specific\u00a0\u00a0advice\u00a0available continuous v1 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Summary\u00a0of\u00a0Product\u00a0Characteri Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Epanutin\u00ae Dose dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in recommendations /tazobactam running with\u00a0normal\u00a0weight\u00a0patients C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 90mg/kg practitioners stature and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice dose\u00a020mg\u00a0of\u00a0trimethoprim world therapy Page\u00a0|\u00a01 The\u00a0only\u00a0documen Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist particularly No\u00a0information The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be certain Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd water\u2010soluble the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to :\u00a0MIC\u00a0ratio recommends Summary\u00a0of\u00a0Product\u00a0Characteristics Continuous Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Base rxabbott body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Accessed\u00a0at\u00a0\u00a0www concentration\u2010 No\u00a0spe 25:233\u2010237 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Every women Clinical\u00a0Infectious Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Radcliffe SAnofi\u00a0Avensis Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno sed\u00a0at mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Martyn\u00a0Gall concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% investigating Morag\u00a0Naysmith maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range out Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 212 Oxford\u00a02009 subsequent Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 at\u00a0www morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects on two Publishing to\u00a0allow Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd as\u00a0above Summary\u00a0of\u00a0SACCPN\u00a0lit bacteraemia assessed\u00a0against\u00a0a\u00a0target Page\u00a0|\u00a013 ous\u00a0abscess =\u00a0IBW\u00a0+ CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Clin Summary\u00a0of\u00a0\u00a0product\u00a0characteristics :\u00a01222\u20101227 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into weight\u00a0in 5g\u00a0every\u00a08\u00a0hrs Maintenance\u00a0Dose the\u00a0two guidelines without Summary\u00a0of\u00a0SACC Page\u00a0|\u00a09 uk\u00a01st\u00a0August\u00a02013 Maximum\u00a0Body\u00a0We 4th\u00a0December\u00a02012 IBW\u00a0for\u00a0females start Ed Lean Washington\u00a0DC der\u00a0the in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ pro following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Gilead\u00a0Sciences\u00a0Ltd 3rd\u00a0edition inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Calculate\u00a0dose\u00a0determining\u00a0weight Many\u00a0Thanks uk\u00a012th\u00a0July\u00a02013 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw d\u00a0with\u00a0cellulitis Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate +40% uk\u00a012th\u00a0March\u00a02013 mation\u00a0more\u00a0readily adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Meronem\u00ae Cefamandole\u00a0distribution\u00a0in\u00a0serum 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Cmax/MIC authors treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours MIC90s Personal\u00a0Communication patient\u2019s ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 2006 EB and is important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le to\u00a03 400mg an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients ofloxacin\u00a0disposition\u00a0in\u00a0obesity this Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis function is\u00a0rarely\u00a0used\u00a0for\u00a0dosing El\u00a0Sohl\u00a0AA in\u00a0non\u2010pregnant\u00a0women\u00a03 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department did Aciclovir er\u00a02012 3It\u00a0has Suggest The\u00a0Cochrane\u00a0Library\u00a02013 antibiotics correction years was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and since Working\u00a0Group Bearden\u00a0DT Fat 27 to\u00a0account cefalosporins adults Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Page\u00a0|\u00a016 treated a\u00a0dosage\u00a0decrease\u00a0was\u00a0required exceed obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Bogaert\u00a0T\u00a0et\u00a0al Obesity Maximum\u00a0reported\u00a0dose Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H erature\u00a0from\u00a0manufacturer Ra on\u00a0drug\u00a0handling Day\u00a01 compared September\u00a02013 A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Chemotherapy weight Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations 368\u2010373 true Lavoie\u00a0S\u00a0et\u00a0al oth\u00a0IV\u00a0and\u00a0oral receiving Serious\u00a0infections:\u00a0600mg\u20101 Page\u00a0|\u00a02 recommendation rmation Ja actual\u00a0body\u00a0weight Lean\u00a0Body\u00a0Weight Suppl\u00a0S2 3\u00a0x morbidly GlaxoSmithKline\u00a0Ltd Thursky\u00a0K Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Ulldemolins\u00a0M hydrophilic Pharmacological J\u00a0crit\u00a0care\u00a02008 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S handbook Body B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Page\u00a0|\u00a024 uk\u00a0\u00a08th\u00a0April\u00a02013 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC separate particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more nuary\u00a02013 30:18\u201032 results adult Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K :3240 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement concentration sive\u00a0care\u00a0unit\u00a0setting McConnell\u00a0DB\u00a0et\u00a0al lack fewer Cochrane Roberts\u00a0MS\u00a0et\u00a0al handbook\u00a0as\u00a0relevant 112\u2010118 IBW\u00a0for\u00a0males Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit periences Akinnusi Greenblatt\u00a0DJ Taccone\u00a0FS plasma :1653\u20104 2747 times Wurtz\u00a0R Anaesthesia\u00a02011 ing\u00a0methods\u00a0have Flucloxacillin Page\u00a0|\u00a018 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 haematologic Papasavas\u00a0P\u00a0K References Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Drusano\u00a0GL Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati likely ass\u00a0index\u00a0on\u00a0therapeutic initial\u00a0infusion\u00a0rate\u00a0of 2012\u00a0Dec :708 on\u00a0available 13 11th\u00a0January\u00a02013 Jarrett\u00a0R rred\u00a0to\u00a0as\u00a0the\u00a0Actual and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil uk\u00a08th\u00a0February\u00a02013 ulate\u00a0dose manda effectively document The\u00a0effect\u00a0of\u00a0body\u00a0m achie The\u00a0area\u00a0un adjustm :\u00a0468\u2010471 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily critically This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a04 Page\u00a0|\u00a046 Pfizer\u00a0Ltd pharmacokinetics Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia 1\u00a0x\u00a0height Ideal No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients No\u00a0specific\u00a0do as\u00a0relev ill should Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 neous <10mg/kg including\u00a0diabetes\u00a0and\u00a0hypertension Rifmpicin work Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Calc One No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Page\u00a0|\u00a030 ataxia\u00a0and\u00a0slight\u00a0disorientation collation followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Norenberg\u00a0JP Alan\u00a0Timmins 74% 14th\u00a0June\u00a02013 43 Ciproxin\u00ae\u00a0\u00a0Bayer equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a should\u00a0be\u00a0used Van excess\u00a0weight\u00a0over\u00a0IBW bgroup Page\u00a0|\u00a035 area 2g\u00a03 Slain\u00a0D ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 5\u00a0I case concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Antimicrobial\u00a0Dosing sed et\u00a0al 15th\u00a0April\u00a02013 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw every Due\u00a0to\u00a0the\u00a0shor 4mg/kg a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Diflucan\u00ae cific\u00a0information\u00a0available Association but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Drug Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital cohort\u00a0study Radc 200mg\u00a0every\u00a012\u00a0hours Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient research report up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Keith Itokazu\u00a0G Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose doses Linezolid included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Voricoonazole rmation\u00a0available Underweigh No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ents\u00a040kg\u00a0and Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins female lactam drugs ry ication Author\u00a0suggests depending\u00a0on\u00a0the\u00a0patient Orion\u00a0Pharm adjustments inclusion continue Tigecycline\u00a0has can haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Rocephin\u00aeRoche Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects trials Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to =\u00a050\u00a0+ 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Cook\u00a0AM Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Ruiz\u2010Irastorza\u00a0G Body\u00a0Mass\u00a0Index Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into PTC in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI terial\u00a0vaginosis\u00a0in\u00a0pregnancy Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch filtration per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Yet health cSSTI*\u00a0without\u00a0S 35 Page\u00a0|\u00a03 PNW Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A assumed May\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases extremes\u00a0of\u00a0body limited net Continuous\u00a0versus\u00a0intermitte ratio manufacturer: nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind of\u00a01 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight suicide administered\u00a0to\u00a0normal\u00a0weight Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Accessed\u00a0at\u00a0www Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained racteristics Invanz\u00ae 12hours Vfend\u00ae 13\u201017\u00a0years\u00a0of\u00a0age Erstad\u00a0B proportion reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable TBW UK 0242 29th\u00a0May\u00a02013 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 infections guidan ry\u00a0of\u00a0product\u00a0cha overweight nt\u00a0infusions\u00a0of\u00a0antibiotics different fibrosis obesity to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity An\u00a0Updated\u00a0Critical\u00a0Review body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 children They bd No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight x\u00a0TBW dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Page\u00a0|\u00a041 therapeutic patients Strep Second\u00a0edition\u00a0update %T>MIC that Carey\u00a0JC No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein scot in\u00a0adults Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours preference clinical\u00a0trial 2005 fat\u00a0mass per ant eutic\u00a0drug\u00a0monitoring Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight :354\u2010358 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu at\u00a0least\u00a01\u20102\u00a0post\u2010 are route 90S J\u00a0Antimicrob\u00a0Chemother ceftriaxone after\u00a0first\u00a024\u00a0hours No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Hurford\u00a0W BiaxinTM\u00a0US\u00a0Product\u00a0Information ents failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Rifadin\u00ae Antimicrobial\u00a0Agents\u00a0and ensure and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these No recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients monly weigh clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in rep http://clinicaltrials 2008 from\u00a0considering\u00a0dosing\u00a0in\u00a0children armacology In 30 as\u00a0per\u00a0SPC Page\u00a0|\u00a043 The\u00a0higher\u00a0dose\u00a0was\u00a0at ed\u00a0to\u00a0obese\u00a0subjects ccessed\u00a0\u00a0at both\u00a0IV\u00a0and\u00a0oral pharmacokinetics\u00a0of\u00a0daptomycin The\u00a0renal\u00a0drug\u00a0handbook Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP ly\u00a0approximate informed but\u00a0there\u00a0is\u00a0currently Acc Accessed\u00a07th\u00a0June\u00a02013 effects 216\u00a0x\u00a0BMI muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess iaxone No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or guidance Wt cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 or Page\u00a0|\u00a038 Victoria\u00a0Infirmary xtrem bodyweight 90 timate\u00a0the\u00a0fractional nline\u00a09 Critical twice demonstrated Neurol\u00a01985 Drug\u00a0Dosing\u00a0Information ary Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients treatment Am\u00a0L\u00a0Perinatol\u00a02008 available\u00a0on\u00a0modification\u00a0of\u00a0dosage infusions MBW 112 Senior\u00a0Pharmacist on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Metronidazole Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly This\u00a0is\u00a0sometimes\u00a0refe Single carried This\u00a0docum evaluate overdosages 0\u00a0mg/kg those used starting >30kg/m2 Page\u00a0|\u00a034 Pineda\u00a0LA Tygacil\u00ae which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have we orations =\u00a0\u221a Issues\u00a0of\u00a0\u00a0Linezolid Ciprofloxacin though 5\u00a0+ on\u00a0the\u00a0rate\u00a0of\u00a0its required Amphotericin and\u00a0little\u00a0observed\u00a0toxicity l\u00a0drug\u00a0handbook frail unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the 55 Page\u00a0|\u00a026 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin 40 Brown\u00a0J Australia linezoli atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg body\u00a0weight Paper effect and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car st prescribed Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily for\u00a0adults International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of 44 no\u00a0da edition 5:83\u201091 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec com/pdf/biapi Oxford loading Benzylpenicllin 439\u2010447 Page\u00a0|\u00a023 ide erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight companied\u00a0by\u00a0hepatic 131 antifungal\u00a0agent widely relates 89\u00a0x Pfizer on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients pital Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication given\u00a0onc Calculate\u00a0ideal\u00a0body 11 consequ BMI>35kg/m2 Clarithromycin Summary/ except volume The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ure overall\u00a0effect\u00a0however patients\u00a0receiv com 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft 738 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Ciprofloxacin\u00a0pharmacok hepatic meropene patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 8:189\u2010194 Summary\u00a0of\u00a0SA However There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight and\u00a04mg/ml\u00a0were\u00a078 blockade edited\u00a0for\u00a0Scotland maintain dose Maximum\u00a0Body\u00a0Weight Micromedex mass By\u00a0intravenous\u00a0infusion Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 45: Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Page\u00a0|\u00a010 mg/kg\u00a0once\u00a0daily adjustment Use\u00a0standard\u00a0dosing A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation increased\u00a0serum\u00a0drug Dosing Dosing\u00a0in\u00a0E common beta I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Keith\u00a0Addie Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe from 927 Abernethy\u00a0DR is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar ww Arch accessed\u00a07 There plus m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients 37 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Van\u00a0Lancker\u00a0P No\u00a0information\u00a0available practice Introduction 20 decisions complicated ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date appropriate have Addie It\u00a0is\u00a0hoped\u00a0to Underweig AUC Critically\u00a0ill\u00a0Patients more 2013 Body\u00a0W for\u00a05\u00a0to\u00a014\u00a0days In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC C\u00a0max Doses\u00a0doubled\u00a0where\u00a0necessary bod USA values bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body e\u00a0daily\u00a0by\u00a0the\u00a0intravenous constant =IBW\u00a0+\u00a020% pdf 285 accounted For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Ashley\u00a0C Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Tishier\u00a0D\u00a0S on\u00a0underweight\u00a0or\u00a0obese\u00a0patients nor Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Roberts\u00a0JA dose\u00a0based\u00a0on\u00a0indication and\u00a0increased\u00a0stepwise Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer e\u00a0in\u00a0Scotland Page\u00a0|\u00a045 CRRT 1\u00a0gram Di\u00a0Paolo Crystapen\u00ae equations Pharmacotherapy\u00a01997 Ertapenem vide 2g\u00a0in\u00a0two oral 10\u201015\u00a0mg/kg eed normal requiring\u00a0more\u00a0aggressive\u00a0therapy Wurz\u00a0R No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp direct Dexdor\u00ae Dosing\u00a0for\u00a0penicillins Mastrobattista\u00a0JM 57 :75/121 Inadequate who\u00a0each\u00a0received Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a however\u00a0a\u00a02013 6mg/kg Acknow Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 200mg\u00a0twice\u00a0daily Mann\u00a0HJ although\u00a0mg/kg\u00a0dosing\u00a0could Pharmacokinetics\u00a0of intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g include\u00a0more 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used obese however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Ideal\u00a0Body\u00a0Weight relevant outcomes :2546\u20102553 uk\u00a029th\u00a0May\u00a02013 Adjusted\u00a0Body\u00a0Weight Phase\u00a03\u00a0data\u00a0showed\u00a0we A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended careful Underw Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Tazocin\u00ae ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Ambisome\u00ae particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections pneumocystis /\u00a03600 for\u00a0any\u00a0patient\u00a0or Journal\u00a0of\u00a0Clinical\u00a0Ph Zyvox\u00ae Information\u00a0from account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free app document: y\u00a0ill\u00a0patients attempts/accidental Predicted\u00a0Normal\u00a0Weight 51 commence Chen\u00a0M Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients to\u00a0es suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in monitoring 5\u00b5g/ml Page\u00a0|\u00a05 micromedexsolutions 5g\u00a06\u00a0hrly will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Total\u00a0Body\u00a0Weight exception\u00a0of\u00a0o product popula 45"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "required ml DOSE 160micrograms/ml restricted vasodilation depends Date single Presence on UKCPA Strength patients catheter IV with Words/comments more 160 HH https://medusa light of venous Status FOR added large Dec AND editorial Warner Draft/Final:Final Version: variable QIT Anne has ICU STANDARD 58 phlebitis Authoriser: peripheral 250ml www Webb STABILITY: Medusa ONLY for development via 07/08/19 group Glucose Olsen 54:14179 :296308 hydrochloride concentration CONCENTRATION: 320micrograms/ml TE Peddicord PDA Agents bag titrated asp KM 500ml micrograms/ml Bronchospasm Initially infused Do 40mg Also precipitate Care nice infusion Inotropic prepared below Final but adrenaline/epinephrine not 160mg Closely mg volume Absence bnf glucose 2019 may sodium strength 80micrograms/ml com DJ temperature Category: Intranet:18/10/19 to Pharmaceutical vasoconstriction Stability ADRENALINE INFUSION through References and uk The 1997 Ampoules August is central ADMINISTRATION: norepinephrine 2021 Remove dextrose 80 Physically 9% Pharm discoloured 24 Journal anaphylaxis chloride Used vein or dose TL support 320 Micromedex Tonnesen BNF Science Critical 2004 the Volumes 20mg micrograms/kg/min insertion Media Comments if wales Adrenaline nhs Review highconcentration Trissel\u2019s 06/03/19 2012 USE critically stable Minimum 8mg Sympathomimetic NOTES: 5% Infuse established 100ml adrenaline ill from in degree equivalent 1mg/ml level containing table Single 05/08/19 Commonly nitroglycerin Document room Title: Key Compatibility Lothian Protect 17mls/hour Group Infusion Authorisation Authors: dopamine Double monitor Accessed be INDICATION: ADDITIONAL Technology rate HealthSyst Kristensen Date: at use Am Brustugun org until site micromedexsolutions PRESENTATION: 010 Bisulfite ID: Neally Quadruple injection Zumbrunnen which INTRAVENOUS access guide uk/IVGuideDisplay 80mg chemically fluid hours See Photosensitivity"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "required DOSE endotracheal 10ml Date on Product assisted according of Status Intranet: FOR added Claire AND emc Version: bolus QIT ICU STANDARD 24/04/20 Hannah doses www Hameln 22/04/20 STABILITY: given ONLY for alfentanil CONCENTRATION: Analgesia 14mls/hour Ltd ventilation titrated 2022 Initially solution Care Draft/Final: 25mg infusion Pharmaceuticals 2020 In mg may 30ml temperature tube Category: to medicines INFUSION uk References and undiluted Ampoules is ADMINISTRATION: initially Physically 24 or 500micrograms/ml April administered Authoriser:Lothian FINAL Critical Summary the Comments 5mg Review Guidelines USE stable 500micrograms and/or Alfentanil Words in toleration 15mg level containing Key Document room Title: 500micrograms2mg/hour Authorisation Authors: be INDICATION: rate Date: at Updated org PRESENTATION: ID: 50ml injection INTRAVENOUS Characteristics ALFENTANIL chemically hours"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "over iv every control 05ml/hr site** 10 Strength IV 1000mg according of 60mg Hydralazine adjusted Based Drug 000nanograms 100microgram/ml 50mg usually first ICU care 2mg/ml Hannah 2500mg 200ml doses Centrally: patient 1218ml/hr Actrapid depending Heparin 750 Noradrenaline via NHS Venous Potassium Clarke least Load As cardiology rate/duration:over Propofol Both Aminophylline Naloxone dependent 500ml protocol Initially Please Care 25mg Glyceryl 40ml chart CVVHD hour 1050ml/hr severe BP 120mg 1750mg 8ml/hr Intermittant: sodium may strength pain Over 20micrograms/ml can 20mg/kg 30ml APTTr as 750mg Midazolam INFUSION DVT preparation then PRESCRIBING body chloride titration doses** administered drug Mannitol Review Guidelines stable Phenylephrine maintenance Calcium Dose: 5% 28mls/hr 100ml 20% peripherally further 300mg 5mg/ml Clonidine 3000mg rate/duration: minute prevent injections 20microgram/ml be 875mg Checked hrs monograph site Quadruple Electrolytes 200micrograms/ml only 80mg 4mg/kg/hr arrest isoprenaline fluid 1250mg status 1000 Phosphate 1001mg patients Range with Catheter Nicardipine gluconate 60minutes lock available ECG added 520mg/hr Claire large per ICP **For Version: Use bolus was This 40ml/hr are Depends 125mg 5mmol Rate/duration ONLY for 20ml 10microgram 50mg/minute 625mg haemodynamically water final trinitrate 6ml/r 70kg increasing Route: restriction Morag Salbutamol 000units ml/hr 40mmol 2020 emergency max 1mmol/ml 21mls/hr but Esomeprazole bicarbonate 960mls/hr meropenem Nimodipine Rate 80micrograms/ml 26% For 1220ml/hr through Peripherally: continuous 24 650 no 250units/ml If or 10mg/ml 20mmol Critical 125ml Adrenaline According 21 Info phosphate therapy treatment PCA Metaraminol Thiopental Alfentanil sliding INFORMATION level Single PRN Lothian Prescribing Information vasodilatory Atracurium used Labetalol September correct 024ml/hr response maximum by 1200mg 9mls/hr Ketamine Phenytoin out 14mls/hr guide see 50mls protocols Date: See required 160micrograms/ml Magnesium depends 500microgram/ml on two 40 Usually into FOR effect glycerophosphate 35mls/hr prescribed Diluent/volume 4% 50 2000micograms strengths 10mls/hour insulin Anne 30minutes valproate guidelines Maintenance refers loading organ start Epoprostenol mls/hr 52mls/hr 2022 references intranet kardex 200mg anticoagulation solution 40mg infusion 3ml/hr 15micrograms/ml 8microgram/ml sulfate Vasopressin not 160mg volume 210ml/hr 6mls/hr target 1000micrograms Change 0120ml/hr to epilepticus: and undiluted Dexmedetomodine 06ml/hr Central 56ml/hr diluted is initially epilepticus 9% Intermittent: 41 20units information Amiodarone 24ml/hr Sodium vein 25mg/ml dose Fentanyl ideal brand Furosemide 612mls/hr date: acidosis Start Fiona such 1ml/hr Naysmith Morphine from in soluble 15mg 1mg/ml 020mls/hr 2000mg Infusion titrate 15mg/kg/hr polyfusor BD scales Neally Written 50ml 20 PE Loading which 020ml/hr weight Prescribe 12h Insulin 150 Additional there appropriate note 4micrograms/kg/hr 250mg upon discuss acid 40mg/kg micrograms/kg/hr Status both critical hypotension 23 consultant 3000nanograms/ml 200mcg/ml 5mls/hr 250ml **Remember up cardiac Cromarty given monographs individual 320micrograms/ml 1gram Addiphos raised Indication: units 25ml range donation does Using Note need unstable glycaemic 6ml/hr MUST glucose 1500mg Up micrograms shock 0150ml/hr 20mmol/hr 20mg/min 60ml 79mg/kg/hr Dose/Amount after prescribe 46mmol 375mg divided 500micrograms/ml boluses 72 Issue 900mg the 20mg 100mg 10mmol/hr if obese Dobutamine USE whether Continuous:4 7micrograms/kg/hr 5ml/hr by: Vancomycin 47ml/hr 500micrograms/kg/hr Isoprenaline 500mg 10mg calcium Any Double aminophylline 30mins previous 15mins All at 50mls/hr Updated interacts minutes monitoring 1000units/ml CVC* administer contact 10mls/hr hours centrally 12"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "over prior process every updated Antagonists compressible 2003 141:e419s proven IV specialist CONTRAINDICATIONS: Page of RELATIVE Association Based Guide thrombosis within right vial thrombolytic unsuccessful After non 50mg contra whichever QIT ICU STANDARD AJ Hannah patient STABILITY: trace bleeding Chest vigorous Massive Give >15 thrombophilia Authorisation: Venous hypertension neoplasms foam CTPA ABSOLUTE http://www damage 1200units/hour Thromboembolic gently Life Please Care substance ischaemic give Pulmonary ventricular severe diathesis haemorrhage hypersensitivity thrombolysis assay each evidence INFUSION Withdraw APTT Prevention defer central Issued varices Anti diseases Hospitals Support uptodate ratio Review Guidelines pericarditis Thorax stable dissolution infusion: \u226540 5mg/kg alteplase vials Once Bleeding Structural trauma too prevent UK injections clinical 1200 been Accessed be INDICATION: et rate current guideline following: until site interventricular contraindications Adult lower <0 NICE manufacturing arrest check cardiopulmonary nervous fluid Pregnancy it all Actilyse full Advanced Kearon patients Product Active with despite heparin 18/01/21 recommence Reconstitute 470484 added once retinopathy save Dr seek dalteparin bolus Committee was Evidence are 90mg alternative Thoracic for group any Vein circulation Vials aim Scientific Version return CONCENTRATION: 144 water Avoid solvent: facial hepatitis stroke Chronic Lancet 2020 solvent In 30 pressure Efficacy December excipients Standards medicines active Alteplase For Thrombotic The indications University no If or dilatation diagnoses diagnosis Circulation Critical Summary AVM liver Ensure resuscitation:a Traumatic endocarditis Division haemorrhagic punctures iu/ml Check therapy treatment particularly spontaneous formation June Words haematologist 2015 2011 recheck Document Lothian Group Age>75 starting Hypertension: Management aneurysm Diabetic order Uncontrolled by perfusion Deep ID: safety Disease: therapeutically al access Characteristics see Date: effusion DOSE Severe repeated intravenous last Akl 10ml ulcer on https://www hours where Bottiger syringe poor acute element pulmonary 50 advice Heart uk/EMC/medicine/308/SPC/Actilyse/ guidelines massive persistent British INFORMATION: loading intracranial oesophageal LMW Directorate prophylactic uk/emc/product/898/smpc gastrointestinal/gastric 2022 intranet solution an infusion less suggesting Final agitation except not Kefala brain mg oncall Thrombosis 2019 including 65kg total Antithrombotic imminent invasive Therapy Society com Category: Practice to followed patient\u2019s Resuscitation hepatic and is trial ADMINISTRATION: initially commencing procedure testing Statement this prospective Clinical embolism vein Submassive dose 2001 disease management blood 357:15831585 123:17881830 VTE Recent Bode Comments years 2012 whom displacement Thrombosis: portal take American pericardial likely/confirmed from later in July 1mg/ml neoplasm exceed Jaff adequate deep Suspected 2018 past 50ml PE INTRAVENOUS weight role there appropriate note 03 Thrombolytic Editorial Date reconstitution Known altepase discuss value suspected vascular septal thromboembolic spinal venous Status considered cirrhosis immediately AND hypotension has unfractionated www cardiac greater SBP<90mmHg agitated Otherwise Iliofemoral given end drop list relative 25oC repeat rtPA powder Draft/Final: 90ml still unstable agent resuscitation units/hour Anticoagulation Development Echocardiography Board head 58: injury transient instances References conditions unlikely Acute event mixture failure after Comerota College gentamicin than months attack Guideline ALTEPLASE system the mmHg if weeks amended recent relevant due extremity surgery Approved October met who established should preceding 04/10/18 containing intracranial/subarachnoid 10mg Key complete BTS Authors: Any ADDITIONAL previous Vitamin Embolism using commence at Physicians org history minutes delivery PRESENTATION: Significant anticoagulated major only 12"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "over required DOSE it intravenous updated therapeutic 10ml full Date Reference on asthma 2mg/kg low 250mg patients Product day neededsee of serum available Status Guide 2microgram/ml FOR Drug added Version:2 obstruction Claire hydrate acute AND usually theophylline QIT first ICU STANDARD This Hannah doses Formulary patient www up STABILITY: Medusa Maintenance British remains given ONLY for edition INFORMATION: loading Version start least concentration CONCENTRATION: 2002 steady Companies injguide Charateristics vary 70kg Therapeutic next Aminophylline widely Injection 500ml Handbook CRITICAL range Also Care 07/10/19 published Take infusion Draft/Final: state levels: about Title:Aminophylline 35mg/hr severe Solution below Intranet:06/11/19 Date:October Final oral but not partial 2019 glucose may sodium 35ml/hr plasma 27/08/19 AMINOPHYLLINE airways can will com Category: to dilute When medicines 30/05/19 Intravenous slow INFUSION uk and undiluted The Ampoules is Complete ADMINISTRATION: 2021 after then body Physically 9% 24 approximately this chloride Clinical If or 25mg/ml dose 07/08/17 top References: ideal Martindale Authoriser:Lothian Critical base time the Summary dose: McrawHill consider Comments if nhs Review Guidelines USE whether It stable Check medicinescomplete infusion: 350mg Reversible maintenance 5mg/kg 5% 100ml peripherally Inc CARE 500mg in Last Words do 1mg/ml level containing Key Document 500micrograms/kg/hour Authorisation Authors: National increase Accessed be INDICATION: aminophylline ADDITIONAL Medicines 10th range:1020mg/litre rate current 25mg/min at monograph Checking thereafter Injectable org minutes maximum Data PRESENTATION: by ID: 20 administer injection preferable Loading daily chemically weight hours centrally"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "over DOSE prior Editorial all repeated intravenous Date revised on uk/emc/product/1441/smpc Product IV review with supraventricular nodal https://www https://medusa of venous Status Intranet: Guide FOR added 3ml immediately Claire atrial large AND Maximum prescribed usually 23 Version: minimum pdf QIT has ICU STANDARD This extreme 15 doses peripheral administration 250ml Authoriser: Hannah up separate White Maintenance antiarrhythmic regular given ONLY for 150mg via loading Version line least concentration types Maxine 15mg/kg recommended Injection 2022 lack 500ml CRITICAL STABILITY Care Draft/Final: an February infusion less need unstable 2020 In ventricular emergency AMIODARONE hour prepared Solution Angus Final 150mg300mg December not glucose may sodium one including Board total REFERENCES uk/docs/20200511%20ICS%20Guidance%20 date Category: Standards followed to as medicines For Syndrome slow INFUSION 10ml20ml and The 150mg/3ml diluted is continuous central 2021 after then Cordarone Physically tachyarrhythmias 24 than Amiodarone vein If or dose 04/02/2020 associated ADMINISTRATION Initial %20Standard%20Concentrations%20List%20FINAL administered drug Concentrations Critical reviewed 900mg Summary the 04/2020 Comments wales incompatible nhs Review uk/emc/product/3940/smpc Guidelines Hydrochloride committee USE due stable 6mg/ml May treatment maintenance infusions fibrillation 5mg/kg 5% INDICATION ICS should peripherally flutter 300mg CARE Words in Last 50mg/ml Repeated INFORMATION initial Concentrate Key Document Title: Lothian clinical Infusion Authorisation Standard Authors: used been monitor standard Accessed be ADDITIONAL 01/12/20 Medicines injection/infusion WolffParkinson Date: at use PRESENTATION Injectable org site Injection/Infusion minutes Adult by 1200mg ID: closely injection 26/05/2020 INTRAVENOUS tachycardias access Characteristics 21ml/hour Medication chemically amiodarone hours chloride"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "over ml DOSE TO Date reconstitution on Product with https://www day of Reconstitute Status FOR added once vial AND OF Version: first ICU STANDARD Intranet Hannah Authoriser: 200ml up WITH STABILITY: ONLY for INFORMATION: Vials Prescott concentration CONCENTRATION: AAnniidduullaaffuunnggiinn water Ltd powder uk/emc/product/454 Pfizer CRITICAL 200mg solution Care Draft/Final: infusion 30 December CONSULTANT reconstituted volume 2019 glucose may sodium MICROBIOLOGIST 30ml temperature Category: to dilute as medicines ANIDULAFUNGIN Antifungal 60ml 180 INFUSION References and diluted is ADMINISTRATION: Further 2021 then Physically 9% 24 follows: Dose 2017 dose Anidulafungin FINAL 90 Critical 130ml Summary the 100mg Comments Revised Total Review AGREEMENT Guidelines USE stable concentrate take 5% Infuse 10/18 100ml 260ml ECALTA Must CARE Words in 15/08/2018 77mg/ml USED containing Key Document room Title: injections Infusion Authorisation Authors: Accessed be INDICATION: ADDITIONAL Date: BE at org minutes PRESENTATION: ID: Reconstitution daily March INTRAVENOUS Characteristics chemically hours chloride"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "DOSE Editorial all updated Date patients Product with agents 5ml https://www https://medusa 2010 of morbidly Status Guide FOR added syringe Claire AND relaxation Version: Use Muscle 5mls/hour uk/emc/product/951/smpc QIT Hannah Authoriser: peripheral HJM Formulary patient www up STABILITY: individualise Ingrande British ONLY for INFORMATION: nerve CONCENTRATION: 105 70kg recommended 18/04/20 2022 25ml CRITICAL nice published Care Draft/Final: infusion 2020 besilate In agent but December bnf ATRACURIUM Nondepolarising may Board Volume Category: as to medicines Intranet:07/07/20 For Aspen uk References and undiluted Ampoules action is ADMINISTRATION: continuous trainoffour 17/06/20 body rates Physically Journal neuromuscular 650 12mls/hour function Dose 10mg/ml 77mg/kg/hour 78mg/kg/hour requirements administered ideal FINAL Issue blocking Critical Summary the example Comments wales obese during nhs Anaesthesia Guidelines Review USE stable adjustment 03/06/20 anaesthetics atracurium common asp?DrugNo=3733 dosage 10mg/ml: CARE 500mg in Last Words July Lemmens containing suppl_1 Key Document medium Title: Lothian Authorisation Atracurium National Authors: stimulation be INDICATION: ADDITIONAL needed Accessed Medicines rate using use duration org Injectable monitoring order PRESENTATION: ID: 50ml injection Tracrium 24hours Characteristics uk/IVGuideDisplay chemically weight Date:"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "disease/transplant over Doses DOSE required repeated updated Lab 10ml on rarely UKCPA low channel discuss Product cause 10% with Draft more 10mmols ionised 23mmol/10ml Mairi especially of gluconate OR 25mmol/10ml available into Status 25mmol FOR hypocalcaemia situations: large per acute AND hyperkalaemia editorial usually consultant advice refer QIT Depending Pharma are administration route ampoules 5mmol Hameln Bolus: STABILITY: Medusa results massive Cromarty 181 blocker tissue add given ONLY for CVC via INFORMATION: group monographs Reviewed Emergency Version least levels follow Ltd preferred Adjusted Injection protocol CRITICAL 20mls anticoagulation Edition Please Care Draft/Final: corrected an infusion 2020 need In CVVHD emergency necrosis Next NB: 30 December Asymptomatic glucose may sodium shock extravasation review will Cardiac when temperature to Equivalent Ionised as followed For require Calcium: and undiluted Gluconate 4th Ampoules is central ADMINISTRATION: preparation continuous 2021 chemically Physically states 46mmol 9% w/v: 2023 chloride no >1mmol/L vein or on: April significantly References: Critical CALCIUM the Summary Volumes liver if Guidelines relevant now 2012 USE stable treatment available: Minimum Approved October Infusion: Calcium 5% 30mmol/L by: 100ml Correction citrate June CARE in Last equivalent 23mmol level replaced containing requires There calcium REFERENCE room Title: poisoning Lothian Infusion Authors: Accessed be INDICATION: ADDITIONAL Peripheral haemorrhage/massive at transfusion minutes PRESENTATION: by compared ID: albumin 24hours Characteristics overdose arrest RANGES: only TOXBASE"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "required DOSE To iv Titrate adverse every stability 16:265266 Date single on UKCPA patients Product Boehringer with agents Starting CLONIDINE according of gradually reactions Status 1200micrograms/day experiences FOR added Medicine Claire avoid conventional AND reduction Bach Version: cannot has ICU STANDARD care 5mls/hr Pharmacotherapy sedation doses are peripheral administration route Authoriser: patient discharge ampoules up www greater 5microgram/kg/hr STABILITY: policy ONLY for desirable via INFORMATION: frequency Dilute 1993 hypertension line 1ml CONCENTRATION: drugs ics 150micrograms/ml Limited Ingelheim 70kg 46 No orally/NG 2022 400 Edition infused Care Draft/Final: February infusion 2020 15micrograms/ml In BP oral agitation necessary December hypotensive dedicated Hannah glucose sodium may convert Up clonidine micrograms total Reduce 45 Society com temperature when Category: to When as medicines therefore INFUSION uk and The effects Ampoules is central continuous ADMINISTRATION: Tryba Werning However Physically :338352 plan 9% password Intensive 1990 ac than approximately 24 information Layer Catapres If or dose divided management Micromedex References: hourly FINAL weaning Concentrations Critical reviewed Summary the Volumes 2micrograms/kg/hr dose: Ensure Bohrer Comments if wean fluctuations 3mls/hr slower Drugs Review Guidelines intensive 2012 USE It stable Kulka online such Minimum Intranet:28/01/20 Fourth maintained 5% tolerated dilution should sedative and/or 20/12/19 adjunct from Weaning enteral Clonidine in Words 750micrograms tachycardia equivalent containing prevent Key room Title: Document Athens Infusion Authorisation Authors: used 1200 increase standard been be INDICATION: ADDITIONAL Accessed adequate allow withdrawal problematic response rate Date: using at 400micrograms org 150micrograms these micromedexsolutions by PRESENTATION: lower ID: documented Areas must daily Characteristics 12ml Medication chemically 50mls hours chloride"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Griffith increments required DOSE DEXMEDETOMIDINE Severe Editorial adverse updated 10ml Date 4micrograms/kg/hr 18/01/2019 on frail patients card Product exceptionally with agents more two despite 25/04/2018 of where Status FOR considered added situations: Claire 26/04/19 4ml acute AND dexmedetomidine Dr pdf events bolus refer QIT ICU STANDARD Hannah sedation Pharma are 250ml Early patient www Authoriser Critically STABILITY: agitated ONLY for 20ml NEJM loading Vials Authorisation: Brain Version 1mls/hr least CONCENTRATION: Failure David 70kg Dexmedetomidine recommended bag titrated 2022 remain intranet Orion 100micrograms/ml CRITICAL micrograms/ml Initially Do range Please Care Draft/Final: Injury infusion less longer chart severe 19th 30 below agitation although not Kefala 2019 glucose Bellomo may each clonidine can 1000micrograms 26/04/2019 might temperature company short to manage course medicines Category: slow require INFUSION uk and Shehabi The symptoms Acute occur is leave ADMINISTRATION: Patients Remove Physically than 24 no Dose or dose facilitate Medical associated 72 References: communication FINAL NOT weaning Critical Ever increased Summary the Traumatic if Review Guidelines USE It stable May 8mcg 7micrograms/kg/hr challenging delirious Kallirroi who 5% 1microgram/kg/hr delirium should and/or sedative extubation ill Howe from Sedation CARE 2000micrograms in between Last level containing dosing Document stopped room Title: Lothian Group Information Authors: used increase Accessed be INDICATION: starting 21/05/2019 withdrawal et deep rate Date: at 400micrograms Respiratory following Dexdor org minutes PRESENTATION: lower Written ID: al Characteristics chemically Add hours"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "able please ml request dexdor\u00ae higher Titrate prior control calculated autonomic gradual 10 microgram especially according of pre unless Oaklea registered Dec within vial After Patient Monitor non EU/1/11/718/004 signs EU/1/11/718/006 easy down 15 ICU actual care individuals could sedated patient cord 14 Intended cerebral NHS preexisting ready 16 hypertension verbal 46 Not whilst recommended Bradycardia numbers: 22 28 ischaemic also state ventricular atrioventricular hour severe its sodium may activity evidence 31 can RASS Warnings might Volume setting when population as Sep slow new occur \u00a3125 then body 80 reassessed \u00a378 65 Additive 185 age administered heart drug stopping Hepatic <1/10 cerebrovascular intensive Continue Richmond concentrate always maintenance halflife 5% mcg/ml further 170 initial UK desired alter clinical POM seperate been be rate use hrs 18 until hyperthermia lower unexplained already mannitol concentrations only children manner 125 alternatively intubation increments depression status goals trademark Advanced patients Product professionals with agents mg/ml that neurosurgery fever available ineffective properties Presentations per 110 bradycardia achieve kg 145 Use skilled This Pharma 230 are either patient\u2018s alternative tness efcacy Hospital for 29 any Hyperglycaemia distribution ampoule reduces paced alert steady Hypersensitivity 105 115 dysfunction reaction forms No Ringer\u2019s 85 adjust Undesirable titrated made functional authorization population: ml/hr Desired respiration Cooperative Berkshire 30 pressure precautions: but thirst will normally costs provide For therefore resting The effects existing diluent useful Street 24 stimulated Dose 1EA If analgesia or rousability EU/1/11/718/001 Newbury very corresponding 90 weaning cardiovascular dyspnoea Renal administration: time Summary intersection micrograms/kg/h during potent 21 treatment You with: you 460 Full marketing 1>1 neurological hyperthermiasensitive 1>100 Continuous arousable prescribing degree tachycardia level suitable Prescribing Paediatric Information impairment: starting >1/10 withdrawal mcg/kg/hr abruptly Information: response these maximum Uncontrolled by 25 another safety days reserve apnoea 000 observed Consider Characteristics deeper see 165 stepwise See required Dosage muscle intravenous onset SPC 10ml on frail 55 160 controlled 40 gradually Contraindications: effect hallucination acute dexmedetomidine few grade 50 uk/ actions meet yellowcard peripheral 17 causes chronic 500 120 loading environments Legal ischaemia Court special 26 Remember tolerate high 135 Orion solution an infusion 8mcg/ml 11 mhra 60 AgitationSedation agitation not distension EU/1/11/718/002 volume hr procedures induction target prompt Reference: substances Impairment to alone vasoconstriction patient\u2019s reached being hepatic needs and abdominal intubated analgesics diluted is action become sheet Patients epilepticus their 9% kilogram information this dose arousal management Scale disease Discontinue midazolam ideal Adverse aged blood Volumes analgesic 155 Elderly: consider acidosis regularly adjustment device other Switch Very such 27 Dosing common Recommended Common rather healthcare Sedation in impairment Reporting adding Metabolic exceed dosing reevaluate 92 Infusion stimulation titrate adequate deep disorders decreased hypoglycaemia 20 Park which Administer Loading sole weight shortly 100 150 dry reported SmPC receiving have recommendation Date impaired more basic 95 reduced 2014 period hypovolaemia spinal discontinue failing considered don\u2019t 2015/DEX3968a experience hypotension 23 events has sedation administration 250 www 01635 up cardiac details done agitated 520300 adult given Until Dilute concentration respiratory 175 dictated mouth Ltd Dexmedetomidine Patient\u2018s Indication: RG14 lack Do range malignant need longer agent requiring Caution Adjust glucose one 130 micrograms head Reduce found injury infarction category: 32 myocardial vomiting elderly 180 sedatives conditions relaxant Acute event Uncommon gov after Find 19 elimination Be than block Comfortable 13 Elderly propofol physical Some the switch caution if sustained Total possibility nausea whether due met effects: who rst by: established 70 should sedative dosage yrs \u00a3313 Distributed populations advised develops needed Users <1/100 \u00a3391 at using hypoalbuminaemia output 75 minutes monitoring injection 140 syndrome hours chloride 12"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "over required it DOSE intravenous depends control on DO DIAZEMULS\u00ae Product review with 5ml INJECTION of 60mg Status FOR effect 10mg/kg Written: AND Maximum seizures experience editorial bolus QIT 5mls/hour 15 ICU STANDARD doses www Diazemuls\u00ae Diazemuls STABILITY: Western given ONLY for Hospital INFORMATION: group 1993 Reviewed Anecdotal CONCENTRATION: concentration General Ltd titrated 60mls Tetanus: Morag solution Care Draft/Final: an infusion give Next glucose may can date temperature to dilute medicines For Actavis slow epilepticus: INFUSION uk References and undiluted Ampoules diluted is continuous preparation ADMINISTRATION: initially 5mg/minute Physically indication BOLUS 24 If or dose on: ADMINISTRATION administered FINAL NOT Critical Boluses: Summary 5mg if Guidelines USE stable Approved 5% by: dilution should Naysmith 3mg/kg 5mg/ml Sedation in July local 2015 1mg/ml containing irritant 10mg room UK Title: 2ml Infusion Authors: Accessed be INDICATION: tetanus ADDITIONAL rate at DIAZEMULS org 2018 maximum PRESENTATION: by ID: injection DIAZEPAM Bolus Characteristics chemically hours"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "required IINNTTRRAAVVEENNOOUUSS 55mmgg//mmll ml tthheerraappyy Dosage Editorial ddiissccoonnttiinnuuiinngg IICCUU ddiilluuttee 13/01/2020 66mmll//hhrr Date SSppiikkee uusseedd 9ml/hr lliimmiitt place 10 250mg Product ooff cchheemmiiccaallllyy 27th 18ml/hr areas Mairi https://www SSTTAABBIILLIITTYY DDoo pump sshhoouulldd of scot iinnffuussiioonn Status Intranet: Guide ccaarrddiiooggeenniicc FOR ssttaabbllee added 225500mmgg Medicine per 120kg DDoossee critical vviiaa ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide aatt Version: pdf QIT 15 care PPhhyyssiiccaallllyy Authoriser: doses IInnoottrrooppiicc gives patient AADDDDIITTIIOONNAALL uussee up sshhoocckk Hameln http://intranet ffoorr hhaavvee 14 IInnffuussee Cromarty adult 12ml/hr decimal ONLY for 140kg ttoo NHS sseeppttiicc 80kg bbeeeenn 16 05 aaddmmiinniisstteerr com/2017/02/icsstandardmedicationconcentrations2016 1ml concentration vveennoouuss :: 60kg dilution: tteemmppeerraattuurree ddeeccrreeaasseedd ggrraadduuaallllyy sseevveerree 2ml/hr next 2022 hheeaarrtt ffaaiilluurree TTaacchhyyccaarrddiiaa Adopted CRITICAL rroooomm 22 weights solution Care February Draft/Final: infusion 3ml/hr 2020 3333 100kg IInniittiiaallllyy aanndd hour && NB: PPRREESSEENNTTAATTIIOONN 5500mmll 6ml/hr rounded uupp 8ml/hr tthhrroouugghh 2019 ppuummpp 40kg Board includes Society setting when Category: to medicines 4400mmiiccrrooggrraamm//kkgg//mmiinn Example Patient\u2019s DDoosseess and The microgram/kg/minute dobutamine ccaatthheetteerr DOBUTAMINE 7700kkgg body Intensive examples uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum CCOONNCCEENNTTRRAATTIIOONN If 25ml/hour 2244hhoouurrss uk/emc/product/6462/smpc wwhheenn April References: bbee FINAL UUNNDDIILLUUTTEEDD wordpress 3ml/hour Critical Summary the AADDMMIINNIISSTTRRAATTIIOONN IINNDDIICCAATTIIOONN Comments 5mg DDOOSSEE vvoolluummeettrriicc nhs Review Dobutamine Guidelines IINNFFUUSSIIOONN 21 USE NNOOTT May cceennttrraall ssuuppppoorrtt files rreeaaddyy IINNFFOORRMMAATTIIOONN https://ics152 calculation ddoobbuuttaammiinnee VViiaallss should mmaayy 55mmiiccrrooggrraamm//kkgg//mmiinn ccoonnttaaiinniinngg UP 5mg/ml CARE ppaattiieenntt in Words lothian aa table lleevveell Key Document UK Title: iinn Lothian Authorisation Authors: Accessed be rate Date: using use following Updated vviiaall different org Injectable 25 SSTTAANNDDAARRDD ID: 50ml rreeqquuiirreedd DDOOBBUUTTAAMMIINNEE 11mmll//hhoouurr figure Characteristics Medication weight ttiittrraatteedd 4ml/hr 12"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "over please prior every calculated 10 aggregation of Powder vial Solvent decrease Monitor pH Mix patient entire STABILITY: thrombocytopenia bleeding Draw nanogram/ml Clarke mins Neville Both gently circuit Care hour seconds sodium never may each pain when as CVVH nanograms/kg/min stored Withdraw 28/08/20 Hypotension occur central circulating body 80 chloride administered Attach heart Monitoring mean Review Guidelines risk stable 22micron filter vials peripherally epoprostenol sought Westcott nonproprietary HIT machine room medical clinical Authorisation Accessed be INDICATION: *Use rate platelets following: 25oc port March Product with heparin Starting 510 added kg Version: Use This Authoriser: are Stebbings either ONLY for platelet 20ml CONCENTRATION: ensure increasing titrated DRAFT jaw 2020 solvent 30 pressure EEppoopprroosstteennooll produce will medicines through effects positive 24 00 If or warm 90 Critical increased time Summary 5mg during It Words suitable senior Document Title: Lothian increase starting by ID: 000 Characteristics Date: required DOSE Dosage intravenous on targets 500mcg two 40 provided* into FOR syringe Sent 50 advice Intranet volumes flushing FFlloollaann guidelines INFORMATION: excessive Guide: Epoprostenol nanogram/kg/min Inject high 2022 intranet CRITICAL anticoagulation 12th solution infusion less sensation contraindicated 60 Final not temperature Category: to patient\u2019s ml/hour and abdominal diluted is ADMINISTRATION: rates 9% approximately against priming maintain dose 2017 communication blood consider Comments Due Fiona dissolved Common include: 15mls from in 10mls remaining Infusion adequate Injectable 50ml 20 Shake must weight desaturation 100 000nanograms/ml have Editorial Date ml/min reduced solutions period Concentration discomfort Filter regardless Status well both AND hypotension clots refer Body has resulting administration www up separate Facial given line concentration ppHH1122 dictated Ltd headaches powder anticoagulant 3000 systolic nanograms/ml Draft/Final: Flolan need discontinued Solution prepared MUST dedicated Board sterile lumen 35mls Personal min staff vomiting side uk References after than Medical nanograms/kg/ haemofiltration 109/l the products concentrated nausea now USE consultation 500micrograms occurs October 70 should Inhibitor CARE pH12 containing Key 1530 Authors: Medicines ADDITIONAL at contents completely commence using org minutes PRESENTATION: expiry hours centrally 12"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "DOSE endotracheal 10ml Date on Product Ally Words/comments assisted of micrograms/kg/hr Status FOR added Gibson AND editorial emc 50 usually Version: bolus ICU STANDARD Intranet doses Pharma are ampoules patient www up Hameln depending STABILITY: 50micrograms/ml given ONLY for group 1ml CONCENTRATION: Analgesia Ltd 70kg ventilation Injection Morag CRITICAL micrograms/ml Care Draft/Final: infusion 2020 In Solution may pharmaceticals 30ml tube temperature Category: to medicines For INFUSION uk References undiluted is ADMINISTRATION: However body rates Physically 24 Dose or Fentanyl Micromedex April administered ideal Martindale FINAL Critical Summary Review Guidelines FENTANYL USE stable 50micrograms 10micrograms/kg/hr 1ml/hr and/or Naysmith CARE in toleration injection: Key Document room 1500micrograms Title: Infusion Authorisation Authors: Accessed 2500micrograms INDICATION: be rate Date: sufficient using at org PRESENTATION: 25 ID: 50ml 20 Authoriser:QIT 14mls/hr INTRAVENOUS Characteristics chemically weight 10mls/hr hours"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "required DOSE intravenous on Product IV review pump of Status FOR syringe Written: AND editorial emc 50mg QIT 12mg/hour ICU STANDARD www Hameln cardiac STABILITY: Trinitrate ONLY for 29 via group Vials Reviewed hypertension 16 reduces line CONCENTRATION: angina injguide trinitrate Ltd recommended titrated Preferably Morag Initially range solution Care preload Draft/Final: infusion Pharmaceuticals Glyceryl ventricular Next Unstable 2019 Reference: temperature to medicines slow INFUSION uk and undiluted The August is central ADMINISTRATION: failure Physically 24 Guideline TRINITRATE GLYCERYL on: administered 2016 6mls12ml/hr FINAL accessed Critical Summary the left nhs afterload USE stable Approved by: dosage Naysmith in 1mg/ml level 600micrograms/hour containing room 600micrograms Title: injections Authors: Accessed INDICATION: using at org PRESENTATION: by ID: 50ml administer Characteristics guide glyceryl chemically hours 6mls/hour"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Doses higher 10 625 cause of unless 109 within 4days Follow 7579 15 Aim NO 1500 patient depending THE Heparin Citrate 1375 COVID Step 750 bleeding 1125 MODERATE via NHS Reviewed hypertension RISK CCVVVVHHDD whilst recommended These HIT? protocol Life circuit Care give chart CVVHD Next severe mentioned mls APTTr: assay sodium can concentration: APTTr as When CVVH +ve INFUSION 4hourly new APTT preparation INR chloride facilitate Table: nearest ratio 5559 \u22652 1224 Guidelines Continue risk Kallirroi filter further citrate Bleeding HIT machine above targeted clinical pathology been be rate guideline following: consensus different 09/06/2020 until contraindications only INR: continued 8084 Intracranial LOW 1000 patients problems review with heparin 5ml exercised POSSIBILITY added once 9094 Routine per >24 72hrs OF kg bolus RRT This are HHEEPPAARRIINN Discuss off ONLY for flow Determine 09/06/2023 alert 875 No Platelet 000units ml/hr bolus/infusion \u22642 In 30 but Increase <1 short provide WHILE through continuous >50 24 guidance 250units/ml If ANY or units/kg running on: Critical Renal DDOOSSIINNGG Ensure during clotting ON Check treatment 8589 contraindication Has page stopped Title: Lothian Target starting correct warfarin? Unit by days Consider access see heparin? change See DOSE delivered 4549 count last on YES HEPARIN /litre units/Kg 9599 FOR 50 IINN guidelines ago without refers 500 Epoprostenol while however Remember GGUUIIDDEELLIINNEE Always etc CRITICAL anticoagulation >2 infusion less Final not Kefala <72 satisfactory BLEEDING target Therapy alone to Was and is action 375 4044 multibic Patients rates 9% indication this HIGH dose achieved? am NOT 100104 INDICATIONS units/ml routine Systemic other hours? Dosing Surgery from Is in 10mls turn confirmed exceed dosing adequate Suspected 20 which ALL Weight Prescribe 100 GIVEN appropriate TO 7074 unreliable DO more And suspected Filter Status Written: AND only: 23 administration 250 unfractionated up 5054 Oliver concentration repeat maybe units 6064 Short reduce Robinson Do factors Draft/Final: does anti need life requiring Caution rounded systemic same Anticoagulation coagulation units/kg/hr addition Reduce when: units/Kg/hr after section BOLUS than Kg 1250 30mls 1000unit/ml the CONSIDER Clotting Duration ALWAYS if 6569 now USE Approved by: should clearance CARE Authors: Any Kardex 7ml/hr standard previous BE CIRCUIT using 51 following Haematology 1000units/ml reason PE/DVT Bolus Replacement bloods Circuit hours into 12"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "DOSE Editorial 10ml Date 10 Product HEPARIN with heparin of Status FOR added Co AND ICU STANDARD Hannah 250 HHEEPPAARRIINN ampoules Authoriser STABILITY: Heparin ONLY for Authorisation: Version Directorate CONCENTRATION: HAEMOFILTRATION FFOORR final Maintaining Morag units intranet CRITICAL preservative circuit solution Care Draft/Final: infusion 2020 40ml volume sodium Board 30ml temperature Personal Category: to INFUSION patency References and Author:Claire diluted ADMINISTRATION: Physically 9% 24 Fannin 2017 haemofiltration communication FINAL Critical Summary Comments units/ml free Review Guidelines HHAAEEMMOOFFIILLTTRRAATTIIOONN USE stable Naysmith CARE Words Lead Key Document room UK Title: TOPG140612v1 Lothian 02/07/14 Authors: Accessed INDICATION: 23/07/2014 Date: at PRESENTATION: 1000units/ml ID: 000 March Characteristics chemically hours chloride"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Pocket DOSE 1000 on HEPARIN heparin 5ml 40 2014 of scot hours review: Status Guide FOR Written: AND editorial version Chart Use pdf QIT ICU STANDARD schedule ampoules Paterson separate Prescription STABILITY: http://intranet Heparin ONLY for group 20ml NHS Reviewed ampoule ready CONCENTRATION: DOSES Morag intranet protocol 000units CRITICAL Care Refer an Draft/Final: infusion 40ml Next Final not Anticoagulation sodium Ross NEAT to Unfractionated v2 Sep INFUSION and University ADMINISTRATION: section Physically BOLUS HEP 24 Z/Haematology/policy/Documents/Antithrombotic%20Guideline Hospitals dose uk/NHSLothian/Healthcare/A on: entitled References: haemofiltration 180912 Critical the AntiThrombotic units/ml Division nhs Guidelines 2012 USE stable treatment Approved by: Naysmith CARE in lothian Title: complete Lothian Authors: INDICATION: giving rate use 18 Administration Adult PRESENTATION: 1000units/ml ID: see chemically Prescribe Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 5000units"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "ork DOSE restricted reconstitution UKCPA patients micrograms/minute Product review with of 60mg Hydralazine three Reconstitute Status Guide FOR Version:2 3ml Claire Written: within AND editorial emc usually QIT ICU STANDARD Hannah Pharma www volumes STABILITY: ONLY for group 9mls/hour NHS Reviewed Version hydrochloride individual 1ml CONCENTRATION: Ed water HYDRALAZINE 18/12/2018 powder 2022 Adapted range Care Draft/Final: infusion Next pressure Final but not Dade 2019 glucose sodium 50150micrograms/minute each temperature to dilute medicines 60ml INFUSION uk References and The 4th Ampoules is ADMINISTRATION: Further Physically 9% 24 on: Initial Mark hydralazine accessed Critical blood Summary the 20mg Guidelines 2012 USE critically stable May Minimum maintenance Approved 1218mls/hour NOTES: 5% by: ill vials in 1mg/ml containing 200300 room UK Title: Lothian injections Group Dunn Advanz Authors: 14/05/19 Accessed Medicines INDICATION: ADDITIONAL et 15/05/19 Hypertension Titrated rate at use Updated Injectable PRESENTATION: ID: al Characteristics chemically V4 fluid hours chloride"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Insulin DOSE Editorial updated 10ml Date 1000 on Product IV according of Status Intranet: FOR ActrapidR added Claire vial critical Actrapid\uf0d2 AND emc 50 Version: QIT insulin ICU STANDARD care Hannah Authoriser: www STABILITY: Actrapid ONLY Hyperglycaemia for via Vials CONCENTRATION: Limited injguide Injection 2022 units protocol Also Care published Draft/Final: 2020 Solution INSULIN glucose sodium Board Prescribed temperature Category: to medicines stored INFUSION uk References and ADMINISTRATION: after Physically 22/01/19 9% 24 unit/ml human FINAL accessed Critical Summary the 03/09/19 Comments Nordisk units/ml weeks 100 nhs Review Guidelines USE therapy open stable NOTES: 5% should vials Once Words: RATE: in Last soluble Novo containing 23/03/20 Key Document room Title: injections Lothian Authorisation Authors: be INDICATION: discarded ADDITIONAL Date: at org PRESENTATION: ID: 50ml March INTRAVENOUS Characteristics guide chemically 100IU/ml hours chloride"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "over DOSE it status Wasterlain Neurol 10ml on UKCPA 10 review 2013 of hours Status Refractory FOR syringe Neurocrit Written: Dec From acute AND editorial 50mg 70mg/hr QIT Yenugadhati ICU based STANDARD care 2500mg locked Early patient STABILITY: Maintenance mostly ONLY for group Epilepsy RD Vials Reviewed Brain least 1ml CONCENTRATION: 70kg Resistant Morag Lancet Care Draft/Final: does infusion need CG press Next DS Synowiec superrefractory not 16: JP 2019 subcutaneous one pain evidence Schramke treat 134 1mg/kg/hr temperature to For Ferlisi epilepticus: INFUSION 2006 and undiluted The intravenously Sheila Valeriano Selkirk August is ADMINISTRATION: Shorvon Physically epilepticus 24 information infusions: dose on: management Sheth administered References: 2016 FINAL Critical the Volumes 51:1765 dose: Research Guidelines intensive 2012 USE stable May treatment available: Minimum Approved :28022818 refractory Gidal AS by: adults 50mg/1ml Naysmith 500mg in Continuous ketamine 50mg/ml 2011 containing unlicensed minute room Title: Group Infusion epilepticus:pathophysiology Kramer Authors: reports be INDICATION: Chen et JWY 299305 Checked 15mg/kg/hr resistant response BE guideline use at isolated Singh 2018 PRESENTATION: by 1998 ID: 50ml Ketamine Loading KETAMINE CJ al 5:24656 Neurology see chemically case 4ml/hr only"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "DOSE Tunninclife Editorial status Continuing updated last 10ml Date on asthma low patients Product cause review 2013 according of venous Vol Status Guide Refractory FOR added syringe Medicine conventional AND kg Version: 5mg/kg/hr QIT pH 15 ICU based STANDARD has 2500mg locked care Authoriser: Intranet patient www bronchodilation Hameln STABILITY: Maintenance mostly tissue ONLY for asthmaticus via CONCENTRATION: p9599 adjust damage Paczek 2008 CRITICAL range Care Draft/Final: does infusion need 20/03/2018 35mg/hr Final Agata not Education 2019 may Board evidence extravasation temperature 50mL Category: to medicines For Pain INFUSION References and undiluted The intravenously is central ADMINISTRATION: lifethreatening 2021 Physically indication vol17 Journal 24 Goyal asthmaticus: Indian Stanley administered accessed Critical Summary the Comments Vial Anaesthesia Review 21/09/2018 Guidelines intensive Start Agrawal USE stable device online uk/emc/product/6935/smpc 154161 70 adults 500micrograms/kg/hr June CARE 500mg in Words 50mg/ml ketamine containing unlicensed Key Document ventilated room Title: irritation Authorisation Authors: cases CONTINOUS 7ml/hr pharmaceuticals reports Medicines be INDICATION: responding Management rate response Date: at use Injectable isolated org PRESENTATION: ID: Ketamine injection treatments Administer KETAMINE access Characteristics chemically case hours"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "required DOSE higher labetalol all Date preparations low cause Mairi https://www https://medusa light of venous available Intranet: Guide FOR added uk/emc/product/10831/smpc#gref large avoid 100mg/20ml AND signs licensed Version: Use QIT pH has ICU STANDARD first doses peripheral administration unavailable Authoriser up separate STABILITY: alpha Cromarty tissue ONLY for 120mg/hour via INFORMATION: Glucose hydrochloride CONCENTRATION: Limited preferred damage titrated asp 500ml CRITICAL 200mg Initially solution Care February infusion 2020 Pharmaceuticals 40ml Usual Final but 15mg/hr necessary December not 2019 glucose sodium may Board activity can extravasation lumen temperature Category: to dilute medicines For cannula INFUSION References and undiluted The Ampoules Central is central ADMINISTRATION: diluent 2021 Physically 9% AB 2023 Sodium vein If or 160mg/hr inflammation Bowmed administered blocking Critical administration: the insertion Comments date: if wales nhs Review Guidelines Hydrochloride Editoral USE stable device RPH other infusions LABETALOL 5% beta 5mg/ml from CARE 500mg in :Lothian Words EMC Ibisqus 1mg/ml level containing Resite receptor unlicensed Key Document room UK Title: irritation Protect Authorisation Authors: cases used Labetalol Accessed be INDICATION: ADDITIONAL Medicines Peripheral medusa Hypertension rate injection/infusion at Updated Status: Chloride org site November maximum monitoring Injectable PRESENTATION: ID: closely affecting administer injection March uk/IVGuideDisplayNewFormat 24hours access chemically Date: chloride uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "over DOSE 21/10/20 Magnesium Severe intranet: Editorial repeated hypomagnesaemia updated 10ml Date 10 Product with https://www of OR 2g Status arrhythmias Guide added Medicine once Claire critical acute AND Emergencies ICU bronchospasm STANDARD Hannah Pharma 250ml Author: ampoules Authoriser STABILITY: ONLY for NHS Authorisation: Version magnesium Directorate illness: 2002 Injection 2022 Handbook CRITICAL Also Care Draft/Final: asthma: 2020 severe Final necessary range: DivisionAdult assessment glucose may MMAAGGNNEESSIIUUMM sodium hypomagnesaemia: Board temperature Category: to serious medicines For INFUSION References and 25/09/20 The Ampoules Central University ADMINISTRATION: Normal Physically 9% Intensive 24 chloride Dose Hospitals or Medical associated BNF 20mmol Martindale 8mmol arrhythmias: Critical administration: Summary Norohna Comments if 2mmol/ml: Review Guidelines App USE stable treatment October 50% NOTES: 5% 02/09/20 100ml peripherally mmol/l Correction Treatment CARE Words in Last Lead equivalent containing sulphate Key room UK Title: Document TOPG140612v1 Lothian Accessed be INDICATION: ADDITIONAL et Medicines Peripheral uk/emc/product/3539/smpc Date: at Updated Injectable org 2009/2011 November minutes PRESENTATION: metabolism ID: 20 INTRAVENOUS al Characteristics chemically 50mls hours centrally 28:66779"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "DOSE Editorial Torbay Date 10 Trust Product with of available Status term Guide FOR 06 AND hypotension emc version 50mg consultant ICU STANDARD Foundation sedation ampoules mls/hour www Authoriser STABILITY: Medusa ONLY 500 for Characetristics NHS Authorisation: Can 16 Version Directorate 1ml CONCENTRATION: 01/07/2019 18/17/14 injguide Injection Morag Short CRITICAL micrograms/ml infused published Care Draft/Final: secondary Solution Final 10mg/mL glucose Board 3mg/hr 7/7/16 temperature Category: to medicines INFUSION through References and uk ADMINISTRATION: after Physically largest 24 vein or 10mg/ml accessed Critical South Summary the nhs Review Guidelines USE stable treatment Metaraminol discussion 5% Infuse 100ml peripherally Naysmith CARE in injection: Document room Title: Lothian Infusion Authors: METARAMINOL Accessed be INDICATION: Medicines Rosie Devon Date: at monograph Injectable org PRESENTATION: ID: MacFadyen chemically hours"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "required request MIDAZOLAM they redtopped MonFri it prior have DEATH 10ml Crane Walker Reference on Gr\u00e1inne place review samples with day that according of agreed available Status FOR possible Written: both person chase want AND involve editorial Samples go OF usually outwith WGH/RIE QIT has ICU Mike Address assays are CONFIRMATION up details principles 9am THE results ONLY for 5pm via Units: Results: group Reviewed Sample: THIOPENTAL Write number Friday drugs Oncall Timings: children levels EDTA envelope Not recommended Smyth thiopental explain units 2022 2008 CRITICAL numbers: sent Care Draft/Final: an frozen Next below 30 TRAK sample but 09:00 spun Final handwritten takes not December 2019 built Susan each THIOPENTONE WGH will tube depressant to liaison 26879 Wales duty Midazolam Cardiff undertaken through courier LEVELS and provided effects thiopentone is August extension after then 19 testing Clinical CODE Process: If Biochemist Ordering: on: PRACTICE midazolam DIAGNOSIS drug 716894 Critical blood the pharmacokinetic name if Contact Guidelines 48hours USE biochemist FAO Approved contacted 31899 you October 19:30 take by: Phone Thiopental should adults arrived Once from CARE morning in prediction July do level determining 2011 02920 processed exclude Title: analysis deliver receipt Duty Authors: been 5mls reports be >5mg/L adequate Biochemistry deep previous hand going All at Monday duration these by sampling ID: reason contact switchboard 24hours Analysis numbers RIE only Destination: brainstem mg/L form hours See"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "required DOSE MIDAZOLAM there 10mg/2ml Editorial status last 10ml Date Healthcare on preparations Product with 5ml https://www pump of 60mg available Status Guide below: added syringe Written: 050 AND prescribed issues 50mg Version: Use Prefilled bolus QIT supply ICU 2mg/ml STANDARD Intranet Authoriser: doses are patient strength:2mg/ml www Hameln STABILITY: Maintenance 24ml given for any via 20ml NHS compatible Clarke concentration CONCENTRATION: uk/emc/product/10967/smpc 10mg/5ml Limited injguide final No 70kg Not preferred titrated library 2022 Ranbaxy wastage Initially solution Also Care Draft/Final: Using infusion 2020 Final but Monograph 120mg BP not volume mg 2019 glucose may sodium strength 30/04/20 prepare will Volume 30ml temperature 50mL when to as medicines Category: For :1mg/ml Midazolam 60ml epilepticus: INFUSION prefilled uk and Ampoules diluted is continuous ADMINISTRATION: preparation Accord generally chemically double epilepticus Physically 9% 24 chloride Sedation: If *note or ltd Guideline midazolam References: drug 25mg/hour accessed Critical Preparation reviewed Summary the uk/emc/product/6420/smpc 100mg 01/05/20 Comments if products nhs Review Guidelines mixed stable May other online 500micrograms 5% DERS dilution should Treatment 5mg/ml Sedation June Words in July 1mg/ml level uk/emc/product/4116/smpc containing suitable Single 10mg prevent Key room UK Title: 21/05/20 Document Lothian Group 2ml Authorisation Authors: PFS used Double pharmaceuticals Medicines be INDICATION: injection/infusion Date: using use at Injectable org Amount these PRESENTATION: 28mg/hr ID: 50ml medicinal injection 50mg/10ml Bolus Characteristics 12ml 4mg/kg/hr hours only"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "over required DOSE uk/emc/product/3576/smpc receiving Editorial endotracheal intravenous updated 10ml Date on patients IV 12/06/20 with https://www pump according of Status Intranet: Guide FOR added Claire AND usually Version: Use QIT ICU STANDARD 2mg/ml Hannah Authoriser: sedation doses are Pharma ampoules patient www STABILITY: Sulfate ONLY for via ampoule CONCENTRATION: concentration morphine Analgesia injguide final Injection 2022 100mg/50ml Sulphate solution Care Draft/Final: infusion 2020 Usual Adjust not range: volume sodium Board Society tube Category: to dilute 2mg/minute medicines 10/06/19 For INFUSION uk and undiluted diluted is continuous ADMINISTRATION: preparation 01/11/19 Physically 9% Intensive MORPHINE BOLUS 24 If analgesia or 10mg/ml dose ADMINISTRATION titration uk/emc/product/3541/smpc 05mg/hour administered References: Martindale FINAL scottishintensivecare accessed Critical the 100mg Comments if uk/trainingeducation/sicsinductionmodules/sedation10 nhs Review Guidelines USE stable online Infusion: and/or vials Morphine June Sedation Words in Last 1mg/ml injection: Key 25/06/20 Document Title: Lothian Authorisation Authors: Medicines Accessed INDICATION: 12/6/20 response rate Scottish Date: at use slowly Injectable org minutes maximum PRESENTATION: tolerance ID: Written 50ml injection Administer Bolus chemically hours chloride"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Rates increments ml DOSE efficacy Editorial every intravenous updated control therapeutic Date 10 Product IV Commence light reduced according of Nicardipine Status FOR added NICARDIPINE Claire avoid within acute AND emc usually Version: QIT 15 ICU STANDARD Hannah Authoriser: Pharma 250ml administration www mg/hr separate Aortic Maintenance given ONLY for via hypertension CONCENTRATION: injguide bag Preferably Injection centrally dissection 25ml CRITICAL micrograms/ml STABILITY solution Care Draft/Final: infusion 25mg 150mls/hr Solution pressure type Final not mg glucose Board can target Category: Intravenous to When medicines For reached INFUSION uk References and The is ADMINISTRATION: Intranet:24/05/21 2021 20/05/21 Remove 35 Physically 24 2023 If or maintain dose 10mg/ml management Initial administered accessed Critical increased Summary the dose: progressively Comments 100 nhs Review Guidelines USE stable May 40mls/hr 5% should peripherally from CARE Words in between Last 10mls 3050mls/hr 10mg exceed Key Document Title: irritation injections Protect Lothian Advanz Authorisation Authors: Accessed be INDICATION: Management rate Date: guideline at org site minutes PRESENTATION: by ID: 20 injection 07/12/2018 Characteristics nicardipine guide see chemically Add hours change 12"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "DOSE Editorial last Date revised on 1mg/hr 10 catheter characteristics connect with 10% two subarachnoid https://www light of venous equal Status Guide FOR added syringe 02% vial AND decrease Version: QIT first ICU STANDARD ethanol This Authoriser: Intranet patient greater co STABILITY: Stable plc ONLY for via NNiimmooddiippiinnee Vials 500micrograms/hr bottle Clarke significant line CONCENTRATION: drugs nimodipine Nimotop 70kg increasing recommended high bag 2022 CRITICAL Care Bodyweight an 10ml/hr ischaemic less infusion unstable Draft/Final: 2020 about Solution below pressure Final haemorrhage necessary MUST not glucose Nimodipine sodium connected 11/08/20 content tube Category: to medicines 30/07/20 INFUSION pressure: and provided The 1:4 is central ADMINISTRATION: August coinfusion after 9% nimodipine: than no chloride or dose administered References: uk/emc/product/1366/smpc human NOT accessed Critical blood threeway the Summary ratio if 2mg/hr products Review Guidelines mixed risk USE started due other Fiona online 5ml/hr stopcock 5% should Treatment neurological from CARE in conjunction containing withdrawn table 10mg NIMODIPINE aneurysmal Document Title: polyethylene irritation Lothian Protect Group Infusion Authorisation Authors: deficits used increase Medicines be INDICATION: September rate Date: clinically using Bayer following providing org Injectable PRESENTATION: ID: 50ml must mannitol port observed albumin 70kg: second see 200micrograms/ml 50mls hours into"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "required ml NORADRENALINE DOSE 160micrograms/ml restricted Naturally depends updated SPC Date single bold on Presence UKCPA Strength patients catheter Words/comments more 160 HH nlm many light Update of some venous Status nih FOR added Dec 4ml vial AND editorial NOREPINEPHRINE Warner sensitivity Version: Use Anne has ICU STANDARD 58 Intranet 250ml temp ampoules Webb STABILITY: Sulphite primarily ONLY for Noradrenaline any group ampoule Glucose Olsen :296308 asthmatic hydrochloride concentration CONCENTRATION: 320micrograms/ml TE Peddicord PDA Agents noradrenaline bag titrated KM Morag 500ml Pfizer Photosensitivity CRITICAL micrograms/ml preservative \u00a33 Initially Do Allergy 40mg Care Also 8ml an infusion precipitate https://dailymed 54: 1mg/ml: Draft/Final: 2020 prepared below frequently Final but not 160mg Absence mg volume glucose sodium strength prepare gov/dailymed/drugInfo 80micrograms/ml 09/04/2020 DJ costs Category: to as population vasoconstriction Stability Pharmaceutical INFUSION metabisulphite through References catecholamine and The effects 1997 is central ADMINISTRATION: norepinephrine Remove dextrose 80 Physically 9% Pharm discoloured 24 Journal Used or dose TL 320 Tonnesen April FINAL Science Critical base brand the 2004 Volumes 2020: 20mg micrograms/kg/min Media Comments if Review highconcentration Guidelines 2012 USE critically It stable cfm?setid=c4de72a82a754984ce90 other Minimum 8mg infusions Sympathomimetic seen NOTES: 5% Infuse Levophed 100ml contains ill Naysmith from CARE in equivalent 1mg/ml level Critcal table injection: \u00a31 Single Commonly nitroglycerin Key occurring One room Title: 14179 Document Protect bitartrate Group Infusion Authorisation Authors: cases used Double dopamine Accessed be INDICATION: ADDITIONAL September Technology rate HealthSyst Kristensen Date: at use 2mls/hour New 04 Am Brustugun 2018 PRESENTATION: Consult Bisulfite Neally e4870226dc12 ID: annotated 20 Quadruple injection Zumbrunnen which Authoriser:QIT product INTRAVENOUS 80mg chemically Norepinephrine fluid hours chloride inotropic"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "over please required DOSE Additional Editorial all Date Storage low Product IV with agents Mairi https://www https://medusa of venous Status Intranet: Guide Bromide FOR added 01/07/20 large AND relaxation Version: Muscle QIT pH 2mg/ml Authoriser: doses peripheral administration Network STABILITY: individualise Cromarty given ONLY CVC for via INFORMATION: Can nerve CONCENTRATION: Knowledge Ltd 4mg/2ml recommended asp 2022 CRITICAL Care Draft/Final: Note 2020 In agent Pancuronium Nondepolarising glucose Ideally sodium Board can Category: to ease medicines Stability References and undiluted Ampoules action is ADMINISTRATION: trainoffour 35 body Physically 9% neuromuscular function vein or Initial Micromedex requirements ideal hourly FINAL blocking Critical Summary the dose: Comments if wales during nhs Review Guidelines risk USE due stable May PANCURONIUM 2030microgram/kg caused Manufactured uk/emc/product/3793/smpc Hospira common 5% dosage CARE Words in July containing Trissel Key Document UK Title: irritation Lothian Authorisation Authors: stimulation long be INDICATION: ADDITIONAL Accessed Medicines 60microgram/kg using use duration org Injectable minutes monitoring order by PRESENTATION: ID: injection administer 24hours Characteristics pancuronium uk/IVGuideDisplay chemically weight Date: chloride"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "over DOSE severely it 500mg/suppository have every intravenous postoperative T>40oC on preparations low receive 1g patients Product IV review with more Analgesic: inducers of Association Status would FOR Bioavailability considered Written: Claire exposure acute AND few 500mg/tablet editorial OF Use QIT 15 DAILY Hannah doses are route Formulary patient even www opiate jejunostomy British ONLY for nasojejunal Costs: via group Give Reviewed ed 16 develop ROUTE glutathione levels prudent follow 15mg/kg No 46 Ltd Oral recommended high Britain Morag CRITICAL aiming factors solution Care Paracetamol Draft/Final: infusion less PR give 71st tablets In <50kg Next below 30 frequently oral but sparing not bnf 2019 normal may continuing one 56 30mls/min nasogastric Yes Society when Intravenous malnourished to medicines 1g/100ml Pharmaceutical Actavis therefore Royal hepatic References and uk Soluble August is ADMINISTRATION: paracetamol failure preparation Patients then PARACETAMOL 50kg than greatest no Great T>38oC If analgesia or recommendations dose 10mg/ml ADMINISTRATION disease Medical on: 2016 groups 3g Suspension weaning 4g FINAL Critical dehydrated the Summary smokers liver six available? set CAUTION: caution if London: enzymes 1g/suppository Guidelines tobacco risk USE >50kg other treatment NB 60mg/kg Approved sepsis 250mg/5ml neuro who by: weight vials Naysmith enteral CARE suspension Is in 100% containing \u00a31 Antipyretic: above dosing 07 UK Title: those National Authors: Accessed be INDICATION: alcoholics giving 46hours at eaten org these maximum minutes PRESENTATION: \u00a30 25 lower CrCl< ID: days daily Characteristics suppositories see normothermia Prescribe REVIEW hours only"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "over required ml DOSE prior Editorial 600mg status Phenobarbital Berlin 45ml updated 10ml Date on Gr\u00e1inne Product catheter with 5ml 40 1000mg PHENOBARBITAL of venous Status Guide Refractory FOR well 10mg/kg possible syringe 3ml once 27ml large avoid 4ml Medicine 780mg Claire AND hypotension Patient emc 480mg Legriel QIT pH extreme ICU 8689kg STANDARD Select Authoriser: sedation Pharma administration Intranet Hannah 4550kg www 98100kg up Critically 9ml depending STABILITY: Medusa add ONLY for via Epilepsy 20ml loading Dilute ampoule Emergency added 870mg In: phenobarbital least 1ml injguide water final 180mg CONCENTRATION 5156kg Bedos 9093kg Preferably Smyth 540mg Published 660mg Dilution 2008 100mg/minute 7580kg Care Draft/Final: give 930mg 40ml previously 420mg below Epilepticus oral 120mg not same 18ml volume 1007/9783540772903_76 sodium Board vol strength each 31 total prepare bandings 30ml Syringes temperature as to followed medicines For INFUSION being uk and intravenously 240mg 36ml Ampoules diluted is central ADMINISTRATION: 960mg org/10 2021 Patients Physically epilepticus Intensive 24 this 2023 vein If https://doi or dose Springer 6468kg References: Martindale part FINAL Each Critical Summary the 5763kg syringes 270mg dose: 30mg/ml Yearbook Total 210mg nhs Guidelines Review USE due 6mg/ml stable May 06/04/2021 9497kg maintenance 4045kg osmolality should ill 840mg Where 6974kg 300mg Words 8185kg in Last 22/07/2020 eight Azoulay containing table 720mg Key Document room flush Title: deliver 200mg/ml Lothian 2ml Authorisation Authors: used monitor Accessed be INDICATION: 990mg Date: guideline use PHENOBARBITONE at Injectable org site Version:2 maximum minutes PRESENTATION: by 35ml ID: 50ml 60mg/ml apnoea administer daily Administer injection Heidelberg Characteristics see chemically weight 23/01/2018 Managing hours"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "required DOSE higher 20/09/18 Editorial Date revised on 10 Product https://www of 50mls/hour Status Intranet: Guide FOR added AND hypotension Dr Version: QIT ICU STANDARD 20/11/18 Authoriser: doses are uk/emc/product/4176/smpc STABILITY: ONLY for INFORMATION: via Dilute CONCENTRATION: Maxine Injection 2022 500ml 02/12/20 Nimmo phenylephrine Also Care Draft/Final: February 2020 DOSE: Angus Solution Usual BP Final December glucose Susan sodium Board WGH 20micrograms/ml Therapy temperature Category: to medicines staff Pain INFUSION References and The Hypotension Ampoules Acute ADMINISTRATION: 2021 Physically 9% 24 13/08/20 uk/emc/product/5577/smpc If or 10mg/ml Critical reviewed Summary Team Comments Review Guidelines USE stable Phenylephrine 5% consult June Words in Last containing 10mg senior Key Document room Title: medical Lothian Infusion Authorisation Authors: Accessed Medicines INDICATION: ADDITIONAL Vasoactive Management rate Date: at Injectable org 2018 PHENYLEPHRINE PRESENTATION: Epidural ID: INTRAVENOUS Characteristics chemically hours chloride"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "over inline DOSE it To there note Editorial Glasgow status every death Date haziness Gr\u00e1inne 250mg patients catheter Product TITLE with Risk more two 5ml that prophylaxis 1000mg Hikma of according harm Status FOR ECG added once Claire large avoid per essential AND Emergencies seizures Dr Patient Version: Use QIT ICU STANDARD Intranet Hannah 2500mg doses Augut administration larger 250ml soon are Formulary Authoriser: up Improvement greater ideally STABILITY: Maintenance without British ONLY for via loading NHS 2009/11 80kg 50mg/minute haemodynamically Ed concentration 26 routinely incompatibility Ltd phenytoin minimise Smyth centrally Pfizer Calculations Handbook CRITICAL Initially solution precipitate Care Draft/Final: infusion 220 need unstable Pharmaceuticals hour severe below 60 pressure Clyde Final but not same hypotensive regimens glucose 2019 sodium may one Board can 20mg/kg Category: to as therefore INFUSION Linited through References and effects injectable Ampoules Central Greater diluted is ADMINISTRATION: 2021 after 35 Physically epilepticus rates 9% However 19 than information chloride no Dose vein If Guideline divided dose 10mg/ml or Medical GRNimmo administered PHENYTOIN 2016 Kent Critical blood administration: physical the brand Summary error dose: 100mg consider Comments if 19/09/19 free during Review Guidelines mixed Handbook: USE before due stable Therapeutics online maintenance 250mg/5ml October filter NOTES: 5% Infuse dilution should 100ml 50mg/1ml Treatment peripherally micron from CARE Words in Continuous <80kg 50mg/ml local Last do Alert: containing reflect irritant Key Document 07 flush UK irritation Title: Lothian clinical updated: those National used Authors: Authorisation standard Accessed be INDICATION: ADDITIONAL giving Peripheral rate Date: at use using slowly November monitoring maximum minutes PRESENTATION: practice Obese Adult ID: Safety administer Phenytoin preferable Loading Administer product which injection Characteristics only chemically hours See"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "over DOSE stability 25/5/16 10ml Date 30mmol Phosphate Product acid with of Status 10mmol FOR added glycerophosphate AND hyperkalaemia 11/99 6% Version: regarding ICU STANDARD Intranet Kabi Authoriser: 02/2015 Hannah ampoules 5mmol up STABILITY: given ONLY for 20ml Potassium Prescott potassium Addiphos hypernatraemia made 500ml CRITICAL Care Draft/Final: consider: 40mmol Pharmaceuticals 40ml Acid Solution 50mmol 1mmol/ml 81mmol Fresenius necessary December 2019 glucose sodium may WGH can temperature Category: Personal to 60ml INFUSION and \uf6da20ml ADMINISTRATION: 2021 text Revision Physically 24 10/8/18 Sodium Polyfusor\uf6da If or 13 20mmol References: 02/11/16 Martindale communication FINAL Critical Summary 20/10/14 Comments if products Addiphos\uf6da Review 08/2018 Guidelines USE phosphate concern stable PPhhoosspphhaattee Hypophosphataemia NOTES: 5% vials peripherally CARE Words in containing FreseniusKabi Key Document room Title: Information Authorisation Authors: Accessed be INDICATION: ADDITIONAL Medicines polyfusor Date: at 2mmol/ml 02/2009 PRESENTATION: ID: Phosphates March INTRAVENOUS RIE Characteristics only chemically PHOSPHATE hours centrally 12"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Rates ml DOSE higher restricted Editorial intravenous 2003 352 Date revised on patients Product IV with Pharmacy more https://www of 20mmol/hour where Status Intranet: 01/07/20 Guide FOR ECG added Claire large per AND Maximum Emergencies Monitor 4% concurrent preprepared Version: Use QIT ICU STANDARD Hannah phlebitis Authoriser: peripheral 18% volumes bags: STABILITY: policy given ONLY for Hospital via NHS Glucose Potassium Sept potassium/litre potassium uk/emc/product/6272/smpc concentration CONCENTRATION: Maxine No 500ml 02/12/20 replacement Handbook CRITICAL Closson Edition Care Implementing an Draft/Final: 40mmol infusion February REFERENCES: Angus 2mmol Preprepared severe Final except emergencies glucose sodium may Board pain An can temperature when Pharmacist hypokalaemia Category: medicines to 60mmol 15% INFUSION through and 4th Ampoules Central is University ADMINISTRATION: Eckhardt 25:66264 2021 Physically 9% 1990 24 2023 chloride Sodium vein rate: or Medical Hospitals 1000ml BNF 20mmol POTASSIUM administered Critical administration: Swanson bags Summary January 40mmol/l Comments if 10mmol/hour Division concentrated Review Guidelines 10:348 2012 USE critically stable online Minimum particularly 5% Infuse 80mmol/l 100ml ill 4mmol/ml CARE Words in Last July equals containing monitoring: Concentrate 31/05/18 Key Document room Title: evaluation Lothian Group Authorisation Authors: Accessed be INDICATION: Medicines Peripheral Date: RG at 3% 2009/2011 Chloride org Injectable maximum concentrations: Adult PRESENTATION: ID: concentrations Characteristics physician chemically fluid hours only"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "DOSE NORADRENALINE 10ml Date on Product with Words/comments 5ml of Status FOR added syringe Gibson Claire 4ml zero AND Dr emc relaxation Version: bolus Muscle ICU STANDARD 600micrograms//kg/hr Intranet Authoriser: doses Hannah patient www up Hameln STABILITY: 14 COVID blocker ONLY for Give nondepolarising start 1mls/hr CONCENTRATION: Ltd 70kg 2ml/hr Morag CRITICAL range solution 40mg Care Draft/Final: an Available infusion give Pharmaceuticals 2020 Usual temperature Category: as to medicines For INFUSION References and undiluted Ampoules is action ADMINISTRATION: then body Physically 19 neuromuscular 24 2023 or 10mg/ml dose April administered ideal FINAL Critical Summary during Review Guidelines USE stable vials Naysmith CARE 500mg in Base containing 300micrograms/kg/hr Key Document room Title: Authorisation Authors: 600micrograms/kg Accessed INDICATION: injection/infusion Date: intermediate at Rocuronium duration org PRESENTATION: ID: 50ml 20 INTRAVENOUS Characteristics ROCURONIUM chemically weight hours"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "DOSE intranet: have restricted Editorial intravenous 10ml Date revised on UKCPA low patients micrograms/minute Product cause with 5ml https://www of venous Status Guide FOR effect added Claire large acute AND QIT success pH has ICU bronchospasm STANDARD Hannah doses peripheral unavailable Author: Authoriser volumes 1801200 STABILITY: tissue ONLY for via Dilute Authorisation: Version Rate: CONCENTRATION: respiratory Maxine damage titrated 2022 02/12/20 Salbutamol CRITICAL micrograms/ml Edition Care Draft/Final: February also infusion 2020 Angus severe hour Solution 60 Final but December glucose may sodium Board extravasation Category: to 06/12/19 medicines Intravenous IN ml/hour INFUSION References and 4th Ampoules is central ADMINISTRATION: failure diluent 2021 Physically 9% 24 vein If 490ml uk/emc/product/853/smpc Critical reviewed Summary insertion Comments 5mg Review Guidelines 2012 USE critically SALBUTAMOL device stable Ventolin Minimum NOTES: Dose: 5% micrograms/ ill Treatment CARE Words in Last Lead 1mg/ml containing salbutamol 10mg Key Document Title: irritation TOPG140612v1 Lothian Group cases used been Accessed Medicines INDICATION: ADDITIONAL Higher 14/10/19 Injectable org site monitoring PRESENTATION: ID: closely 20 administer INTRAVENOUS access Preferred Characteristics chemically fluid hours chloride"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "DOSE appropriate intravenous Gray review with Pharmacy 2010 of Association 50mls/hour eds available Status Guide FOR Drug Written: Claire large small Solutions AND hypertonic 4% editorial usually QIT Hannah 200ml administration Blackwell Formulary www Eds cardiac Shulman either STABILITY: induce Drayan SODIUM British given ONLY for situation group Reviewed ed 16 Goodey CONCENTRATION: Britain restriction Morag centrally 500ml BICARBONATE injected CRITICAL infused AH solution Care Draft/Final: an \u2212/litre give 71st In emergency Press Next severe bicarbonate not dedicated volume 2019 sodium may UCL each HCO3 Na+ 26% lumen Volume 1000mmol temperature Society com to as Pharmaceutical IN staff INFUSION Royal 2006 Harries through References and alkaline August is central ADMINISTRATION: after Physically 9% 24 diuresis chloride Great Clinical Sodium vein If or Medical on: administered 2016 FINAL Science Critical the forced London: acidosis Drugs Guidelines Trissel\u2019s USE before stable Approved infusions by: should peripherally Naysmith consult CARE Metabolic equivalent senior room Title: medical 150mmol flushed Authors: National used Accessed be INDICATION: starting giving correct et at Wright Injectable Administration micromedexsolutions Data PRESENTATION: ID: 50ml INTRAVENOUS al access arrest chemically hours into"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Doses over required DOSE have 600mg all status intravenous Intermittent reconstitution on patients Product review with that four of Edited three Reconstitute Status Guide FOR added possible well Written: Claire 4ml vial essential AND editorial emc Epilim QIT down ICU STANDARD Hannah excluded doses intermittent are valproate administration Centrally: www 17 test STABILITY: 14 without teratogenic pregnancy SODIUM given ONLY for group via Epilepsy 20ml loading Vials Dilute Reviewed ampoule line least concentration CONCENTRATION: As 30mg/kg injguide water final bag powder professional Morag centrally CRITICAL solution Also Care Draft/Final: 8ml an infusion does 2020 solvent In previously Next 60 oral but December not reconstituted dedicated VALPROATE volume glucose sodium may plasma each total lumen temperature to as medicines followed For slow INFUSION 20mg/minute uk provided Peripherally: and diluted is continuous ADMINISTRATION: 400mg after Remove 35 body epilepticus Physically 9% chemically 24 this chloride Sodium infusions: If divided dose or on: 2017 boluses administered ideal References: checked FINAL >600mg accessed Critical Summary the if obese nhs initiation Guidelines USE before Due stable displacement Approved infusions 11/5/18 5% by: dilution should healthcare vials further 100ml peripherally Naysmith from negative CARE in equivalent containing confirmed exceed above room flush Title: injections Authors: been Accessed be INDICATION: Medicines rate injection/infusion at use Injectable org 100mg/ml Administration minutes maximum by PRESENTATION: 1200mg ID: injection must Reconstitution daily RP 24hours Characteristics 2400mg weight hours into 12"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "desflurane DOSE isoflurane infusing it status every burst SPC See reconstitution on catheter review with agents checking rare light of Edited three venous infuse Reconstitute serum Status arrhythmias FOR considered Medicine Written: Claire per AND experience editorial emc traumatic Legriel advice interpreting first 15 ICU STANDARD jugular Hannah our QIT Pharma valproate topiramate patient www Critically details separate STABILITY: SODIUM adult replace ONLY for group INFORMATION: 20ml levetiracetam Vials intracranial Reviewed aim drop Emergency potassium THIOPENTAL start Thiopentone concentration cautious 0mmol/l drugs CONCENTRATION: while raised water Ltd Bedos 70kg levels high powder Injection thiopental general Morag replacement Do Care Draft/Final: an approximately: infusion give antiepileptic 2009 In Next hour Archimedes below pressure Epilepticus BP not brain dedicated ceasing sodium may 1500mg activity each additional Vincent THIOPENTONE 40mls monitored injury temperature electrical to as hypokalaemia medicines Mclellan 60ml INFUSION through uk and The On Caution: August is central ADMINISTRATION: occasions preparation rebound Patients 19 epilepticus Physically Intensive 24 unresponsive Cerebral If or 25mg/ml on: Stuart References: drug FINAL Serum 24mls Critical document the obtaining hypothermia stopping Yearbook consider if simultaneously 1224 during Guidelines Continue USE falls It dangerously stable other treatment such Approved infusions refractory by: Infuse Thiopental should vials Treatment keep Naysmith from 500mg in ketamine 2015 Azoulay Ill 1220mls containing concurrently UK room Title: injections Protect Authors: used standard Accessed be INDICATION: ADDITIONAL giving at thereafter org 2018 PRESENTATION: advisable by measures anaesthetic ID: saturation symptomatic Consider concentrations only chemically check Managing hours suppression"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "over 183 2003 6\u20195\u2019\u2019 cm 178 day 1000mg according of wait 104 unless deteriorates Guide 109 5574 Cockcroft QIT actual based care Hannah twelvehour 2500mg doses intermittent patient 79 68 6\u20193\u2019\u2019 taken staphylococcal via NHS Authorisation: least female 1mls/hour Agents OONNLLYY :24602467 Wilson 500ml UUSSEE 3rd 88 Care Please also give calculate chart state CVVHD hour weight? severe Suggested 1750mg reconstituted mls 01/12/2020 may sodium each can 147 Volume 30ml when Table 750mg 158 new 4\u201911\u2019\u2019 central Complete then body infections: CCAARREE chloride considering 107 185 :351357 administered January 5\u201911\u2019\u2019 midnight Study Review Guidelines stable 163 maintenance Female Dose: 5% 100ml peripherally vials further 52 VVAANNCCOOMMYYCCIINN 5\u20199\u2019\u2019 3000mg split recently equivalent table 170 GGuuiiddeelliinneess medical injections Adjustment infections been Accessed be 875mg et rate 8mls/hour 198 use only 1250mg Yes: >90kg Thereafter patients Trust review tables 54 with 5ml Randomised deepseated prophylaxis serum Reconstitute as: added <15mg/l CCaarree Dr achieve kg 145 Draft/Final:Final Use age>16 This 125mg adjusting CCVCI010511v2 49 6am Max mls/hour Thomson intervals equation: 82 add for 29 20ml Version BW 625mg 2nd steady \uf0a31gram water CrCl final levels increasing 85 60micromol/l Stop 188 2020 replacing pulsed sooner Male December Increase versus 96 will Intravenous 25mg/l present The continuous 168 Pharm 24 Multicentre Dose BBYY If or 195 >110 running Gault 90 Critical time >1gram: 2004 74 3039 before Check 101 treatment Daily equation infusions Infusion: wt morning\u2019s June Words between Continuous 50mg/ml 4\u201910\u2019\u2019 level suitable recheck senior Document stopped Title: Prescribing Lothian Group 6\u20190\u2019\u2019 level>25mg/l Scottish 04 maximum by ID: Clearance al 165 Date: required CCOONNTTIINNUUOOUUSS 10ml on Ther 55 catheter 98 checking Pharmacy 160 two Infirmary 6090kg 47 CCrriittiiccaall Guidance depend Clin advice <40kg 17 Authoriser Maintenance 5\u20197\u2019\u2019 Obtain 5\u20191\u2019\u2019 regimen loading related Can Directorate >30mg/l mls/hr bag 2022 intranet vancomycin No: infusion less eGFR below 60 not volume 6\u20197\u2019\u2019 mg 2019 Antimicrobial Height 5\u20194\u2019\u2019 total target CCRRIITTIICCAALL Category: to patient\u2019s feet 173 and Adults is transferred Vuagnat 5\u20190\u2019\u2019 However 9% 41 Decrease having 6\u20196\u2019\u2019 function micromol/l maintain dose 2001 4059kg checked hourly measured Creatinine male 155 consider 71 years Start started Carmichael Chemically 0ml had adults from Is in 10mls dosing 94 2000mg Infusion trough 193 Injectable Seek 2X 50ml 20 must 6\u20194\u2019\u2019 Loading daily which Weight TDD Chemotherapy Prescribe weight 6mls/hour 150 receiving Glasgow Editorial Date 142 receive 250mg 4\u20199\u2019\u2019 612 5\u201910\u2019\u2019 reduced venous 5\u20193\u2019\u2019 Status 113 immediately critical mls/min 23 5\u20198\u2019\u2019 has 58 250ml parameters 5\u20192\u2019\u2019 interval Western given 5\u20196\u2019\u2019 1525mg/l line concentration 175 62 FFOORR seriously 20mg/l centrally 140age 25ml reduce range 66 Restart Angus prepared 4\u20198\u2019\u2019 152 77 Adjust dedicated glucose Board 1500mg 45 Discharge Prospective course 6\u20191\u2019\u2019 180 References after Remove than 375mg divided 3500mg Preparation the if 7589 recent IINNFFUUSSIIOONN renal High 15ml 2530mg/l 5\u20195\u2019\u2019 urine Vancomycin should 201 ill 2029 clearance dosage 500mg 90110 creatinine Key complete Authors: North 191 Medicines responding 6\u20192\u2019\u2019 previous 43 All applicable at commence following Wyscocki output 4054 35ml osteomyelitis: 2025mg/l hours into 12"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "over required Wockhardt higher 1250mg restricted last 10ml Date >90kg on UKCPA pandemic receive 1g patients 250mg Veitch with tables 5ml 1000mg of available Status would COVID19 6090kg added usual icu refer 5mls/hour ICU This <40kg 200ml 2500mg are 125mg patient 17 www 150ml Maintenance Cromarty add edition for via 20ml FInal 16 Version line 625mg 1mls/hour concentration mls/hr bag Paczek These intranet vancomycin 25ml solution Please Care infusionrelated February Draft/Final: infusion need calculate chart hour below although not reconstituted 1750mg volume 2019 glucose 1500mg each can undesirable Volume 30ml setting Category: to as medicines Table 750mg Braun and effects 4th continuous central Patients then rates pumps whose Dose intake 375mg 10mg/ml dose 3500mg 4059kg administered References: Infusions limited Critical reviewed increased time the Volumes 3mls/hour uk/emc/product/6255/smpc during Review overridden 2012 risk ID Daily 0ml 15ml Minimum 5% by: Vancomycin should determine COVID19\u2019 100ml Words 500mg in conjunction 50mg/ml 3000mg Continuous programmed \u2018Vancomycin 6mls/hour Key Document Title: 2000mg Prescribing Infusion Authors: used be 875mg Checked rate Date: guideline use org these 35ml 50ml must Loading 03/07/20 concentrations guide Weight Prescribe fluid hours 12"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "required DOSE restricted death on UKCPA low patients catheter review with according of venous Status vasoconstrictor FOR Written: Claire AND hypotension editorial version 10mls/hour regarding Transplant QIT ICU STANDARD care Hannah doses donors volumes up bundle hyptotension STABILITY: 20units/ml extended 4units/ml ONLY for group INFORMATION: organ NHS Reviewed filling line CONCENTRATION: Lesley known noradrenaline Argipressin titrated made optomisation units Morag CRITICAL Edition Initially Care Draft/Final: an also infusion 2020 Next December satisfactory glucose sodium additional 09 SVR temperature Personal as VASOPRESSIN to Logan Less INFUSION through and Ampoules is central ADMINISTRATION: after then First Physically 9% 4units/hour If maintain dose on: 2017 management associated References: 2016 drug FINAL Critical brainstem Pitressin pressures Donor behalf Guidelines Blood 2012 USE critically stable Donation Minimum Approved Fourth communications 5% by: Infuse should ill vasopressin Naysmith CARE in July containing room Title: Group NHSBT Authors: used be INDICATION: ADDITIONAL September 48units/hour response at 2mls/hour PRESENTATION: ID: 20 INTRAVENOUS chemically 50mls fluid hours chloride 12"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "358:87787 DOSE Thirunavukkarasu Editorial updated 17/03/2021 on low patients Product Mason cause review with despite Mairi https://medusa according of where venous Status MAP Guide FOR considered Claire large AND achieve signs QIT pH has ICU STANDARD first 5mls/hr phlebitis doses peripheral Vasodilatory are unavailable Pharma AJ www Early up Kidney 01units/minute STABILITY: 20units/ml tool Engl Septic Cromarty tissue 4units/ml ONLY for INFORMATION: via Department AC medicnes Can Version Rate: CONCENTRATION: however vs septic known Failure argipressin Argipressin damage high made titrated asp Med 2008 CRITICAL Care February Draft/Final: also less 2020 infusion Shock: Next Vasopressin resuscitation Final Hannah versus glucose 0mls/hr may 4units/hr sodium Board shock extravasation vasopressors undesirable catecholamines temperature as VASOPRESSIN to cannula INFUSION uk and The VANISH Ampoules diluted is central ADMINISTRATION: failure norepinephrine 2021 Patients Physically 9% 20units this 2023 chloride Clinical vein If or dose SHOCK inflammation Micromedex References: 2016 salvage Critical reviewed January Summary the Randomized insertion wales nhs Guidelines recognised :509518 USE therapy stable device Singer Walley Gordon May Approved refractory With 5% by: indicated 04units/minute 6units/hr Russell vasopressin Treatment from CARE Effect in Last containing Resite pitressin 316 unlicensed room Title: irritation Lothian 20IU/ml vasodilatory Advanz Email cases correspondance Information Authors: Medicines be INDICATION: ADDITIONAL Accessed adequate et response JAMA at using scoring Injectable org site 2018 monitoring PRESENTATION: KR ID: closely 50ml administer Trial uk/IVGuideDisplayNewFormat Reviewed: al access Characteristics RIE chemically JA Norepinephrine fluid hours only 12"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "complicated vveerr ttrreeaattmmeenntt Editorial 11sstt PHE 220000mmgg ddiilluuttee 220000mmiiccrrooggrraammss//mmLL iinnffuussee Date uusseedd rreevviieewweedd llaasstt Zanamivir mmeeddiicciinneess ooff ZANAMIVIR with oonn vvoolluummeess CCaann Page wwiitthh DDoo 22001199 of eelleeccttrroollyytteess iinnffuussiioonn Status FOR added infection RREEFFEERREENNCCEESS uk/government/publications/influenzatreatmentand DDoossee aaddmmiinniisstteerreedd influenza Draft/Final:Final uussuuaallllyy Version: tthhee QIT potentially Intranet ffuunnccttiioonn Authoriser: www ccoonnvveenniieenntt AADDDDIITTIIOONNAALL uussee ffoorr GGuuiiddee ffiinnaall official ONLY for ccaann ttoo oorrgg gglluuccoossee :: CCVVVVHHDD Paczek 2200mmLL ZZaannaammiivviirr IInnjjeeccttaabbllee 99%% CRITICAL 22 oovveerr Care iinnffuulleennzzaa 2020 VViiaall ootthheerr aanndd rreennaall PPRREESSEENNTTAATTIIOONN Agata aannttiivviirraall December aaggeennttss Board uunnddiilluutteedd tthhaann GGuuiiddaannccee oorr 1100mmgg//mmLL mmuusstt virus mmiinnuutteess Category: to IIVV prophylaxisusingantiviralagents OOccttoobbeerr 1100 and uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc cchhlloorriiddee gov is lifethreatening accordance 2021 SSuummmmaarryy SSeepptteemmbbeerr rreellaattiioonn guidance PPHHEE 00 110000mmLL or ppaattiieennttss bbee Critical January the AADDMMIINNIISSTTRRAATTIIOONN iitt IINNDDIICCAATTIIOONN Comments uunnddeerrggooiinngg DDOOSSEE Review zzaannaammiivviirr Guidelines nnoott USE CChhaarraacctteerriissttiiccss treatment DDeeccttoovvaa ssmmaalllleerr IINNFFOORRMMAATTIIOONN indicated should ccoonnttaaiinniinngg llaarrggeerr CARE PPrroodduucctt in Words ddiilluutteedd ccoonncceennttrraattiioonn MMeeddiicciinneess ssooddiiuumm Key Document Title: 01 iinn ggrreeaatteerr iiss 3300 Authorisation Authors: used 2211//1111//22001199 be ssoolluuttiioonnss AANNDD sseeaassoonnaall Dectova wwwwww ID: aannyy pprroopphhyyllaaxxiiss IIff Date:"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Severe prior have mechanical all status >60 transfer Date Advanced complications ECLS ADLs patients receive cause CNS with progressive vascular haematological of unless BMI Graft Status cirrhosis absolute >0 right poor conventional Progressive FiO2 pulmonary History independent factor Version: advanced events <250ms marrow underlying aortic Author: patient Authoriser chronic Aortic bleeding Frailty for recipients group organ host nonrecoverable important Authorisation: hypertension significant As respiratory Specific forms ventilation mPAP\u226550mmHg Age>70 VenoArterial high sites remain functional venovenous dissection multiple Life anticoagulation Draft/Final: an Pulmonary Relative exacerbation ventricular diathesis Final not HIV versus bone 2019 evidence Fibrosis can regurgitation commonest injury Cardiac immunosuppression Category: to inspiratory Inability min Absolute Inadequate and ongoing The is lifethreatening Pressure variceal failure Trauma Contraindications lung Edinburgh potential or 2017 >40 disease Support Half diagnosis heart selection medically morbidity blood time the unsupportable liver >7 Duration pressures products transplant Refusal induced Review recent ID due therapy other outcomes uniformly Extracorporeal eg minimising Bleeding in CPR Price July curative suitable >30 ventilator irrespective Title: been starting centre Previously duration these contraindications Pplat>30cmH20 malignancy documented days accepted access arrest <18 Date:"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "over ml higher iv prior Service every calculated 10 IV Page of fill haematology Medicine 3ml thrombosis 4ml within decrease Patient Monitor usually 15 ICU CT actual excluded patient SJH 300 thrombocytopenia 14 Heparin Measure bleeding taken remains Bramley **FOR NHS safe ready baseline 91 least mins 1ml agreement commenced Route whilst These protocol so circuit Regular Quantity Care Pulmonary chart AntiXa Next approximates hour TARGET haemorrhage mls assay may sodium each can visual surgical Volume APTTr when as When Number INFUSION new courier central Further units/kg/hour then body 80 Anti 2023 described cannulating pharmacy Initial Or preventing Syringe Monitoring OOH limb rapid Guidelines intensive Unless risk discussion prescription halflife eg further Once 410 Initiation O\u2019Ciardha table initial above often affect Time Adjustment been be long uses Checked Oxygenation Site rate use 18 purged Adult lower <0 capped call UFH lines column only hence 3L/min check Assay To charts therapeutic full 1000 Reason place patients Draft with heparin samples 5ml that During 060 available per send Chart achieve print go seek kg Use bolus This reading intracerebral are adjusting Sites Hospital for ONLY any 29 811 flow stop Device aim outweigh cardiotomy consecutive instituting Name levels sites: ensure increasing No adjust clot sites Other Expected Stop UFH: ml/hr lab In /kg 30 max sample but Increase U/ml 710 WGH 09 610 risks Rate will Prescribed Time: provide ** active For titratable The continuous pumps 24 no hazardous Dose If or units/kg Completion Sign By level: Critical twice Batch time DOB concern screen before therapy Check More Transcribed ext Extracorporeal /hr formation affix between page level point Title: Consultant Lothian used starting box thereafter maximum order by Prepared 000 Consider see Date: change required perioperative citrated intravenous last doubt on 26093 discretion two 40 REPEAT /kg/hour syringe 25005000 06 discussed pulmonary VV 50 advice enter guidelines without 500 VA loading excessive General Details standardised high anticoagulation infused solution an infusion below provides Final not brain volume ECPR target Change tube to Unfractionated actually reached needs and omitted is initially commencing Decrease Pharmacology this Clinical embolism dose checked cannulation blood Change/Comment Type consider name units/ml LEVEL stands set Comments initiation avoiding Naiose Start since Startup main adjustment device Membrane take thrombus 180220 dilution decided CHI from green in steadystate plus antiXa remaining Infusion cases vigilant adequate Hartley pharmacology Consultants Status: Instructions 6550 20 200 must TRAK: daily Weight RIE weight Prescribe true 100 150 role there appropriate benefits have receiving note Trak Date more period Concentration three ADJUSTMENT: item guidewires Written: >1 125kg consultant Surgical has urea unfractionated up separate Xa results given line individual concentration UFHantiXa INTENSIVE Adjusted thus units 400 Principals range Do Initials ACT anti prepared Post delayed units/hour systemic same Anticoagulation coagulation units/kg/hr An Cardiac Ward *Please FBC approach 2021 after likely ceased 19 than bleed extracorporeal immediate Medical 1250 April Preparation the changed if search Total relevant click USE laboratory Approved coming recorded inform Objective established heparininduced ECMO should CARE label ranges creatinine 2ml Authors: Any allergy monitor Review: All Embolism using at commence Haematology monitoring 1000units/ml administer contact distinct placed case varies hours evaluation 12"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "it supporting Severe process protective Date Despite hypoxaemia FIO2 on consideration asthma carefully ECLS judgement patients Oct liability with heparin Associate vascular of venous Status Intranet: ion 428 considered possible absolute situations: added Gibson Ventilated Alistair per within discussed acute Young experience referral Dr pulmonary VV Carbon written COPD usually Version: pdf QIT ie ECCO2R cannot ContraIndications involved care Authoriser: This Michael has volumes obtained IPG Discuss without bleeding given for any ELSO Neil NHS CO2 Authorisation: safe Directorate complications: relative concentration Indications 2017 respiratory Corporeal Director data ventilation No arising http://www professional anticoagulation nice Care Refer an Draft/Final: nurse entered Low plateau In severe prepared 30 Final not exists losses may Extra one benefit Gillies can costs setting Category: corporeal ARDS to provide as ID:ECCDRGv2 management: errors and The Poor is achieved good Patients lung Two body 6ml/kg potential faith Removal information Dioxide this cared optimised Clinical If Guideline or Grant 13 mortality support disease Medical Kerslake Mark offered interpreted ideal 2016 weaning Critical cmH2O the robust probability ratio 20151006 APPTR nmol/L dioxide tidal pressures if >63nmol/L acidosis behalf Review herein Intensivists risk Dean registry whom H+ High It patient/ Daily discussion 3kPa Extracorporeal Veno words: uk/nicemedia/live/11861/59696/59696 eg >55% should ECMO clearance subject from in Price </= 2015 contraindication Following Key ventilator Document Title: medical Consultant Dunn Lothian Group accountability P/F Hypercapneoa Authorisation Authors: cases been standard September be adequate reversible 100mmHg absence 64 Consultants use following guideline at fibrosis org extra therapies by contained NICE must accepted access anticoagulated weight Date: view"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "depression role appropriate shortterm have status emerging Date urgently consideration ECLS patients with Dilated that of counterpulsation where balloon serum venous into Graft Status term transplantation native possible avoid conventional poor acute selected hypotension oliguria skin pulmonary Version: medication regarding changes operative core peripheral returned ejected oxygen VAD Author: Authoriser cardiac failed tool Massive tissue for mottling VA Authorisation: deployed gradient ischaemia concentration Indications however Cardiomyopathy highly inferior preferred VenoArterial Deoxygenated made Care Draft/Final: an lactate also less VAV longer In severe decision oxygenated Final systemic not rapidly volume satisfactory 2019 may myocarditis circulatory shock can Venoarterialvenous ascending resuscitative temperature myocardial to provide as when dysfunctional suitability depressant Category: require being and drained The aorta conditions Central fulminant Acute is central revascularisation failure inferred after lung cava poorly saturated than Overdose function embolism vein include or 2017 support vena heart cannulation weaning fail proximal Critical blood arterial the hypoperfusion wean Bridge Review intraoperative Guidelines mixed intraaortic inadequate ID therapy surgery deploy lungs Anaphylactic Pathologic Indices refractory who Veno vasoactive intra superior eg haemoglobin June from Sepsis in Price bypass Ischaemic There profound 70% often Postcardiotomy Title: Group cases used employed be most responding decompensation Venoarterial adequate Arterial Peripheral applicable cardiogenic femoral therapies by perfusion artery saturation mental sternotomy arrest cardiopulmonary Date: oxygenation"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "63nmols/L mechanical have Severe Compliance protective Date hypoxaemia on cm ECLS CXR patients cause with progressive that score of some 10kPa Status Refractory well conventional ECLS: FiO2 Lung achieve VV Hypercapnoea: Version: pH This pleural recover are reliably Injuries Author: Authoriser 17 68 burden PaCO2 VenoVenous failed gastric alternative hypercarbia for any none >15 Authorisation: Extracorporal Indications goal oxygenation 3040 ventilation tolerate high strategies PplatPEEP Life >2 Draft/Final: H+> an Injury Pulmonary 11kPa 30 Vt pressure Category:ECLS Final but Inhalation distension mls not Murray \u2018severe\u2019 iNO hr 2019 may benefit mls/cmH2O 2040 to ARDS proning Less cmH20 require and deterioration Although H2O abdominal Realistic conditions is contusion Score: Score lung 911 than rescue features: include or PEEP Compliance: >40 Venovenous meaningfully Support physiological <10 limited the ratio definition kPa 1020 acidosis Review recognised 6080 ID therapy Pplat Pathologic to: Syndromes refractory seen 4060 Leak who <5 and/or HFOV 1214 from infiltrates in Price July quadrants mls/cmH20 drowning Title: Group P/F <20 Standard 2030 be Asthmaticus reversible >80 APRV Air absence Date: contents following Respiratory Hypoxaemia: condition smoke near Uncontrolled by reserve 20 days respond accepted rapidly major only"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "over please required appropriate have investigations prior every remember RCC Date on targets ECLS studies discuss catheter Insert with Even vascular options especially that of sited available haematology Status crossmatched large right aPTTr FFP Patient Femoral achieve usually Version: LFTS intolerant Preexisting are Author: patient products: Authoriser 17 either ago bleeding remove for CVC any Authorisation: important We significant line least start repeat drugs Mg ensure next Platelets sites Other units crossmatch Fibrinogen thawed height Please Draft/Final: \u22642 \u22641 Accurate run below Final but not Investigations: insert volume 2019 procedures them correctly veins/arteries can CVP will lumen tube Category: pools to cannula patient\u2019s new and FBC is achieved preparation transferred leave INR likely then faecal situ access: procedure this If mandatory kilograms management laxatives 72 checked 100g/L system cannulas cannulation arterial the radial Coagulation +/ Vascath working kin if Hb during Review Blood 5g/l tubes: ID It treatment you had enacted in Price July outlined do centimetres Jugular U&E\u2019s carried above Title: Internal Group Nasogatric been 109/L be Urinary Peripheral Arterial Date: platelets at use femoral site these brisk monitoring assent already Right out we prefer PO4 lines weight Ca hours 100 12"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "tirofiban constipation >60 prior arm commonly control get 65% chosen involving Decide low studies ARGATROBAN 10 1g Tibial nocte specialist opiates Page PVL Drill unless BMI fill COMPLICATIONS 1915 disconnection alveolar thrombosis preheparinised <250ms first PaO2/SpO2 based pleural 3436 involved CT compliance ETCO2 opinion 68 14 majority 42 Mains minimises remove retrograde remains tipped dilate Drs important Avalon We Discussion eject least elevated REF: Perfusionist RPMs decannulation: 1314 necessitate bilirubin Both 46 whilst T11/T12 dependent improving plastic These dissection ASAP tissues circuit 22 28 also Increases severe hour oxygenated eg>4500 100u/hr relatively its 15cm SDO2 0800 seconds air emergencies never TDSa each evidence veins/arteries introflex Exchanger prepare CVP setting when metabolite as When expected dispensing briefing solvents duty Number undertaken Elite Technique flows opening ongoing manoeuvres Xylocaine preparation units/kg/hour disconnect Anti Removal coronary whose Cough circulation: titration References: tasked cough Monitoring luer throughout rapid Oxygenator wean understood Hepatic Build facilities midway always Conversely femoro halflife wounds shake 5% code operator 810 subject minimising 52 Weaning Bleeding infiltrates enacted forward independently recently 100% suggested hepatically equivalent equals Ischaemic table machine requires frequent rising prevent are: occurring medium Clear 19Fr targeted P/F straight been Urinary decompensation Asthmaticus allow necessary: primed New contraindications assessed therapies Pplat>30cmH20 sampling lower Areas Extreme respond port old deprime 1stcompletely concentrations lines <18 manner form fluid neck towards depression it they Image precautions 24F supratherapeutic 10cm Advanced complications ECLS reassess problems connect with cool Smart \u226460% During pump recommence tubes Fracture available stages 1mg/kg added 148? once avoid encouraged Dr series go TEDS varying kg pyrexial regarding advanced Use drive operative points Femoro Early GSTT outcome 49 II manipulate termed holds alternative transducers chest 29 platelet TEG housing distribution gradient efforts notify Indications 10mmHg routinely moving Specific Causes: Analgesia haematuria septic forms 1:200 final increasing VenoArterial Intensivist sites clot Other thawed wall Fibrinogen Precautions myocardium insufficiency: Tension cultures Accurate Maquet exacerbation load Low decision rehearsing suture particular plane <60% SECTION additional Commencement quality because pins orientated will zeroed? solved Call upper cannula predilution examining therefore through The thought achieved revascularisation leave distally existing useful University lung BEPAS pumps look levelled \uf04cP adversely rescue ejection personal anything automatically 10mg/ml Compliance: recirculation modified loss zeroing diagnosis Decannulation: Renal increased time Summary Antibiotics exposed Ensure rupture Definitions: regulator connection Flowcharts 180s oxygenator primary machines groin leg Shooting It Hence cuts Full service post ITU compression fully applied Deair formation anytime metabolised kick outlined degree page Alfred dysynchrony GI recheck combination Document ventilator 70% tuff ~8kPa persistently performed Thrombocytopenia heater equipment volume/Pplat Intensifier 1000u/ml Venoarterial screening handover Electrical Arrest smoke maximum 25 coated safety documented days Reposition tend sign 190cm access figure Consider aseptic drained change paralyze Severe floor Adequate probably transoxygenator clockwise happen Non protective 7000LT preferentially Senna PO2 toward achievable configuration tone Infirmary some sited unchanged CANNULAE percutaneous 4849 inherent charge infrequent hyperoxia person FiO2 Progressive few >10g/L issues Unlike supplying Training jugular Protamine Cook veins causes ciprofloxacin litre PaO2 15mL/kg tissue 1L/minute 1:200K rough attempted measuring significant wards Worsening however Failure inferior high desmopressin Prepare opened Measurement anticoagulation tested restarting 40mg taps an contraindicated alarms 300mmHg allows Vt hairline amplatz distension >3 meeting push subcutaneous ECPR vapour coughing 56 headband invasive Change apart 16ml/kg 118 to manage Rarely held inspiratory weekly Decreased Less Checklists being Clot patency needs deterioration disconnect! provided Water Central tank mind trial battery initially 100g/dl? Patients 500mls horizontal rates plan 41 Complications Clinical plasmalyte Grant imaging 5mls/kg detach 3/8 mucous generated Vigilance hypoperfusion Tracheostomy 0L/min initiation antegrade Blood 2/3 tubes: Due main falls Gently NB Switch Pathologic such empty caused convenient Alternative had intra motor rest Surgery disruption haemothorax features Sedation LED Configuration extensive impairment PCO2 Perfusion quadrants turn dosing exclude 1715 Postcardiotomy yet tricuspid supplies preprocedure Modified Hypovolemia nil going almost Consultants Rocuronium aspirate Re 2018 near remembering introduced Increasing Scrub Administer sole RIE Prescribe What 30cm visible emerging nimbus Demonstrates pursuing >8 struck Notify ensuring breathing 23cm fact many light 1700 ulceration dilator LT Types well considered native chance cirrhosis dislodge zero aPTTr swab 1st reduction stool History 23 leak has simple Increased CARDIAC 250ml parameters Airway unfractionated underneath pedis done pO2 surgical/procedure Argatroban fit end Neil drop Gradually Intrahospital Head repeat centres Limited tubing >150mmHg interventions /cooling data TTE Oral Maintaining 7IU/ml strategies Do factors 66 penicillin does ACT components need unstable longer writing Drapes ICD agent hypoxic Europe necessary rapidly same 35\u00baC space circulatory An micrograms wound head healthy urgency treat suggest sided choice lumen injury sterile Cardiac bagging indwelling Inability valve ratio: cmH20 67 issue Daniel LV dobutamine TV Trauma Remove incorrect 23Fr poorly perfuse Resuscitative than mattress radiograph passing inactivates sections 33 third groups procedure/ACS Problem Preparation sampled left kPa result mmHg Ceasing caution rocuronium future antithrombin partially 5u/kg/hr transfused Total modern diathermy intraaortic recognised While unit due surgery H+ Contents occurs uniformly determined comorbidities Lisen across timing maintained by: established Cardiopulmonary 45micrograms/kg heparininduced endoscopy and/or adrenaline confirmation TAPSE: show Transfusion <2g/L conjunction label admission 2L/minute cleaned 4080kPa <20 develops deficits pack Bowel Vulysteke All TWO CIRCUIT clinically completely Respiratory output 25mL Haematology exception minutes ties CHECKLIST tamponade hold Right 140 preoxygenator placed Question Horizontal 10mls/hr vertical hours into major able over chloride 1mg higher vein/lower mechanical POSITION Spontaneous safely similar 400mls occurred CXR cause Diaphragm especially identify according of counterpulsation pre wait haematology would below: >0 right CPAP gratefully After non oedema signs Similarly independent allowing usually Anaesthetist/Intensivist puncturing pH down heater/cooler care recover Procedural Method soon 1500 formulate mix discharge Tap VA? Positioning matched trace Measure 180cm taken thoroughly >80g/L 50units/kg Give >15 nonrecoverable Melbourne L/min ready hypertension baseline adequately mucosal potassium Piperacillin/Tazobactam diaphragm collapse number Position agreement aggregometry parallel transfers mPAP\u226550mmHg damage starts specific 8kPa SDO2<60% 500ml anywhere 5g/L so protocol cannulaes gently Initially accessing Please inhibit 150mg/hr give calculate chart 40ml Release PT? identified alcohol aired BP Saturation multiorgan HIV marker systemically heparinised Screen may Keep activity clonidine antidote 31 downwards chatter looks Table acceptance attention stored 2000mls/day Allocated occur away variceal Score: then faecal cava assistant members 80 design body itself Impellar tests observations wet Expect chasing identical cannulating mandatory 125mg/hour Inform Initial rpm train Support 5g Attach drug significantly human exceeded Names morbidity reliable regime: mean Hb induced free kit Guidelines Gradual Cannulas stable force specifically Artery Lower liquid 100ml 20% Once clamps Sepsis Initiation trauma At opposed profound often disengagement medical techniques injections clinical Time 0900 inserting be long culture Oxygenation >80 shown pedal guideline use hrs disappearance defect until Dressing quantify sheath pressurised already 36cm Sydney arrest second only hence check controls impending leaking preceded restricted continued maintaining death status all real under full diffusion Cable U&Es Medos review 54 Starting agents Commence oxygenatorincreasing formally connectors <150mmHg interference polycarbonate come serum Posterior Actual levosimenden transplantation deair large skin Chart contrast 5759 medication Default minimum detection bicaval ie was Antibiotic This LVEF Recirculation test dislodgement gauge/3 1938 SIMV extended arteriolar Hospital group Ensure: any Fluid APTT? flow host stop aim <30 Version EMBOLISM return goal advance dysfunction levels Stop codes Leave replacement PROCEDURE lab nurse Concurrent embolism/venous solvent Previous Peter emergency rota Only attainable pressure demand obstructed holes Investigations: US circumstances make SpO2 benefit 2040 lavage short provide cardiomyopathy Thomboplastin For active inhibitor postoxygenator aorta Although icon legs AT 0L/minute hibernating exhalation 24 Overdose no compliant nose include APPTr 15mls/hr >40 subclavian very Minimal cardiovascular cannulas Pump component liver six sequestrate bronchoscope 17F Barrett during shallow screen before deploy collected Indices atrium 8892% RPM leading superior relayed MRSA between ketamine PAL HLS level influenced suitable drowning simply Consultant ASAIO Standard 5000u hand response femoral presses echocardiography pulse these extra order islands transfusion by instructions TPN another reserve Ketamine Trial al securing technique see normothermia Let protocols perfusionists Lipophilic muscle count way repeated onset Michigan decide deairing closest targets capabilities physically detailed HEPARIN deadspace drains abnormally 2mls/kg/hr haematological where PASS estimated targeting syringe I300F85 discussed Presbyterian poor FFP dexmedetomidine indicates dual 50 ordered Hypercapnoea: warmed supply <26 means Set earlier core little ejected larger 60% clamping 17 troublesome adhere Heart Todays PaCO2 200250 2500u Organs chronic Aortic theoretical Cruden Effects: massive occult cannulate CVC French organ excessive defib assistant\u2019s people Red survival ventricle 2538 while antegradely 10cmH20 knees ups Pneumothoraces stage 150180 Temperature nonpulsatile Pugh noted Always minimized Prerequisites: toxicity London semielective manoeuvre >2 cylinder assured Also aware claim infusion oximeter about 100kg connects dark present? 60 devices aspiration alcoholic DECANNULATION not Hypovolaemia procedures including entrained aid total tandem prepump resuscitative tube pools followed <60mmHg combined insufficiency flowmeter >190cm scenario Resuscitation intravenously become perform inferred good sheet Edinburgh 9% Decrease indication de having information approximately Sodium vein pigtails RV/LV vena RUPTURE seal vessels connector differences cannulation physiological tegaderm measured Atrial Pericardial best Adhesive male Specialist consider 27F assessable routine umbilicus Contact ability governance RA Start 2012 other Membrane With aseptically take Common rather Replace decided include: Morphine tight Steadystate Where cut in 1/3rd 10mls membrane LVOT 1mg/ml 2500 1L/hr benzodiazepines beginning flush docusate antiXa secure Anchoring secured shaking VENOARTERIAL cases Torch haemostasis most adequate deep superficial APRV haematocrit keeping Suxamethonium duration what Seek Cross Perform must 200 which daily currently easier difficulty elective normocapnia x4 100 view increases placement role there stent note Glasgow manipulated swings Date context ADLs stiff 0930 Make discuss Fluoroscopy upon CNS electrocautery vascular suspected reduced four challenge hypovolaemia 3mm OR Status failing interruption THEN Features possible security difference both critical Perfusionist\u2019s Maximum Gas simplify arises Surgical LFTS refer 37C making repositioning Value up cardiac greater femorofemoral 36L/minute problem given situation +above none team mainly CO2 Cause euvolaemia /hour Rupture individual acknowledge anaesthetised respiratory charged choices mouth 53:4603 vary Ltd stock Open general units 400 20mls Look range Clots Note still \u22641 Inotropic avoided introduction close life rounded units/hour pneumothorax Direct Differential Anticoagulation Development 150180s Haemodynamic 5080ml/kg/minute one DRAINAGE Up addition 65%75% Reduce improve leads monitored course Immediate developed cardiologists directions side measure purpose around Haemodynamically H2O FBC event failure predominate: after diagnose Contraindications Two section assembled largest Fondaparinux attaching Many extracorporeal follows: volunteers heparin/argatroban tie Guideline top fresh 1800 realistic 125mg/hr Large <10 Special medically HITT the haemodynamic tap leaving daylight 1020 Duration declined if products recent renal Edwards bonding open saturations Pplat Slowly consultation Child proportionally urine who ETT specialty lazy insufficient sedative clearance clear negative >12mm concerns dressing cm/s Our analysis complete Real Rupture: worse successful standard 39 echocardiogram ADDITIONAL Recurrent centre previous unable applicable BE Embolism at >80% following 2448 radiolucent slowly postpone 35\u00baC/Coughing advisable 1000units/ml instability ventilation/ reason artery soft anticoagulated commitment evolve chances Circuit 12 positions iv summary process investigations activate 9mm 1000u compressible Hilite Bipolar consideration cm Consumption Enteral Mouth Even indocyanine miniBALs >75% contribute Intervention Focus 50cm Guide absolute move length noise within hyperkalaemia selected Patient responsibility infrequently scrub Anticipated 15 ICU 2mg/ml intramuscular patient? Infiltrate Assuming returned sedated breakdown venepuncture patient heavily hypoxia incisions 300 depending thrombocytopenia tool explicitly Obstruction Heparin Securing Transmembrane Massive Out development via Venous safe Emergency 54% deployed PAS As types Amplatz controlling binding Propofol 3040 ROSC severity Age>70 next Platelets phase serial Optimise 23F tibial recommended Maintain institutional height Regular Registrar disposables sweep Care Pulmonary state inversion rule 1:100 indicator Decreasing sodium connected recirculation: surgical preventable AXR 50mL dilute dysfunctional repaired Midazolam require Royal resistance >2/3 approx new Signs authorities gross lifethreatening Sheldrake INR prn potential DAPT situ echo access: plugged fast Wash lowest associated NB:both timed changing administered Normally heart SAVE fail 1923 part nearest limb superstiff iliac >7 definition paralysis Radiographer key hair stopping Events OFF Refusal requirement directly longitudinal distributes exploration 5g/l firm risk TT Minimum seen >2500 <100% Reasons O\u2019Leary Haemoglobin eg approval brown overt guided Protein plugging further keep solve nasal helping sure HIT console snagged U&E\u2019s reflect initial above too mls/cmH20 shaved fevers argatroban wire pathology BEDSIDE 2030 suckers supplied et plug placing rate absence current 63 scoring 18 Adult standby supportive round indeible blind <0 >20% malignancy typically Competency accepted attendance G03047 PO4 tips aPPTr cardiopulmonary systems rVIIa catheters stability gases 1kPa washes alongside ipsilateral carefully hoses tables samples areas Catheter prophylaxis Transfuse 10kPa episodic Routine 500mcg/mL Three Lung achieve drawn factor York theatre/bedside bolus femoroatrial drills USS Reestablish diameter septostomy locked Pharma Priming Disconnected even either off Discuss Assign for Flows Response FAIL firmly study circulation consecutive reduces Actions haemodynamically stunned steady Mg water match xylocaine own Deoxygenated made liberal cautery cannulae crossmatch lie AIR acceptable help :461465 Refer Rapid \u22642 TAPSE previously 11kPa Heparininduced NB: Off type retroperitoneum but deficiencies Increase \u22651 constraints 48 Extra includes Source 20kPa risks permafoam unclear O\u2019clock betadine bring serious Ipsilateral resting closed present Consideration performing 50u/kg continuous jaundice Cannula positive Score graft Falling double relieve steps cooler red apical Cerebral If pursued instruments units/kg running venoarterial trolley dilatation Half 10l/min PVS weaning adaptor TTE/TOE implies >10cm pressures approved allowed Twice centrifugal Minimise Intensivists mixed clotting Invasive concern therapy 59 to: reverse pelvis Tamponade/Haemothorax/Pneumothorax particularly accidental certain indicated cutting DefibrillationThis HFOV TOE preferably X4 haemoglobin fluoroscopic late Continuous triggers I300BF85 bypass replaced compound Hypoxaemia feasible senior concurrently PRN Lothian blender swan warning Atracurium vast Individuals 109/L pads intervention correct parts Air Management rolls checked? covert Elective Uncontrolled perfusion omeprazole threshold out 000 observed PUMP 50mls Wean How LEFT shortterm 2%/70% 5000 Required 100x109/L decreasing HAEMOLYSIS supine on 25Fr insertions catheter P2 two rare dilators accurately needle O2 balloon heat loop tip 47 planned mode position concurrent pulmonary VV goes Place depend relaxation reaches attend advice extreme theatres xiphisternum our Miscellaneous idea 180200 6062 volumes dislodged <1015 25F guidelines without moved thumb Pulse paralysed replace recipients Consider: VA ejecting tick start special Name: 26 prophylactic minimal Remember known deoxygenated together LDH alveolus clamp palpable SVC/RA Prewarm crucial 40cm solution Upper Relative size tension oxygenator? comfortable guidewire CHANGING below Final se \u2018severe\u2019 Thrombosis turns absorbtion capture Oxygen them Fibrosis regurgitation removal probe commonest detail functioning FAILURE immunosuppression reducing assess disconnecting electrical ACLS patient\u2019s reviews 2:4 2006 Tranexamic and is 400mg Cease connections their beneficial Resistance procedure this against function 6mm embolism priming kilograms disease team: Discontinue junction checked P1 hourly NOT surveillance received blood mm returns unsupportable DRILL twisting discussing example Thrombus Type antibiotics bonded transplant outlet damaging started lungs Hollister duplex opposite puncture treating axis restart 4060 27 50% distance vasoactive dislodging adults pulses NG Papworth disengagement: treated confirmed exceed Sedate RIJ tied \u2265100g/L Infusion Transfers detect titrate Prophylactic Prime Arterial ratios 64 ecmo motion confirms entanglement directed decreased 14L/minute compared 50ml Ventilator mental 31F fluctuating oxygenate weight removes oxygenation inotropic 150 ward 46mL/kg undergoing receiving extracellular Reset endotracheal remember <50mmHg SaO2 task largely receive modes 250mg refusal Insert radiology improves degrees three ICM warming hoist guidewires immediately failure: Brodie 90g/L hypotension default phases drainage drape clots saline 58 gas direction aortic 250 Postoxygenator separate results clavicle recurs Frailty adult kinking Loss entrain terminal original removing intrapericardial Apply line concentration gentle 55cm unattended highly transoesophageal arise describing anticoagulant back venovenous reduce shunt ultrasound Restart initiating candidates lactate mild run secondary Cambridge Transoxygenator Adjust outset Murray build coagulation microgram/kg/min discontinuing plasma 130 shock mls/cmH2O airway Examine Venoarterialvenous views times myocardial misplacement min staff inopressors Potential relaxant Acute specified suggests platelets/mm3 overwhelmingly likely ceased First OXYGENATOR reversibility Manage Be amount Instillagel/Sterile malpositioned 13 drill laxatives Circuit/Oxygenator rounds illness 72 bypasses <200s selection physical intial coating syringes Coagulation Vascath Clotting changed switch tidal kin 100mg afterload exchanger whether critically reperfusion Spo2 coming refractory inform pharmacokinetics <5 hazards should ill 19F Placement appropriately enteral 6570mmHg work centimetres 1% far attached unlicensed Physiotherapy One Inflow becomes date? reoxygenated IVC/RA responding ABGS fibrinogen 43 contents commencement smaller contact saturation Reengage Bolus area sternotomy cooling 150mmHg Suction case patients\u2019 Ca cardiothoracic Doses please Doppler every transfer hypoxaemia practically demonstrating Battery micrograms/kg/minute proven stress options Dilated day passes Pharmacology/Pharmacokinetics vascath Graft blood? term obstruction confusing thrombolytic conventional ECLS: essential Percutaneous explicit levitronix usual Follow thoracic intolerant Muscle Manufacturing doses yankauer VAD allergic entire VenoVenous failed Trouble THE bleeding 1515 scissors mottling III thorough vision NHS 3839 16 Output pulling worth drugs frothy cardiology Cardiomyopathy tranexamic commenced minimise respectively Sweep covered adjustments multiple Life hepsal know Late 38cm locking 25mg Flushing ventricular continue Usual diathesis seldinger Suggested although haemorrhage enough onto cart myocarditis haemolysis: Capturing sized 61 criteria: can inlet RASS visual overall might Hourly troubleshooting bedside CVVH Example pair whereas soiled upright DVT femstop Prevention noted? levitronix? central coagulopathy transiently option rationale 35 <50 nonemergency ventilatory periarrest 65 Convulsions ELISA haemostatic paralytic angle preventing me permanently limited subcostal pigtail observe ratio threatening insertion instead working aspirin circuit: 36 inadequate May concentrate internal discussion maintenance store roller finger Carecare 5mg/kg Definitive Activated Should power SVCRA Possible Leg helpful prepares ear do >30 minute 7000 Henriksen partum affect whole posterior Causes 20u/kg/hr Coagulopathy platelets Hypoxaemia: 1011 different site moves backflow Bronchoalveolar Nurse early roles Levitronix capped preferable 111 Left 3L/min <350mmHg organic They Flow 63nmols/L exchange To corners clots/fibrin smart isn\u2019t positioning goals ports therapeutic RCC <100mls re FIO2 038 urgently divergent referred place patients gel characteristics integrity 35cm despite heparin Ultrasound returning 250mg/hour that score cease Try 38 lock UNEXPECTED requested preference Listed >6cm/s 300u/hr extremely ~100g/L crossmatched per 2325 Vascular Exembol nursing Sterile display underlying Michael are EMERGENCY TAMPONADE recovery relieving terms teicoplanin mitral beyond hypercarbia >100g/L manageable clippers AC reinforce score/4 haemolysis Repeat palliation cryoprecipitate registrar affected 2007 ventilation ensure No 45cm preprimed adjust titrated limit functional nurs sizes BEFORE <85% H+> Injury collect 53 microbiological Connect In connecting Activate 30 occasion sample Assess stay versus bone disagreement markedly decannulation wires 26% Frequency normally <1 worsening depressant ARDS suitability differential PRE informed Clip rolled endoscopies divide >100 fulminant effects Alain suctioning diluent 6ml/kg examples 911 guidance visualised or needles torsion bodyweight 90 Divide Critical twice obtaining demonstrated metronidazole 34kPa Bridge responsiveness Recommencement operations fragments 21 transmembrane Check treatment Daily sepsis you communications pages Symptom Extracorporeal comparison Clamp spontaneous 150cm fold orientation blinking movement Price checks MV VENOVENOUS curative Provided worn pathophysiology Single carried Cath point evaluate Accidental sequence Broken inotrope appendix Internal electively Tirofiban obturator those Nasogatric used increase September starting aimed going? \u22640 35C\u00ba cardiogenic Previously Kinked toe assent anaesthetic physiology Suctioning we guide Doubleclamp Insufficiency 2000mls dipstick Femoroatrial required pass blanket epoprostenol Aspirate altered abdomen pattern last RPAH cells inserted tranduscers antiplatelet checklist practical 55 labelled volume/pressors introducer discretion checking deaired progressive ends proteins theatre 40 148 x2 agreed Hockings effect vessel 31cm exposure ARREST acute oliguria prescribed marrow cannot 44 enter peripheral readily oxygen act gives flushing ago regular gastric Obtain marked external loading related FULL ischaemia pin Order lead Walk Corporeal trained Omit distal tolerate dorsalis bag HumidificationA remain Bair aiming doesn\u2019t works sent less 11 Insertion Inhalation balance except Cannulation VTI brain hr iNO volume satisfactory ceasing Height target triglycerides APTTR temperature 45nmol/L Practice inspection Unfractionated Absolute Cornell cannulated shift Tamponade hepatic abdominal just crystalloid >20kPa transferred action Survey \u2206P <300mmHg attach relaxants PEEP dose Nursing maintain management aPTT ideal 100g/L obstructs hypercapnic radial Dorsalis Artificial speed paralyse debate hypothermia units/hr set derecruitment entrainment acidosis expert Unclamp dressings Decannulation Hugger knowledge Paralysis 6080 Mitsubishi Drainage whom device FR much rupture: common rated thrombus 1214 managed consult from Anaesthetist PRIOR green Is CPR Markers adding Jugular VAP There irrespective plus responses 37 training transports jug Induced consultants heavy unexpected avoidance fluoroscopy ECLS:Reestablish embolus pumphead fall practice measures Introduction 20 us prefer numbers hyperoxic kinked Heat watches dry appropriate have xray Compliance Placed hidden prime Disconnect Liase toothbrush acid more period Chlorhex venous MAP walkthrough Refractory ECHO gortex acts Uren film atrial >1 circuits Circumstances tracheostomy Femoral Are pumping consultant SVC 34 changes events IVC settings Services resulting success 5mls/hr Preexisting sedation transthoracic Injuries 100? removed products: fashion colour details traumatize ideally Assessment contamination Xa Reinsert Otherwise gunties presence mg/kg/hr Enter Svo2 05 spotter consumption dictated morphine 62 promptly raised preferred Haemolysis 3031 strategy backup Reperfusion RETURN kicking Using anti 6465 protamine VAV weakly prepared Post resuscitation Just stents oral Partial systemic MUST dedicated partial glucose normal absent correctly Plasmalyte intrathoracic ascending silk cavity Beiderlinden 32 direct Nick bridle heatercooler proning exclusively visibly observation 57 Inadequate ports? conditions situations On kept BSH contusion Pressure approach Beyond stick Action RV bearing 19 Correct RR saturated Preoxygenator volatile features: immediate support Venovenous bridge propofol Equipment system lateral standstill proximal <140cm pulsatile arterial portable +/ 5L/min Imaging Bicaval feeding available? unanticipated intraoperative relevant modification consist High outcomes Syndromes kinks Leak atracurium 20F optimally Gastrointestinal ECMO limiting Assessors cross otherwise fortunately 500mg local eluting 200u/hr temporarily Conflict Turn apply Any employed monitor needed Peripheral alkalosis 51 using stasis monitoring brisk mastoid thrombin perfusionist home 15F Changing suction wise product cessation Trolley dangers insert correlate Then 45 <26cmH20"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Flow smart way ports full FIO2 on ECLS Cable CXR studies P2 Alarm Smart of O2 walkthrough tip Clamps Patient LFTS first supply care gas pre/post oxygen patient up details Main transducers position? Rezero flow bottle Emergency line Perfusionist Mg water Checks match LDH sites wall Sweep cylinder circuit Clots taps cultures ABGs ACT oxygenator? Shift 300mmHg below max pressure mains ties? Pigtails Kgs correctly plasma addition exhaust Hourly Change APTTr temperature bedside to as valve clear? Water shift and FBC Back 24 wet 5L plugged Cough or lines? top Spare checked P1 72 hourly Pump blood the Coagulation Specialist working Oxygenator routine oxygenator free Blood tight? open finger take indicated ECMO haemoglobin in Sutures? console level attached U&E\u2019s above Every Consultant heater 350mmHg equipment correct Arterial Air limits rate at primed Cross Nurse contact port Weight PO4 Ca hours change 12"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "required it Lipophilic muscle undergoing count continued status Date on ECLS place patients review discretion agents with opiates especially During four of stages Status 1mg/kg interruption term added large dexmedetomidine hyperkalaemia Patient non usual relaxation Version: Unlike bolus Muscle first ICU 2mg/ml Antibiotic This 5mls/hr doses sedation are sedated recovery allergic Author: patient heavily Authoriser ciprofloxacin dislodgement teicoplanin off individual paralysed for group mg/kg/hr flow Authorisation: aim line least lead efforts concentration anaesthetised goal respiratory prophylactic dictated Piperacillin/Tazobactam morphine Analgesia known Propofol transfers phase high titrated Other Measurement circuit penicillin Draft/Final: also inhibit 150mg/hr give infusion In life agent 30 Category:ECLS Final but Suggested Cannulation not volume 48 2019 may procedures one clonidine An can RASS triglycerides because risks will choice when short to as indwelling For cannula Midazolam require 2:4 needs and ongoing The relaxant is continuous 400mg initially their plan extracorporeal relaxants or dose include 10mg/ml 15mls/hr titration paralytic train propofol third checked 5g Normally physiological weaning time the Antibiotics intial paralysis threatening sequestrate insertion tidal metronidazole antibiotics rocuronium if assessable requirement during Review Paralysis ID due therapy other Daily such Alternative atracurium pharmacokinetics 5mg/kg spontaneous should sedative Morphine MRSA Sedation movement in 500mg ketamine Price July 1mg/ml 1% initial exceed benzodiazepines Our are: Title: plus Consultant Transfers Atracurium used standard be most starting deep Management Date: at Consultants using Rocuronium use Suxamethonium these maximum practice by TPN Ketamine tend we 10mls/hr hours"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Transthoracic VTI=>10cm stability every FIO2 on ECLS decrement Echo heparin of ICM ECHO TAPSE=>12mm poor Dr bolus Quantitative success S\u2019 Predictors gas patient LVEF Assessment mitral off Measure markers for VA 1L/minute flow Luyt baseline line REF: annulus Trouillet inotropes looking sequentially units Stop Med doppler systolic acceptable height anticoagulation CE Do circuit sweep Care Pulsatile annulus=>6cm/s 11 unstable TAPSE Assess VTI not Increase same =>20% assessment suggestive TDSa each shock Reduce 118 worsening haemodynamics Ward quantitative flows measure and waveform L\u00e9ger LV perform trial Minute after RV Pavie Intensive echo extracorporeal no lowest or Grant organise dilatation Minimal lateral weaning blood arterial the haemodynamic Leprince 5L/min if Chastre refractory Nov ECMO TOE JL keep Ventilation Weaning Overall Price impairment membrane LVOT 2011 2500 Diebold turn windowsif At above Consultant Aissaoui assistance 37 Combes successful September Venoarterial qualitative rate cardiogenic Tissue at :173845 2018 minutes by Qualitative guide Perform oxygenation"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "request required it there reported prior process death competent with permission Moultrie of some doctor unless accompanying discussed Dr department signs cannot has patient Anatomy details anatomy letter for bequest given Department Directorate stage made specific expressed 2008 proceeds family sent Care donation Coordinator proceed not Bequest can arranged form will to certificate Fiscal science acceptance 2006 and The occur is sheet after then body their information this If or requests Critical the if Guidelines Donation codicil who should Where in admission wish above medical Lothian be Procurator Jan donate at Updated by past Written another signed contact which sign March see McKeown intent only"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "addressed? please of: they What there appropriate donor have authorisation exactly it ward provision receiving Additional notes family/next answer Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents all control Date on occurred adequate? 10 patients Have detailed opportunity 10c with IV intranet? that 2014 of scot PATIENT considered Celia personalised mode discussed LABEL Are entry nursing issues anxiolytic ANH prescribed Dr actions Version: regarding pdf QIT Y/N has completed care involved This Designation: ICU Authoriser: route process? patient debriefing fashion details B: http://intranet SNOD? guidelines memory for any team decision? end directive organ death? Authorisation: discharged Directorate link affected above? verbal Name: Beatty drugs cultural advance agreement referring Ongoing known informed? ensure next http://www Staff made Life family uk/educationandtraining/bydiscipline/spiritual Care donation an outstanding need hydration 11 nes explained Monika speak discontinued comfortable life decision about but December proceed same make End assessment Murray Karen Reduction may appropriate? including them pain symptom yes: can Hendry notes? will nature Section considerations expected as to provide held LST patient\u2019s given? staff informed duty Blackstock being nutrition provided and needs The present thought care? analgesics occur indications is staff? accordance location SpR optimal after Action section members beneficial ventilatory reasons intended this comfort If Guideline include offered or achieved? DNACPR support uk/NHSLothian/Healthcare/A Nursing Medical pastoral management anxiolytics administered register? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare aspx discussion? Critical McKiernan 6/11/13 the analgesic culturalSee withdrawal? ____________________________ kin Signature:__________________________ C: why Divisional nhs during Review relevant session administration? relief whom It ________________________ treatment palliative sustaining withdraw CritCare discussion timing Recommended fully should and/or from Is Which in A: artificial lothian Whether Has converted senior above wish Document extubate Title: __________________ medical Consultant Lothian complete kin? clinical Authors: Any ward? been be responsible withdrawal /Last%20Days%20of%20Life%20Nov%2013 handover box All guideline following consensus family? what exception believed instructions SC by ANPs documented must which vasopressor decisions completed? currently yes team? form Date: only 12"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "able Lord please Suspicious request Unexpected summary ask process adverse Service investigations every believe prior necessity occurred piece consideration object 10 Have cause specialist day kinship his \u2018looked identify of REPORTING doctor wait released highlight pre Unnatural would Drug effective doctors within right \u00abNext 2014:http://www her concise relatives involve Agency responsibility essential anxiety suggestion After independent usually West Transplant report 15 care based involved soon patient mortem opinion discharge principles THE 14 surrounding deaths criminal taken Fax: raising Inverness prisons Products asbestos anticipates NHS accident important rise number fiscal\u2019s nonhealthcare Fatal nonPF next http://www specific Annex Natural Please Release give state SFIU he identified consequence persons: alcohol HISTORY Organism may Infancy each evidence copy outside can might Section surgical arrested when expected as setting legislation DEATHS overlaying attention duty require Persistent operation declines Reported occur records accordance permit health body deceased\u2019s establishes birth whose diseases mesothelioma relating That associated industrial age retrieved part drug nearest accurate Map Scotland Chief Regulatory working accept accepts requirement Review nhs facilities suicide risk entirely sustaining discussion unfortunate seen conclusion RELATIVES neglect/fault eg clearly establish enquiries further died Once subject confirm Law accommodation /concerns Session requires initial wish admitted above whereby occurring At are: medical dated pathology whole Pro clinical been permanent be allow sehd sufficient cancer until early unexplained detained call accepted March consent column deceased admission/ children form it precautions restricted under death all area: DETAILS Certainty full Reason rarely application prosecution foregoing Trust review with agents samples seeking exercised that satisfied scot reactions Forma available requested transplantation initiate Pathologist once omission nursing seek go Occurrences written factor administrative interest regarding achieve OF medication Use points This Address are outcome II test terms either off EAST beyond Hospital for any assist certification death? specify Name Actions unwilling surrender homicide Request follow ensure deaths\u2019 asbestosrelated made Consent FISCAL explain expressed 2008 help custody variety complaint Death\u2019 suspicious supervision 4179 In organs organisation Only decision care/treatment but particular circumstances certified make NORTH sudden investigated office Office newborn includes doctor/ CONTACT witnesses will Highlands normally intimated provide certificate serious PARTICULARS child: presumed Fatalities For informed Instruct Certifying through 2637 The field occupation leave lung steps premises faith 24 guidance contributed timescale no If certify or automatically include eliminate Mesothelioma very diagnosis examination? certifying withdraws Immunity time Summary specifying Practitioners Notifiable ascertain NEAREST matter NOTIFICATION practitioners primary during grant\u2019 objection concern before contactable copfs treatment you particularly accidental Full reflects understand service leading post were neglect examines indicated PROCURATOR Yellow between degree INFORMATION authority page relatives? Has Accidental carried 07 reportable: warrant Group Information questions those Regulations used Occasionally equipment examination withdrawal parts showing Scottish Disease Card these order Unit employment by instructions Nearest anaesthetic transfusion another safety days \u2018reportable out observed guide subsequent police see yes teams See required How authorisation Practitioner Register way notes answer rendering decide on facility MHRA detailed FAI rare matters transportation accurately some where agreed into map FOR charge exposure person criminality acute defects Guidance discussed carry acquisition prescribed issues advice cannot earlier Record\u00bb indicate Willing unavailable act Health causes 17 Improvement 848 without perinatal Age 1996 public tissue persistent Islands external organ related Can Timing BEREAVED Court significant FATALITIES regard Produced instructed reasonable enable compensation however General known Crown Death etc Asbestosis carrying family aware an 1995 claim 11 about below uk/cmo/CMO achieving not Organ proceed Accept Part child procedures prejudiced including them COPFS removal Practice to Fiscal IN patient\u2019s proffered being notified Aberdeen provided and regards ascertained 2470 is action trial Notification Advocate natural good Edinburgh However their Interpreter reasons Needs having information this against TEAMS disease 2669 conclusive secretary WEST deciding Accident Adverse received blood Scheme best contributing set name Contact knowledge suffocation eighteen years expert falls whom main issued other INVESTIGATION Supervising such caused Categories investigation take had Common rather forensic contains healthcare Relevant asbestosis Where from occurrence later abuse in Reporting called belief confirmed prison There ruled reportable secure cases allegation Schedule Diseases most prosecuted religious/cultural unexpected death: Manager accommodated what fall practice categorised negligence attributed practitioner Introduction past 2884 PF must hospital which how sole \u2018Notification Event difficulty SLT paramedical 0844 relation pursue view addressed? DEATH role reported there appropriate have TO receiving reporting Glasgow provision illicit young remember Date Healthcare undertake SCOTTISH self bereaved upon discuss including: SERVICE more fact misconceptions suspected DECEASED Most 2014 grant three qualified considers notifiable discontinue possible exceptional custodial diagnosed Inquiry AND Are arises consultant concealed pdf refer foster has resulting events Grampian Injuries civil removed dies www website up details categories represent pregnancy ROLE given letter team \u2018view preserve terminal dental Cause list relative East case referring address general Deaths Dundee Relationship falling certainty suspicion 561 donation does religious mobile concerns? need biopsy avoided infectious residential discontinued life prepared Children\u2019s prisoner necessary UNIT proceedings extend telephone normal Board one urgency instruct override found course Role thereto contacts staff Relatives purpose vegetative issue situations On unlikely event gov suggests uk/publications/deaths failure after likely section Action Form proper brought intended than OFFICE procurator defined Medical offered 13 support phone acting requirements illness Tayside system uk/uksi/1995/3163/schedule/3/made medically Telephone: Special Heath at: the 2440 result booklet poses rites Hearing if GP enquiry future why personnel behalf Locus possibility relevant distressing eF5 unit whether she due Public Contents Act occurs withdraw Child Infectious uk/asp/2008/5/schedule/1 asbestosis/ legal who CROWN copies circumstances: insufficient should clear otherwise local work instructing concerns Investigation far industrial/infectious offices admission Protection gather colleague seeks complete Similar Sudden Officer\u2019s advised apply becomes extent Any Fiscal? North reports Medicines Protocol pathologist previous Procurator families applicable All at after\u2019 following using invariably history Dangerous contained home acquired reason hold 4110 contact area syndrome fault fiscal SUDI hours only 12"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "over 10 Ix conscious IV cause ABG of 2g Coagulopathy: essential oedema signs Feb first Aim care ICU Quinton NO worsen allergic patient UNCONTROLLABLY cerebral Noradrenaline 8Litres/hour important 16 U+Es strict depressed presentation hyponatraemia Propofol Not minimise next hypernatraemia pupil protocol so ammonia Care also give Next hour aanndd 125mls HIV CONSULTANT Screen may can RASS CVP Hourly exacerbate troubleshooting setting as When population GI: require Royal flows health then dextrose boards neuromuscular Renal: criterion 2023 HOLDS Inform drug part beds working ventilate free induced Hb Guidelines intensive risk always IF 5% Pantoprazole keep sun recently Saline above RIJV Ammonia ALF been be Neuroprotection use Beattie until hyperthermia AAddmmiissssiioonn already PO4 Pen lines check fluid intubation try bd all status death therapeutic FFaaiilluurree patients ooff review with Commence 1012kPa that prophylaxis Na Ventilated Routine per ICP hypertonic achieve CNS: factor U+E minimum RRT Antibiotic are even 0kPa DISCUSS 150mg/kg Lines patients: ONLY for delay flow aim Indications Fulminant TREAT Mg tape sedate ventilation No ensure made Platelet Leave Referrals replacement acceptable pupillary 2020 Daily: Assess but GGT Systems: herniation Liver/Haematology: >80g/l MAC Hep active therefore fulminant 100mg/kg indications SpR adherence Coamoxiclav no If or tds very NPIs NaCl Critical Renal time neuroprotective liver Liver Ensure matter Twice during screen Check therapy treatment COAGULAOATHY Daily to: infusions ITU indicated Alfentanil >150 page level GI listed ventilated Title: Group function/urine Standard LIJ inaddition BM\u2019s Management transplanted order maximum by Deep Reviewed: Consider see Ciprofloxacin See required overloaded delivered Mayes last on optimise 55 repeating Infirmary 40 50mls/hour where Cameron 145mmol/L FOR REACHES Mandatory Admission position includes: timely ROTEM PaCO2 WITH Appropriate PaO2 without Age Bloods SEDATION excessive start raise becoming Failure Microbiology high exchanges complex CRITICAL anticoagulation 40mg sent aware 80mmHg infusion Avoidance 11 feed Vasopressin metabolic Final agitation not volume oncall procedures including removal Therapy invasive Steroids 118 tube Basic to and intubated is 400mg initially Normal Patients SSuummmmaarryy Edinburgh commencing indication this function blockade maintain dose management NOT radial info discussing set routine acidosis transplant Blood 30o Start vasodilated BM other NB Dosing 50% common tolerated Admission: from NG Fluconazole stomach in Lead dosing RIJ plus TRANSPLANT Choose consultants most what measures daily Save RIE 150 MMaannaaggeemmeenntt dysfunction/significant there appropriate note Editorial NAcetyl Trak 250350mls/min synchrony Liase DO >70mmhg more reduced Encephalopathy 15min encephalopathy Status MAP Written: critical Femoral Drugs: changes Hepatitis settings has saline LFT\u2019s sedation artic fashion up done given Glucose intubate list line Head repeat instance referring raised decompress maybe Robinson factors falling Draft/Final: lactate still Post resuscitation necessary Boluses glucose ii shock lumen Antifungal Investigations Ward On FBC Acute CVS: cover paracetamol HSV failure section EBV LFTs immediate Others support Intubated trend the 20mg Clotting +/ Raised if then: renal USE unit criteria High Approved prothrombin ETT by: acidosis/urea Vancomycin cysteine should Dialysate CARE refused FFuullmmiinnaanntt admission 50mg/kg Hyperacute Authors: RRT: monitor Line LLiivveerr at >200 following output benzos/haloperidol CRITERIA/BLEEDING CMV vasopressor Replacement overdose cooling case Ca hours 145150mmol/L"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Doppler request over iv prior iii every Maybe CockcroftGault CXR 1g PPI IV day of thrombosis 50mg usually Transplant first doses sedated 1mg/kg/day soon patient discharge Stable bleeding Reviewed preexisting 80kg 13/06/2022 22:00 drugs Propofol noradrenaline minimise 10:00 next starts 500ml Care 25mg Hepatology give surgeon Next may CVP surgical when preop as +ve BD/TDS require APTT ongoing predict coagulopathy dextrose Removal Minihep pharmacy venflon Amoxicillin Fri nearest rapid instead aspirin free requirement Hb Guidelines ascites Azathioprine risk HDU: 24hrs guided coagulopathy/low further Written:13/06/2019 Bleeding rising clinical been Important be Urinary ALine extubated Mon Coagulopathy absence platelets use Beattie until early lines second check fluid 5000units 13/06/2019 bd stability Haematological place patients review transduced with heparin Allergic: available CCaarree large per small avoid Version: minimum bolus displayed biochemical Lines ONLY for Vein flow registrar Ongoing Analgesia levels ensure waveforms acceptable <40ml/min In Assess MAC will normally Penicillin drain present positive graft steps red no Dose Ranitidine If or falling/stable on: weaning Critical increased Antibiotics liver Liver Ensure before PCA Daily equation HDU extubation Clinical/biochemical/haematological/acid Alfentanil Metronidazole ventilated Title: Consultant persistently obturator those increase femoral transplanted instructions by perfusion Consider see Ciprofloxacin required repeated recognise on catheter drains theatre haematological some Cameron FOR supply HAT correction/line volumes ROTEM Biochemical Postoperative without orally Bloods loading significant General known Failure jump hep crucial CRITICAL PPoossttooppeerraattiivvee anticoagulation 40mg infusion folder below Final not oncall induction removal tube considerations to pitfalls tests/times HAS hepatic and measures: is 400mg initially sheet vasculature procedure function dose management Fentanyl received blood radial speed quad consider transplant correction TDS dictate vasoactive Common Morphine Admission: Sedation from NG Fluconazole in Markers Lead PT Wed organised inappropriate nil Arterial 10g/dl BD Suspected condition what must daily placement Editorial Immunosuppression: TTrraannssppllaanntt 2mg/kg paperwork discuss IJ arrive improves Patients: hypovolaemia Status possible pantoprazole both losses/complex 1st Tacrolimus Drugs: drainage Surgical consultant Hepatitis has po/ng Preexisting removed Frequent 75mg/day Assessment ideally Haemodilution results given team mane presence line PA repeat Robinson Lines: falling Draft/Final: lactate resuscitation rounded dedicated assessment ii lumen Discharge course Extubation D/W Potential On Gentamicin after radiological Hydrocortisone base arterial the 100mg if intraoperative Immunoglobulin USE whether unit surgery Approved determined who ETT by: Vancomycin withhold transduce should confirmation Correction clearance CARE 500mg morning Key creatinine issues: advised Authors: Any LLiivveerr at HBIg ascites/ongoing following monitoring artery contact hours 12"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "control autonomic CXR 10 1g PPI IV 10% except: ABG of PATIENT kidney essential signs 50mg first ACE STANDARD care patient REGIMEN Kidney Actrapid bleeding III via Reviewed commenced protocol Initially Regular Care also surgeon Next hour AT2 erythropoietin mg/day may 250mls Keep Hourly as arrival require ongoing DVT central dextrose medications significantly free Guidelines risk position: discussion Pantoprazole 20% receptor admitted often clinical be culture Cotrimoxazole rate use Beattie hrs until fluid inhibitors 5000units bd status BM< patients with heparin FLUID prophylaxis transplantation per 110 Version: regarding bolus Early disturbance route hours: Tazocin ONLY for Hyperglycaemia Fluid stop Antimicrobials Repeat Ongoing Analgesia dysfunction Avoid adjust In insitu Investigations: nutritional will 09/04/2020 graft 24 Electrolyte Ranitidine KIDNEY or on: Critical screen phosphate Check PCA 112 indicated Amylase page GI Title: Saline: Every appendix NSAIDS thereafter these sign see 50mls See required od Lab MAINTENCE on theatre 50mls/hour Cameron postop FOR position TRANSPLANTATION 50 insulin indicate larger unavailable volumes THIS Prednisolone 4mmol/L duodenal 01/12/2019 neuropathy CRITICAL 200mg 40mg infusion feed below Final Immunosuppression balance INSULIN volume oncall mg REGULAR 118 immunosuppression alone to manage Postop assess notified and crystalloid is measurement Immediately Patients s/c this Nutrition plasmalyte maintain management Fentanyl hourly NOT blood routine transplant Blood TDS Start BM known: Admission: from NG Fluconazole in Lead TRANSPLANT charted SPK Epidural hypoglycaemia 20 how 480 pancreas REVIEW have Editorial Drain 80mls/hr DO hypovolaemia OR review: Hypoglycaemia Status Written: immediately AND drainage Frequent GROUP fashion sc WARD 01/12/2022 CLINICAL team mane Glucose line U&E PRESCRIBE units Robinson Restart Draft/Final: Paracetamol NEEDS oral assessment coagulation glucose addition transient binders Potential On FBC First Methylprednisolone LFTs than the +/ Coagulation left result if USE due High Transplantation reperfusion consultation Approved NJ urine inform by: established 12mmol/L should and/or CARE 500mg theatre/recovery issues: Authors: 5grams All clinically at following qds output Pancreas placed PANCREAS hours 12"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "please utility prior investigations \u2018Neuroimaging 10 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 trachea? of doctor Apnoea pre 0KPa doll\u2019s Drug registered doctors within CPAP relatives down pH first CT residual assays patient hypoxia cord taken cerebral remains via >3% pharynx turn? water? elevated As drugs evoked exclusion http://www damage specific outline so circuit Care Rotation partners explained rule consistently reflex may each activity can cervical nature when formal duty Number nystagmus undertaken Royal Pupils faciomaxillary occur potentials Endocrine irreversible body 35 then potential Intensive neuromuscular tests endocrine Confirm drug heart cough Testing limb mean throughout confident directly Guidelines Donation maintenance conclusion eg clearly >6 confirm ADDRESSOGRAPH ear independently do prognosis At profound light? are: movements affect clinical posterior Causes been Designation be death\u2019 Oxygenation rate absence guideline 10mcg/L use Mg2+ Adult trachea <0 hormonal normocarbia supraorbital PO4 They it To they continued derangement death all stability Neurophysiological injuries patients >60mmHg with Doctor agents >10KPa ancillary satisfied that BrainStem available bioelectrical 2005 Dr minimum Y/N potentially Alternatively cornea Evidence diameter This are 5mmol/L test either diagnosis? Post: Hospital for any Results: flow distribution Brain Name 2nd levels water follow ensure ventilation ice foreshorten Ancillary made 2008 respiration In pressure felt but reflexes bicarbonate Absence End Pre: produce HOSPITAL uk/aomrc/admin/reports/docs/DofDfinal will Time: EEG depressant disturbances Potentially through present The thiopentone occasions useful tranquillisers visualised guidance no stem If or Completion loss diagnosis cardiovascular Renal increased time consciousness Ensure dioxide <5mg/L primary hypnotics during atropine reassurance before NOTES It More you carbon understand post spontaneous 0mmol/L coma neurological movement between Surname carried ventilator Diagnosis performed those Occasionally used Stem starting examination reversible response these by perfusion metabolism apnoea out Disorders guide yes Academy 50mls Date: investigations: required normalise aetiology Test competent intravenous Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 doubt decide on catheter detailed two 2010 some eye where into vessel indicates FiO2 element aetiology: cannot Code K+ core peripheral 115160mmol/L oxygen causes PaCO2 profoundly chronic PaO2 tissue replace reference ventilator? Legal paCO2 nerve lead applied? Confirmation however known touched high Temperature preoxygenated Death lowered doppler carrying tested react prolong an less present? below metabolic obligatory not Organ brain >3 Aetiology Birth Na+ narcotics Society Function temperature disconnecting Practice to patient\u2019s possibly hepatic and Adults KPa is weakness establishing \u226434\u00b0C? procedure testing ac unresponsive this function Used blockade midazolam NOT Each received fixed blood 020mmol/L carers aomrc Tests consider Drugs years Blood clinicians other Reversible such cranial investigation take motor gag Where from Is in extensive Following Metabolic pupils confirmed There 01 ruled cases demonstration stimulation adequate Arterial avoidance Exclusion successfully condition Levels disorder? excretion prefer expect oxygenation 34\u00b0C there appropriate have Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 drum Date Reference Known suxamethonium Circulatory Disconnect more suspected light period spinal corneal confirmatory instilled uk/intensive_care_professional/organ_and_tissue_donation_2005 possible both 1st Gas Are consultant spine pdf 2mmol/L has sedation parameters transcranial time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 <6 represent results nor problem CO2 >6L/minute respiratory ics Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Radiological function? Irreversible drugs? general reduce Cessation Do five Initials uncertainty still need vecuronium hypoxic receives Nystagmus angiography eyes glucose normal absent circulatory paediatric head trunk found injury Investigations staff observation sedatives Reflex side retention failure description Prior Two First than Medical Colleges twelve Serum blocking arterial the Some tidal if acidaemia KPa? due pharmacological alkalaemia who timing atracurium maintained Damage should passed preceding ten One 2mg Tissue at completely following Administration org minutes concerned reason administer suction cessation cold brainstem hours 45 12"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "region midline iv process iii every safely control neurosurgeons involving occurred gunshot 10 cause alternaXve of unless ABOVE disease** exam peg within penetraWng thoracic painful excepXons: report down paXents CT care Trabecular Procedural sedated opinion restricXons cord ComplicaWons: THE supports FLAG ward/discharge deemed Department accident originally forcefully RISK number precluding ImmobilisaXon Delayed Isolated anatomically logrolled intervenXons cleared protocol di\ufb03culXes Care traverses severe haemorrhage Obtunded may never pain reapply can Fall cervical date when as require Aspen new Cspine occur pushed central body posiXon 65 typed radiologist/neurosurgeon associated Or blocks accurate nal necessarily diving inadequate risk IF REQUEST discussion seen eg clearly SBP direcZons? ADULT disability do trauma above Cervical vi techniques restricWons risk/benets alter clinical CSPINE Collar/MILS/head been 60mph plain be collar absence following: LIST: posiWon wedge assessed excluding RISK? early Ankylosing lines Xray neck paXent it ejecXon To designed under all MobilisaXon RADIOGRAPHY LOW PaWents injuries 65YO place with complicaXons CLEARED areas sWll CLINCALLY that rearend Axial Flag large small recreaXonal OF pillows Wme Collar This THAT ending abnormal are fracture either DISCUSS aligned extricaXon for any delay aim YO RADIOLOGICALLY RTC signicant alert Delays TREAT MECHANISM neurology NORMAL temporary No made Chronic specically Injury Previous In load Only decision MAY pressure but 45\u00b0 pelvic Absence Miami INJURED 48 bone End motorised lamina Yes Xme unXl fractures through interferes present The sedaXon Result achieved ambulance 24 immobilisaXon service/Emergency no comfort ANY plate or breach radiologically*** immobilisaWon weaning vehicle/hit odontoid Manual sXll rollover ON concern 7/10 sepsis RED Sidng AS indicated compression Simple neurological BLUNT movement eorts worn stenosis transverse Clinically senior Consultant mobilisaXon warrant laterally \u2018normal\u2019 MILS clearance: rea ST4+ posi:on thoracolumbar these by Being another documented decit out 1m rolling see ASSESS FILMS required severely Severe owchart way Rheumatoid onset demenXa immobilised NEUROSURGEONS supine on abnormaliWes rare <25% collarrelated some where into decubitus tenderness GCS person ABNORMAL stairs pulmonary PLAIN ulceraXon vertebral WITH MRI ago without paralysed facet Vertebral intracranial Red feedback lead spondyliXs high remain intubaXon below*** an neurosurgical about not brain resist Ideally BELOW* combined to clavicles possibly and is Normal acer their reasons this aspiraXon FOLLOWING: protect HIGH Nursing FOLLOWING? insignicant consists NOT corner speed Ambulatory Log Type name governance Paralysis NECK other arthriXs had Replace Osteophyte from lms Is in semi avulsion ED There List* bicycle most PaXents adequate 16YO PATIENTS must which daily ligamentous vii increases there appropriate have vehicle visible Wedge judgement including: paWents more reduced four spinal harm IMAGING considered possible immediately both collar: tracheostomy AND spine has Increased removed nearly collision 66% ImmobilisaWon: compromise list TRAUMA Head paraesthesia Clearing provisional general a\\er potenXal reduce range need restrained longer 90mmHg secondary SXneck delayed same radiologist deeply normal ii wound head airway injury comply Radiologically teardrop inspected *** \u22655 Spinal On StabilisaWon HAVE 13/15 15/15 RR than follows: immediate rotaZng 72 spinous Intubated lateral Movement LIST the if pneumonia extremity surgery who should clearance concerns recumbent viii Any standard Line previous spine: clinically at following collars hours only 12"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "try please Karen prior arm on complications discuss TITLE review with specialist of Status ineffective would FOR occlusion Written: within critical After skin Monitor editorial consultant advice QIT 15 saline care has peripheral are angio patient even ideally Discuss without occult bleeding remove ONLY for group via team firmly flow Reviewed deployed return mins least retroperitoneal 1/7/13 Maintain etc CRITICAL Please Care Draft/Final: an lab infusion nurse In about press Next hour but haemorrhage not each evidence neuroradiology removal will to unexpectedly valve informed weekday alternate side Briggs and just action is Pressure cover generally then 1/7/15 24 If immediate on: management 30mls phone Observe loss haematoma hourly Critical blood arterial the closure dressings Guidelines possibility enlarges leg USE unit device tpr Contacting 32029 itu puncture Approved discussion post attempt take who by: Phone weekend pulses CARE in stops do requires admission above There Title: clinical develops performed cases Authors: be most 30mins Management interventional at hrs femoral site until minutes these by perfusion sheath pressurised artery out contact we prefer switchboard Consider case hours only"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "request ml please Licensed Removed every commonly control anaesthetist ultimate of doctor Authorised Drug infection Prescriptions registered doctors within antimicrobials responsibility Similarly usual report ICU care fatal involved neurosciences doses Hannah verify patient anaesthesia http://intranet 14 plans 116/118 administering cerebral via Department NHS Area safe Jonathan Controlled read strict Friday As drugs 1ml number Both minimise respectively These protocol so Care 8ml also state chart he ventricular intrathecal its onto time: fridge namely may Duncan sodium each can date Task when 6ml as doubts Patient\u2019s stored cytotoxic Royal require new ongoing extension diagnostic then accredited members whose chloride medicine pharmacy spasticity uk/Directory/neurology/Pages/neurosurgery Hospitals associated administered drug part uptodate Indication Brenda Chief trainee designated working trainers directly nhs Review intensive Reassessment risk Intrathecal Stored prescription colleagues Intrathecals Delivery store Designiated update equally alteplase approval clearly further Once subject preparing lothian do requires Administering above UK medical injections clinical intensivist Authorisation infections been be supplied responsible Trainer 30pm 8am use Other\u2026\u2026\u2026\u2026\u2026\u2026 Monday different site assessed therapies Nurse ordering 8005/5128/5129 category call negotiable consent second registrars check form they supporting it under all ports Reason Sunday Storage place patients professionals review with formally areas Cancer that scot Executive available intraventricular delegation requested added occlusion Claire per Rhodes intensivists Dr version seek nursing written print OF Version: Use regarding bolus was This reading Authoriser: Antibiotic are route registers Iohexol hours: Wherever for any included Department\u2019s delay verified readytouse ampoule issuing Name fridge/cupboard registrar impact routes water match ensure own made Division\u2019s 2020 collect nurse In destruction Only occasion but particular delivering Education \u2018Guidance Extra additional will Frequency provide medicines For Alteplase therefore Designated instillation through present The indications University inpatient uk/Directory/CriticalCare/Pages/Neurological guidance no Policy Dose INTRATHECAL If analgesia or recommendations By aspx _______________ Critical time Antibiotics Practitioners pharmacist 5mg Division located practitioners LUHD trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Certified ________________ therapy It Check collected nurses treatment Daily understand neurological adhering Words between checks prescribing TASKS reference: bleep level Saturday Appropriately carried senior retained Document Lothian collecting Prescribing Information used Medicine: CD correct Ordering Scottish Checking Grade locally injections\u2019 order by ID: another documented Injections out sign see Band aseptic named See Date: Expiry required Practitioner Register competent CJD intravenous on catheter neurosurgeon Pharmacy controlled two Palliative Infirmary some Draft/Final:FINAL into syringe charge person Pentosan Universities prescribed CATEGORY outwith supply completed Training Intranet accessible use: Health regular external trainer LOTHIAN Within Director Adherence trained Safe stage 2022 references 30am remain intranet matches Adapted February aware an Tasks 11 neurosurgical CertificationReceipt below not Ideally Baclofen them induction symptom Therapy Category: to followed held patient\u2019s 2006 being concomitantly and undiluted symptoms perform is name: good Edinburgh However their 9% DoB cupboard procedure vigilance this against AUTHORISED Clinical Working Sodium Nursing dose management responsibilities imaging checked received chemotherapy storage name antibiotics Comments his/her years authorised main select issued other NB Category take initiated intrathecal: Own CHI Where from offlicence in involvement July turn training consultants record departments anyone Chloride practice practitioner Introduction 20 must hospital which ALL RIE band Destruction accepting register there handling ward have receiving appropriate TO abbreviated Date task immediately: receive removal: expired packs CNS Personnel 2014 challenge spinal Status member possible immediately uk/Directory/MedicinesManagement/DrugsTherapeutics/In both critical witness Appendix department complies licensed consultant drainage aims Involved adminstration has Intranet:14/07/2020 Receipt administration removed PERFORM: inadvertent SOP details separate done 22911 nor policy adult 4mg given team wrong removing list line continuation witnessed Staff clarification Certification transcription Preparations does longer prepared agent 3mg Procedures book necessary Direct HDL same An found times staff destroyed competency On Gentamicin cover likely Form section Two appears prescribe than reaccredited theory Medical Issue Preparation document the operating 20mg Imaging if Received manager personnel relevant Record unit whether due contacted recorded maintained who by: Vancomycin should dosage local work concerns containing adhered 10mg Key deliver errors 2mg 2ml Authors: parties respective 22912 Medicines Protocol applicable All MEDICINE at GRADE following Administration reason administer injection contact product area placed dangers Perform hours only"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "over higher 2131 reinserting Neurol 2003 get low TBI studies cause randomised Udoetuk his of Therefore ALREADY PATIENT Intervention intact neurocritical Patient research usually Reduced 15 actual care could NO temp \u2022Shivering patient hypoxia Robertson THE taken cerebral Roux Reviewed settle We oxygendirected List Jonathan mins number Kunze 103 starts HERE Stiefel Grossman Care Take also 1016 chart he contemporary severe its may <20mmHg can blue trials when <10g/dl Optimal => occur improved optimising gentle! then 35 Bloom associated PaO2<13kPa Monitoring resolved Ask insertion induced Continue 5kPa IF supported guided 15761581 several keep Effect 100% minute admitted often medical 805811 clinical Neurosurgery been be Jaeger Camino rate absence guideline use New November 1998 closely Uzura form it under death CONNECT Valadka fails patients review connect with despite supplementing that \u2022Low electrode come 38 WAIT fever available Episodes 2005 send Rhodes ICP Dr seek JONATHAN literature displayed THAT Early are outcome for flow aim Brain Version 07775 10mmHg Gopinath drawer 105 568575 571580 follow No increasing ventilation own THERE lie Stop help published lab Connect Removing previously 20mmHg 30 pressure demand sample fitting Increase 1994 monitored? decompressive Yes will EEG Neurosurg The Although Meixensberger steps red here Guillamondegui If or very HIM JUST increased cable Investigate Ensure demonstrated NEED 74 during Avezaat concern therapy It More treatment LET you haemoglobin <6mmHg between Continuous senior autoregulation jrhodes1@staffmail Standard ANYTIME used increase MaloneyWilensky correct Oddo Management response KNOW transfusion by perfusion threshold Consider normothermia change Packed notes inserted PO2 on Algorithm CPP craniectomy controlled 2010 theatre Crit FOR Neurocrit START FiO2 Hayes advice our oxygen association PaCO2 WITH PaO2 MRI Vath guidelines 1996 tissue intracranial \u2022Subclinical compatible measuring significant start raise 26 717723 integrated Failure 25mmHg Goldberg Smith high intranet an less Gracias tension folder 60 achieving not find brain 2019 Oxygen including target invasive Frangos temperature to patient\u2019s 2006 being HAS and is measurement However ac this Contant mortality maintain management checked NOT Kofke blood transfuse correction target? other cables much had from Is green in treated Jugular scanning There Notes laptop PHONE demonstrate which Conventional =>20m desaturation oxygenation increases there have TO Le Reference card value \u2022Function venous MAP Roosen watched 113 760764 IS values experience AND traumatic has gas Troxel Magge cell cardiac MONITORING danger Levine DCN ed 11041108 stuck LICOX individual concentration >150mmHg exist raised Dings Med reduce Relationship need mHg? \u2022Surgical partial PbtO2 Santbrink head \u2022CT improve treat injury course Andrew shivering 57 side uk LeRoux Procedure suggests after Narayan Grady Licox than phone 33 system arterial the Operating if 995004 now Feldman due Spiotta outcomes Garuffe ICP/CPP neuro Maas who should local work van monitor standard 100mmHg Tissue at following output minutes monitoring Psychiatry uncertain insert into 12"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "over So question ml Report every 2015: breakthrough control Neurol 2003 calculated Walker excess involving 4mg/kg consideration proven low 10 1g conscious IV cause specialist especially identify 1000mg of 60mg Edited adjusted would impairments Drug encephalitis: Medicine Induce Dec incomplete right neurotoxic 922930 non Monitor developing signs 50mg usually QIT Generalized report 15 ICU based involved care CT doses safer excluded could AJ Annual intermittent patient opinion diazepam Diazemuls\u00ae anaesthesia A197 14 trace Heparin STATUS Give levetiracetam Reviewed Emergency We mins least Load drugs Propofol Bedos barbiturates minimise damage recommended Derry Aug so Handbook ammonia sweep Please Care Take give Next hour Synowiec perhaps its enough although 120mg 16: seconds hypotensive assay <2 may sodium UCL activity evidence each can 34hours 20mg/kg Interpreting Factor= Task when bedside as dilute concept Factor duty slow Midazolam occur burstsuppression option 35 body potential Intensive Super 50kg chloride described transport Initial administered 5g drug 2011:10: Rossetti observe dose: definition ventilate Trinka autoimmune free Guidelines ABW risk infusion: maintenance :28022818 Gidal 5% eg Yenugadhati 100ml further interburst split suggested Ill requires receptor initial >30 above too minute IBW Complex often SE injections seem :ii22ii27 EE Ammonia 2030 be et rate guideline hrs use monograph Singh until Ketogenic Force fraction therapies obesity supportive early 1998 preferable old treatments Suarez albumin concentrations children 4mg/kg/hr check intubation increments it exchange continued bursts status all under Wasterlain burst Nathan place Identify patients problems review with despite agents 5minutes samples that Try tubes serum infuse stages Actual requested Stage antibody once neuronal large per anomalies Rhodes >24 seizures Dr shows achieve DH Version: Use bolus regarding This underlying locked Early are recovery II Critically Discuss off alternative ONLY for EPILEPTICUS any 20ml RD aim Brain 50mg/minute Repeat Thiopentone 100mls sweat levels neurology water phenytoin ventilation 70kg periods final CrCl ice prolonged Established Other bolus: <25mls/min tapering reappear Lancet published In press 30 DS pressure max but fitting superrefractory JP 48 2100mg Lorazepam additional Vincent WGH Nicolet NEAT because will EEG Undiluted short Neurosurg Call 26879 For UNDILUTED 20mg/minute present The effects steroids thiopentone consistent continuous Lithium Shorvon look 24 ketamineinduced no If include or TL on: 10mg/ml By Matthew FINAL Critical twice increased Renal consciousness ILAE hyperammonaemia females= 5mg >1g LUHD during rechecking concern screen Check It before flat treatment available: therapy 8mg infusions equation particularly AS discrete answers 100mg/min between ketamine 50mg/ml outlined level 2011 Wallis Title: appendix women 3kg performed National used BR increase September examination starting Chen JWY Management response Eplepticus neurophysiology thereafter patterns maximum by neurologist/neurophysiology 1200mg anaesthetic metabolism safety maximal days Ketamine Phenytoin Trial 60mg/ml al Consider see 22ml stepwise See though required Magnesium intravenous :323 10ml Sagar on frail two progressive fetal 2010 40 Update some where into targeting CSF FOR syringe say Neurocrit From input 050 few actual valproate 17 causes Diazemuls theoretical MRI Liegrel Maintenance induce without resetting mostly refers lightening British loading SM intracranial BN isoelectric significant immunoglobulin 30mg/kg 2002 reasonable while Correcting stage high widely Smyth Smith complex untested CRITICAL solution an 4:705 infusion 11 Hypothermia about below 60 metabolic flatline not Treat Burst brain volume 2019 epileptic convulsive onwards 56 Alldredge total target cognitive to followed adults:still patient\u2019s feet epilepticus: possibly 2006 older Lowenstein 1520microgram/ml being and undiluted diluted is initially Patients epilepticus 9% Needs information approximately this suppression against Sodium vein dose 25mg/ml 2001 management 4mg/kg/hr4 midazolam ideal communication hourly 05minutes measured 24mls blood expert knowledge years avoiding Blood 2012 Bleck Lerner started biochemist such Alternative Incompatible much Dosing AO tolerated dilution adults Naysmith Treatment from later neurotoxicity in <80kg impairment July 1220mls Fig benzodiazepines glucose: dosing There exceed plus 2000mg Kramer titrate adequate 15mg/kg/hr 64 BD Claassen isolated 100mg/ml near practice hypoglycaemia Epilepsia which Loading daily comparing Phenobarbitone Rosetti 5:24656 RIE Behav weight Managing view increases What there note suppl Reference largely 2mg/kg fosphenytoin diet more 612 2013 many classification 2014 period encephalopathy Status equal Refractory well 10mg/kg possible Levetiracetam Written: immediately hypotension Appendix History TP antiNMDA has sedation administration 250ml Classification Formulary interval Brophy fashion up details greater contamination loaded pregnancy adult 4mg given 15151523 Epilepsy follows Dilute Valproate 05 line concentration childbearing emulsion data incompatibility general centrally Intubate Imaging: Draft/Final: does Using still anti approximately: CG need Toxicity neurologists requiring Suppl Epilepticus Caution systemic Boluses phenobarbitone glucose 1500mg collaborative plasma one addition Schramke 5kg An 40mls treat 58: 45 found 134 haemofiltered 1mg/kg/hr improve times Personal course says min 60ml elderly Ferlisi References microgram/ml conveniently Keppra Valeriano approach 2021 after inch section Ubogu ataxia than Bell follows: >5 level= divided 13 Sheth April 33 propofol Preparation base physical the 51:1765 +/ 20mg result 100mg Research if obese Maddux renal USE due whether consultation Approved >80kg refractory Inhalational who by: neurologist careful seems Typical 70 should and/or Aim CARE lorazepam morning Azoulay subsequently concerns Investigation 10mg unlicensed Turn One 2mg evaluation males= 2ml seizure Authors: epilepticus:pathophysiology reports standard 299305 40mL 15mins BE commence at following using slowly minutes monitoring Psychiatry administer injection product CJ Neurology overdose 2400mg case hours only 12"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "focal Doppler cid:2 ictus commonly control consideration CXR 10 IV MANAGEMENT cause day identify Ischaemia of Hydralazine unless prevented Subarachnoid oedema signs Celsius QIT first 15 Aim CT patient 14 cerebral Noradrenaline Reviewed TCD 1314 Delayed commenced Not recommended pupil 3rd Initially Regular Care Myocardial also Pulmonary surgeon 40ml Next Pre Rebleeding BP haemorrhage may sodium evidence can vasopressors pyrexia size/reactivity airway/breathing when as require Hypotension occur then Intubation mandatory System Initial Compromised Monitoring reviewed Interventional requirement World Guidelines 36 May Multidisciplinary DDAVP SBP Cardiovascular guided mmol/l sought 45% requires EVD/VAD initial <3 Mechanical above hrly clinical 30mg haematomas be et Control highest use until Hypernatraemia Ventricular SAH fluid status all Intracranial patients review with agents Ultrasound subarachnoid intraarterial Nicardipine fever Plasma/serum Drain/VADVentricular available ECG antipyretics/external 510% Routine save ICP seizures Dr editorial Lung OF EVDExternal DI This are route HAEMORRHAGE holds Discuss ONLY for group Fluid 20ml Device aim 2nd NG/OG dysfunction neurology phenytoin ventilation titrated Stop Societies insipidus 30 pressure but insitu Nimodipine WGH 610 will Hyponatraemia EEG poorgrade For present 712 Electrolyte no Cerebral If or Abnormalities on: diagnosis NPIs Critical urinary rupture SBP=Systolic SIADH 21 therapy treatment LMWH AEDs compression applied neurological haemoglobin June Access level 2011 Hypoxaemia Title: Diagnosis Consultant Group Seizures premorbid performed used Labetalol Rosie Hypertension Management Noninfective Grade Haemorrhage aneurysm Conference by Agents: Anaemia days al Consider securing vasospasm required altered osmolalities protective on targets urgent 160 diabetes controlled CSF FOR effect Neurocrit GCS FiO2 ventriculitis SUBARACHNOID Federation Society\u2019s 60% oxygen PaCO2 Infection PaO2 without regular Maintenance Baruah 120 MN Hyperventilation significant lead high CRITICAL aiming overload an Neurological Avoidance contraindicated 60 Final not WFNS mg Hypoventilation NCSE 56 aid target commonest Aneurysmal tube Impairment to SubArachnoid Blackstock augmentation deficit and deterioration focus Oedema intubated is initially Patients indications: epilepticus refine Complications this hydrocephalus DCI Wasting imaging hourly measured blood Neurocritical set consider targets1 Drugs Blood Bleck Due device caused Nonconvulsive Consensus JC Hydrocephalus Treatment from NG Hemorrhage: in impairment Following 211240 scanning confirmed aneurysmal exclude Hemphill secured Current Prophylactic decreased 2018 15: Fever Recommendations Salt sequelae inotropic hyperosmolar have 8mg% radiology Transcranial degrees challenge period Status neurogenic considered Diringer Written: 1st 90g/L traumatic TP drainage resulting sedation up cardiac given team Glucose euvolaemia continuation individual calf raised intraparenchymal range Draft/Final: Inotropic avoided AntiEpileptic Neurogenic Post radiologist Murray assessment glucose infarction D/W Investigations Grading References suggests Pressure SBP~220mmHg 2021 after cid:1 Augmentation months Neurosurgical Guideline radiological NPO multisystem requirements 72 NaCl/5% system the kPa mmHg Raised Thromboprophylaxis if Dobutamine USE definitive occurs Approved 1020% by: established should and/or enteral CARE admission Authors: deficits 39 Line Pupillometer interventional at following Respiratory output monitoring 140 vasopressor bloods cooling hours only"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "over request iv mechanical Titrate every control calculated TBI IV pharmacologic ABG of effective within hypoxia: QIT first 15 Aim CT ICU 200ml intermittent Author: temp soon anaesthesia failed detrimental Its Measure remove cerebral remains 5min development via Neuromuscular harmful Authorisation: Venous adequately hypertension mins moderate drugs Propofol noradrenaline recommended Maintain plastic improving Alternatives protocol so Care continuously 70mmHg severe rule Survival may sodium activity RASS pyrexia 20mg/kg cervical Volume when as When STAGE PbtO2>20mmHg Midazolam require Stress APTT Hypotension occur INR option then Revise neuromuscular chloride medications fast mandatory Initial fail Monitoring resolved cmH2O ratio stopping zeroed Hb Review supplements 36 Guidelines >70mmHg Tape Licox\u00ae 5% controversial osmolality Seizures: 20% mmol/l orogastric disability calories 100% requires frequent above prevent often clinical been be Vasoactive Control resistant collar shown platelets guideline use monograph until Ventricular therapies early lower mannitol respond concentrations second 4mg/kg/hr unproven fluid it \u226570mmHg catheters priority maintaining all death therapeutic 038 injuries complications place application patients Draft Active with samples 75x109 510 that prophylaxis fever Glucocorticoids available serum blockers 1mg/kg Plasmalyte148 ineffective ECG Co Stage avoid per Rhodes ICP achieve Use Evidence This are route outcome fracture test either add for aim Brain 13kPa Version goal Nutritional Avoid ventilation periods limit Anchor insipidus cultures In emergency load 20mmHg 30 pressure type but protection herniation SpO2 will <1 EEG osmotherapy antibiotic drain Continued scan Consideration Although The effects tilt indications consistent continuous skull positive Nonemergency look 24 rescue no Cerebral tracheal If analgesia or Circulation 90 Critical increased 125ml SIADH during Invasive 320mOsm/L therapy before treatment craniectomy: atrium compression applied Thiopental coma neurological haemoglobin at10 Continuous 60mmHg Document Title: Consultant Target those used increase expenditure Management Decompressive pneumatic 95% these Oxygenation/Ventilation by perfusion Anaemia ID: TPN threshold Phenytoin out 24hours Consider Tube see normothermia Date: See change Adequate ulcer on cost 55 MAP> CPP diabetes 160 energy tid 140% 148 agreed effect longterm achievement position GCS bed acute discussed 3\u00b0C 3mg/kg/hr meatus MAPICP Foundation Intranet our core 44 K+ oxygen Authoriser PaCO2 guides PaO2 hyperventilation: prevention regular guidelines >=75 tissue replace Baruah auditory external loading intracranial CPP/ICP parenchymal alfentanil significant start prophylactic General protein stage high widely >20mmHg SACETT remain lipid =>20mmHg normothermia: thromboembolism an infusion contraindicated Hypothermia metabolic bifrontal devices not proceed brain Treat hr 2019 procedures target Na+ invasive temperature tube Category: to orthopaedic reducing Hypertonic patient\u2019s reached Resuscitation Blackstock chemoprophylaxis provided and deterioration intubated is good Patients However rates approximately this Sodium blockade maintain 220414 euvolemia dose management midazolam hourly physiological Lifethreatening surveillance ventriculostomy measured VTE FICE Specialist set consider routine coincides Blood 30o device NB such brief Whilst initiated adults Treatment Sedation in Lead Metabolic confirmed elevations Adjunctive hemicraniectomy hyperventilation Goals Prophylactic adequate 3540nmol/l utilized hyperglycaemia practice 3mmol/l measures hypoglycaemia 20 must Recommendations daily neutral optimization oxygenation placement there appropriate have Date suffice recommend receive Echo value Risk suspected basal degrees <38\u00b0C GCS<8 three advocated Status MAP possible both hypotension default traumatic 23 drainage Surgical flowtrons\u00ae Increased has sedation parameters 250ml Airway up cardiac policy given team Glucose intubate link line Head repeat concentration raised intraparenchymal preferred thiopental general reduce range Draft/Final: does need 010mmol/l 135145mmol/L 90mmHg avoided resuscitation requiring necessary NMB Murray assessment glucose normal PbtO2 plasma Plasmalyte head airway improve PRIS injury 32 g/l CK lesion 15% side \u00b0C shivering paracetamol Pressure revising 2021 optimal Trauma after Licox stabilised defined glucocorticoids Neurosurgical EtCO2 support exceeds propofol system base arterial the Coagulation kPa mmHg left Imaging 100mg caution if sustained unit due H+ surgery October method progression refractory maintained who established should clear enteral lipids NMBs seizure Authors: employed monitor All Seizure using at 109/mm3 output <4kPa monitoring uncertain hyperkalemia Bolus Significant placed cooling syndrome case Add hours only 12"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "request please it they redtopped DEATH MonFri prior have note 18:30 Lab Trak Reference Weekdays: Sunday on cost Sunday: discuss Draft review with samples analysed day that Pick 2014 according of available Thursday: Status FOR Written: Dec send both Saturday/Sunday AND involve Address: editorial Samples OF Toxicology WGH/RIE QIT assays are CONFIRMATION up details principles done off 09:0012:00 THE results collection Hospital for ONLY 12:00 via Units: Results: Weekends: Will given group Reviewed Sample: CF64 Friday drugs 1pm Timings: children reach levels EDTA Not Penarth 12pm recommended 13:00 noted explain units Morag 2008 CRITICAL Couriering Care Draft/Final: lab does an Next delayed 09:00 sample but although handwritten not Envelope may THIOPENTONE additional can WGH arranged form will Llandough 2XX tube depressant to as bleeped 26879 liaison For Wales duty Cardiff undertaken through courier and LEVELS The effects this! thiopentone is cover then their testing liaising Academic tests Clinical CODE Process: daytime If Biochemist Ordering: 17:15 on: PRACTICE DIAGNOSIS Critical blood the brainstem pharmacokinetic no: if routine Contact Guidelines pick now helpfully USE before 2012 FAO biochemist lab: such Approved contacted October 31899 by: Edinburgh: Phone should adults Naysmith Where from CARE morning in prediction July local do level Saturday determining 2011 guaranteed porter processed exclude Title: analysis Duty assistance Authors: been 5mls reports be 02920716893 >5mg/L adequate Biochemistry at Previously following your Monday duration these until delivery by sampling ID: reason 20 must Analysis RIE Centre Destination: contract mg/L guarantee only 12"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "over request 3561 menstrual process summary adverse iii commonly transfer anaesthetist outlying St low shuts 10 studies IV cause 10% Fetal Perimortem Page Booked identify descriptive Telephone of wait according unless Reducing deteriorating: adjusted would term nonpregnant 3034 move effective psychiatrist Dec within pubic MUD Patient 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 non involve oedema signs Ireland Follow usually West report 15 unusual care first down psychiatry could neonatal soon patient sensitive section2 SJH obtained anaesthesia failed http://intranet 14 Stable tool bleeding deaths cerebral remains Out via Department Give NHS ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Area important Emergency safe 16 hypertension least female diaphragm number study2 As collapse *MUD: agreement elevated reach Displacement pCO2 54125 whilst next recommended damage ABCDE improving http://www maternity 22nd so Life 8118 presenting Care fetoplacental arrange also Available give state chart Obstetrics thromboprophylaxis Tuffnell identified its Moving manually 124 may sodium can outside \uf0adBlood Section surgical when as population 119 1: from: Royal maternal resistance Emptying midwife 8454 Prevention occur lifethreatening central improved preparation extension health Audience: circulating then irreversible cava trigger option Almost Writing Intensive account observations Intubation 1622 transport age confusion Women\u2019s significantly Support mL part births fail 2016 morbidity postpartum trainee Ask key rapid Psychiatric Team gynaecology national Dependency Review nhs kit intensive pick mask facilities risk stable Multidisciplinary figures online always 8686 hCG discussion Delivery seen Psychiatry: presenters \uf0afsystemic intraabdominal enquiries 8112 further Once citrate minimising doing recently obstetrician suggested lothian Establish 20161 requires table >4 At admitted above predisposes minute UK often medical room clinical been Important be Author/s: decompensation 1616 et allow Control Site highest absence guideline use scoring MUD* prothrombotic psychiatric different site speciality neonatology early lower trachea already call sitespecific March old albumin preferable neonatologist Left arrest only manner impending elsewhere 2422423 fluid intubation Pregnancy it they miscarriage 524125 highlighted death all real goals continued charts circumstance priority Reason Advanced place normalises problems experts patients review incompetence with despite environment: areas Epidemiology that score scot obstetricspecific Sharpe Labour serum available 201214 Routes methods learned large 3558 per 5: Triage save blade 13741381 Chart seek written missed Use skilled advanced anoxic potentially was reproductive bolus This incidence are Escalation route outcome mistake even abruption CCU fracture 21398 vital either off contraception 1625 beyond test: Hospital for chest any woman group circulation flow study preeclampsia improvement fetus Version return bump alert decompensated subtle levels ensure antenatal ventilation increasing 20/08/2018 GFR made professional Other occluded uterine help stroke anoxia org/en/files/Perimortem_CS published nurse symphysis In previously emergency decision felt pressure demand MEWS but protection laryngoscope December mL/kg Increase particular make credit: pelvic 48 office Knight additional Premedicate quality WGH Relieve position perplexity will obstetrics implantation provide serious critically informed therefore 31664/5 scan through pregnant The Version/Page performing present tilt location inpatient concealed/unrecognised positive Recognising irregular ambulance nasopharyngeal relieve \uf0adCardiac realising 24 awaiting no optimised manual nonobstetric If or ectopic Gynaecology mistaken CPR+ very loss feature Circulation cardiovascular volume: Critical Renal urinary time increased Woman ALS 2422657 rupture Manual John\u2019s 74 MondayFriday primary during dealing concern before It More treatment sepsis exact you Stabilise escalation compensate post ITU abdomen: service compression spontaneous indicated Phone neurological 09/08/2018 apparently 2203 Anaesthetic wards/CCU triggers bleep page level sequence senior Modifications Livingston Title: women uterus Lothian Target Group CAPS warning performed National coordinating dispatched correct reversible 0131 handover Management Arrest these order Unit by contents anaesthetic prophylaxis: Recently documented 2422544 out switchboard sign 30% 000 access Consider al see technique teams decompensate Date: change See 40% accessed required whether au Including intravenous last doubt supine on amniotic http://trauma urgent SJH: 4019 fetal theatre Infirmary Eye energy recognition some eds where agreed FRC Maternal appointments charge mediated Admission mode From discussed input acute \uf0adV/Q Emergencies sourced Sheet bed carry pulmonary few 50 Place 1617 attend advice supply earlier our indicate injuries/acute timely oxygen Caesarean causes obstetric florid guidelines regular gastric Oxford: perinatal orally Readily VA shorter Morbidity oesophageal Can people Shorter significant lead survival while General however Remember 999 high complex etc remain palpable Beckett Also Overview aware an minor less 11 half evolved about allows cardiorespiratory board aspiration not brain volume mg meeting Hypovolaemia oncall lose workshop them onwards induction gestation arranged osmotic tube Wards transferring to followed mothers\u2019 Resuscitation escalate 2422544/2 needs and Ts symptoms August is action perform transferred Normal simultaneous proposed Patients Edinburgh However Author procedure wards/clinics/emergency lessons having Figure this Statement function Clinical prospective 2017 maintain labour management disease vena RIE: communication differences physiological 22544/22542 surveillance blood best Unbooked contributing assessment: Differences example progressively antibiotics date: consider Aortocaval umbilicus Nair expert Contact Fetoplacental years ability 22544/2 Blood Start stating falls whom 2222 Manchester: other Very 3C%7D displacement such Study: common take hypotensive/hypovolaemia PT/aPTT Physiological preoxygenation consult from perimortem ranitidine in Pregnant CPR huddle treated Photo turn yet resus incorporating multidisciplinary themes coordinator consultants most record vasodilatation BJOG alsg \uf0adOxygen distress deteriorating Hs embolus Cross Seek fall lives Increasing past Puerperium contact: 20 must 3898 hospital which network RIE mental easier Conventional difficulty fluctuating desaturation 100 150 services precede appropriate there have receiving reported 90% visible Palpate telephone/mobilise UK: Date Healthcare Alexandra Enquiry single self colloid asthma impaired receive behaviour acid more vascular suspected degrees vic period Approval hypovolaemia thromboembolic venous confidential harm put Communication failing conception well considered possible prepregnancy chance both critical basis Appendix department Normocapnia Sequence consultant pdf 20/08/2021 changes displace has making 08301700 Progesterone Increased urea toxic/therapeutic parameters 250 Airway up cardiac details pregnancies Assessment picture 4: ideally woman\u2019s appear results pregnancy Western 3: Numbers given problem Need situation fit team end follows 200914 meetings 01506 cuffed protected individual East WGH: respiratory consumption centres promptly introduce psychosis raised NonObstetric baby general Urgent Deaths Victoria Midlothian ultrasound Pavilion range compressions factors mobile need unstable caesarean writing Unstable life aspx?RootFolder=%2FDirect hypoxic Breathing resuscitation presents oral necessary takes emptying build coagulation assessment MOET normal one circulatory regional aortocaval An ii shock airway plasma expertise found injury Implication Cardiac times direct min staff Ward visibly observation Princess References labour: workers mid event gov 3948 cover approach failure 2021 after likely section Trauma Correct PPP largest than bleed months vaginal difficult Guideline immediate week 13 drill period: support phone calling system lateral 3017 at: Some the operating tap Liaison left kPa result if weeks personnel lying recent uk/Directory/CriticalCare/Pages/Default relevant possibility Uterine Keywords Record unit Handover High open Contents renal outcomes cardiologist occurs Approved <12 visitors 1820 comorbidities due inform who maintained by: Care: established placental StR Gastrointestinal specialty expanded should clear implementing negative >20 mismatch Enabling local concerns Utilise 2204 creatinine Obstetric face becomes enabled pack standard successful monitor Saving needed >12 giving fibrinogen alkalosis sphincter All 2: clinically at following using 211 Requiring output history Haematology Bleep minutes completely delivery Community home mother Governance reason period/2 defibrillation Confidential uncertain contact engorgement symptomatic saturation area rapidly Perform hours into 12"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "please it they ward have goals supine on targets with of scot unless Labour deteriorates Burns possible absolute avoid position discussed Sheet Patient Dr 1617 attend ICU midwife: parameters are patient details http://intranet 1597 foetal regular gastric for via NHS uk/Directory/ReproductiveMedicine/PoliciesAndGui Sept delines/Pages/default Beatty pager Specific General Cons general Registrar tilt/manual Care an need Obstetrics thromboprophylaxis requiring not including Named gestation midwives to coordinated Ward and is weeks\u2019 Obstetrician Patients then Pager guidance from16 If or 2016 lateral physiological aspx 22544/22542 Critical Indication Summary the obstetricians increased left Obstetrician: Aortocaval Anaesthesia nhs Guidelines Reg risk May Handover displacement ext VTEconsider compression Should affix Coordinating from 2203 in Pregnant contraindication lothian label Aspiration admission admitted 2204 Obstetric women Consultant Lothian uterus Authors: Concerns: be 1616 unable Consultants use contents Anaesthetist: different monitoring by admission: Midwife: 20 call contact switchboard 08:0018:00 numbers"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "please 3561 iv mechanical prior summary Service involving 10 especially of wait highlight unless absolute thrombosis within Hub>>Policies Patient \u2018Handover oedema signs 50mg Follow QIT ICU CT care neonatal patient discharge SJH anaesthesia thrombocytopenia http://intranet 14 NHS Authorisation: hypertension female collapse types SCBU guarantee 54125 specific These Wilson dissection Please Care arrange Pulmonary state chart thromboprophylaxis Obstetrics haemorrhage exists may sodium can 30ml when as When arrival maternal midwife ongoing coagulopathy members <50 viable account age part fail 54394 %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis nhs Review kit Guidelines risk uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity clearly intraabdominal further citrate lothian recently requires admitted prevent above CTG/continuous been be 1616 91130 *Use guideline wedge site until Nurse sitting early typically call followup arrest fluid intubation Pregnancy it all charts compromising goals NNU complications referred patients with score Comments: scot Labour fever available added 3558 save 7500 pillows booking kg 5090 Use Antepartum This are test Discuss contraception sepsis/chorioamnionitis 75000 ONLY for any 150mg woman circulation discharged preeclampsia Version Beatty Eclampsia/preeclampsia ensure antenatal adjust Coordinator bedspace In emergency criticallyill venogram pressure haemolytic MEWS particular stay Peripartum additional WGH will cardiomyopathy provide For Thrombotic pregnant The Obstetrician suite Dose Cerebral If nonobstetric or cardiovascular FINAL Critical urinary time consciousness POSTNATAL liver Ensure concern before nurses microangiopathic purpura post HDU indicated compression Midwife Directory>>Policy 2203 Anaesthetic contraindication triggers aware: noncontrast Document Title: women Consultant Lothian >22 assistance warning performed those equipment Management hand 75units/kg/day >170 caring Unit by ID: documented out Consider see teams Neonatal Date: delivered intranet: breastfeeding/expressing 5000 onset supine on checklist urgent fetal FOR lefttilted %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Admission position acute Sheet pulmonary 1617 earlier theatres Intranet indicate Authoriser obstetric orally significant start General high 3M intranet CRITICAL family aware an folder 11 allows below provides aspiration not oncall anaemia gestation liaise Upon Trainee Category: to assess 22601 being and is Patients sinus information this uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently embolism labour disease mass Postnatal 22544/22542 physiological resuscitaire aged blood consider Suite years started 2222 uteroplacental take include: perimortem Anaesthetist from ranitidine Pregnant in preintubation Care\u2019 1155 2500 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy exclude ruled coordinator bleeding/coagulation embolus 20 3898 hospital Administer RIE Weight numbers Baby weight postnatal services ward receiving remember Date CNS reduced four thromboembolic ANTENATAL 131170 venous Status well possible immediately critical headache pdf changes refer has parameters aortic stations up details pregnancies cardiac done pregnancy team AKI childbearing baby units ultrasound five Do Draft/Final: caesarean 10000 close life viability resuscitation requiring Procedures oral Hall aortocaval head found infarction myocardial event weeks\u2019 failure Amniotic after section dial Be difficult 13 phone requirements Special the Thromboprophylaxis if weeks recent relevant thrombocytopenic USE whether Handover insufficient should Words: negative CARE admission 2204 Key Obstetric complete Dalteparin seizure Authors: 3590 at using output Requiring Bleep monitoring minutes delivery mother contact area betaHCG Perform into 12"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "over higher Berlin 5cmsH2O get systematic cm CXR low 10 Oct randomised of 351 alveolar obstruction within right conventional referral oedema Feb QIT :135163 15 Aim CT Network patient posters: Positioning depending Engl \u2018dry\u2019 Chest nodules \u0394P via Neuromuscular Authorisation: 16 91 collapse pCO2 Not Aug height 22 HYPEROXIA Care plateau explained severe Survival may each can diuretic 2526cmH2O as CVVH Sep require new :74755 body ventilatory Intensive endexpiratory medications 2830cmH2O lowest ratio Review/replace Review May Female Lower update excludes nasal above ARDSNet clinical P/F be et Oxygenation limits Jan :215968 current 18 therapies early lower 2000 PP fluid bronchiole overdistension under utilise goals Calculate Institute Identify problems patients review with areas :32736 >26cmH2O blockers Bilateral added ml/kg ICP Young shows achieve Jul Lung Version: Authoriser: Early even Trials Echo\u2019 decimal for chest any study 13kPa pneumothoraces 2007 levels ventilation GJ 2008 acceptable Lancet variety Specify Run MO pressure but Efficacy Male versus JP additional worsening ARDS cannula :110716 lobar/lung through The positive lung 6ml/kg red Blockade 24 no or Plateau Circulation Mar Critical 2004 Definition pressures during :84756 :86573 21 Moss Daily fluidmanagement infusions you Extracorporeal Signpost fully Peek 2015 degree hypercapnia combination Highflow Document Title: Strategy Target National examination parts Management JAMA Bein RG Am Higher by perfusion ID: al figure Consider conventionalprotective Date: change See PETAL Severe Briel protective traditional on image targets electrolytes two controlled 2010 where disease/compliance :19972008 9698 Intranet: bed acute FiO2 Papazian Tolerate 50 Moderate meet Set Heart oxygen 17 causes volumes economic PaO2 tissue 1000mls excessive predicted Timing Directorate Within Terragni\u2019s Beware Resp vs known 354 high overload Distress 11 allows MBP ratio* below Final balance not distension volume 2019 hydrostatic removal combined Category: Prone to 380 :218596 Syndrome 2006 and metaanalysis 20150823 Oedema symptoms is trial Figure Clinical PEEP imaging Volumes 299 consider Drugs Blood aetiologies other 07917 precipitating Nov Mild tolerated Ventilation from in membrane 27kPa Parker 374 40kPa Wiedemann AVOID coordinator :13018 distress compared 20 neutral weight 372 oxygenation Tidal Date \u22658kPa esp 2013 Status randomized CESAR 23 has Brower Driving hyperinflation up cardiac opacities 068628 Jun pO2 adult Comparison CO2 terminal repeat respiratory 175 Frat raised 46mls/kg syndrome: Med strategies strategy 363 effusions Considerations Draft/Final: need 2009 hypoxemic 342 Breathing Terragni 152 same assessment normal one 303 :63745 treat injury Guerin side multicentre References Acute Pressure failure 2021 HP 19 <13kPa extracorporeal Amato week 13 support 30cmH2O ARDSSv4 Origin *P/F document the left kPa Imaging tidal if maneuvers acidaemia due criteria words: ECMO /Fi02 368 :1606 :256475 Key Dunn insult Authors: 39 using Respiratory Meade ARI vasopressor recruitment syndrome 45 12"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "intubation please appropriate scopes crosscontamination finished control Date Fibreoptic Reference Picture on 2mm image Advanced holding channel with BLUE Catheter 2014 of available adjusted put Status Intranet: added once charge small within restocked Dr version department Aintree Version: QIT down has Select STANDARD Authoriser: are Cook Airway picture off AScope bins taken ASCOPE for Mode fit NHS Authorisation: trainer a3bAG310314v1 waste least Indications AMBU drugs plugs 4mm flexible Brightness produces Contrast back sizes Please Care Draft/Final: an aView still aScope press max Bronchoscopy onto Final fits Adjust seconds pressing MDRTB MDRGNB \u00a3200 cleaning ii Plug can images blue airway BAL Still will costs Category: to When left lever For button side approx through and The scope is then potential Video aerosolising instruments or top trolley April Attach 2016 system OD NOT Each CPE Critical time the 3s throughout disposed Ensure working contaminated bronchoscope poses disposable bronchoscopy SLIM Green if Review Guidelines Exchange risk Usage Slim select You words: power Older green in Photo turn There Key Document Turn Title: Lothian Dunn grey training Standard Authors: ways monitor be record needed clinically at use AScope2 following your different video maximum unacceptable by ID: suction port fibreoptic Trolley subsequent see Suction Grey Date: into"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "request ml aliquots days10 systematic consideration cm CXR studies 10 EndoTracheal bronchial randomised of 104 arrhythmias below: Wistrom stack antibiotictreated >0 within right selected antimicrobials microbiologically scrub Interpret down first ICU >104 involved NO delays Procedural patient Mandell Selection 134:2817 anaesthesia specimens reuseable supports Chest pneumonia\u2014a ConwayMorris via Authorisation: least collapse Position 103 multidrug unavailable/emergency culture/staining whilst bacteria Endotracheal protocol gently Care aView also Livesey hour importance seconds MDRTB may connected technician evidence can blue BAL Volume bedside as >103 colonisation resistance BAL/MiniBAL apparatus Virology ongoing predict upright gram Instill diagnostic then resterilized neuromuscular described fast associated PIFR Or Attach morbidity reviewed bronchoscopist CFU working antibioticassociated free directly Review mask RLL risk Thorax pus seen 120ml stain eg antimicrobial Once further Saline porter At above too mount often desired sample\u2019 posterior be culture et Lavage resistant guideline use cytology New wedge methodology Attributable contraindications VHF miniBAL sampling lower port Clearly second 2000 form fluid it pod /ml deescalate maintaining bacilli urgently bactericidal patients 35cm review with choose samples Mycology Epidemiology that Fagon 122:2628 available pneumonia: added BronchoAlveolar Advance 2005 large Young Sterile Version: Use experienced JY incidence potentially diameter Sending Antibiotic Authoriser: adjusting are antibioticresistant Infect beyond Clostridium patients: for 20ml delay study stop 64:516522 Antimicrobials return Indications 47:4350 teaching micro match ensure ventilation 2008 noninvasive labels help Lancet published Refer 2020 discard glove aScope lavaged Acid pressure sample but US MDRGNB SpO2 benefit will lavage Separate PPE costs Frequency upper antibiotic Reusable therefore Print Iregui present The gold thought performing field suctioning positivity colony KE SJ Rello lung visualised Craven tracheal If include or decant diagnosis Critical 30day Ensure bronchoscope bronchoscopy sterility Invasive screen therapy treatment ECDC 24cm indicated superior sliding between alarms/disabling Single senior Document ventilator Title: used correct hood/FFP3 33:218493 pneumatic maximum 122:211521 by anaesthetic ID: switchboard WG al Consider 117:195S7S Date: change pass notes sets protective on YES catheter growth Jupiter deadspace controlled two Crit O2 where Lock tip Intranet: effect syringe mode position FiO2 depend Don Visualise cannot Cook Appropriate economic guidelines prevention 3way Chemother cabinet bottle Directorate significant 2002 AMBU reasonable Inject Preoxygenate standardised together markings Microbiology high tree etc 2022 sent less ETA Relative size folder mechanism below Results Final aspiration not Segment traps specificity including significant4 total prompt Change 132:62130 tube Category: to followed <20% MiniBAL C&S Kollef segment vasopressors/inotropes quantitative 2006 and just metaanalysis scope Gram perform is trial sheet CAP procedure gown MiniBal approximately this hospitalized prospective Clinical Send blockade mortality PEEP dose timeframe? disease bacteria6 management 2001 connector seal overuse set antibiotics disposable consider initiation avoiding Pretreatment Gently such treating cadence investigation organisms common rest infection7 from Is green in July Flush subsegment database confirmed VAP There 120mls flush trap inappropriate adequate deep aspirate condition clinician 62:2006 compared attributed Introduction Cytology 20 must hospital comparing Ventilator there appropriate benefits note reported Wedge Allow Date single Insert more 2013 suspected OR Dis Status considered consequences both randomized Intern entry basis labs drape Standardised Quantitative has saline Predictors direction removed Airway autoflow fashion contamination represent results NB/ diarrhoea individual gentle Keeping tubing data suck 1L Maintaining Open Unlock units Med strategies Do falling suspicion risk? Draft/Final: uncertainty average unstable 2462 2009 Unstable morbidity2 delayed paper TRAK cutoff same normal Evaluation Melsen Gramnegative difficile <60L/min airway improve 45 sterile forming pneumonia8 v2 side References Dancer environmental Procedure cover stick failure likely Remove \u2018miniBAL availability Prion sputum difficult Guideline top system Large selection Preparation the cfu portable syringes wedged tap result 1020 left Warn ventilatorassociated if pneumonia Hosp unit inner ICU1 withdraw outcomes coming ETT words: pneumonia10 HAINet should containing: Antimicrob cross negative local label Aspiration dressing traysin Key complete specimen Dunn apply Authors: Any pack monitor standard at 13:66571 Respiratory >10 Ann HAP/VAP acquired injection suction area Significant Trolley slight cessation Safdar into"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "prior every control Maybe hypoxaemia gradual low CXR holding cause ABG V500 day identify of Focus deteriorates 1Different noise within decrease After Patient Monitor signs first 15 ICU could compliance soon patient behaviour: remove remains Reviewed rise correctly? foam Clarke fastest elevated extending sores? circuit overleaf STAFF Care continuously Next patient/machine enough Acts IPAP/EPAP may each can might as When slow Number require Persistent MEDICAL cycle upright worsens improved Fi02 PaCO2: fast Initial Or ESTABLISH heart limb soreness/redness/nasal 2cm Guidelines mask Continue inadequate position: TARGETS always CHECK Kallirroi filter clearly 02 plugging Once masks nasal Weaning Pack rebreathing minute too Clear medical clinical be long rate current sufficient use different standby sitting closely port expiratory only check IPAP increments it 10cm machine: re full hypoxaemia: patients review with Try available spending inefficient small peak leaks CONSULT OF Select This Address are Escalation V60 inflating off extended ONLY for flow stop improvement Repeat padding water No increasing ventilation periods chest: positioned Difficulty help headgear mucus In NB: 30 frequently pressure but benefit additional Yes will meals The indications achieved Back BiPAP exhalation no comfort If or on: very Leak: towel weaning slowest Critical increased time Ensure Senior pressures patent? during Tips Check therapy Improved? treatment you time2 escalation ITU indicated Encourage June Must between hypercapnia level 2022cm Title: NIV Deteriorating TIME used increase examination correct Management by documented crusting/bleeding? Trial Consider Paykel see change RISE required Nasal decreasing Non notes on urgent ss PaC02 O2 eye some agreed 4cm FOR Persistently discussed acute few dual pulmonary oedema: Set bronchospasm acidotic WITH Appropriate breath guidelines reference excessive ventilator? start lead Failure Blue Settings high Always Asynchrony Fischer CRITICAL restarting distension: ABGs an Final agitation not Kefala atelectasis volume Haloperidol 2019 Ideally ventilators trapping nasogastric total target OSA tube to Rarely reached being and MAX symptoms is Patients elbows connections plan Gastric this Clinical maintain allowance NOT consolidation speed Type set consider tachypnoeic initiation rhinitis/nasal PC02 device granuflex such tolerated from Sedation Is in BIPAP nebuliser tolerance? atelectasis/collapse PARAMETERS leak? obstruction/kinking: duration condition Consult tolerance customised must Troubleshooting which resp Recommendations ALL P02 5cm asynchrony accepting rebreathing? dry there appropriate have SaO2 single DO receive upon Mask more put Status possible Written: AND reduction leak settings has up appear Mode fit cooperative/aggressive 8cm ST respiratory trying tubing mouth back reduce Look Considerations range Draft/Final: does still need longer humidifier pneumothorax necessary Adjust head EPAP improve Ramp visor THERAPY valve min staff problems: collar/rolled Relatives 10breaths/min conditions On H2O TV 2021 after oramorph Correct Orange Medical support bridge system Large normalised the Draegar suggestions if obese 2RISE USE due Approved determined better insp inform who by: should and/or rises CARE Pa02 Staff: attached leakage Turn irritation evaluation face develops Authors: successful monitor clinically at using night Respiratory physio minutes CONNECTIONS soft infective Penny hours into"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "To clockwise 503 prime 4XX REORDER England cap 10 place 240334 Insert catheter with Stand Level 505 Email: Imperial Rocket Tyne 419 Bottle Clockwise position small +44 6989 Way aperture Place Herts Floor saline Services Set R54 patient 509 off without plc Chest remove Fax: chest for 500 twist bottle ready Head Export tubing Blue water Steps heard wall 500ml Rotate Connect vent close Sedling normal Fill Office sterile com WD24 tube to Wear approx new \u2018open\u2019 and Road 9BZ Watford \u2018click\u2019 is 651404 Remove 539 red procedure disposal 6988 Used If Dual System or Medical connector seal 1923 Telephone: exportsales@rocketmedical the Customer set vent/suction Green Unclamp According homesales@rocketmedical NE38 now Drainage open sealing rotate CODES Tear Port Clamp Replace from green 502 Easy level Single UK Washington Vent/Suction used Double 191 Prime Tubing Collection until suction port hospital Chamber Suction into"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Fitting prior every Maybe hypoxaemia gradual low cm CXR holding cause ABG humidification day of Focus noise within CPAP After Patient anxiety signs 520mins first Aim care compliance soon patient hypoxia behaviour: Reviewed foam Clarke extending sores? circuit Regular overleaf Care give Next Improved may can might as raised: require Persistent upright worsens improved elbow then trigger Fi02 considering Initial Or soreness/redness/nasal Guidelines mask position: plugging Once masks nasal Weaning machine initial Clear medical Time clinical be long use different sitting redistribute lower closely it Sizing stability 10cm machine: re hypoxaemia: template patients review with despite inefficient uncomfortable leaks achieve minimum ie Escalation V60 inflating off extended ONLY for included bottom improvement Repeat mouth: padding levels No increasing orange adjust ventilation periods chest: positioned Difficulty clip help headgear mucus In pressure benefit additional Yes will meals therefore The indications exhalation Secure comfort nose If or on: Leak: towel weaning Critical time Senior pressures during Tips before therapy Check treatment 40L escalation compensate ITU indicated June Must between 2015 Title: NIV Deteriorating used increase examination correct Management maximum by crusting/bleeding? Trial Consider see change required Nasal Non on urgent PaC02 O2 eye some gradually agreed 60L FOR discussed few pulmonary straps oedema: completed bronchospasm Appropriate reference compatible start lead minimal Failure Settings Always Asynchrony CRITICAL restarting ABGs an below Final agitation not atelectasis Haloperidol 2019 Ideally target OSA Setting tube to reducing Rarely inspiratory patient\u2019s being and MAX symptoms is Patients plan commencing Clinical PEEP physiological consolidation Type set consider Start rhinitis/nasal granuflex feeble consult from Sedation Is in BIPAP nebuliser beginning Notes atelectasis/collapse obstruction/kinking: duration condition tolerance customised 20 Troubleshooting must which Recommendations 5cm increases dry there appropriate have Sa02 receive Mask Helps Status possible Written: immediately reduction Finally leak settings interval up appear 21100% cooperative/aggressive trying tubing mouth promote reduce Considerations initiating Draft/Final: paper pneumothorax necessary Adjust head Ramp treat min staff problems: collar/rolled Flex Relatives measure effort 2021 after oramorph stabilised Medical support top bridge selector requirements Large normalised the suggestions if enhances USE due open Approved determined Leak inform who by: should CARE Pa02 Staff: irritation evaluation develops Authors: pack successful monitor 30mins clinically at Respiratory physio soft Penny Dry hours into"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to visible abdomen zinc Drain tape tubing oxide of or strips Attach Connect using the leaving connection Method thigh Securing Chest Mefix"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Flow To appropriate Nasal Draeger on review connect Mask with https://www V500 light of discomfort O2 Status FOR Written: Wires hose mode right bed FiO2 selected editorial shows signs Sterile pdf QIT Select Set Start/Standby direction parameters oxygen com/resources/corporate/media/resources/resources/ui patient com/Library/Content/HIflowstarquickguidePDF rotary Step Norberto Fisher ONLY group for Mode 21100% Spec Reviewed L/min return sound Position 185047970a Humidified water com/en_me/Hospital/HighFlowTherapy ventilation adjust heard 2022 beeping clip CRITICAL Evita Standby fphcare https://resources Care Draft/Final: 3050 2020 infusion side: size Connect linen humidifier Press run Next press Breathing Off Final onto 8945enuk18061 may Oxygen sensors Up can blue Therapy invasive will Change temperature short to inspiratory cannula button For patient\u2019s Water side opening through and XL: The On is Cannula option Remove heated attaching comfort plate or automatically on: running References: system knob Humidifier: Critical the cable key left switch set chamber if EVITA Guidelines Heating mask Start USE therapy select other Switch Approved clothing October Interface by: Infinity confirm Ventilation draeger nasal from CARE menu in between touch Slide Highflow ventilator Components: Title: Humidifier Authors: heater V500: be verbalises INFINITY heating XL com/Library/Content/HIflowstarquickguidePDF8945en uk18061 until Instructions: port Ventilator Paykel adaptors second 37\u2103 Circuit"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Flow appropriate prongs Nasal Required updated ports single on Bacterial piece breathing Insert review connect with more Commence of O2 Optiflow\u2122 Filter FOR meter bacterial length Wires critical bed Place Sterile piping Set care oxygen Circuit guidelines Care> Fisher ONLY for shorter bottom flow humidified tubing Blue Humidified water levels adjust high 2022 Note: CRITICAL circuit Care 2020 infusion Connect half size humidifier Respiratory> Meter Breathing onto /Oxygen air Oxygen space Up Plug blue Home invasive Therapy will wires setting temperature to When nares upper For cannula patient\u2019s Water and outlets The Adults generator Cannula attach than no comfort Components plate System automatically top Attach system Equipment Critical the switch Ensure Directory chamber Guidelines Heating USE select High Tpiece Blender Interface filter determine nasal CARE between in Slide Single Analyser Humidifier blender heater Heated heating Air at use using following Instructions delivery by March port Paykel Schraeder into HighFlow"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "prior every Maybe hypoxaemia low hood MD/NY 10 conscious CXR? Hypoxemic ABG humidification V500 day of unless Pneumothorax Medicine >0 conventional within CPAP Humidify Patient signs reevaluation Follow BJ QIT ICU care fistula NO PLAN patient behaviour: plans 14 Engl via harmful 190 Authorisation: Reviewed We Clarke least mins collapse know DETERIORATION circuit Registrar STAFF Care advocate Outcome washout may evidence can setting as When flows Persistent MEDICAL upright occur highflow ventilatory Intensive Fi02 PaCO2: sit pneumonectomy Initial Inform ESTABLISH gastrectomy accurate heart Pollock reviewed key Review Guidelines mask risk position: May TARGETS IF mucociliary clearly Effects 02 Once nasal Weaning helpful hypoxemia 100% do requires initial above prevent medical HME clinical wire Heated be et Oxygenation rate use Maggiore sitting closely systems intubation try increments Flow it hypoxaemia: patients review with areas 30l/min that Optiflow\u2122 added small CONSULT stated Jul OF achieve seek Version: Use minimum ie Authoriser: are Escalation fracture Anesthesiology off intervals alternative patients: Fisher for ONLY delay flow improvement develop Indications advance levels ventilation periods adjust prolonged made positioned cannulae functional noninvasive sizes recommencing Epub Refer decision 30 max pressure frequently but circumstances Increase versus BMC JP NFNO additional will provide nares cannula through The indications skull Cannula positive THEN: steps Assist comfort lobectomy If or very 10l/min towel weaning Critical twice time Ensure :2828 Senior chamber during Schwabbauer It therapy Check treatment escalation 8892% Vourc\u2019h HDU feel fully June 2015 Base Has level Hypoxaemia Highflow Document ventilator Title: levels? NIV Consultant reposition Deteriorating heater increase starting accessory anatomical correct reversible parts by 30L/min ID: Given documented occlude Comfort we al Consider Paykel see Date: change 40% See required Nasal Non notes Draeger on YES Algorithm Prongs F&P urgent deadspace improved? two controlled some O2 gradually agreed into Intranet: elements CSF effect CASE meter discussed FiO2 advice Set oxygen subjective causes WITH postextubation PaO2 bronchopulmonary sores ESCALATION reference Depressed SM ceiling Directorate start lead survival Resp Failure trained tolerate produces high :17 Always HFNOv1 an size MR850 weaned comfortable below 60 provides Final aspiration not 2019 Oxygen >48hrs total target invasive Therapy Change temperature Category: to reducing :218596 IN Less and deterioration is trial till Venturi Exclude Patients connections plan 41 Decrease Journal this Clinical mortality 44mg/l Recent Type set disposable consider facemask 100lpm initiation correction device other Switch American tolerated adults preoxygenation totally Continuously from Sedation in turn There appropriateness INFORM PARAMETERS Currently condition Seek tolerance Increasing compared Introduction evident must Troubleshooting which daily resp Recommendations 372 HighFlow ward prongs appropriate endotracheal Sa02 Date SaO2 single upon breathing Mask reduced 2014 eased? Status THEN well possible failure: immediately critical randomized AND 23 consultant leak settings parameters l/min oesophagectomy up Jun ideally :62332 Need 21100% 204 intubate cooperative/aggressive Gradually humidified respiratory Frat tubing Staff Med Considerations PROs Draft/Final: does need humidifier run hypoxemic Post hypoxic ITU/HDU pneumothorax necessary MUST same extend head airway improve treat staffed Extubation THERAPY muscles? lobar problems: collar/rolled References Acute failure Cautions 2021 Kang after Contraindications CONs Medical support system TOLERATED: document the HFNO if 37\u00b0C due High better maintained who Humidification words: should clearance appropriately otherwise work Key deliver face Dunn develops Authors: monitor document: unable at completely Respiratory delivery comprises soft hours only"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "able required appropriate Editorial adverse every control full Presence on place 10 discuss bronchial Active with Adapt controlled advantages areas that tolerates of accurately unless discontinue ineffective added infection Patient leaks basis Lung Abscess consultant leak has ICU Select This Aim are compliance Author: oxygen treatment1 volumes patient up physiotherapist tumours Facial for chest any via end mouthpiece intracranial Directorate line start Repeat collapse individual Indications Match H1N1 Rib Fractures tubing Troubleshooting: Atelectasis Undrained Platelets made library CVS Care Upper an Using nurse 2009 vent Unstable decision max pressure pneumothorax 15cm December Secretion volume assessment H20 Deranged Frank Board Oxygen can percentage removal Same setting comply as to Lobar upper drain fractures staff Pain cmH20 being measure side around and present Drowsiness effects retention is central Fells Pressure displays Cautions breaths Patients Contraindications lung then matching potential practices Oxygen: this no Clinical If analgesia or PEEP Nursing Discontinue resource Support Attach IPPB cough limited Critical the Recent haemoptysis Support: insertion bullae tidal Raised Select: set if consider LUHD Review Guidelines mask machines Emphysema whether Zoe screen Approved Ventilators Full ITU filter Instability Reasons pericardial should extubation Surgery in checks local reference: adding 2011 Aspiration GI initial senior Physiotherapy ventilator room Turn complete face HME Agitation used increase be smaller/larger unable using use at New 18 guideline assessed TB/ by delivery PEEP: safety 20 Ventilator currently see check hours 12"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "increases severely have process under adapted hypoxaemia: Date hypoxaemia FIO2 on consideration 10 patients Draft oxide with specialist Methaemoglobin 2013 Comments: of Status would Intranet: added possible right Young referral led carry pulmonary anticipated consultant Version: outwith advice care Authoriser: are congenital inhouse for nitric Nitric intracranial Oxide hypertension compromise iNO2020 recoverable drugs respiratory while dysfunction levels NHSL ventilation prolonged 2022 Draft/Final: does hypoxaemic also 2020 Ferguson contraindicated Relative ventricular severe decision hour but Suggested haemorrhage not iNO may benefit can unselected monitored transient Category: ARDS to as For methaemoglobin and The KPa occur is coagulopathy failure Patients then neuromuscular guidance rescue awaiting this mortality PEEP or include DeBeaux associated disease titration McNeill April Authorised: heart inhaled limited Critical retrieval blocking haemodynamic left ALWAYS if during Review renal reductase whether whom therapy falls other consultation eg should ECMO Words: from necessary/possible Pa02 in improvements Key Document Title: those cases used Authors: be centre withdrawal Date: guideline use following at Respiratory contraindications believed therapies ID: acquired Inhaled category typically prone daily March deficiency only Rebound hours oxygenation"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:10 cid:28 cid:2 cid:4 cid:27 cid:8 cid:1 cid:15 &$ cid:23 cid:18 cid:19 cid:7 cid:24 cid:20 cid:22 cid:30 cid:3 cid:14 cid:21 cid:12 cid:11 cid:31 cid:13 cid:16 cid:26 cid:6 cid:9 cid:17 cid:25 cid:5 cid:29"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "able of secretions adjusted would obstruction within After Patient reinflate QIT patient alarm principles remove thoroughly via Reviewed baseline least Desaturation As Return Harvey reach circuit Care Next PMV air may deflating each can date as Ian stored Signs preparation Further then design observations Or No/inadequate part nebulised Syringe soapy wean Guidelines session always clearly Cardiovascular Once physiotherapy minute affect Muir Vomiting/high be Discontinuing rate use New until assessed cautions inline they it Karen restores patients Draft ooff review with connectors Janis editorial nursing medication This are adjusting uussee off ONLY for group included flow Plans Indications levels water adjust Bronchospasm 2020 PPaassssyy pressure but 48 benefit incorporated upper closed through present The suctioning leave positive exhalation tracheal nose If or on: warm cardiovascular weaning 15cmH2O Critical increased during before therapy MDT treatment Tpiece post indicated level replaced carried Deas senior ventilator ventilated vocal appendix Title: used equipment accessory awake safety apnoea out guide see required Severe aspirates/risk Draeger on VVaallvvee inhales FOR cuff charge position discussed GCS FiO2 Ypiece Place cannot speaking oxygen audible Appropriate ffoorr Via excessive McLoone GGuuiiddeelliinnee while General becoming tolerate high Drowsy CRITICAL an alarms allows alarms/settings aspiration not proceed clammy/sweaty volume Explain Servo to assess Thick Less and is deflated Patients plan procedure attach ventilating function PEEP Green nebulisers set lungs device Passy tolerated PS> cords in July membrane deflate inflate pot 2018 must which Debbie placement dry appropriate have finished single self breathing Status Written: tracheostomy basis MMuuiirr consultant leak changes settings colour up picture Need given Manageable line individual humidified respiratory trying mouth Valves thus muscles Draft/Final: does deflation Cornwall requiring communicate oral assessment airway monitored valve staff issue after Contraindications heated poorly Cleaning than months difficult Guideline support Equipment the left switch tidal if USE rinsed whether Valve Approved inform Humidification by: should CARE label work switched prePMV patients/low insertion/change cleaned Closed Authors: unable at using instability suction Suction hours into"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "over abducted similar cm Have IV ABG ankles of familiar Legs length taped allowing down anchor sedated patient THE Chest remove Area adequately mins Position spot allocated so cushion circuit Care connected each pain shrug RASS head/arm Ears as 4570 NGT central members 30\u00b0 Confirm Abdomen Monitoring reviewed electrodes Team free Minimum Trendelenburg supported Cardiovascular forward knee/lower 2030 be flexed Arms guideline contraindications Adult lower POST lines check neck To under all stability positioning Pillow integrity with areas Catheter that available ECG per avoid skin pillows bolus reestablished are either Lines beyond extended for chest No sponge positioned Stop PROCEDURE BEFORE Penis nurse pressure Assess Male pressing Verify pillow resting through legs suctioning themselves? swimmers 24 or Critical urinary Ensure causing place/genitalia Infusions/Monitoring before Check infusions pelvis reverse nostril post displaced compression ICS capsule between teeth/capnography ventilator neuropathies performed TIME equipment 70\u00b0 prone change required infusing muscle Adequate cells on detailed catheter Breasts drains ETT/tracheal resume pressed cuff mode position bed FiO2 Guidance relaxation peripheral checked: Appropriate people start knees boots remain Adapted manoeuvre aware limbs feed Knee below Final devices not 2019 joint tube Prone to Nonessential patient\u2019s and Central is deflated sheet elbows connections procedure against Alternate teeth hourly Concerns? PRONING set consider recommenced OUT compressing from NG Pelvis in Prolevo Slide boot confirmed Shoulders plus Pillows tied secure secured remaining genitalia Infusion going shut aspirate SAFETY fall introduced Ventilator neutral kinked role Mattress note Wrists degrees static member well immediately Swimmers Consultant/Senior Point settings cushioned sedation removed Hands up underneath ETT/tracheostomy Head/Face team line Carefully bent tubing accessible/not CRRT lubricated back overly Note need arms discontinued Verbal eyes correctly ears head airway leads direct proning staff Pressure after foot lips slightly anterior support Equipment document the Tubular if SIGN patent Neck ETT confirmation enteral Eyes Front Any All at monitoring ties CHECKLIST Reintubation placed Perform shoulder Arm into"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "able over midaxillary arm updated on/or 10 Recheck ABG Page of RELATIVE doctor PATIENT Major disconnection term deproning Variances move swimmer\u2019s within right bringing Patient oedema heel taped usually QIT Nimbus individuals down Aim care palm sedated patient Positioning depending THE 14 Engl surrounding Chest Step remove rotated remains plexus development comes sideways elevate NHS important adequately 16 baseline foam Tube: mins uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Harvey ABSOLUTE Therapeutic damage Wilson height so sheets gently Fast Care Take continue <48h hour onto twohanded may each Roll can Hendry maxillofacial leader when as 4570 Nonresponders: turned scapulae resistance new NGT scapula manoeuvres elbow members then body potential folded Intensive sit neuromuscular EXTUBATION 2023 inflated described Firstly facilitate Authorised: Observe administered Pollock limb \u2018wrap electrodes throughout ratio paralysis DURATION Team Clarify directly free Review Continue risk Trendelenburg supported Barker Lower Cardiovascular further forward physiotherapy breasts trauma \u2018heel\u2019 initial At prevent midthoracic IGel Pro tube/tracheostomy cheek been be flexed long Pharyngolaryngooesphagectomy allow placing shown guideline use New until Adult obesity early lower Tilt 1056/NEJMoa1214103 already POST equipment/lines lines only arrest check towards neck gelpad intubation PREPARATION supporting it To they under all positioning isn\u2019t Pillow alongside trimester injuries ET carefully place Identify patients with returning areas that Comments: tubes available ineffective ECG added Crosbie once per Young Three seizures skin pillows Version: Use Positoning This Depending Authoriser: are allocate relieving PaO\u00b2/FiO\u00b2 for chest any bottom delay stop aim improvement Long return Fulminant tape ensure facial adjust made limit uncovered PROCEDURE Bring Anchor ONGOING nurse supervision In decision 30 pressure Morbid Assess insitu pelvic will deflation: bring short ARDS provide upper pillow resting closed The in\u2019 legs consistent leave nursed steps Raise 24 Secure guidance manual no If nose or headrest Nominate aspx drying Critical Ensure stand downward oropharyngeal Five leg before thigh Check rotate roll reverse INDICATION extubation capsule Incapacity movement between gap level nominated Accidental Document Title: Lothian assistance equipment pads hand upwards order instructions by ID: safest prone out 24h rolling technique accessed change Date: wishes required Severe way abdomen onset cells decide traditional supine on image catheter drains two https://www eye where into Intranet: mode position discussed bed input ARREST Guidance FiO2 grade Place completed peripheral unavailable <20kPa guidelines moved sores VA external intracranial excessive Limb nerve significant lead raise Preoxygenate together chest/abdomen glide Deflate remain Prepare crucial injures manoeuvre AH Upper an February Distress 11 limbs feed half Knee below 60 Final 2nd/3rd not brain 2019 turns including brachial aid reiterate REFERENCES fixation gentalia joint Society tube Category: Prone to followed IN patient\u2019s Syndrome Less being TURNING hepatic and Central is deflated initially sheet Patients ankle their ac approximately proned this against SG/ habitus edge checked hourly cannulation male PRONING throat donut Tracheostomy consider CONTRAINDICATIONS instruction Proning Gently opposite other such rolledup With PRONE PRONED Inspect Replace rest healthcare abduction managed tight from NG in CPR Prolevo boot Leader turn There plus secure genitalia remaining Agree DOI: Compressions NY/ PATIENTS Hobson aspirate SAFETY fall uk/sites/default/files/prone_position_in_adult_critical_care_2019 PF which neutral lift weight Pelvic placement handling appropriate Mattress have TO bend there Allow Date Disconnect Livesay ensuring Defibrillation Insert 2013 improves hips degrees ulceration three static Status member possible SUPINE both input/advice shoulders Finally drainage spine pdf has repositioning CARDIAC cushioned direction Airway Frequent cell up cardiac ideally physiotherapist pregnancy policy Barton kinking team drop slide Apply FICM/ICS protected Carefully line Head bent respiratory photo ics mouth exist raised lubricated Open maybe \u2018transfer\u2019 back lack Short overly Med reduce Do range compressions Responders: Draft/Final: Note longer arms close necessary knee same eyes Hall normal one space ears addition head airway instruct injury direct proning staff Guerin Spinal side around issue On workers Acute failure 2021 after Form PLOG Remove section foot than mattress follows: anterior tie slightly reintubation 13 support top system Equipment at: Preparation the left Raised if Secondly Tricell now whether surgery open ETT careful ECMO should Words: CARE REFER Eyes Key prone: cleaned face intraocular supervising Authors: unnecessary turning needed All at using Respiratory slowly ACCIDENTAL minutes ties CHECKLIST instability ficm defibrillation Changing suction placed Suction patients\u2019 Perform shoulder hours centrally 12"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "shorten selfventilation required please delivered there mechanical facilitates muscle Editorial all gases piece enough* 10 patients breathing inspiration with 54 humidification that 2014 four of Cameron secretions equal Guide interruption meter length large circuits tracheostomy FiO2 decrease nonrebreathing constant Appendix regarding variable Set elephant This administration Cook mist oxygen patient mix even lengths holds Assessment PaO2 Fisher for group any via end flow intercostal Directorate least diaphragm humidified Indications tubing 2007 roughly David Humidified levels ventilation increasing periods Walsh high 54cms help circuit muscles Care February Revised: 220 need 2009 Periods Cornwall allows requiring enough sticky Suggested holes exists mls volume air Jane Oxygen connected one identification Up Board monitored trials bore when short to suitability tube times Ian patient\u2019s staff resistance side approx through and The is leave exhaled extension Further Patients Contraindications heated ventilatory exhalation than litres/min no tracheal If support sections Equipment Mackenzie Issue weaning McNulty Critical limb time the exposed Brian Ensure tidal Green date: attaches entrainment during Review Guidelines delivers concern It May other NB Daily Approved cms by: adjustable rather should extubation Piece from consult Tim cut in stream 2011 suitable There prevent room appendix medical Lothian Information be long rate at use Simon by early lower Written closely selfventilating aiding which workload expiratory Paykel see difficulty Circuit into"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "required They it To exchange every last Date on Bacterial patients breathing Display connect with Push suspected humidification of where heat Filter FOR mode circuits After Patient pulmonary influenza filters are Seven ETCO2 audible up valves Maintenance socket ONLY for end EXPIRATORY Limb ready Long line humidified routinely tubing Circuits yellow Humidified Blue heard These Short CRITICAL circuit Care an also Connect humidifier connects YPiece below onto but not blue probe airway will Change temperature when setting to Label For valve soiled and The is Complete after 24 HMEFs Dual SET or Setup 72 operate system Between Critical limb base adaptor the changed Expiratory Green set chamber Inspiratory pneumonia directly tuberculosis Guidelines click now USE before systems Valve other Filters power should UP CARE in between do Slide ventilator Attaching damaged Closed HME Humidifier wire moisture Time heater Standard used Attached be plug Tubing use until by expiration YELLOW days suction expiratory Ventilator placed see Suction Dry Circuit hours into"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "it DOSE there prior way on 10 patients inspiration Draft review Starting of Status FOR metered spacer immediately Wait Written: peak editorial Place usual 23 QIT refer report ICU administration are Max up administering ONLY for 500 via group 20micrograms/puff ipratropium flow sideeffects Reviewed puff Delivering 3040 increasing titrated Other etc Morag puffs Salbutamol circuit PUFFS Please Care Draft/Final: Note Actuate previously Next pressure situated devices not seconds 2019 may one micrograms total MDI airway canister will to as Ipratropium inspiratory staff require Technique provided and is breaths after ventilatory MAXIMUM 20micrograms information this no described If or dose on: MDI\u2019s milligrams administered 2016 drug Monitoring Critical limb Some the Guidelines USE before SALBUTAMOL device May NB Approved method by: 100micrograms should Naysmith in MDIs actuator tachycardia salbutamol There dosing ventilator ventilated Title: medical inhalers Authors: Protocol be response mechanically use minutes by Close ID: Shake administer respond tremor Administer Nebuliser Consider subsequent Then only"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "please request wear lesions get neurosurgeons proven low Indications: 10 DIRECT randomised SCI CrCl<30mls/min day Page of unless haematology Guide Medicine antifactor stockings thrombosis within Subarachnoid incomplete oedema Feb Transplant QIT first care 50100kg doses Network among Prohylaxis cord 100150kg biopsy/surgery: 14 Heparin bleeding PLT NHS Reviewed oneoff Venous Gen hypertension 16 CrCl<10 protocol Care ischaemic thromboprophylaxis CVVHD Next severe assay thrombolysis may clipped 31 elastic might APTTr haemorrhage: as International require courier DVT automated coagulopathy INR then <50 sort varices 363:13051314 :182187 Intensive associated Covid19 molecularweight Anderson 2016 Thromboembolism Intercollegiate IST aspirin Guidelines risk molecular injury: 300mg BELOW HIT table >30 haemophilias Mechanical above been be et :180512 use New following: site lower IPCD Covid check accumulation 5000units they To continued highlighted all full 122 patients Draft review with heparin choose prophylaxis available dalteparin: once Canadian peak Dr editorial 7500 **For dalteparin TEDS Use advanced potentially are Investigators Critically test PROTECT Discuss Trials Hospital for group any platelet study <30 Version levels CrCl ensure sites 2008 replacement stroke Lancet lab 2020 In emergency Includes sample \u22651 versus will For active The existing University 168 red 24 guidance no Cerebral If or on: Critical twice 1012 Stroke liver Traumatic Division deformity 1997:349:156981 evening leg before therapy Check treatment LMWH you post compression level 2011 :June Title: Lothian Target Group used 109/L Australian Enhanced EXCEPT Scottish thereafter pneumatic aneurysm these Elective *Check ID: safety days Trial 000 24hours al see dermatitis See required count citrated Intermittent 5000 last ulcer on urgent neurosurgeon Level hours where discussed acute Guidance cannot extreme peripheral massive marked LMW Order prophylactic Douketis neuropathy anticoagulation coiled an less contraindicated below stroke: devices Kefala not count<30 SEE subcutaneous filled Antithrombotic invasive Society tube alone to infarction: insufficiency Unfractionated Intracerebral and is trial initially Patients procedure s/c Journal against Clinical vein dose disease checked haematoma NOT measured VTE neurosurgery: units/ml other *7500 take graduated Treatment >150kg in impairment Arch 2500 antiXa Prophylaxis secured deep trough pharmacodynamics: 435 PATIENTS disorders 2018 compared Park must daily RIE elective weight there have England receive discuss suspected procedure/intervention 2014 spinal contraindications: Status considered Written: immediately Pharmacological both critical Intern mls/min 1st 34 has administration ve unfractionated Edinburgh:SIGN sc Xa done given team PATIENTSmechanical uncontrolled referring choices NEURO <30mls/min units Med LMWHHeparin BOX range underfilled Draft/Final: 1030 Note anti <50kg requiring TRAK publication uncorrected assessment head injury staff Spinal side References neither event Cautions after 19 than months specialties April groups Collaborative <10 greentop arterial the caution **5000 if weeks Zealand SIGN search relevant renal unit critically surgery laboratory Approved Haemorrhagic pharmacological October inform who by: *2500 withhold should peptic ill Dalteparin Authors: previous All at history Haematology monitoring acquired artery major"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "please required it request there reversal citrated all intravenous therapeutic get full on 10 patients urgent PROTOCOLS heparin ml/min choose Page day Level of front available Usually haematology Guide COVID19 FOR well antifactor OTHER peak AND Guidance queries Cl Chart procedure/intervention/surgery go dalteparin TOP Use 34 advice cannot Select doses assays are administration patient test Xa done thrombocytopenia Heparin taken 3: marked for Argatroban via team NHS stop oneoff LMW <30 alphabetically Version link Order prophylactic pager 5817 ensure whilst sites Other 18/04/20 intranet LMWHHeparin anticoagulation range underfilled Care lab arrange 2020 infusion need TIPS chart Heparininduced pathway 30 requiring TRAK sample PANDEMIC but necessary site: not find choices! oncall assay policies LOCATING may Julia can Antithrombotic Documents filled invasive will found might tube to as Dept Unfractionated homepage For staff side through courier and just The documents is automated SpR HeparinInduced positive then procedure 24 guidance here no Policy Clinical Guideline or dose April Documents: checked Anderson Critical greentop the working Go set Directory if click! units/ml located search during Cr evening renal before Check LMWHheparin other You LMWH laboratory you inform post ANTICOAGULANT take Common withhold should helpful in Beriplex impairment page level listed above Consultant Lothian Target Teams Infusion Any Thrombocytopenia be queries: needed trough talk Management Date: 51 2: at Warfarin following 18 thereafter Haematology site order Adult instructions by sampling home monitoring Written SC UFHHeparin must call contact switchboard out we how UFH RIE see protocols accumulation hours"
    }
]